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Abstract 
THE UNIVERSITY OF MANCHESTER 
 
Submitted by Stephen Beesley for the degree of Doctor of Philosophy and entitled: 
Circadian Clocks, glucocorticoids and the gated inflammatory response, September 
2010. 
 
In mammals endogenous, self sustained oscillators, known as circadian clocks, have 
evolved as a result of day night cycles, with a period close to 24 hours, and are involved in 
many physiological processes; such as sleep wake cycles, metabolic and hormonal activity.  
The suprachiasmatic nucleus (SCN), is the central oscillator, and is synchronised to the 
external environment by light, via the eye.  It has been demonstrated that peripheral clocks, 
too, contain the circadian oscillator, with tissues such as the lung, liver, heart and kidney as 
well as many isolated cell types remaining rhythmic, in culture, for many days.  However, 
these peripheral oscillators require a signal from the central oscillator in order to co-
ordinate a synchronised time.  Leading candidates in the relay of this information are the 
circulating glucocorticoid hormones corticosterone (rodents) or cortisol (man), which are 
known to have potent effects on the peripheral clock, both in-vivo and in-vitro.  Further to 
this, glucocorticoids have been used for many decades to suppress the symptoms of 
inflammation, a by product of many human diseases. 
 
This thesis aims to address the temporal regulation of the peripheral clock by the 
endogenous glucocorticoid, corticosterone, using a transgenic mouse harbouring a 
luciferase conjugated clock reporter, and circadian reporter cell lines.  It also aims to 
address the relative contribution of the two closely related nuclear hormone receptors, the 
glucocorticoid and mineralocorticoid receptors.  A further aim of the work with 
glucocorticoid signalling was to design a flow-though culture system, in order to address 
the effects of the endogenous pulsatile release of glucocorticoids on the peripheral 
oscillator.  This thesis also aims to characterise the inflammatory response in relation to its 
circadian characteristics; its relationship with corticosterone and the effect of inflammation 
on the central clock components.  Finally, this thesis aims to investigate a potential 
input/output of the clock, a member of the family of C/EBP transcription factors, C/EBP 
alpha, and whether it is under endogenous circadian control and regulated by 
glucocorticoids. 
 
Work in this thesis has shown that glucocorticoids dynamically regulate the peripheral 
clock at all phases of the circadian cycle and that this regulation occurs mainly through the 
glucocorticoid receptor; yet the mineralocorticoid receptor does have a function in the 
immediate response to glucocorticoid administration.  Furthermore, as a result of the initial 
temporal profile after corticosterone addition, on the clock protein PERIOD2, I have 
shown transient regulation of the clock through Caveolin-1 based signalling.  There is also 
a significant circadian component to the inflammatory response, which appears, at least in 
part, to be REV-ERB alpha mediated, and the inflammatory response also has profound 
effects on circadian gene expression in the periphery.  A functional flow-through system 
was designed and a working model produced, albeit with technical difficulties, to address 
glucocorticoid pulsing and circadian timing but much more work is needed for effects to be 
fully understood. C/EBP alpha appears not to be under circadian regulation nor under 
direct glucocorticoid regulation, at least in peripheral models used here. 
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~   approximate 
-/-   knock out 
+ve   positive 
-ve   negative 
α   alpha 
AA-NAT   arylalkylamine-N-acetyltransferase  
act D   actinomycin D 
ACTH   adrenocorticotropic hormone  
AMP   adenosine monophosphate 
Amp   ampicillin 
AR               androgen receptor 
AP-1   activator protein-1 
ARNT   aryl hydrocarbon receptor nuclear translocator 
ATP   adenosine 5’ triphosphate 
AVP   arginine vasopressin 
β   beta 
BAT   brown adipose tissue 
BCA   bicinchoninic acid assay 
bHLH   basic helix loop helix 
BMAL                         brain and muscle ARNT- like 
bp   base pair 
BSA   bovine serum albumin 
bZIP   basic leucine zipper 
c-Fos   immediate early gene 
c-Jun   immediate early gene 
CAMKII  calmodulin kinase II 
cAMP   cyclic adenosine monophosphate 
casein kinase 1  CK1 
cav-1   caveolin-1 
CCL2/MCP1 (JE) monocyte chemoattractant protein 1 
cDNA   complementary deoxyribonucleic acid 
C/EBP   CCAAT/enhancer binding protein 
cGMP   cyclic guanosine monophosphate 
CHX   cycloheximide 
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CKII   casein kinase II 
CLOCK  circadian locomotor output cycles kaput 
con   control 
COPD   chronic obstructive pulmonary disease 
CORT   corticosterone 
CRBP1  cellular retinal binding protein 1 
CRE   cAMP response element 
CREB   cAMP response element binding protein 
CRH   corticotropic releasing hormone 
CRY   cryptochrome 
CT   circadian time 
Ct   cycle threshold 
CXCL1  KC 
δ   delta 
DAB 3-3’  diaminobenzidine 
DAPI   4',6-diamidino-2-phenylindole 
DBD   DNA binding domain 
DBP   albumin-D-site binding protein 
DD   12hr dark: 12hr dark (constant darkness) 
DEX   dexamethasone 
DMH   dorsalmedial nucleus of the hypothalamus 
DMSO   dimethylsulphoxide 
DNA     deoxyribonucleic acid 
dNTP   deoxynucleotide triphosphate 
D. melanogaster Drosophila melanogaster 
ε   epsilon 
Ec50   half maximal effective concentration 
ECL   enhanced chemiluminescence 
EDTA   ethylenediaminetetraacetic acid 
EGTA   ethylene glycol tetraacetic acid 
ELISA   enzyme linked immunosorbant assay 
EMS   ethyl methane sulphonate 
ENU   N-ethyl-N-nitrosurea 
ER   estrogen receptor 
ERRβ   estrogen related receptor β 
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F1   forward primer 
FACS   fluorescence activated cell sorting 
FAM                        6-carboxyfluorescein 
fASPS   Familial advanced sleep phase syndrome 
FBS   fetal bovine serum 
FEO   food entrainable oscillator 
FRQ   Frequency 
GABA   γ- aminobutyric acid 
GAPDH  glyceraldehyde phosphate dehydrogenase 
Gc(s)   glucocorticoid(s) 
GCNF   germ cell nuclear factor 
GFP   green fluorescent protein 
GI tract  gastro-intestinal tract 
GR   glucocorticoid receptor 
GRE   glucocorticoid response element 
GSK3β  glycogen synthase kinase 3β 
h   hour 
HAT   histone acetyl transferase 
HBSS    Hanks’ balanced buffer solution 
H and E  hematoxylin and eosin 
HEK293  human embryonic kidney cells 293 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HDAC   histone deacetylase 
HIOMT  hydroxyindole-O-methyltransferase 
HPA   hypothalamic pituitary adrenal axis 
HRP   horseradish peroxidase 
11-β HSD  11-β hydroxysteroid dehydeogenase 
HSP   heat shock protein 
Hyg+   hygromycin (+ = hyg positive) 
IgG   immunoglobulin G 
IFNγ   interferon gamma 
IL (6)   interleukin (6) 
IMS   industrial methylated spirit 
Inhib   inhibitor 
IL-(6)   interleukin-(6)   
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i.p.   intraperitoneal (injection) 
LD   12h light: 12h dark (light: dark cycle) 
LPA   linear polyacrylamide 
kbp   kilo base pair 
KC   keratinocyte chemoattractant or keratinocyte-derived chemokine 
Kd   dissociation constant 
KO   knock out 
LB   Luria-Bertani broth 
LB Amp  Luria-Bertani broth with ampicillin 
LBD   ligand binding domain 
LD   12hr light: 12hr dark 
LDL   low density lipoprotein 
LPS   lipopolysaccharide 
MAPK   mitogen-activated protein kinase 
MEFS   mouse embryonic fibroblasts 
methyl   methylcyclodextrin  
mGR   membrane GR  
mins   minutes 
MMTV  mouse mammary tumour virus 
MR   mineralocorticoid receptor 
mRNA   messenger ribonucleic acid 
mut   mutant 
NcoR1   nuclear co-repressor 1 
N. Crassa  Neurospora crassa 
NFκB   nuclear factor kappa b 
nGRE   negative glucocorticoid response element 
NLD   nuclear localisation domain 
norpA   gene encoding phospholipase C in D.Melanogaster 
NP-40   nonident P-40 
NPAS   Neuronal PAS domain protein 2  
OX   over expressed 
PACAP  pituitary adenylate cyclase-activating peptide 
PAI-1   plasminogen activator inhibitor 1 
PAS   per ARNT single minded 
PBS   phosphate buffered saline 
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PBST   phosphate buffered saline with Tween-20 
PCR   polymerase chain reaction 
PE   phycoerythrin 
PEC   peritoneal exudate cells 
PER   PERIOD 
PER2::luc  PERIOD2 luciferase 
PPAR α   peroxisome proliferator-activated receptor α 
PFA   paraformaldehyde 
P   phosphorylated 
PI3K   phosphatidylinositol 3-kinase 
PKC   protein kinase C 
PLC   phospholipase C 
PMA   phorbol 12-myristate 13-acetate 
PMSF   phenylmethylsulfonyl fluoride 
PMT   photo multiplier tube 
PRC   phase response curve 
PVN   paraventricular nucleus 
R1   reverse primer 
Rat-1   Rat-1-R12 cell line  
RARα   retinoic acid receptor α 
RBC   red blood cells   
RLU   relative luciferase units 
RGC   retinal ganglion cells 
RHT   retino-hypothalamic tract 
RNA   ribonucleic acid 
ROR   retinoic acid receptor (RAR)-related orphan receptor 
RORE retinoic acid receptor (RAR)-related orphan receptor binding 
element 
RPM   revolutions per minute 
RT   room temperature 
RU   RU486 
sal   saline 
SCN   suprachiasmatic nucleus 
SDS   sodium dodecyl sulphate 
SDS PAGE  sodium dodecyl sulphate poly acrylamide gel electrophoresis 
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sec   seconds 
Ser   Serine 
Sim   single minded protein 
siRNA   small inhibitory ribonucleic acid 
SPE   steptavidin phycoerythrin 
spir   spironolactone 
t1/2   half life 
T25/75/225  tissue culture flasks (number represents the surface area, cm2) 
TAMRA  tetramethylrhodamine 
TBS   tris buffered saline 
TBST   tris buffered saline with Tween-20 
TF   transcription factor 
THα   thyroid hormone α 
Thr   threonine 
TIM   timeless 
TIM2   timeout 
Tm   melting temperature 
TNFα   tumour necrosis factor alpha 
TPA   12-O-tetradecanoyl-phorbol-13-acetate 
TR4   testicular receptor 4 
UCP-1   uncoupling protein-1 
V   volts 
VIP   vasoactive intestinal polypeptide 
VNTR   variable number of tandem repeats 
WAT   white adipose tissue 
WT   wild type 
Zeitgeber  German for ‘time giver’ 
ZF   zona fasciculata 
ZG   zona glomerulosa 
ZR   zona reticularis 
ZT   zeitgeber time 
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A poem that sits on my Gran’s kitchen wall, by Robert H Smith: 
 
The Clock of Life  
 
The clock of life is wound but once 
And no man has the power 
To tell just where the hands will stop, 
At late or early hour. 
 
To lose one's wealth is sad indeed, 
To lose one's health is more. 
To lose one's soul is such a loss 
As no man can restore. 
 
The present only is our own. 
Live, love, toil with a will. 
Place no faith in 'tomorrow' 
For the clock may then be still. 
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1.1 Overview 
The circadian clock exists in virtually all forms of life, from humans and the mammalian 
system to the relatively simple prokaryotic system.  This high conservation, throughout 
evolution, suggests that the clock is of critical importance for the survival of the organism 
and subsequently the species.  In the last 20 years a great deal of progress has been made in 
defining the roles of individual genes and proteins within the molecular clock. There has 
also been a steady progression in technology to allow the wider use of transgenic animals, 
allowing for rapid advances in the discovery of clock gene function.  This introduction 
aims to provide a brief synopsis of the circadian system, addressing the discovery and 
circuitry of the clock, and subsequent interactions.  It will provide an introduction into the 
regulation of the core oscillator and discuss input and output pathways, such as the 
inflammatory response.  It will also address the known regulation of the central oscillator 
by glucocorticoids (Gcs), and their profound effect on the clock, which provides a running 
theme throughout this work. 
1.2 The Circadian Clockwork 
1.2.1 What Are Circadian Clocks? 
 
It has long been reported that living organisms have a daily cycle or oscillation, with one 
of the earliest reports credited to Alexander the Great, in the fourth century B.C. (Fu and 
Lee 2003).  In more recent times John Wren described, in his Herbal Treatise of 1662, the 
daily flows of the four humours; blood, phlegm, cholic and melancholy.  This treatise 
described the fluids, which were thought to be the basis of life, and at which times of the 
day they were most influential (Hastings et al. 2003).  Even though we now know that 
these ‘humours’ were not the full story, Wren was thinking along the correct lines; that 
rhythmic cycles do control our bodies and play a vital role within them. Furthermore, the 
French astronomer Jean-Jaques d’Ortous de Marian observed, in the late 1720’s, that the 
leaves of his Mimosa plants moved on a daily basis (Schibler 2006).  To investigate 
matters he set about answering the question, ‘Is this movement based on environmental 
cues such as light or on something within?’  The answer came when he placed the plants 
into constant darkness and discovered that the movement persisted, and this perhaps was 
the first experimental demonstration of an endogenous clock.  
 
Daily oscillatory cycles are referred to as circadian rhythms coming from the Latin circa 
(about) dies (a day), and thus have a period of about 24 hours.  These rhythms refer to a 
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great variety of processes across the kingdoms; such as glucose and lipid metabolism, cell 
cycle control and division and sleep-wake cycles (Gallego et al. 2006).  Circadian rhythms 
are thought to have evolved in response to the earth’s rotation about its axis, forming night 
and day, and the orbit around the sun (Paranjpe and Sharma 2005).  The earth’s rotation is 
predictable, as are the environmental changes which accompany it, most notably the 
changing of the seasons.  Therefore, it is reasonable to assume that over the course of 
geological time, organisms have evolved to read the environmental cues (Paranjpe and 
Sharma 2005).  Circadian clocks are thought to  enhance the organisms ability to survive 
under the changing environment with the ability to anticipate the availability of food, light 
and mating partners (Paranjpe and Sharma 2005), and, perhaps more importantly, the 
presence of potential predators.  Circadian clocks are also thought to influence core body 
temperature, mood, cortisol (man) or corticosterone (CORT, rodent), melatonin release and 
performance.  It is, therefore, to the organisms advantage that it evolves a method of time 
keeping (a circadian clock or clocks) in order to synchronise itself with the external 
environment; and organisms that do not, will be filtered out of the gene pool (Hastings 
2003).  It is also interesting to point out that circadian rhythms are temperature-
compensated.  This means that where most chemical reactions double in rate of reaction 
(speed up) for ever 10oC increase (referred to as a Q10 = 2), circadian oscillations remain 
stable over physiological range (27oC - 37oC) with a Q10 between 0.8 – 1 (Barrett and 
Takahashi 1995; Izumo et al. 2003) in order to provide the organism with a precise measure 
of time, regardless of external or internal temperature.  Studies on rat and squirrel 
suprachiasmatic nucleus (SCN, the location of the central oscillator, section 1.4), chick 
pinealocytes and hamsters have all revealed temperature compensation over a 
physiological range (Tosini and Menaker 1998).  In fact the circadian oscillator is said to 
be overcompensated, meaning that it will run faster (have a shorter period) at lower 
temperatures i.e. less than Q10= 1  (Izumo et al. 2003).   
1.3 The Molecular Clock  
1.3.1 Classical Circuitry of the Oscillator 
 
The molecular clock is made up of a number of core genes and their respective protein 
products, defined as, ‘genes whose protein products are necessary for the generation and 
regulation of circadian rhythms’ (Lowrey and Takahashi 2004).  This is brought about 
through the positive and negative regulation of genes and their protein products, with an 
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oscillating period of about 24 hours, (Ko and Takahashi 2006).  The clock comprises of 
both a positive and negative arm, which act to induce and repress transcription respectively 
(Fig 1.1).  The positive loop of the clock comprises Brain and Muscle ARNT-Like protein 
(BMAL1) and Circadian Locomotor Output Cycles Kaput (CLOCK).  These two are 
members of the basic helix loop helix (bHLH) family of transcription factors (TFs), which 
dimerise via their Per ARNT Single-minded (PAS) domains (Gachon et al. 2004b).  The 
BMAL1:CLOCK heterodimer binds to the nucleotide E-box sequence (CANNTG, where 
N stands for any base) in the promoter regions of Cryptochrome (Cry1-2) and Period 
(Per1-3) (Ko and Takahashi 2006) and activates their transcription.  The protein products 
of Per and Cry form the negative arm of the clock and the heteromeric complex of PER1-
2/CRY1-2 (Gachon et al. 2004b), which interacts with the kinases Casein kinase 1 epsilon 
and delta (CK1ε/δ) (Gallego and Virshup 2007), F-box proteins (Godinho et al. 2007), and 
histone deacetylases (Naruse et al. 2004).  After a delay of several hours the PER:CRY 
complex will translocate back to the nucleus to repress their own transcription through the 
inhibition the CLOCK:BMAL1 heterodimer (Lowrey and Takahashi 2004; Reppert and 
Weaver 2002).  As a consequence Per and Cry mRNA levels fall, followed by their protein 
products, until their nuclear concentration is no longer high enough so sustain repression; a 
new cycle then begins.  
 
NR1D1 is the ‘orphan’ nuclear receptor known as REV-ERBα, which along with RORα 
adds a further dimension to the clockwork linking both the positive and negative arms 
(Preitner et al. 2002).  Heme was recently found to be the natural ligand, and acts to 
enhance the thermal stability of REV-ERBα and increases its recruitment of the nuclear 
receptor co-repressor (NCoR1) (Raghuram et al. 2007; Yin et al. 2007), which then 
increases the repressive activity of REV-ERBα.  The CLOCK:BMAL1 heterodimer can 
activate the transcription of both nuclear receptors, Rev-erba and Rora (Preitner et al. 
2002), through their E-box elements.  REV-ERBα and RORα then functionally compete 
for the receptor element, RORE, in the promoter region of Bmal1, and to a lesser extent 
Clock, (Sato et al. 2004b).  REV-ERBα acts to repress Bmal1 transcription through binding 
to the RORE and inhibiting transcriptional protein interaction, where RORα activates 
transcription by binding to the same element and recruiting transcriptional proteins.  RORa 
binds to the deoxyribonucleic acid (DNA) element at all times and is removed by 
competitive REV-ERBα binding (Akashi and Takumi 2005).  Rev-erbα transcription is 
eventually repressed by itself and the PER:CRY heterodimer complex (Adelmant et al. 
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P 
P 
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Cry 
Per 
Rora 
Rev-erba 
Bmal1 
1996; Triqueneaux et al. 2004).  To enhance its activity REV-ERBα can recruit the co-
repressor, NCoR1, which binds to REV-ERBα via its co-repressor interaction region, 
discovered through yeast-2-hybrid screens (Burke et al. 1998).  The full cycle (Fig 1.1) 
takes about 24 hours to complete, and is achieved through the described feedback loop; 
posttranslational modifications, (such as phosphorylation and ubiquitination) and 
controlled degradation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Diagram of the molecular clock:  This diagram depicts a brief, simplistic 
overview of the circadian transcription/translational feedback loop.  The dashed back 
arrows represent nucleus to cytoplasm translocation.  The dashed grey arrows represent 
translation from mRNA to protein.  The thick black arrows represent activation with the 
black bars showing repression.  The thin black arrow shows phosphorylation events (P). 
1.4 The Central Oscillator: the SCN 
 
The central oscillator in the mammalian brain is a small paired bi-lateral structure called 
the SCN, which sits below the third ventricle and above the optic chiasm in the anterior 
hypothalamus (Fig 1.2).  Each SCN nuclei consists of 8,000 to 10,000 neurons supported 
by glial cells, in the ratio of approximately  3 neurons to 1 glial, as seen in the rat (Guldner 
1983).  The SCN, as the central circadian oscillator, was discovered through ablation 
experiments carried out in the early 1970’s (Moore and Eichler 1972).  Surgical lesions in 
the rodent SCN rendered the animal arrhythmic, as seen through wheel running 
experiments.  Interestingly though, the rhythms could be restored by the transplant of 
foetal SCN back into the lesioned animal.  In this case the rhythm was determined by the 
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rhythm of the implanted SCN and not the recipient (Ralph et al. 1990; Silver et al. 1996) as 
was seen when a short period mutant SCN was implanted into a wild type host.  These 
ground breaking demonstrations showed that the SCN was indeed the site of the master 
clock, and consequently the small structure has been well studied over the past few 
decades.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2:  The location of the suprachiasmatic nucleus in the mammalian brain. 
(http://psyche.knu.ac.kr/notebook/images/c17fi16.jpg). 
 
The mammalian SCN is composed of two distinct sub regions, both functionally and 
anatomically, termed the ventrolateral and dorsomedial regions, (Fig 1.3).  The 
ventrolateral region receives information from the retino-hypothalamic tract (RHT) 
originating in the retina.  This induces Per1 via the MAPK pathway and occurs mainly in 
the ventrolateral SCN, which also contains the greatest density of retinal fibres (Hamada et 
al. 2001).  However, using a Per1::luciferase transcriptional reporter assay, in cultured 
SCN brain slices, Nakamura et al. (2005) showed cellular desynchronisation within the 
SCN itself.  Using this reporter, they showed that Per1 was first transcribed in the 
dorsomedial region with Per1 transcription in the ventrolateral region peaking about 1 hour 
later (Nakamura et al. 2005).  This goes a little way to understanding how complex these 
structures are, as they are not one synchronised population of cells but are divided into sub 
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Dorsomedial SCN 
Ventrolateral 
SCN 
Core 
Optic Chiasm (OX) 
Third ventrical 
regions showing independence from each other, in terms of the molecular interactions and 
transcriptional events. 
 
In addition to the SCN as the central oscillator other self-autonomous oscillators have been 
discovered, in the central nervous system, such as those in the retina and olfactory bulb.  
Semi-autonomous oscillators have been identified too, in brain regions such as the 
amygdale and bed nucleus of the stria terminalis (Guilding and Piggins 2007).  In these 
semi-autonomous structures individual cells can oscillate, but are unable to maintain tissue 
synchronicity without input from the central oscillator, namely the SCN. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Representation of one of the paired SCN nuclei showing the three 
functionally separate regions.  Suprachiasmatic nucleus (SCN).  Reproduced from 
(Hirota and Fukada 2004). 
 
1.5 Entrainment of the circadian clock  
1.5.1 Overview 
 
It is generally regarded that there are three properties that define a circadian rhythm: 
persisting free-running rhythms (in constant conditions), entrainment and temperature 
compensation (Pittendrigh 1960).  In the following I will deal mainly with entrainment, but 
will touch on temperature compensation when reviewing temperature as a zeitgeber in its 
own right.  Persistent free-running rhythms will not be discussed here. 
 
The work in this thesis will focus on the ability of the endogenous Gc, CORT, to re-set the 
peripheral clock.  However, circadian entrainment by Gcs is just one method, and although 
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a very potent zeitgeber there remain many more forms of entrainment.  Circadian 
entrainment itself can be categorised into two basic groups: photic and non-photic, where 
photic entrainment is concerned with the circadian influence of light on the organism and 
non-photic entrainment concerns everything else: food, exercise, temperature, and 
chemical stimuli (Challet 2007; Mendoza 2007; Rensing and Ruoff 2002).  Essentially, all 
known zeitgebers (photic and non-photic) are able to phase shift the endogenous clock of 
the organism and re-set internal time keeping, and will be discussed in turn in the 
following. 
1.5.2 Photic entrainment 
1.5.2.1 Light exposure 
 
Biological clocks are endogenous oscillators that will persist under constant condition, for 
example, in constant darkness, with a period of about 24 hours, (Welsh et al. 1995).  In 
reality, free-running oscillations will be slightly more or less than 24 hours, but are re-
aligned with solar time via light, a process called light entrainment.  Light is a predominant 
entraining factor for circadian clocks, in most organisms. 
 
Light from the environment, such as the sun, is captured by the photopigments in the rods 
and cones in the retina but also by the photopigment melanopsin, found in a subset of 
retinal ganglion cells (RGC) (Hirota and Fukada 2004).  Melanopsin has been show to be 
indispensable, as knocking out the melanopsin gene causes the RGCs to lose intrinsic 
photosensitivity (Lucas et al. 2003), but are unchanged by other means, such as 
morphology.  On light stimulation, in the early night, the amino acid glutamate and the 
neuropeptide, pituitary adenylate cyclase-activating peptide (PACAP) are released from 
the terminal synapse of the RHT and bind to their respective receptors on the surface of the 
SCN neurons (Reppert and Weaver 2002).  This triggers a cascade of phosphorylation 
events, which includes calcium calmodulin kinase II (CaMKII), MAPK, and cAMP 
response element binding protein (CREB).  The phosphorylated CREB, a transcription 
factor, then binds to the cAMP response element (CRE) in the Per1 promoter leading to 
chromatin remodelling, resulting in the up regulation of Per1 transcription (Albrecht et al. 
1997).  It is also known that CaMKII can act on the Per2 promoter, while an alternative 
pathway promotes the transcription/translation of Bmal1, so that the protein product may 
dimerise with CLOCK and induce Per1 and 2 transcription.  There are several other genes 
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activated by this series of events called intermediate early genes such as cFos and cJun, 
stimulated in response to entry into the cell cycle.  The light activation of the Per genes 
only occurs at night and is most likely to play an important role in the phase resetting of 
the clock (Hirota and Fukada 2004), as the SCN only responds to light during the 
subjective night (Takahashi et al. 1984) .  Upon a light pulse at the end of the night a 
different pathway is activated.  Nitric oxide and cyclic guanosine monophosphate (cGMP) 
are activated and with the phosphorylation of CREB this activates Per1 only (Fu and Lee 
2003).  This appears to be the major molecular difference between the observed clock 
delay, in response to a light pulse in the early night, and a clock advance, in response to a 
pulse in the late night.   
 
The ability of light to phase shift the SCN (as measured by behavioural activity cycles) is 
time of day dependent and occurs during the subjective night (under DD) in both nocturnal 
(Takahashi et al. 1984) and diurnal animals (Caldelas et al. 2003).  Furthermore, there is 
often an unresponsive ‘dead-zone’ (Daan S 1976; Takahashi et al. 1984) during the 
subjective day where light has no phase shifting effects, but this is not always  the case, as 
work in humans has failed to reveal any form of ‘dead-zone’ (Khalsa et al. 2003). During 
the light responsive window in the SCN, very similar biochemical events occur in both 
nocturnal and diurnal animals.  A light pulse, at night, will induce cFos expression in the 
SCN both nocturnal and diurnal animals (Kornhauser et al. 1990; Schumann et al. 2006) as 
well as Per1 and Per2 transcript and protein expression (Caldelas et al. 2003; Shigeyoshi 
et al. 1997; Yan and Silver 2004).  The light pulse will only induce cFos during the light 
responsive window and as a result is itself under circadian regulation (Kornhauser et al., 
1990).  It is possible that individual species are responding to tonic levels of light intensity, 
as diurnal species are subject to far greater levels of light than nocturnal species (first 
hypothesised by Jurgen Aschoff) (Daan 2000).  Recent work on the diurnal ground squirrel 
(Spermophilus citellus) has added to this hypothesis, as it becomes active more than 3h 
after civil twilight (the point before sunrise where there is just enough light to clearly 
distinguish objects and define the horizon) and becomes inactive 2-3h before civil twilight 
at dusk (Hut et al. 1999).  This suggests that it is not just light that is required but a specific 
intensity, to induce a response.   
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1.5.2.2 Dark exposure 
 
The re-setting effects of a light pulse in constant darkness (DD) (described above) have 
been extensively studied and reviewed in both nocturnal and diurnal mammalian species, 
but relatively few studies have focused on the reverse effect; a dark pulse in constant light 
(LL).  This paradigm can also re-set the clock with phase advances in the subjective day 
and early night and delays in the subjective night and early day (Canal and Piggins 2006; 
Dwyer and Rosenwasser 2000).  Interestingly, these dark pulse effects have two features; 
they induce both anti-photic and non-photic re-setting.  In terms of anti-photic re-setting a 
dark pulse will induce phase advances during the subjective day and delays during the 
subjective night (opposite to light responses) as seen in the hamster (Boulos 1982), and 
therefore opposite to that of light pulse induction.  Non-photic, dark pulse induction is said 
to occur when a prolonged dark pulse causes increased activity of the nocturnal species, 
and this increased activity contributes to the phase re-setting effects (Reebs et al. 1989).  
Studies between nocturnal and diurnal species have shown that, unlike light pulses where 
the effects are the same between the two sets of species, with regard dark pulses, re-setting 
occurs primarily during the rest period regardless of the active period of the animal, and 
therefore the re-setting effects between dark and light in nocturnal and diurnal species are 
different (Mendoza et al. 2007). 
1.5.3 Non-photic entrainment  
 
Non-photic entrainment can take many forms (chemical stimuli, scheduled exercise, 
scheduled feeding and temperature) which can be classified into two categories, arousal 
dependent and independent timing cues (Challet 2007).  In terms of chemical stimuli 
melatonin, serotonin and GABA are three of the main zeitgebers which can effectively 
entrain the animal to a circadian rhythm.   
1.5.3.1 Melatonin 
 
Melatonin is produced and secreted at night by the pineal gland, in both nocturnal and 
diurnal animals (Slotten et al. 2002), from its pre-cursor amino acid L-tryptophan and the 
two rate limiting enzymes arylalkylamine-N-acetyltransferase (AA-NAT) and 
hydroxyindole-O-methyltransferase (HIOMT) (Simonneaux et al. 2003a).  However, more 
recent studies have shown that melatonin is also synthesised and secreted into the gastro-
intestinal tract (GI tract), and that pinealectomy although results in the loss of a day/night 
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melatonin rhythm, levels are still present in the blood due to its production in the GI tract 
(Konturek et al. 2007).  Melatonin is secreted independently of activity patterns and is thus 
considered an arousal independent timing cue (Simonneaux et al. 2003b; Vivanco et al. 
2007).  The SCN controls pineal synthesis of melatonin, and as the SCN itself expresses a 
high number of high affinity melatonin receptors, it is viewed that melatonin provides a 
feedback loop on the SCN (Pevet et al. 2006).  It has been shown that melatonin can phase 
advance the behavioural rhythm of mice when injected at the onset of the subjective night.  
Furthermore, a daily infusion of melatonin, at the onset of subjective night, has been 
shown also to entrain rats (Baggs et al. 2009; Benloucif 1996).  It also appears that the 
effects of melatonin are independent of the animal being nocturnal or diurnal, as the phase 
shifting effects of melatonin are observed at the same time of day in the diurnal rodent 
(Slotten et al. 2002).  The major difference between the effects of melatonin and light is 
seen at the molecular level.  As discussed above, light induces Per1 and Per2 transcript 
and protein expression in the subjective night, yet melatonin does not do this.  However, it 
has been shown that melatonin can phase advance Rev-erbα mRNA (a repressor) and 
induce prolonged expression of Rorβ mRNA (an activator), as seen in the rat SCN (Agez et 
al. 2007). 
1.5.3.2 Serotonin  
 
Serotonin, also known as 5-hydroxytryptamine, is a neurotransmitter important in circadian 
entrainment.  The SCN and the intergeniculate leaflet (which have direct neuronal 
projections to each other) receive neuronal projections from the raphe nuclei, which 
transmit the serotonin signal (Meyer-Bernstein and Morin 1996).  Activation of neurons by 
serotonin is regarded as arousal-dependent (unlike melatonin above), as activation of 
serotonin neurons has been shown to correlate well with behavioural responses (Jacobs et 
al. 1990).  The expression levels of serotonin, in the SCN, are in phase with the activity 
pattern of the animal, shown in both nocturnal and diurnal rats (Cuesta et al. 2008; Poncet 
et al. 1993).  Activation of serotonin neurons with serotonin agonist injections, either 
systemic or directly into the brain, has been shown to phase advance the activity of 
nocturnal rodents, when given during the subjective day, yet with no change seen with 
administration at other times (Bobrzynska et al. 1996; Tominaga et al. 1992).  Importantly 
these phase shifts were not as a result of increased activity, as preventing the animal 
(hamsters) from moving did not abolish the observed phase shift.  In contrast the action of 
melatonin, discussed above, serotonin agonist studies have the opposite effect in the 
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diurnal compared to the nocturnal rodent.  The diurnal animals’ sensitivity to the serotonin 
agonist is primarily during the subjective night rather than the subjective day (Cuesta et al. 
2008).  Together these data show that serotonin acts to phase shift the SCN clock during 
the animals’ rest period. 
 
Re-setting the SCN clock by means of serotonin agonists has been associated with a down 
regulation of Per1 and Per2 mRNA, as seen in the hamster, which occurs during the 
subjective day (rest period of nocturnal animals) correlating well with the phase shifting 
activity of the agonist (Horikawa et al. 2000).  Further evidence to support this idea was 
presented with the knockdown of Per1 in the hamster producing large phase shifts when 
administered during the subjective day, rather than the subjective night (Hamada et al. 
2004).  These experiments have led to the conclusion that the suppression of Per1 mRNA 
is the cause, rather than the consequence, of the phase shifting effects.  This method of 
entrainment, through the suppression of Per1 mRNA, is in direct contrast to the effects of 
both light and melatonin.  As of yet a molecular model to how diurnal animals are phase 
advanced is unknown, but data from Cuesta et al. (2008) has shown that neither Per1, 
Per2, Rev-erb α or β or Ror α or β transcripts are changed after serotonin agonist 
administration. 
1.5.3.3 γ-Aminobutyric acid (GABA), Triazolam and the methamphetamine oscillator 
 
GABA is very important neurotransmitter involved in circadian timing, and virtually all 
neurons of the SCN and the intergeniculate leaflet contain GABA neurons.  It has been 
shown to be vital in the coupling of the dorsal and ventral parts of the SCN (Fig 1.3) 
(Albus et al. 2005; Moore and Speh 1993).  The activation of GABA receptors with the 
known agonist muscimol will phase advance behavioural rhythms in nocturnal animals but 
delay diurnal animals even when administered at the same subjective time (Novak and 
Albers 2004; Smith et al. 1989).  As such, the phase shifting effects of GABA are 
independent of activity and are classed as arousal independent, like that of melatonin.  The 
phase shifting effect of GABA (as seen through agonist studies) has been associated with a 
decrease in Per1 and Per2 mRNA expression in the SCN of the nocturnal hamster, yet 
only Per2 suppression in the diurnal rat when administered during the subjective day 
(Ehlen et al. 2006; Novak et al. 2006).  Furthermore, neuropeptide Y has been shown to 
have non-photic phase re-setting effects in the SCN (Maywood et al. 2002).  Injection of 
neuropeptide Y adjacent to the SCN and transfer to darkness 7h before lights out shifted 
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the circadian activity cycle, yet a light pulse for 1h immediately after injection blocked this 
behavioural response.  Also mPer1 and mPer2 mRNA levels were suppressed 3h after 
injection but mClock mRNA and mCLOCK protein were unaltered (Maywood et al. 2002).   
 
Triazolam is a drug often used as a mild sedative to treat insomnia, but has also been 
shown to have a circadian effect too.  This short acting benzodiazepine can result in a PRC 
very similar to that of neuropeptide Y (Turek and Losee-Olson 1987), which is 
characterised by large phase advances during the subjective day and small if any delays 
during the subjective night (Albers and Ferris 1984; Smith et al. 1992).  Further work 
showed that Triazolam phase shifting was mediated through the serotonin containing 
neurons of the median, but not dorsal raphe nucleus and that this pathway was independent 
of the pathway used for the phase shifting effects of novel wheel access (Meyer-Bernstein 
and Morin 1998).    
 
Methamphetamine is a nervous system stimulant, which is similar in structure to 
amphetamine, and is regarded as a drug of abuse.  It acts to block the reuptake to 
dopamine, leading to high levels in the brain.  Dopamine is involved in reward, motivation 
and pleasure systems and as such produces a sense of euphoria when taken, therefore 
leading to its potential abuse (information taken from National institute on drug abuse 
website, http://drugabuse.gov).  However, when methamphetamine was administered to 
rats via drinking water, a phase delay in their activity rhythm was observed with respect to 
the LD cycle (Honma et al. 1986).  In some cases rats showed two distinct rhythms, one 
entrained to the LD cycle and another free-running rhythm.  Once the methamphetamine 
was removed it took 2-3 days before the stable entrained LD rhythm persisted i.e. without 
the free-running methamphetamine rhythm (Honma et al. 1986).  The changes observed in 
LD also persisted in DD, and the period of the animal was significantly shorter in the 
presence of methamphetamine compared to the period after its removal (Honma et al. 
1986).  Honma and collegues, continued with their investigations and lesioned the SCN, 
thereby abolishing the locomotor rhythm, yet with the presence of methamphetamine in the 
drinking water a locomotor rhythm appeared, which did not entrain to a LD cycle (Honma 
et al. 1987).  The activity rhythm was also dose dependent with a lower dose producing a 
shorter period.  In addition to this, the two components of the free-running period (activity 
and rest periods) were altered in a dose dependent manner.  A low dose of 
methamphetamine produced a shorter activity time and longer rest time, however when the 
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drug was administered continuously through an osmotic pump an activity pattern similar to 
that of the control SCN lesioned rats was observed i.e. arrhythmic (Honma et al. 1987).  
This suggested that the observed entrainment to methamphetamine is independent of the 
SCN and therefore leads to the idea of an SCN independent oscillator.  Despite the 
methamphetamine oscillator being know about for over 2 decades very little is known 
about it, starting with it location in the brain, yet even that is still a hypothesis, but it is 
presumed that it works through dopaminergic and/or serotonergic pathways (due to the 
action of the drug).  It has been suggested that the methamphetamine oscillator works 
independently of the classical circadian system i.e. not through CLOCK:BMAL1 and 
PER:CRY.  Evidence for this is two fold with mice carrying the CLOCK∆19, and double 
Cry knock out mice, both of which are arrhythmic in DD, become rhythmic when given 
methamphetamine in their drinking water (Honma et al. 2008; Masubuchi et al. 2001).  
Furthermore, NPAS2 -/-, tau and Clock mutants, which are rhythmic with pure water to 
drink lengthened their periods in the presence of methamphetamine and Per1/Per2 double 
-/-, Cry1/Cry2 double -/- and Bmal1 -/-, which are arrhythmic with pure water, were 
rhythmic in the presence of methamphetamine (Mohawk et al. 2009).  Together suggesting 
that the methamphetamine oscillator does not employ the canonical clock genes as none of 
the mutants above affected this new oscillator.  However, much more work needs to be 
carried out on this novel oscillator. 
 
In summary of the overview of photic and non-photic re-setting stimuli described above, 
light acts as the strongest zeitgeber within the SCN and will induce both Per1 and Per2 
mRNA expression at the same circadian time (CT), irrespective of the animal being 
nocturnal or diurnal.  (CT 0-12h is referred to as the subjective day i.e. when the lights 
would usually be on and CT 12-24h is referred to as the subjective night i.e. when the 
lights would usually be off).  This leads to the hypothesis that animals respond to tonic 
levels of light rather than it acting as a binary on/off switch.  In terms of a dark pulse, in 
constant light conditions, there are two effects termed anti-photic and non-photic.  Anti-
photic effects are where advances are observed during the day and delays at night (opposite 
to light pulses in constant darkness) and non-photic effects are a consequence of prolonged 
dark exposure and an increase in activity.  Opposite to light pulsing, the effects are 
observed during the animals rest period, and therefore opposite in nocturnal and diurnal 
animals.  Melatonin, serotonin and GABA fall in to the non-photic category of entrainment 
and are termed arousal independent (melatonin and GABA) and arousal dependent 
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(serotonin) due to their coupling (or not) with increased behavioural activity.  Melatonin 
acts equally irrespective of the animal being nocturnal or diurnal, and phase advances Rev-
erb α and induces Ror β expression rather than Per1 and Per2 mRNA (light pulsing), 
expression in the SCN.  Serotonin expression levels are in phase with the behavioural 
activity of the animal and are therefore opposite in nocturnal and diurnal animals with 
phase advances observed with administration during the animals rest period (subjective 
day and night respectively).  Furthermore, serotonin acts to suppress Per1 and Per2 
mRNA, both opposite to that of light and involving different clock genes to melatonin.  
GABA will induce phase advance irrespective of the animal being nocturnal or diurnal, 
when administered at the same circadian time and has been shown to be associated with a 
decrease in Per1 and Per2 mRNA expression in the SCN, similar to that of serotonin 
action.  There are also certain drugs, used in the clinic (Triazolam) and as drugs of abuse 
(methampthetamine) which affects the circadian clock and in the case of 
methamphetamine it appears that it works independently of the classical circadian network 
(SCN) and the classical circadian genes. 
1.5.4 Food entrainment 
 
Food is a very potent zeitgeber, which has been shown through restricted feeding 
experiments.  In nocturnal rodents, activity and feeding primarily occur at night, however, 
if the availability of food is restricted to a few hours during the day the animals show 
anticipatory behaviour (i.e. become active prior to food delivery).  This restricted feeding 
is also able to uncouple peripheral oscillators and other brain regions from the SCN, which 
remains entrained by light, and induce phase advances in tissues such as the liver, heart 
and kidney as well as the cerebral cortex (Damiola et al. 2000; Hara et al. 2001; 
Wakamatsu et al. 2001).  The action of restricted feeding does change the availability of 
many circulating nutrients (Woods 2005), including glucose which can stimulate circadian 
gene expression, similar to that of Gcs or serum shock, but acts via the suppression of Per1 
and Per2 transcription (Hirota et al. 2002).  Insulin was also considered to be a circulating 
factor involved in uncoupling peripheral clocks from the SCN under restricted feeding, but 
this hypothesis was ruled out in a study using diabetic rats that were unable to produce 
insulin (Davidson et al. 2002).  In this study Per1::luc expression phase shifted in both WT 
and diabetic rats, in response to restricted feeding and therefore ruling out insulin as 
synchronising factor in food restriction and anticipatory behaviour. 
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When animals are entrained to food restriction they become more active prior to food 
availability, show an increase in core body temperature, increase serum CORT levels 
(Krieger 1974) and an increase in duodenal disaccharides (Saito et al. 1980).  However, 
neither adrenalectomy (Boulos et al. 1980) nor hypophysectomy (removal of the pituitary)  
(Davidson and Stephan 1999) prevent food anticipatory behaviour, but hypophysectomy 
does prevent the anticipatory rise in core body temperature.  Importantly ablation of the 
SCN does not abolish the food anticipatory behaviour, the phase-shifted CORT or 
temperature rhythm, and together suggests that there is a second oscillator, the food 
entrainable oscillator, (FEO) (Krieger et al. 1977).  This finding was met with initial 
scepticism but was quickly confirmed with entrainment to a 25h feeding schedule, but with 
a different free-running behavioural rhythm (Edmonds and Adler 1977).  Later studies 
showed that the limits of food entrainment were between 22h and 31h, which could last up 
to 5 days even in the absence of food (Boulos et al. 1980; Stephan 1981). 
 
In an attempt to locate the FEO various researchers have attempted to lesion areas of the 
brain with the hypothesis that this will result in the loss of anticipatory behaviour.  Lesions 
in the ventromedial hypothalamus resulted in a temporary loss in the anticipatory 
behaviour, but this was recovered 14-21 weeks after ablation (Mistlberger and 
Rechtschaffen 1984).  Further attempts to localise the FEO were again unsuccessful ruling 
out paraventricular nucleus and the lateral hypothalamic area (Mistlberger and Rusak 
1988).  An apparent breakthrough came when the ablation of the DMH resulted in the loss 
of anticipatory behaviour (Gooley et al. 2006), with additional evidence provided by an 
increase in neuronal activation (as indicated by cFos activation) in the DMH after ghrelin 
administration i.p. (Kobelt et al. 2008).  Ghrelin is the only known orexigenic hormone 
(appetite stimulant) and plays a crucial part in regulating food intake and body weight 
(Cummings 2006).  Furthermore, the DMH has been shown to play an important part in 
circadian rhythm generation and in the regulation of food intake (Chou et al. 2003; Yang et 
al. 2009a) making it an ideal candidate for the FEO.  Unfortunately, other researchers have 
not been able to confirm the initial studies by Gooley et al. (2006) (Landry et al. 2007; 
Moriya et al. 2009), showing that after DMH ablation there is still anticipatory behaviour.  
So the current literature is still very much at odds with the DMH and the FEO. 
 
The above discussed the possibility that the FEO was located in a single area of the brain, 
similar to that of the central oscillator located in the SCN.  However, evidence from 
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ablating defined areas of the brain, but not successfully removing the FEO, leads to the 
idea that multiple nuclei could be involved.  In fact when an animal is food entrained 
multiple brain nuclei become active (as defined by cFos expression) around the entrained 
meal time (Poulin and Timofeeva 2008).  Of particular interest in the study by Poulin and 
Timofeeva (2008) were the nuclei that showed increased cFos expression up to 3h before 
the meal time (anticipatory behaviour at the molecular level).  In this instance the 
paraventricular thalamic nucleus, the DMH and the anterior hippocampal continuation and 
septohippocampal nucleus all showed this anticipatory expression, suggesting that the FEO 
is the combination of signals from multiple nuclei, yet current experimental evidence 
cannot rule out a the existence of a single FEO oscillator (Carneiro and Araujo 2009).    
 
In a recent review by Carneiro and Araujo (2009), they suggested quite a complex system 
in which food entrainment occurs.  This hypothesis combines a group of connected brain 
oscillators, which are: 
 
1. Directly sensitive to peripheral food related hormonal signals (such as the median 
eminence and the arcuate nucleus). 
2. Indirectly sensitive to peripheral signals, in order to integrate the directly sensitive 
nuclei above (such as the brainstem and hypothalamic nuclei e.g. DMH). 
3. A group of nuclei that are responsible for the variables observed during food 
entrainment e.g. increase in temperature, CORT and anticipatory behaviour (such 
as the hypothalamic and thalamic nuclei, forebrain and motor systems). 
 
Interestingly the food anticipatory behaviour does not necessarily require a functional 
circadian clock, as mice with mutations in some of the core clock genes still show this 
behaviour, reviewed by (Mendoza 2007).  Clock∆19/∆19 show a longer or arrhythmic period 
but the food anticipation is still present.  In the Per1 -/- mice, they run with a shorter period 
but again food anticipation is still observed.  However, in the Per2 -/-, where the animals 
remain behaviourally rhythmic but run with a shorter period, food anticipation is absent, 
even in constant darkness (Feillet et al. 2006).  Similarly, the arrhythmic Bmal1 -/- mouse 
is also without food anticipation.  It has been concluded that the CRY proteins are not 
involved in food anticipation even though in the double knockout mouse food anticipation 
is slow to establish and unstable (Iijima et al. 2005).  Per2, it seems is quite important in 
food anticipation.  Not only does PER2 oscillate in the absence of a local oscillating clock 
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(liver), by taking systemic timing signals (Kornmann et al. 2007) but it has a very distinct 
(from that of PER1) role in food entrainment.  Furthermore, the loss of Per2 in the mouse 
results in an increased reliance on glycolysis, with an increased expression of key enzymes 
in the glycolytic pathway (section 7.3).  Also Per2 -/- mice do not run as far as WT mice 
(Bae et al. 2006).  Interestingly, in relation to the last point, in WT rats under severe food 
restriction (6g food/day) they will run almost continuously, despite the calorific 
expenditure and develop stress ulcers within days (Yi et al. 1993).  These quite distinct 
pieces of data suggest a very prominent role for PER2 in food entrainment and the 
anticipatory response.  
1.5.5 Temperature entrainment 
 
Temperature, as a zeitgeber, is rather poorly understood and understudied, with respect to 
food and photic entrainment.  This lack of knowledge is even more so when looking at 
temperature entrainment in the mammalian system, as the majority of studies have taken 
place in ectothermic organisms (animals whose temperature mirrors that of the 
environment) where the circadian clock can easily be manipulated by the external 
temperature (extensively reviewed by (Rensing and Ruoff 2002)).  In the cyanobacterium 
Synechococcus, the protein synthesis and activity of the enzyme nitrogenase can be 
entrained to a temperature cycle with an range of just 5oC, yet, in conjunction with a 
light/dark cycle light entrainment was more dominant (Lin et al. 1999).  However, a 
protein mechanism has not been characterised but is thought to involve the rhythmic Kai 
a/b/c system (Kageyama et al. 2003) but not their phosphorylation status, and as such 
hypothesised to be the state of the KAI A/B/C complex formation or changes in the state of 
the KAI C hexamer (Yoshida et al. 2009)   The fungus N. Crassa has been clearly shown 
to entrain to temperature cycles with a dynamic range of just 2-2.5oC, in constant 
conditions (Francis and Sargent 1979; Rensing and Ruoff 2002) and a temperature range of 
10 oC or more is a stronger zeitgeber than light (Rensing 1989).  At the molecular level this 
entrainment appears to be mediated via the oscillating protein FREQUENCY (FRQ).  At 
whatever phase of the circadian cycle the temperature is altered an increase in temperature 
will result in a re-set to the subjective day (CT0), as the cell will view whatever quantity of 
FRQ present as the minimum.  Conversely, a decrease in temperature will be re-set to the 
subjective night (CT12) with the cell viewing the FRQ concentration as maximal, 
regardless of phase (Garceau et al. 1997). 
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The rhythmic behaviour rhythm of the fruit fly D. melanogaster has been shown entrain to 
a temperature cycle with a range of just 2oC (shown in over 50% of individuals), with 
entrainment of blind flies to a temperature range of 3oC (Rensing and Ruoff 2002; Wheeler 
et al. 1993).  It has been shown that pulsing Drosophila with increasing temperatures has a 
dose dependent effect on the degradation rates of PER and TIM (two proteins involved in 
the feedback loop, (section 1.6.1) when applied at either CT15 or CT21.5 (Sidote et al. 
1998).  However, in this study a phase delay only occurred with a pulse at CT15, as a pulse 
at CT21.5 resulted in degradation but also rapid increase in both PER and TIM, which is in 
direct contrast to light pulsing at this time, which resulted in PER and TIM degradation and 
a 2h phase advance (Lee et al. 1996; Myers et al. 1996).  More recent data has suggested 
that temperature entrainment, in Drosophila, may well be the product of a signalling 
cascade involving phospholipase C (PLC).  PLC acts to splice the 3’ end of the Per gene in 
response to cold temperatures, leading to an earlier accumulation of Per mRNA and an 
advance in behavioural rhythm (Majercak et al. 2004).  The association between PLC and 
temperature entrainment was shown through mutation studies of the gene encoding PLC, 
norpA.  A mutation of norpA led to constitutive 3’ splicing regardless of temperature 
(Glaser and Stanewsky 2005).  Furthermore in this study, a novel gene termed no circadian 
temperature entrainment (nocte) was isolated as it had an impact on temperature at the 
behavioural and molecular levels in response to constant light.  
 
There has been relatively few studies with regard temperature entrainment in endothermic 
organisms (warm blooded e.g. mammals and birds) (Francis and Coleman 1988; Goldman 
et al. 1997; Refinetti 2010) compared to ectothermic organisms (cold blooded e.g. reptiles 
and fish) (Evans 1966; Foa and Bertolucci 2001; Samejima et al. 2000).  This fact is not 
surprising considering that endothermic organisms are essentially buffered against external 
temperature changes and therefore temperature as a zeitgeber is far less potent in these 
organisms.  It has been reported in a number of rodent studies that some, but not all 
animals, in a particular study will entrain to a temperature rhythm with a range between 
4oC and 14oC (Rensing and Ruoff 2002).  In a recent study standard domestic mice (CD-1 
strain) were shown to entrain to a 12oC temperature rhythm (16h at 24oC:8h at 12oC, or 
16h at 24oC: 8h at 32oC). However, only 60-80% of the mice entrained to these 
temperature cycles, with no defined PRC, compared to 100% which entrained to light 
(Refinetti 2010).  This confirmed previous studies which suggested that temperature is 
indeed a much weaker zeitgeber than light in endothermic animals.  Although the 
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molecular mechanism for temperature entrainment has not yet been fully characterised 
some work has been carried out on cell lines showing that temperature changes can induce 
second messengers such as Ca2+ and cAMP (Kiang and McClain 1993; Kiang et al. 1991), 
but also act to lower the internal pH, Na+ and change the membrane potential (Skrandies et 
al. 1997).  It has also been hypothesised (as yet without full experimental evidence) that as 
a positive temperature pulse and a light pulse act to phase shift the clock in the same way, 
using melatonin as a circadian marker (shown with dispersed chick pineal cells) (Barrett 
and Takahashi 1995; Robertson and Takahashi 1988).  These data suggest that the two 
entrainment pathways could be very closely linked.  Furthermore, it has been hypothesised 
that the small fluctuations in the internal temperature of the animal may be  just another 
internal entrainment factor like melatonin, food and Gc, acting both as a clock output and 
feeding back onto the clock itself (Tosini and Menaker 1996).  However, it is just a very 
weak internal synchronising factor.  More recent work by Buhr et al. 2010 suggests that 
circadian changes in body temperature, in mammals, acts on the SCN which is then used to 
synchronise the peripheral system (Buhr et al. 2010).  The authors showed that the SCN is 
indeed temperature compensated but network interactions are required i.e. cell to cell 
communication and that the heat shock pathway is essential for both temperature re-setting 
and compensation (section 1.5.6) (Buhr et al. 2010).  
1.5.6 Temperature compensation 
 
Temperature compensation is one of the main contributing factors to what makes an 
endogenous circadian clock Pittendrigh (1960).  Tosini et al., (1996) showed that in the tau 
mutant hamster temperature compensation was lost in the retina, when assayed for 
melatonin release, with a Q10 = 1.487 compared to the WT = 1.096.  The tau mutation 
results in a gain of function mutation in the CK1ε protein (Meng et al. 2008a) leading to a 
period of 20h in the homozygote mutant, as seen in both hamster and mouse (Meng et al. 
2008a; Ralph and Menaker 1988).  This study by Tosini et al. (1996) led to the hypothesis 
that CK1ε may have a role in the temperature compensation of the clock.  Recent studies 
have shown that although chemical inhibition of CK1ε, which leads to the phosphorylation 
and degradation of its clock target protein PER2, lengthens the period of PER2, the activity 
of CK1ε WT or tau was insensitive to temperature change as was the phosphorylation of 
mPER2 protein (Isojima et al. 2009).  This suggests that CK1ε is an important enzyme in 
temperature compensation of the clock, as well as more recent data is pointing to CK2 
(Mehra et al. 2009). 
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1.6 The circadian system 
1.6.1 Discovery of circadian genes 
 
Much of the early work on circadian rhythms was undertaken using the fruit fly, Drosphila 
melanogaster, and the fungus Neurospora crassa, but work rapidly progressed on a 
number of organisms including mammals, particularly rodents, using both biochemical and 
genetic techniques.  In 1971 Konopka and Benzer discovered the first of the clock genes, 
termed per, in D. melanogaster, with its locus on the X chromosome (Konopka and Benzer 
1971; Sehgal et al. 1994).   Using ethyl methane sulfonate (EMS) chemical mutagenesis 
the authors observed three altered locomotor rhythms in the flies; one which had an 
activity of longer than 24 hours, termed perL; one which ran shorter than 24 hours, termed 
perS; and a third which rendered the fly arrhythmic, per0 (Konopka and Benzer 1971).  In 
the mid 1980’s two papers showed the sequence of the per sequence in Drosophila 
locating it to a 90kbp region in the 3B region of the X chromosome, further work then 
located it to a 7.1kbp region of the gene which encoded a 4.5kbp RNA transcript (Bargiello 
and Young 1984).  This 4.5kbp region is eliminated in per mutants that retain some 
rhythmicity but it was suggested that two novel transcripts substitute for its loss.  The 
previously mentioned 7.1kbp fragment of DNA restored rhythms in Drosophila which 
carried mutations, when transduced back into the fly (Jackson et al. 1986).  Jackson et al., 
1986 also published a predicted amino acid sequence for the PER protein, which was 1127 
amino acids in length.  The PER amino acid sequence had high homology to the rat 
chondroitin sulphate proteoglycan, which was know to be distributed around the cell 
surface and in extracellular locations.  A year later, in 1987, mutations in the per gene, 
resulting in the arrhythmic and short running flies were mapped to either a nonsense 
mutation in the third coding exon, or a nucleotide substitution in the forth coding exon 
respectively (Yu et al. 1987).  The arrhythmic mutation was a glutamine to stop codon 
change, which resulted in a truncated protein missing the C-terminal end, and the 
arrhythmic phenotype.  The short running fly was the result of a serine to asparagine 
mutation at position 589.   Hardin et al., (1990) used RNase protection assays with 
Drosophila heads to determine the cycling activity of per mRNA.  In this work the authors 
used the long and short mutants, discovered by Konopka and Benzer, and compared them 
to wild type.  There was no difference in the overall amplitudes just with a shift in phase, 
either earlier (perS) or later (perL) depending on the mutant.  They then postulated a model 
by which the per gene product regulated its own transcription (Hardin et al. 1990), yet with 
Chapter 1_______________________________________________________Introduction 
 
 48 
the added uncertainty of how this occurs, either at a transcriptional or post-translational 
level.  This then led the way to further characterisation of the biochemical clock, and a 
number of years later the second mutant gene, timeless (tim), was discovered and mapped 
to chromosome 2 (Sehgal et al. 1994), again in the fly.  It was subsequently discovered, in 
the fly, that the dPER protein heterodimerised with TIMELESS  and using tim mutant 
experiments dPER could not be detected in the nucleus (Vosshall et al. 1994).  It was 
discovered that dtim mRNA levels show a definite circadian rhythm, in the Drosophila 
head, as do dper mRNA levels. It was then shown that both dtim and dper mRNA cycle in 
phase with each other (Sehgal et al. 1995).  Following these initial breakthrough 
discoveries many more clock genes and their subsequent proteins followed, leading to the 
dissection, and subsequent understanding of the biological clock, although the 
understanding aspect was still very much a working progress.  Genes such as cryptochrome 
(Cry) and timeout (Tim2) (Vodovar et al. 2002), were discovered.  dcycle was another 
gene, first characterised using EMS mutagenesis experiments in the fly, as an essential 
clock protein and member of bHLH PAS family of transcription factors, with homozygote 
mutants becoming totally arrhythmic (Rutila et al. 1998).  dclock was a gene, identified as 
a core clock component in the fly, again discovered using EMS mutation, which resulted in 
uniform arrhythmic phenotype in the homozygote mutant fly (Allada et al. 1998). 
dCLOCK was discovered to heterodimerise with dCYCLE and was co-expressed with 
dPER, in the fly.  However, it was subsequently discovered, using a newly developed 
antibody, that dCLOCK did not cycle with a definite rhythm, unlike dPER, and was also 
found to express in non-oscillatory cells, suggesting a circadian and a non circadian role 
(Houl et al. 2006).  However, subsequent studies revealed that this statement was wrong 
and dCLOCK was only expressed in oscillator cells and the mistake was made due to 
antibody cross reactivity with another protein BMC DACHSHUND (Houl et al. 2008).  
Following on from these initial discoveries regulatory components were discovered, such 
as the kinase dDoubletime, the Drosophila ortholog of the mammalian CK1ε and dShaggy, 
the ortholog of the mammalian glycogen synthase kinase 3β (GSK3β) (Hughes et al. 1992; 
Ruel et al. 1993), which are involved in the posttranslational modification of the core clock 
proteins (Preuss et al. 2004), resulting in the period of the oscillation being roughly 24 
hours.  The fruit fly is an extremely useful model to use in the lab as it has a relatively 
simple genome with only 4 chromosomes including a sex chromosome, although each 
gene has mammalian homologues, and it has a generation time of 2 weeks, together 
making it a very useful genetic tool. 
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1.6.2 The mammalian PER and CRY system 
1.6.2.1 The Period genes 
 
A mammalian homolog to the Drosophila per gene was found simultaneously by 
independent labs (Sun et al. 1997; Tei et al. 1997) and Sun (1997) termed it Rigui, now 
Per1.  It shares 44% homology to the Drosophila per gene and is expressed in both central 
and peripheral tissues.  In mammals there are three Per genes, (Per 1-3), all containing 
PAS domains (Fu and Lee 2003), (Fig 1.4), but which do not directly bind to DNA.  In the 
fly the dPER protein is the main oscillator and showing a rhythm independent of its mRNA 
rhythm i.e. the PER protein shows a rhythm even when per mRNA is constitutively 
expressed (Zhang et al. 2004).  Likewise in the mouse, the mPER2 protein can oscillate 
even in the presence of constitutive mPer2 mRNA (Zhang et al. 2004), this is due to 
posttranslational modification (Gachon et al. 2004; Iitaka et al. 2005).  In the promoter 
region of the mPer genes lie a number of E-boxes, mPer1 contains 3 and mPer2 and 
mPer3 contain 7 and 4 respectively (Travnickova-Bendova et al. 2002).  This suggests 
tightly controlled CLOCK:BMAL1 driven E-box regulation, with a resulting peak 
expression at circadian time (CT) 10-12 (like that of mCry1; section 1.6.2.1) (Albrecht et 
al. 1997; Shearman et al. 1997).  CT is the time of day when an animal is placed into a 
constant environment i.e. with no external time cues.  The resulting mRNA translocates to 
the cytoplasm and the protein products can then complex with other proteins like PER2 
and CRY (Hirota and Fukada 2004).  In the cytoplasm, CRY proteins complex with the 
PER proteins at their C-terminal, and aid nuclear translocation (Vielhaber et al. 2001).   
PER2 is modified post translationally by a number of different proteins (further discussed 
in 1.3.6).  More recent evidence suggests that both Per 1 and 2, rather than the CRY 
proteins, are essential for the functioning of the molecular clock (Chen et al. 2009), as the 
CRY proteins were previously shown to be the rate limiting factor in nuclear accumulation 
and the major component of CLOCK:BMAL1 transcriptional inhibition (Griffin et al. 
1999; Kume et al. 1999).  It has been demonstrated that the PER proteins bind to the 
CLOCK:BMAL1 complex, that is itself bound to the DNA (Lee et al. 2001), rather than 
CRY binding directly to repress E-box transcription.  This model proposed by Chen (2009) 
suggests that PER bridges between CRY and CLOCK:BMAL1, to allow CRY to initiate 
transcriptional repression (Kume et al. 1999).  Per2 has also been shown to oscillate even 
in the absence of a tissue specific functional clock.  Kornmann et al. (2007) over expressed 
REV-ERBα, in the liver, which suppressed Bmal1 expression, resulting in an arrhythmic 
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liver clock and the loss of Cry, Rev-erb and D site of albumin promoter binding protein 
(Dbp) rhythms, although the rest of the animal was rhythmic.  However, a subset of 31 
transcripts, in the ‘arrhythmic’ liver, still oscillated including Per2 and other heat shock 
proteins (Hsps).  Promoter analysis suggested that Per2 has 5 heat shock elements within 
1700bp of the promoter region conserved in mouse, human, rat and dog (Kornmann et al. 
2007) indicating a much simpler independent oscillator aside from the more complex core 
loop (Fig 1.1).  Other data though has shown that the Per2 transcript does not oscillate in 
the SCN of Bmal1 knockout, arrhythmic mice, as seen by in-situ hybridisation, (Bunger et 
al. 2000) and neither was it shown to oscillate in liver explants from Bmal1 knock out mice 
(Liu et al. 2008) or liver from SCN ablated mice, (Reddy et al. 2007), using qPCR.  
Together these data suggest that Per2 can oscillate in the absence of a local clock but the 
central clock must be intact to relay systemic signals.  Furthermore, the loss of Rev-erb α 
resulted in constitutive levels of Bmal1and Clock transcript and protein but unaltered Per2 
expression at transcript or protein level (Preitner et al. 2002), leading to further evidence to 
support this independent Per2 peripheral oscillator. 
 
mPer1
PAS a PAS b CLD
CK1ξ binding 
domain NLS205
484
 
Figure 1.4: Schematic representation of the various domains of mPer1:  Per ARNT 
Simple minded (PAS) dimerisation domain, cytoplasmic localisation domain (CLD), 
nuclear localisation domain (NLS), numbers refer to amino acid position.  Adapted from 
Vielhaber (2001). 
 
Per1 is involved in phase resetting.  Mutations, in the rodent, can shorten the period length 
(Zheng et al. 2001) or result in an arrhythmic phenotype after a few days in constant 
darkness (DD) (Bae et al. 2001).  Mutations in Per2, can also lead to an altered behaviour 
rhythm resulting in the shortening, then an arrhythmic behaviour after a few days in DD 
(Bae et al. 2001).  Furthermore, a Per2 -/- mouse has been shown to have reduced activity 
i.e. reduced wheel running activity and the loss of Per2 results in the loss of the CORT 
rhythm, but the CORT increase in response to stress remains the same as the WT (Bae et 
al. 2006; Yang et al. 2009).  In the most severe human form, a Per2 mutation can result in 
Familial advanced sleep phase syndrome (fASPS) (Toh et al. 2001), a genetic condition in 
which residue 662 of the hPER2 protein is mutated from a serine to glycine.  This single 
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mutation results in the carrier waking up and going to sleep earlier each day, leading to a 
severely disrupted life, out of phase with the rest of society.  However, mutations in the 
PER3 protein cause only a subtle effect on the rhythmicity in rodents, with a slight 
shortening of the period length in constant conditions (Shearman et al. 2000).  However, 
allelic differences in PER3 in humans can have dramatic effects on sleep, but in this case a 
sleep delay.  PER3 contains a region called variable-number tandem-repeats (VNTR) and 
dependent on the number of repeats, either 5/5 or 4/4, determines the endogenous clock 
phase, a 5/5 repeat determines a more morning type (people who prefer to wake up early 
but also go to bed early) whereas the 4/4 determines and evening type (people who prefer 
to sleep late in to the morning/afternoon but stay up all night), which can ultimately lead to 
delayed sleep phase syndrome, opposite to that of fASPS (Viola et al. 2007). 
 
Double mutant mice with either Per1/3 or Per2/3 disrupted show a phenotype no more 
severe than the single Per1 or Per2 mutant, suggesting Per redundancy and that Per3 is not 
essential in the core mechanism driving locomotor activity (Bae et al. 2001).  However, if 
both Per1 and 2 are mutated then the animal shows an immediate arrhythmic phenotype in 
DD, suggesting that both these homologues are essential (Bae et al. 2001; Zheng et al. 
2001).  Furthermore, evidence suggests that PER1 and PER2 proteins independently 
control output pathways.  For example, the gene cellular retinal binding protein 1 
(CRBP1) (essential for vitamin A synthesis) will continue to oscillate in a Per2 mutant 
mouse but not in a Per1 mutant.  Conversely, the gene NG27 (identified as part of the 
major histocompatibility complex II locus - involved in antigen presentation on the surface 
of specific cells e.g. macrophages - but with unknown function) remains rhythmic in a 
Per1 mutant but not Per2 mutant mouse.  There are also examples where Per1 and Per2 
have combined control of other circadian pathways, such as heme biosynthesis (Zheng et 
al. 2001).   
1.6.2.1 The Cryptochrome genes 
 
The CRY protein was first characterised in 1996 by Hsu et al, with a further homologue 
being discovered when trying to purify CRY1, termed CRY2.  These two CRY proteins 
share a 73% identity, with each other at the amino acid level and CRY1 and 2 share 48% 
and 51% sequence identity respectively, with the Drosophila (6-4) photolyase (Hsu et al. 
1996).  CRY proteins are found to oscillate in most tissues of the body studied, in phase 
with PER and in anti-phase to BMAL1.  CRY proteins have also been found in certain 
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retinal neurons, and mice lacking the Cry genes present a reduced pupillary light response 
i.e. a reduced pupil contraction in the presence of bright light (Van Gelder et al. 2003). 
On mRNA export to the cytoplasm and protein production the two CRY proteins will bind 
to the C-terminus of PER1 and 2, with an unknown stoichiometry (Gachon et al. 2004b).  
This interaction stabilises the PER proteins, which was proposed to be the rate limiting 
factor for the CRY:PER interaction in the cytoplasm with nuclear translocation then taking 
place (Kume et al. 1999).  However, endogenous protein phosphorylation studies by Lee et 
al. (2002) suggested otherwise and that the CRY proteins were not indeed the rate limiting 
step but rather the PER proteins were.  Kume et al. (1999) also suggested that the CRY 
proteins were responsible for the PER:CRY complex nuclear translocation and that they 
were primarily nuclear proteins, but mutational studies have shown that the nuclear 
localisation domain (NLS) in PER2 is essential for nuclear translocation of the PER:CRY 
complex (Miyazaki et al. 2001), which backed up the evidence by Lee et al. (2002) 
showing that CRY remained cytoplasmic in Per1/2 double knock out mice.  This suggests 
that the PER proteins are required for feedback repression and that they are far more 
important in nuclear translocation than the CRY proteins.  However, CRY1 has been 
shown to interact with histone deacetylases (see 1.3.6.3) in order to repress Per1 
transcription in a rhythmic manner (Naruse et al. 2004) and is potentially the reason for 
elevated Per1 levels in Cry1 and 2 knock out mice, suggesting that the CRYs are a vital 
part of the feedback mechanism of a functional clock.  There is considerable redundancy in 
this heteromeric complex, as the Cry genes can be mutated individually without it resulting 
in complete arrhythmia in DD (van der Horst et al. 1999; Vitaterna et al. 1999).  A double 
knock-out phenotype is different though, the Cry1/2 double knockout mouse is 
immediately arrhythmic, as is the Per1/2 double knockout, when run under constant 
darkness (Spoelstra et al. 2004; Zheng et al. 2001).   
 
There is conflicting evidence, however, as to the oscillations of mCry1 and mCry2 mRNA.  
One laboratory has reported that both mCry1 and 2 are expressed in the central oscillator, 
the SCN (section 1.4), but only mCry1 mRNA cycles (Thresher et al. 1998) with peak 
expression about CT10-12.  However, others have reported that both mCry1 and 2 mRNA 
oscillate in the SCN, yet with a less defined mCry2 rhythm with a peak stretching from 
CT8 to CT16 (Okamura et al. 1999).  Both the respective proteins oscillate in phase, in the 
SCN (Kume et al. 1999).  The CRY proteins are also important in cell cycle progression, 
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from S to M phase, and mice with an impaired Cry gene show impaired cell cycle 
progression in hepatocytes, but not in the SCN (Matsuo et al. 2003).   
1.6.3 CLOCK, NAPAS2 and BMAL1 
1.6.3.1 CLOCK 
 
Clock is a large gene spanning 24 exons comprising of about 10,000 bp of DNA (King et 
al. 1997). Both the mRNA and protein are constitutively expressed in the central oscillator, 
the SCN (Gekakis et al. 1998), yet show strong oscillations in the majority of peripheral 
tissues (such as the retina, heart, liver, kidneys, testis and ovaries) (Reppert and Weaver 
1997), suggesting a more complex role for CLOCK than purely a core clock gene. 
 
Using a ‘forward genetic’ approach, that is a ‘treat and see’ approach similar to that seen 
with the early Drosophila work, mice were treated with N-ethyl-N-nitrosourea (ENU), 
which randomly mutates DNA.  One mutation led to a 3-4 hour period extension in the 
activity rhythm, with a loss of rhythm in constant darkness (Vitaterna et al. 1994).  It was 
later discovered that there had been an adenine to thymidine transversion at the third base 
position of the 5’ splice donor site of intron 19, which resulted in the deletion of the entire 
exon 19, comprising 51 amino acids (King et al. 1997).  This mutation was termed 
CLOCK∆19 and suggested that CLOCK was an essential component of the circadian clock.  
A decade later Debruyne et al., showed that CLOCK null mice i.e. there is no CLOCK 
present in the mouse still had a behavioural rhythm, albeit shorter than the WT 
approximately 23.3h compared to 23.8h (DeBruyne et al. 2007b), which suggested that the 
CLOCK∆19 was a dominant negative protein and that CLOCK was not essential for a 
rhythmic mouse.  However, peripheral clocks such as the liver and lung do require 
CLOCK to be present for an oscillation as Clock -/- liver and lung are arrhythmic 
(DeBruyne et al. 2007c). 
 
CLOCK protein has recently become of particular interest as it was found to have histone 
acetyltransferase (HAT) activity (Doi et al. 2006).  Thus CLOCK is potentially involved in 
chromatin remodelling as it can acetylate lysine residues in histone proteins (in particular 
histone H3).  In work following that of Doi (2006) it was found that PER2 was acetylated 
and that SIRT1, a NAD+ dependent histone deacetylase (HDAC), binds to the 
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CLOCK:BMAL1 heterodimer in a time dependent manner and deacetylates PER2 (Asher 
et al. 2008), HATs and HDACs are further discussed in section 1.7.3.   
1.6.3.2 Neuronal PAS domain protein 2 (NAPS2) 
 
Neuronal PAS domain protein 2 (NPAS2) was identified as a paralogue of CLOCK, in the 
forebrain (Reick et al. 2001), which could functional substitute and maintain a rhythmic 
mouse (Debruyne et al. 2006).  Further work by Debruyne et al. (2006) knocked-out Clock 
using a Cre-LoxP system which targeted the removal of 2 exons encoding the bHLH 
domain, required for BMAL1 dimerisation and therefore the CLOCK protein was non-
functional.  This system was used for whole animal knock-out and for tissue specific 
studies, where Cre recombinase was expressed (Debruyne et al. 2006).  Once Clock was 
knocked-out, the adult continued to show rhythmic locomotor activity with a period only 
20 minutes shorter than in the wild type, but with an altered response to light, becoming 
active 2 hours before lights off. Furthermore, the maintenance of the circadian activity 
cycles in the absence of CLOCK protein suggested that CLOCK is not an essential protein 
for the rhythmic expression of clock genes, such as mPer1/2, and their respective proteins, 
yet the amplitude of their expression was reduced in the knock-out genotype (Debruyne et 
al. 2006) with respect to Rev-erbα, Per1 and Bmal1 mRNA; although Per2 expression was 
maintained. This then suggested an alternative binding partner for BMAL1, hypothesised 
to be NPAS2, (a known paralogue of mCLOCK and had been shown to co-
immunoprecipitate with BMAL1, in whole brain extracts from both wild type and CLOCK 
deficient mice) (Debruyne et al. 2006).  However, this hypothesis was not verified as 
Npas2 mRNA was undetectable in the SCN of either wild type or CLOCK deficient mice, 
by in-situ hybridisation (Shearman et al. 1999), yet Npas2 mRNA and protein levels were 
increased in the CLOCK deficient liver (Debruyne et al. 2006).  However, more recent 
work has shown that NPAS2 can functionally substitute for CLOCK in the SCN using 
CLOCK deficient mice, which were still rhythmic in constant darkness but with a shorter 
period than the WT.  Also NPAS2 -/- mice, with CLOCK present were also rhythmic in 
constant darkness, but this time with a period almost equal to the WT.  In the CLOCK and 
NPAS2 double knock out, the mouse is immediately arrhythmic when placed into constant 
darkness (DeBruyne et al. 2007a).  Together these data strongly suggest that NPAS2 can 
functionally replace CLOCK in the SCN and at a behavioural level, yet in the periphery 
this is not the case as NPAS2 cannot functionally replace CLOCK (DeBruyne et al. 
2007c).   It could also be possible that BMAL1 forms a homodimer, as revealed by 
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electorphoretic mobility shift (EMS) assay in vitro (Rutter et al. 2001), yet probably 
unlikely, as BMAL1:BMAL1 DNA binding was inhibited by NAD+/NADH co-factors 
(Rutter et al. 2001).   
1.6.3.3 BMAL1 
 
BMAL1 (MOP3) is another bHLH PAS domain containing protein, first identified through 
a yeast-two-hybrid screen as a binding partner for CLOCK and PER1 (Gekakis et al. 
1998).  BMAL1 is found in all the major clock cells in the brain and periphery.  Bmal1 
mRNA, unlike clock mRNA, is rhythmic and peak expression is in the middle of the 
circadian night, about CT18, in anti-phase to Per2 (Hastings et al. 2003; Honma et al. 
1998).  Expression in the SCN exhibits a much lower amplitude than in the periphery, with 
about a 3 fold change from peak to trough in the SCN and retina, compared to 50 fold 
change in the heart and liver (Peirson et al. 2006).  However some report that the BMAL1 
protein (as well as CLOCK) is constitutively expressed in the SCN and that light does not 
affect BMAL1 degradation (von Gall et al. 2003). There is evidence to suggest that the 
binding of the CLOCK:BMAL1 heterodimer is linked to the energy state of the organism 
by the ratio of NAD(P)H:NAD(P)+, which complements the work by Doi et al. (2006) 
showing the NAD+ dependent SIRT1 being directly involved in the central oscillator, and 
shown by Asher et al. (2008) to bind to the CLOCK:BMAL1 complex in a circadian 
manner and to deacetylate PER2.  During a high NAD(P)H:NAD(P)+ ratio the equilibrium 
is shifted towards E-box binding whereas the opposite is the case for low levels.  This was 
reported by Rutter et al. (2001) who used EMS to assess the DNA binding ability of the 
NPAS2:BMAL1 heterodimer in the presence of NADH and NADPH, both in the reduced 
and oxidised state.  Optimal NPAS2:BMALl1 DNA binding was observed when the per 
cent of reduced to oxidised was greater that 75%, with co-factor levels at physiologically 
relevant concentrations. 
 
Bmal1 genetic knock out mice exhibits an arrhythmic phenotype (Bunger et al. 2000) and 
present an age related phenotype such as cataracts, reduced subcutaneous fat and organ 
shrinkage (Kondratov et al. 2006).  Bmal1 -/- mice also show tendon calcification with 
decreased activity, body weight and longevity (McDearmon et al. 2006).  When Bmal1 
expression was restored in the SCN circadian wheel-running was restored but the mice still 
showed reduced activity and body weight.  Yet when Bmal1 was restored in the muscle, 
but not the SCN, normal activity levels and body weight were seen but not circadian 
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rhythmicity, suggesting tissue specific functions for BMAL1 (McDearmon et al. 2006).  
Furthermore, a genetic screen on mutant BMAL1 proteins found that the C-terminal 43 
residues are essential for transcriptional activation and binding to its repressor CRY1, 
however, this mutation did not impair PER2 binding (Kiyohara et al. 2006).  The dual role 
in the C-terminal suggests the need for a molecular switch to convert between ‘on’ and 
‘off’.  This is perhaps achieved through cyclic phosphorylation, as the C-terminus is a 
putative site for CK1ε binding and a mitogen-activated protein kinase (MAPK) binding 
site (Hirayama and Sassone-Corsi 2005).  This then leads to the idea that mammalian 
oscillations could be controlled through the interaction of post-translational events rather 
than purely transcriptional oscillations (Kiyohara et al. 2006) (further discussed in section 
1.7).   
 
BMAL1 has a homologue in BMAL2, which is expressed in up to 9 tissues specific 
isoforms and can heterodimerise with CLOCK to induce downstream E-box containing 
genes (Hastings et al. 2003).  Bmal1 and 2 are very closely associated and if Bmal1 is 
knock out then Bmal2 is also knocked out, a 2 for 1 approach (Bunger et al. 2000; Shi et al. 
2010).  BMAL2 can functionally replace BMAL1 in a transgenic model to restore a 
rhythmic behavioural phenotype.  However BMAL2 cannot restore a rhythmic  oscillation, 
as seen by PER2::luc, in either the lung or SCN but rhythmic oscillations were restored 
after dexamethasone (DEX) treatment in the liver (Shi et al. 2010).  Interestingly, although 
Bmal1 is the only clock gene that when knocked out results in an arrhythmic phenotype 
(Bunger et al. 2000), it is itself not required to cycle to induce a rhythmic sustained 
oscillator (Liu et al. 2008), although the reporter used for this observation was PER2::luc 
and as stated in section 1.6.2.1, Per2 itself has very specific components to its regulation. 
1.6.4 Rev-erbs and Rors 
1.6.4.1 Rev-erb alpha and beta 
 
There are two known Rev-erbs, termed alpha (α) and beta (β), although classed as orphan 
nuclear receptors, however, heme has recently been shown to act as a ligand (Raghuram et 
al. 2007). The Rev-erbα gene locus is found on the opposite strand to the α-thyroid 
hormone receptor (c-erb α) and is expressed in many cell types, predominantly in the brain; 
with the highest levels in the SCN (Onishi et al. 2002), muscle and brown fat (Harding and 
Lazar 1993).  Rev-erbβ is located on a different gene, yet they are both widely expressed 
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throughout the mammalian system (Liu et al. 2008).  Other members of the orphan nuclear 
receptor family are ROR a, b and c, which all activate transcription where REV-ERB α/β 
represses it.  Both RORs and REV-ERBs have a DNA binding domain and makes contact 
with a 5 bp A/T rich sequence adjacent to an AGGTCA half site and the half site itself.  
Unlike the other components discussed, REV-ERBs do not form a hetero/homo-dimer with 
itself or other nuclear receptors (Adelmant et al. 1996; Harding and Lazar 1993), but do 
bind with heme.  REV-ERBs are a major regulator of the core clock gene Bmal1, which 
has ROR/REV-ERB binding site, or RORE.  REV-ERBs are not always regarded as 
essential clock components, since the clock is still functional in their absence.  However, 
significant differences in period length and light induced phase shifts are seen when Rev-
erbα is knocked out (Preitner et al. 2002) and there are dramatic effects on other clock 
components such as Cry1, Clock and Bmal1.  It is interesting to point out that even though 
the amplitude of Cry1 mRNA is dampened in the Rev-erbα knock out mice, the cyclic 
nuclear accumulation of its protein CRY1 does not alter.  It is therefore suggested that 
Cry1 mRNA is not the rate limiting step in nuclear accumulation, similar to that postulated 
by Chen (2009), and posttranslational modifications play a vital role (Preitner et al. 2002), 
with all 7 clock proteins (PER1,2, CRY1,2, BMAL1, CLOCK, CK1ε) associating in time 
dependent, multimeric complexes and all being phosphorylated, (Lee et al. 2001).  Reports 
by Liu (2008) have shown that the two Rev-erb genes are functionally redundant, where 
one can compensate for the loss of the other, but if both are removed then the Bmal1 
rhythm is lost also, as seen in fibroblast cell lines; however the Per2::luc rhythm is still 
present.  
1.6.4.2 The family of Rors 
 
RORa is the main isoform, of the ROR family, associated with the clock, with the mouse 
having four further isoforms RORa 1–4 (Sato et al. 2004b).  The RORs bind to the same 
sequence as REV-ERBα (AGGTCA), which leads to competition between the two 
receptors (Delerive et al. 2002).  RORa is ubiquitously expressed in central and peripheral 
tissues but cycling seems restricted to the SCN (Liu et al. 2008).  RORb is expressed in 
many brain regions like the SCN but not the periphery, whereas RORc is rhythmically 
expressed in the liver but not expressed at all in the brain (Akashi and Takumi 2005; Liu et 
al. 2008).  This does not rule out any potential role for RORb and c in regulation of Bmal1, 
as double RORb knock out mice show an extended activity rhythm (Akashi and Takumi 
2005).  Together these data suggest that, although RORa is the major inducer of Bmal1 
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transcription, RORb and c may aid this in some way, in various central and peripheral 
tissues. 
1.6.5.3 Dec1 and Dec2 
 
Dec1 and Dec2 are bHLH, E-box containing genes that, like Per1 and 2, Cry1 and 2 and 
Rev-erbα, are up regulated by CLOCK:BMAL1 mediated transcription (Nakashima et al. 
2008).  They also serve as transcriptional repressors of CLOCK:BMAL1 mediated 
transcription either through interaction with BMAL1 (Sato et al. 2004a) or through direct 
interaction with E-boxes, via their bHLH domain (Kawamoto et al. 2004).  However, it is 
unknown whether DEC1 and 2 can bind directly to E’ boxes (CACGTT).  This is in direct 
contrast to how PER and CRY repress CLOCK:BMAL1 transcription, as neither PER nor 
CRY bind directly to DNA and therefore repress transcription by binding to 
CLOCK:BMAL1 heterodimer itself (Chen et al., 2009).  DEC1 and 2 were able to 
suppress CLOCK:BMAL1 induced transcription of a E54-TK reporter (made with a region 
of the mPer1 promoter containing 3 functional E-boxes upstream of a luciferase gene), 
from 125% to 13.3% and 5.9% respectively (Honma et al. 2002).  Regarding DEC2 this 
repression was far greater than the repressive effects of PER1 or PER2 and CRY1 or 
CRY2, yet the repressive effects of DEC1 were comparable to those of CRY1 and 2 
(Honma et al. 2002).  Dec1 and Dec2 are both expressed in the SCN in a circadian manner 
under DD and LD conditions.  Dec1 peaks in the early subjective day where Dec2 peaks in 
the middle of the subjective day.  The in-situ hybridisation signal for Dec1, in the SCN, 
was weak compared to other brain regions (parietal and piriform cortices) yet the Dec2 
signal was strong (Honma et al. 2002).  Interestingly, Dec1 and 2 respond differently to a 
30 min light pulse given in constant darkness.  A light pulse given at 20:00, 24:00 and 4:00 
(clock hours not circadian hours) resulted in a significantly induction of Dec1 but not 
Dec2, and a pulse at 24:00 decreased Dec2 (Honma et al. 2002).  Dec1 -/- mice have 
behavioural rhythms slightly longer than WT mice in DD (24.1 ± 0.05h and 23.9 ± 0.03h h 
respectively) and in Dec1-/- fibroblasts Dec2, Per1, and Dbp are all phase advanced by 
2.8, 2.0, and 2.5h respectively, when comparing the first peak relative to the WT cells.  
However, this advance is lost after 4 cycles as the period of each gene (Dec2, Per1, and 
Dbp) in the Dec1-/- fibroblasts  (24.7, 25.2, and 25.0 respectively) is longer than its WT 
counterpart (23.6, 24.4, and 24h respectively).  In contrast the phases of Per2 and Cry1 
were unaffected (Nakashima et al. 2008).  Knock down of Dec2 by siRNA had less of an 
effect as it resulted in a phase advance of Dec1 and Dbp for 3.9 and 1.0 h, respectively, at 
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the first peak and a slightly increased the expression level of Dec1, yet it did not change the 
expression of Per1 and the second peak of Dbp was in phase with the WT (Nakashima et 
al. 2008).  Furthermore, knock down of Dec2 in Dec1 -/- cells reduced the amplitude of 
Dbp and Per1, again advancing their phase by 1.3 and 3.3h respectively yet had little effect 
on Per2 and Cry1 expression and phase.  The knock down of both Dec1 and Dec2 had a 
much greater effect on the expression of Dbp or Per1 than either Dec1 or 2 alone 
(Nakashima et al. 2008).  Furthermore, expression of Rev-erbα, Bmal1, Clock, and Npas2 
were all decreased in the absence of both Dec1 and 2 (Nakashima et al. 2008) suggesting 
that although not essential clock components they contribute to the robustness of the clock. 
1.6.5.4 E4bp4, Dbp, Hlf and Tef as clock output loops 
 
Albumin gene D-site binding protein (DBP) is a proline and acidic amino acid rich (PAR) 
basic leucine zipper (bZIP) transcription factor, which is linked to the circadian clock in 
mammals (Yamaguchi et al. 2000).  Dbp mRNA has been shown to oscillate in the SCN 
(in animals housed in DD) (Lopez-Molina et al. 1997; Yan et al. 2000), and behavioural 
rhythm of the Dec-1 -/- mouse is 30 min shorter than the WT (23.26h and 23.76h 
respectively) (Lopez-Molina et al. 1997).  The loss of Dbp also results in diminished 
circadian amplitude of slow wave sleep, an augmented sleep fragmentation and a reduction 
of spontaneous locomotor activity (Franken et al. 2000; Lopez-Molina et al. 1997).  It has 
been suggested that the circadian transcription of Dbp is regulated by CLOCK:BMAL1 
activation and PER:CRY mediated suppression, through E-boxes in the intronic region of 
the gene (Ripperger et al. 2000; Yamaguchi et al. 2000).  Furthermore, DBP can induce the 
mPer1 promoter in a transcriptional assay and is expressed in the correct phase to induce 
mPer1 in the SCN (Yamaguchi et al. 2000).  Other members of this family, which share 
the PAR bZip domins are hepatic leukemia factor (HLF) and thyrotroph embryonic factor 
(TEF), and both Hlf and Tef transcript levels have been shown to by rhythmic in the SCN, 
and in phase with Dbp (Mitsui et al. 2001).  It has been suggested that the functions of 
DBP are redundant and that TEF and/or HLF compensate for its loss in the Dbp null 
mutant mouse (Gachon et al. 2004a).    Interestingly, in adrenalectomised mice 100 gene 
transcripts were arrhythmic, compared to WT counterparts, as assayed in the liver but Dbp 
(along with Per2) were still rhythmic suggesting an important role in the liver, perhaps 
associated with metabolism (Oishi et al. 2005).   
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Gachon et al., (2004a) produced different genetic knock out mice consisting of a 
combination of the loss of two of the following: Dbp, Hlf and Tef or a triple knock out 
mouse.  Interestingly, a mouse harbouring the loss of Tef resulted in the sudden death of 
the animal, with the death rate highest in the triple knock out (Gachon et al. 2004a).  More 
detailed observations revealed that the triple knock out mouse mortality was due to 
tonic/clonic convulsions with symptoms that were typical for audiogenic seizures; 
however, routine histopathology of brain sections did not reveal any major differences 
between WT and knock out brains.  Furthermore, at nine months old the triple knock out 
mice exhibit signs for early aging, such as cachexia (general weakness and fatigue and 
muscle atrophy), lordokyphosis (curvature of the spinal column) and an absence of vigor 
(Gachon et al. 2004a).  In a gene array experiment, which compared transcripts from the 
liver and kidney of WT and triple knock out mice (Dbp-/-, Hlf-/-and Tef-/-) 14 of the 77 
transcripts down regulated in the kidney were also down regulated in the liver (Gachon et 
al. 2006), with many of the genes being involved in lipid and xenobiotic metabolism.  In 
the array, known target genes of the Constitutive Androstane Receptor (CAR), such as 
members of the Cyp2b and Cyp3a family were down regulated (Gachon et al. 2006).  CAR 
is expressed in hepatocytes and epithelium villi of the small intestine (Handschin and 
Meyer 2005; Qatanani and Moore 2005).  Upon activation with xenobiotic compounds, 
such as barbiturates, CAR dissociates from its chaperones and stimulates target gene 
transcription such as Cyp2b10 (similar to action of the steroid receptors) as a heterodimer 
with retinoid-X receptor (RXR) (Ueda et al. 2002).  In the triple knock out mouse, CAR 
transcript expression was constitutively low, as was one of its target genes Cyp2b10. 
Intraperitoneal injection of phenobarbital significantly induced expression of Cyp2b10 in 
both WT and triple knock out liver and small intestine, but in the knock out the expression 
was greatly attenuated (Gachon et al. 2006).  Furthermore, in the triple knock out mouse 
the liver, of both male and female mice, was increased in size (a marker of xenobiotic 
stress) and the mice had increased plasma levels of alanine aminotransferase (a marker for 
liver damage) (Gachon et al. 2006).  Further work on the Dbp-/-, Hlf-/-and Tef-/- triple 
knock out mouse revealed that it has a heart pathology too, developing cardiac hypertrophy 
and left ventricular dysfunction (associated with low blood pressure) (Wang et al. 2010).  
Blood pressure was also significantly lower and heart rate was significantly higher in the 
triple knock out compared to the WT mouse (Wang et al. 2010).  The triple knock out 
mouse also had increased activity of the sympathetic nervous system.  In terms of 
relevance to humans this is somewhat significant as there are certain mutations in the 
Chapter 1_______________________________________________________Introduction 
 
 61 
human Bmal1 gene which have been associated with hypertension and type II diabetes 
(Woon et al. 2007), and there is considerable conservation between Bmal1 regulated and 
PAR bzip transcription factors  (Gachon 2007). 
 
   
The protein adenovirus E4 promoter ATF site binding protein (E4BP4) is a bZip 
transcription factor with a very similar DNA binding domain to DBP, HLF or TEF but 
which lacks the PAR domain (Cowell and Hurst 1994; Cowell et al. 1992).  E4BP4 has 
been studied mainly in relation to the hematopoietic system (Ikushima et al. 1997; 
Kuribara et al. 1999) but due to its homology to DBP, HLF and TEF and its homology (in 
the bZip domain) to VRILLE (Mitsui et al. 2001) (a transcription factor required for a 
functional Drosophila clock, that is structurally related to DBP (Blau and Young 1999), 
E4BP4 has, therefore, been studied in a circadian context.  Mitsui et al., 2001 showed that 
E4BP4 mRNA was expressed in many brain regions including the SCN, DMH, 
hippocampus and dentate gyrus and was rhythmically expressed in the SCN, with low 
expression during the subjective day and high levels during the subjective night.  The 
respective protein also showed increased expression at CT16 relative to CT4.  However, 
this temporal profile was opposite to that of Dbp, Hlf and Tef in both the SCN and liver, 
which was also replicated at the protein level.  Furthermore, the PAR containing proteins 
DBP, HLF and TEF were all shown to induce transcription, whereas E4BP4 suppressed it 
(Mitsui et al. 2001).  E4bp4 is also a Gc responsive gene with a 4-fold induction, over 
DMSO, 4h after 1µM DEX treatment in mouse embryonic fibroblasts.  This DEX 
induction was similar to that of Per1, yet surprisingly the circadian oscillation, observed in 
the presence of the vehicle control, was lost after DEX treatment (So et al., 2009). 
 
1.7 Post-translational control of the core clock proteins 
1.7.1 Global and multilayered modifications 
 
There is currently a wealth of literature on the vast array of post-translational modifications 
of clock proteins including phosphorylation, dephosphorylation, acetylation, sumolyation 
and ubiquitination (Fig 1.5).  There are many proteins involved in this modification 
process including the core oscillator protein CLOCK, recently identified as having HAT 
activity (Doi et al. 2006).  These modifications result in various changes to the clock 
proteins, and subsequently the cell/organism, For example: pace setting and fine tuning of 
the oscillator; changing the subcellular localisation and promoting degradation of 
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individual proteins; and perhaps, more importantly, linking the clock with other internal 
processes (such as the metabolic state of the organism), proposed to be mediated through 
the histone deacetylase containing SIRT1 (Duguay and Cermakian 2009).  All these 
processes add increasing degrees of complexity to the core oscillator, which need to be 
fully dissected before a true understanding of the control mechanisms can be gained. 
 
 
Figure 1.5:  Large scale post-translational modification of core clock proteins:  
Histone acetyl transferase (HAT), histone deacetylase (HDAC), sumoylation (SUMO), 
ubiquitination (Ub), phosphorylation (P), acetylation  (Ac), S-nitrosylation  (S-Ni).  Taken 
from Duguay and Cermakian (2009).   
 
1.7.2 Phosphorylation events 
 
There are a number of kinases that are known to phosphorylate the clock proteins, with the 
most well studied being CK1ε and δ.  These two kinases are known to phosphorylate both 
PER and CRY proteins as well as BMAL1 (Akashi and Nishida 2000; Eide et al. 2002).  
CK1ε is the more intensively studied due to the gain of function tau mutation, originally 
discovered in the hamster (Ralph and Menaker 1988) but subsequently shown to be the 
same in the mouse.  This mutation, which was the first mammalian clock mutant, is the 
result of a C to T transversion at base 178, of which causes a 4h acceleration in the activity 
of the animal, from 24h to 20h in the homozygous mutant, which is conserved in both 
hamster and mouse (Lowrey et al. 2000; Meng et al. 2008a).  However, a mouse 
harbouring a deletion for the ε gene, a CK1ε null mutant, exhibits very little differences in 
its activity cycle (Meng et al. 2008a), suggesting that ε has a limited role in its WT state, 
and that perhaps δ is able to compensate for the loss of ε.  In fact, more recent data has 
suggested that δ is the major isoform in clock function, as global knock out is lethal and a 
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conditional knock out will increase the half life of PER2 by 20% and lengthen the period 
by 2h, as seen in the liver (Etchegaray et al. 2009).   
 
GSK3β is another kinase, well studied in other areas of biology such as Wnt signalling and 
glycogen synthase activation, which has been shown to phosphorylate core clock proteins.  
GSK3β is quite an unusual kinase as it requires a priming phosphorylation to occur on the 
substrate prior to it being able to phosphorylate the protein itself, this usually occurs about 
4 residues away from the target site (Frame and Cohen 2001).  GSK3β phosphorylates the 
C-terminal end of PER2 on Ser9, as shown in the rat, at a site distinct from that of CRY or 
CK1ε/δ binding.  This results in increased translocation to the nucleus, where it can repress 
CLOCK:BMAL1 mediated transcription (Iitaka et al. 2005), in association with the CRY 
proteins.  The phosphorylation status of GSK3β is itself under circadian control, with peak 
phosphorylation at CT12 (Iitaka et al. 2005), which is in phase with PER1/2 expression 
and their phosphorylation status (Lee et al. 2001).  However, the phosphorylated form of 
GSK3β is inactive, which is phosphorylated by Akt, downstream of phosphoinositide 3-
kinase (PI3) kinase pathway (Frame and Cohen 2001).  
 
GSK3β has also been shown to phosphorylate CRY2, although not CRY1, and REV-ERBα 
(Harada et al. 2005; Yin et al. 2006).  Phosphorylation of CRY2 results in increased 
nuclear localisation, like that of PER2, but also degradation, whereas phosphorylation of 
REV-ERBα promotes protein stabilisation and, therefore, increased Bmal1 repression.  
Most recently BMAL1 was shown to be phosphorylated by GSK3β on two residues, Ser 17 
and Thr21, priming it for ubiquitination and degradation via the proteasome (Sahar et al. 
2010).  In summary, GSK3β is able to phosphorylate many of the clock proteins, which 
together opens a very complex phosphorylation system, all with just one kinase.  The use 
of small molecule inhibitors of GSK3β has resulted in the period shortening, by 
approximately 2h, in an hBMAL1::luc reporter cell line, with a similar outcome observed 
with siRNA (Hirota et al. 2008).  However, inhibition with lithium, another inhibitor or 
GSK3β, resulted in period lengthening.  The reason behind this difference is unresolved, 
but as the siRNA knock down agrees with small molecule inhibitor data then this seems 
more likely. 
 
There are other kinases involved in the oscillatory loop, including MAPKp42/44, which 
play a role in light response in the SCN (Coogan and Piggins 2004) and which oscillate in 
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the SCN too (Obrietan et al. 1998).  Many other kinases have been shown to play a role, 
albeit minor, through mass kinase inhibitor screening projects, kinases such as casein 
kinase II (CKII), Akt, PI3 kinase (mentioned above), MAPK p38 and c-Jun N-terminal 
kinase and protein kinase C (PKC) have all been found to alter period length (Isojima et al. 
2009), suggesting a very complex hierarchical system of modification, and just through 
phosphorylation events.  
1.7.3 Acetylation and deacetylation 
 
Acetylation is usually associated with histone modification and the promotion of gene 
transcription. Whereas deacetylation is associated with the opposite, gene silencing, 
although genes are not totally dormant after deacetylation as this occurs in association with 
demethylation.  Acetylation is carried out by histone acetlytransferases (HATs) which 
modify lysine residues on histone proteins that are associated with DNA supercoiling.  
Deacetylation is the removal of acetylation by histone deacetlyases (HDACs).  
Transcription of the clock and histone modification has been documented with a light pulse 
in the night inducing histone H3 phosphorylation and the transcription of cFos, an 
immediate early gene and Per1, in the SCN (Crosio et al. 2000).  Furthermore, areas of 
chromatin associated with clock genes Per1, Per2 and Cry1 are acetylated on histones H3 
and H4 during transcription (Etchegaray et al. 2003).  HAT activity is often associated with 
transcriptional activator proteins, that induce gene transcription, such as p300 (Etchegaray 
et al. 2003), but HAT activity has also been discovered in the clock activator protein 
CLOCK, which acetylates lysine residues on histones H3 and H4 and is necessary for 
CLOCK induced gene transcription (Doi et al. 2006).  More surprisingly,  however, 
CLOCK is able to acetylate non-histone proteins, in particular BMAL1 (section 1.6.3.3) on 
lysine 537 (Hirayama et al. 2007).  This acetylation does not alter subcellular localisation, 
its degradation or even its association with the Per2 promoter.  It does, however, enhance 
the CLOCK:BMAL1-CRY1 association, which then promotes CRY1 mediated repression 
in association with the PER2 bridge (section 1.6.2.1; (Chen et al. 2009) (Hirayama et al. 
2007).  The CLOCK:BMAL1 heterodimer (more specifically CLOCK) has been shown 
recently to acetylate a cluster of 4 lysine residues (480, 492, 494, 495) on the hinge region 
of the glucocorticoid receptor (GR) (section 1.10.3), which is sandwiched between the 
DNA binding domain (DBD) and the ligand binding domain (LBD) towards the C-terminal 
of the protein (Nader et al. 2009).  This multiple acetylation pattern represses GR induced 
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transcription by reducing its association with the glucocorticoid response element (GRE) in 
GR target genes. 
 
Deacetylation, as stated, is the removal of acetyl groups from both histone and non-histone 
proteins, in order to repress gene transcription.  There are 4 classes of HDACs, termed 1 to 
4, and two of these classes have members associated with circadian protein interaction and 
regulation.  Class 1 HDACs have three members involved in circadian regulation, 
HDAC1/2 have been associated with CRY1 mediated repression of CLOCK/BMAL1 
induced Per1 transcription, after a light pulse (Naruse et al. 2004) and NCoR associates 
with HDAC3 before complexing with REV-ERBα, to repress Bmal1 transcription (Yin and 
Lazar 2005).  The second class of HDACs involved in circadian regulation is class 3, 
which all share homology to the yeast Sir2 protein and are NAD* dependent in their 
activity (Duguay and Cermakian 2009).  SIRT1 is a key member of this class and is known 
to regulate many biological processes such as cell survival, gluconeogenesis, insulin 
secretion and neuronal survival (Wojcik et al. 2009).  SIRT1 has rhythmic protein 
expression, in phase with PER2, but there is no rhythm at the mRNA level, suggesting that 
it is under post-translational modification control (Asher et al. 2008).  In SIRT1 knock out 
MEFs, the levels of Bmal1, Per2 and Cry1 mRNA were all decreased, yet at the protein 
level CLOCK was absent and BMAL1 was barely detected, but both PER2 and CRY1 
showed increased expression, although there was no circadian rhythm detected (Asher et 
al. 2008).  Together these data suggest that SIRT1 activity is required for a robust and 
functional clock.  It is currently unknown which HAT protein acetylates PER2, although it 
is tempting to suggest that CLOCK is involved.  Interestingly other groups have suggested 
that SIRT1 also targets BMAL1 for deacetylation (Nakahata et al. 2008) but this was not 
repeated by Asher et al. (2008), perhaps as Nakahata et al. (2008) had used a transfected 
cell line whereas Asher et al. (2008) had used MEFs, suggesting that the model of 
investigation is critical to the outcome of the experiment and that there is differential 
regulation in different tissues and cell types. 
1.8 Peripheral Oscillators 
1.8.1 Overview 
 
Even though the central clock (often referred to as the master clock), is located in the SCN 
there are known to be clocks in many other peripheral tissues and cells.  Tissues such as 
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the liver, lungs and heart each have their own clocks (often referred to as the slave clocks) 
(Yamazaki et al. 2000; Yoo et al. 2004), but which rely on the SCN to synchronise them to 
exogenous solar time.  This has been shown in SCN lesioned mice where peripheral clocks 
are no longer co-ordinated, neither between the same organ in different animals or between 
different organs in the same animal (Yoo et al. 2004), although prolonged rhythms still 
persist in explanted peripheral tissues in SCN lesioned animals.  In a series of interesting 
experiments Guo et al. (2006) SCN lesioned hamsters and measured endogenous 
peripheral clock transcripts.  In this study, rhythms were lost in all tissues analysed, which 
was slightly different to that seen with Yoo et al. (2004).  However, replacement of the 
SCN restored these rhythms in some (liver, kidney) but not all (heart, skeletal muscle) 
tissues.  These data confirm that peripheral organs differ in their response to SCN born 
signals, and that the liver and kidney must be taking their timing cues from another source 
such as blood born signals or perhaps feeding signals.  However, results such as these 
mean care must be taken when using a ‘peripheral’ model to investigate the clock, it is 
more likely that individual tissues act individually rather than as one population (Guo et al. 
2006).  Furthermore, it is this internal synchronisation, between the SCN and periphery, 
which is the source of a lot of interest in circadian biology at the moment and will form the 
basis of much research over the coming years, including within this thesis.  The principal 
questions asked are, ‘How does the SCN communicate with the periphery’, and ‘What are 
the outputs and consequences from peripheral clocks?’ 
 
Peripheral oscillators are entrained to the external environment by the central oscillator, the 
SCN (Stratmann and Schibler 2006), (Fig 1.6).  This is via hormonal signals (such as Gcs), 
or neuronal signals, but also by other external signals such as feeding (referred to as 
zeitgebers), where daytime restricted feeding of a nocturnal rodent will invert the phase of 
the peripheral clocks relative to that of the SCN, which is largely unaffected (Damiola et 
al. 2000).  The ambient temperature cycle is another possible zeitgeber as temperature 
rhythms can induce oscillation in cultured Rat-1 fibroblasts (Brown et al. 2002).  This 
entrainment process is necessary as mammalian tissues are not directly light-sensitive, 
though peripheral tissues in lower eukaryotic animals are, such as Drosophila and Zebra 
Fish (Hastings et al. 2003) and as such do not necessarily require such entrainment.  
Peripheral clocks, in common with the SCN, are temperature compensated over the normal 
mammalian temperature range, 33oc to 42oc.  The reason for this remains unclear but many 
animals can lower their body temperature, known as torpor, under certain conditions (i.e. 
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on calorific restriction, prolonged exposure to short days and low glucose intake).  
Furthermore, the major temperature decrease is hibernation, yet the animal still needs to 
wake at an appropriate time, such as the Spring, so must maintain a functional clock 
(Stratmann and Schibler 2006).  This may offer a partial clue as to the reason, yet the 
method requires further investigation. 
 
Figure 1.6:  The entrainment of peripheral clocks by the SCN (Stratmann and Schibler, 
2006). 
1.8.2 The lung as a peripheral model 
 
Moving away from the central molecular oscillator, in the SCN, this thesis aims to look at 
the clock in the periphery, with particular interest in the lung, using the mouse as a model.  
The reasons are relatively simple and two fold.  First there has been little work carried out 
on the lung as a circadian organ compared with other organs such as the liver and heart, 
even though expression of clock genes in the periphery (Tei et al. 1997) and oscillations 
specifically in explanted lungs (Yamazaki et al. 2000; Yoo et al. 2004) have been known 
for many years.  Secondly, is that respiratory diseases, such as asthma and chronic 
obstructive pulmonary disease, (COPD), are generally thought to have a circadian 
component, for example airways are narrowest in the early hours of the morning (Brenner 
2003).  In addition Gcs are known to be potent regulators of the peripheral clock 
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(Balsalobre et al. 2000a) (discussed more in section 1.10), are used widely in the treatment 
of inflammatory diseases such as arthritis and inflammatory bowel disease but also in the 
treatment of asthma to alleviate the symptoms of inflammation (Barnes and Adcock 2003), 
yet surprisingly this treatment does not work too well in COPD patients (Barnes et al. 
2004). 
1.8.3 Lung structure: Clara Cells and Type II Pneumocytes 
 
The mammalian lung is structured with the trachea leading from the nasal cavity which 
splits into the bronchi (one each for the left and right lobes), each bronchus then splits into 
the bronchioles and they terminate in the alveoli.  Many cells make up the various sections 
of the lung but key cell types are the Clara cells and Type II pneumocytes.  Clara cells are 
a well differentiated cell type with a high secretory activity, located in the bronchial 
epithelium of the mammalian lung (Fig 1.7).  Clara cells are non-ciliated and form a major 
cell type of the bronchioles along with some other ciliated cells (Cassel et al. 2000).  
Numerous proteins are known to be secreted from the Clara cells but the major protein is 
the Clara Cell Secretory Protein, CCSP (Cassel et al. 2000), which is specific to the Clara 
cell and, therefore, can lead to easy identification (Gibbs et al. 2009).  CCSP itself is a 
small 10kDa homodimeric protein, and has been shown to co-express with both CLOCK 
and PER2, in the lung.  Isolated Clara cells have a sustained oscillation with a period of 
about 23.8 hr +/- 0.4, and selective disruption of these cells with naphthalene abolishes the 
oscillation in lung explants (Gibbs et al. 2009); leading to the conclusion that these cells 
are of vital importance to the lung oscillation. Furthermore, IL-6, an oscillating cytokine 
involved in the inflammatory response (discussed further in 1.8.), has been shown to be 
released from bronchial epithelial cells and although Clara cells were not specifically cited, 
there is a potential link between this cell type and the circadian aspects to pulmonary 
inflammation (Khair et al. 1996). 
 
Type II pneumocytes are a further specialised cell type within the alveoli of the lungs (Fig 
1.8), which potentially express CLOCK and BMAL1,  however, evidence is still 
circumstantial (Gibbs et al. 2009).  They are sometimes referred to as the ‘corner cells’ of 
the alveolus due to their location in the corners of the alveoli in healthy lungs (Ulich et al. 
1994).  Type II pneumocytes have a multifunctional role within the lung, which includes 
secretory, synthetic and progenitor capabilities (Bhaskaran et al. 2007b).  The Type II cells 
act as progenitors for the Type I cells, also within the alveolar epithelium in the event of 
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injury (Fig 1.8).  Type II cells are also metabolically active, with their major role being to 
produce and secrete surfactant proteins.  In contrast, the Type I cells are relatively inactive, 
and their main function is to provide a suitable interface for oxygen exchange between air 
and the capillaries (Ulich et al. 1994).  Surfactant is comprised of phospholipids, especially 
phosphatidylcholine and phophphatidylglycerol, and the surfactant proteins 
released/produced by the pneumocytes are, SP-A, B, C and D (Mason et al. 2003).  They 
are secreted to reduce surface tension at the air liquid interface in the lung, preventing 
alveolar flooding, alveolar instability and small-airway closure (Mason et al. 2003).  There 
have also been limited reports that SP-C has a circadian expression pattern (Kim et al. 
2003) and that transcript expression of SP-A, B and C is up-regulated by exogenous Gcs 
administration, yet no change is seen after adrenalectomy (Fisher et al. 1991), suggesting a 
minor but significant role in administered doses like that seen with asthma.  The Type II 
cells contain a unique organelle called a lamellar body, in which surfactant is stored before 
secretion, and the differentiation of Type II cells occurs relatively late in foetal 
development as the surfactant system needs to mature before birth (Li et al. 1995).  It is 
believed that Type II cells play a prominent role in the morphogenesis of foetal lungs as 
well as producing the surfactant proteins necessary for the transition from the amniotic 
fluid to the air (Ulich et al. 1994).  It is understood that Gcs, estrogen, thyroid hormones 
and epidermal growth factor may enhance foetal lung development and promote surfactant 
production in vivo (Ulich et al. 1994). Both Clara and Type II cells have been identified as 
the putative epithelial lung stem cells.  Clara cells are associated with the regeneration 
following tissue damage, whereas the re-modelling of alveolar structure following damage 
or increased metabolic demand is attributed to Type II cell conversion to Type I, 
(Bhaskaran et al. 2007). 
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Figure 1.7:  Clara cell location in the lung bronchioles of the human lung:  This image 
shows the position of the Clara cells which line the bronchioles in the lung.  Clara cells are 
outlined and marked (image taken from www.bu.edu/histology/i/13805loa.jpg). 
 
 
Figure 1.8:  Position and shape of Type I and II pneumocytes in the lung:  This image 
shows the position and shape of the type I and II pneumocytes in the lung (image taken 
from http://www.ouhsc.edu/histology/Glass%20slides/14_14.jpg). 
 
1.9 C/EBP as clock controlled output genes 
1.9.1 The family of C/EBPs  
 
CCAAT/Enhancer binding proteins (C/EBPs) are a family of transcription factors, which 
belong to the bZip family of proteins.  The first C/EBP protein was identified by McKnight 
and co-workers which bound to a CCAAT element in the promoter of target genes.  
Further work also identified the bZIP DNA binding and dimerisation domain, which led to 
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the discovery of many more proteins with this structure (Landschulz et al. 1988).  There 
are six known isoforms of C/EBPs, which are classified as: α, β, γ, δ, ε and ζ; they all 
contain the C-terminal bZip domain but the N-termini differ in length and composition.  
Furthermore, α, β and ε have multiple protein products, resulting from a secondary 
downstream ATG start site, a leaky ribosome or selective proteolysis, and most probably a 
mixture of the three.  The  α, β, γ, δ  isoforms are all intronless, that is they only have one 
coding exon whereas the ε and ζ isoforms have 2 and 4 respectively (Ramji and Foka 
2002). C/EBPs have been identified, over the last decade, as having a pivotal role in many 
cellular processes, such as controlling growth and differentiation and immune and 
inflammatory responses (Ramji and Foka 2002).  C/EBP α and β are particularly difficult 
to study as knock out mice lead to death with regard to α (Wang et al. 1995), with 
conditional knock outs also proving problematic (Lee et al. 1997) and either death or 
serious liver problems with regard to β knock out mice (Roesler 2001).  C/EBP α, β and δ 
are expressed in high levels in many peripheral tissues such as the liver, lungs and adipose 
tissue; whereas ζ and γ are ubiquitously expressed and ε is restricted to myeloid and 
lymphoid cells.  C/EBPs have been implicated in the differentiation of many cell types 
including: adipocytes, hepatocytes, ovarian luteal cell, neuronal cells and others.   The 
mRNA of C/EBP β and δ is induced during mitosis of the undifferentiated cell in response 
to an increase in cyclic adenosine mono phosphate (cAMP) and Gcs respectively, with 
C/EBP α being expressed after exit from the cell cycle and with C/ebp α being induced by 
β and δ (Ramji and Foka 2002).   
 
Using microarray transcriptional profiling, with a NIH 3T3 cell line Gery et al. (2005) 
provided a link between the circadian clock and C/EBPs, providing evidence to show that 
both Per2 and Rev-erba were altered by C/EBPs, as well as the clock output gene, Dbp.  
The greatest induction, however, was with C/EBPε, giving an 11 fold increase in Per2 
transcription. In a confirmation assay, a Per2 promoter-luciferase construct was co-
transfected with C/EBPα and ε resulting in a 7 and 5 fold transcriptional increase, showing 
that Per2 was induced by both proteins (Gery et al. 2005).  Other roles for C/EBPs include 
control of metabolism, cellular proliferation, a role in inflammation and a novel role in 
long-term synaptic plasticity underlying memory (Alberini et al. 1994) in the Sea slug 
Aplysia, in which ApC/EBP was later shown to be under circadian control (Lyons et al. 
2006).   
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There are very strong links between the C/EBP family and the inflammatory response.  
C/EBP β was first identified as it regulated gene transcription in response to interleukin-6 
(IL-6) and IL-1 (Akira et al. 1990; Poli et al. 1990) and now it has emerged that a great 
many proteins in the inflammatory response are indeed regulated, or at least partially, by 
the C/EBP family (Ramji and Foka 2002).  There is a C/EBP binding site within the 
promoter of the tumour necrosis factor receptor 1 (TNFα), which is required for both 
C/EBP α and β induction, and activation of this gene is significantly inhibited if either 
C/EBP α or β are knocked down by small interfering RNA (siRNA) (Bristol et al. 2009).  
C/EBP β is also very important for the inflammatory response and macrophage 
differentiation (Pham et al. 2007; Poli 1998).  More recently, it has been demonstrated that 
both C/EBP α and β can activate expression of 11β-hydroxysteroid dehydrogenase type 1 
(11β-HSD1), an enzyme used to convert inactive Gcs to the active form (Ignatova et al. 
2009), which act as potent anti-inflammatory agents.  In addition to this, C/EBP β 
specifically binds to the 11β-HSD1 promoter, to up regulate transcription in the presence 
of TNF α, (discussed further in section 1.12) during an inflammatory response and forming 
part of the feedback loop to suppress inflammation (Ignatova et al. 2009). 
1.9.2 C/EBPs, Type II Pneumocytes and Clara Cells 
 
It has been recognised for a long time that C/EBPs are expressed in many cell types 
including the lung, in particular the α, β and δ isoforms (Cao et al. 1991) (discussed 
previously in section 1.9.1).  However, little was known about cellular localisation until Li 
et al. (1995) demonstrated a correlation between C/EBPα and expression of surfactant 
protein in Clara cells, as well as Type II pneumocytes, although with far greater C/EBPα 
expression in the latter.  Further work has shown a correlation between C/EBP α and CCSP 
in in-vitro cell culture models, (Nord et al. 1998), with further studies showing CCSP gene 
activation through C/EBPα and delta binding to the C/EBP promoter elements (Cassel et 
al. 2000).  However, C/EBPδ has far more effect on activating transcription than the α 
isoform. 
 
C/EBPα is known to target genes associated with lipid metabolism and it has been shown 
in hepatocytes that C/EBPα activates expression of apolipoprotein B (Li et al. 1995), which 
is a component of  low density lipoproteins.  C/EBP α mRNA was shown, more that a 
decade ago, to be present in the Type II pneumocytes in the lung and in a paper produced 
by Li et al. (1995) C/EBPα expression also correlated with the expression of surfactant 
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protein genes.  It was further shown by Li et al. (1995) that there is more C/EBPα mRNA 
in the lung than in either the spleen or kidney, using the rat as a model, with a large portion 
of this mRNA resulting from the Type II cells.  Furthermore, in the C/EBPα knock out 
mouse part of the reason for death shortly after birth is the hyperproliferation of the Type II 
pneumocytes, which results in the reduction of the alveolar air space and an inability to 
breath efficiently (Flodby et al. 1996). 
 
In summary, there is good evidence for clock gene localisation in both Clara cells and 
Type II pneumocytes and Clara cells are known to oscillate.  C/EBPs are known to be 
present in Type II pneumocytes and are known to regulate CCSP gene activation, as well 
as Type II cell surfactant protein expression.  These data form a good basis to a hypothesis 
stating that the Clara cells and Type II cells are clock regulated components of the lung and 
that C/EBPs play a prominent role in their physiology as a clock mediated gene/protein. 
1.10 Glucocorticoids and circadian regulation  
1.10.1 Corticosterone: hormonal production and secretion 
 
The majority of peripheral tissues and cell types studied contain functional clocks, yet they 
cannot be entrained directly by light and must, therefore, be entrained via the SCN through 
an alternate route such as neuronal or hormonal, so that the peripheral clocks are in phase 
with the environment (Oster et al. 2006).  It has been suggested that Gcs are suitable blood 
born factors which could relay the phase of the clock between the SCN and the periphery 
(Balsalobre et al. 2000), as the Gc analogue dexamethasone (DEX) can both induce Per1 
and Per2 transcript expression and induce sustained circadian rhythms (Balsalobre et al. 
2000a; So et al. 2009).  Alternative factors, proposed to transfer the phase signal to the 
periphery include; cAMP, protein kinase C (PKC), receptor tyrosine kinases, which are 
intrinsic factors (Balsalobre et al. 2000b) and retinoic acids and the epidermal growth 
factor receptor, which are extrinsic factors (Koyanagi et al. 2006b), but Gcs are regarded as 
the predominant circulating factor.  These alternative factors must be in use in order to 
relay the phase of the central clock and therefore external time, as the removal of the 
adrenal glands (thus loss of the Gc signal) does not automatically result in the loss of a 
circadian rhythm.  In adrenalectomised mice over 100 genes lost their circadian rhythm in 
the liver but Per2 and Dbp did not (Oishi et al. 2005).  This is further supplemented by 
work on tumours where there was no significant difference seen in the circadian expression 
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of Bmal1, Clock, Per2 or Cry1 in tumours implanted in to adrenalectomised or sham 
operated mice, yet the circadian expression of Topoisomerase I was lost (Kuramoto et al. 
2006).  The rat Per2 rhythm in the central region of the amygdala and the oval nucleus of 
the bed nucleus of the stria terminalis is lost when the adrenals are removed, and regained 
when CORT was supplemented in the drinking water (Segall et al. 2006).  Together, these 
data suggest regional specificities of CORT regulation and alternative synchronising 
factors other than glucocorticoids.   
 
Gcs are derived from a cholesterol precursor and are synthesised in the adrenal cortex, in 
regions called the zona glomerulosa (ZG)  and zona fasciculata (ZF) (Oster et al. 2006).  
Gc release, from the adrenal, is under both hormonal and neuronal control, which results in 
both circadian and ultradian secretion (Chrousos 1998; Windle et al. 1998a; Windle et al. 
1998b) (Fig 1.10).  Although relatively little work has been carried out on the ultradian 
rhythm, in relation to the clock, it does appear to be circadian modulated with a less 
frequent pulse release in the short period tau mutant hamster compared to the WT (Loudon 
et al. 1994). 
 
In terms of hormonal regulation, the SCN activates the rhythmic release of corticotrophin-
releasing hormone (CRH) from the paraventricular nucleus (PVN), which is released into 
the median eminence that subsequently induces the release of adrenocorticotropin hormone 
(ACTH) from hypophysial adrenocorticotroph cells in the anterior pituitary (Simpson and 
Waterman 1988).  However, ACTH secretion can also be stimulated by arginine 
vasopressin (AVP) and oxytocin, both released into the median eminence from nerve 
terminals leading from the PVN, which can then induce ACTH release from the posterior 
pituitary (Dickmeis 2009).  ACTH is then released into the peripheral blood stream and 
can induce the release of CORT from the ZG and ZF in the adrenal cortex (Simpson and 
Waterman 1988).   This is known as the hypothalamic pituitary adrenal axis (HPA).  
Interestingly though, there are few direct projections between the SCN and the 
medioparvocellular (mp) division of the PVN (mpPVN) (Fig 1.9), where CRH and AVP 
neurons originate from (Vrang et al. 1995), although the SCN does show direct 
connections with the subparaventricular zone (subPVZ) and  the dorsomedial nucleus of 
the hypothalamus (DMH), which then connect with the mpPVN (Dickmeis 2009), so 
perhaps an indirect SCN connection via the DMH and mpPVN. In Syrian hamsters where 
the SCN had been lesioned, but a fetal SCN had restored the behavioural rhythm the 
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CORT rhythm was not restored.  Equally there was no melatonin rhythm in SCN lesioned 
animals where a graft had restored the behavioural rhythm, nor was testis regression 
observed (Meyer-Bernstein et al. 1999).  Together these data suggest that endocrine 
rhythms require greater neural circuits than those required for activity rhythms.  ACTH 
release is itself under both circadian and ultradian regulation, similar to that of CORT 
(Carnes et al. 1989; Chrousos 1998); in addition to this CRH mRNA also has a circadian 
component to its synthesis (Watts et al. 2004), resulting in the tight circadian control of 
CORT release.  However, ACTH release has been shown to precede CRH transcription and 
as a result their interaction may only be slight.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                          
 
 
Figure 1.9:  Hormonal and nerve connections between the SCN and adrenal gland: 
Suprachiasmatic nucleus (SCN); subparaventricular zone (subPVZ); dorsomedial 
hypothalamus (DMH); paraventricular nucleus (PVN); medioparvocellular division of the 
PVN (mpPVN); interneuron of the PVN (I); corticotrophe cell of the pituitary (C); 
intermediolateral column of the spinal cord (IML); arginine vasopressin (AVP); 
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corticotrophin releasing hormone (CRH); adrenocorticotropic hormone (ACTH), 
(Dickmeis 2009). 
 
Furthermore, under various experimental conditions, reports have been made that the 
release of ACTH and CORT do not align, and as such the regulatory process of CORT by 
ACTH, may be uncoupled (Dickmeis 2009), yet other studies suggest that ACTH release 
peaks approximately 2h prior to the CORT peak (Oster et al. 2006).  These observations 
may be due, in part, to the ultradian pulses of both CORT (Fig 1.10) and ACTH coupled to 
the acute stress response of the animal (where CORT release dramatically increases the 
animal’s survival response).  It has been hypothesised that this stress response is the 
reason, or at least part of the reason, behind the observed ultradian rhythm (Lightman et al. 
2008; Windle et al. 1998b). 
 
 
Figure 1.10: The circadian and ultradian rhythm of corticosterone in female rat over 
24 hours taken in ten minute intervals:  This trace shows approximately 27 pulses in 24h 
which equates to one ever 51 min (Windle et al., 1998). 
1.10.2 Corticosterone: neuronal production and secretion 
 
The above pathway states the generally accepted route through which Gcs in the adrenal 
gland are synthesised, but it is also known that there are alternative routes of production 
leading from the SCN to the adrenal.  In both gulf killifish and rats, surgical removal of the 
pituitary gland did not result in the loss of the Gc rhythm even in the absence of ACTH; 
yet the Gc rhythm was lost in rats when their adrenal glands were denervated (Dickmeis 
2009), suggesting neuronal control.   Virus tracing has shown a neuronal connection 
between the SCN and adrenal gland involving multiple synapses.  Using Fig 1.9 as a guide, 
the SCN connects to the pre-autonomic PVN neurons and then to the preganglionic 
neurons of the intermediolateral column (IML) in the spinal cord.  This connection then 
innervates the adrenal gland via the splanchnic nerve (Buijs et al. 1999).   Interestingly this 
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pathway does not overlap with the HPA axis outlined in section 1.10.1 and Fig 1.9 as the 
two areas of the PVN involved are distinct regions, suggesting a divergence in regulation 
at the PVN level. 
 
In a study using light pulses in the rat Buijs et al. (1999) demonstrated that a 5 min light 
pulse in the early part of the subjective night (CT14) resulted in a repression of CORT 
release but not when light pulsed in the late subjective night or day, as seen in intact 
animals, incidentally no suppression was observed in SCN lesioned mice.  However, a 
similar study using a 30 min light pulse in the early subjective night failed to detect an 
increase in CORT up to 60 min after the pulse, then there was a large sustained induction 
of CORT, which had returned to baseline conditions by 180 min.  This induction was 
independent of an ACTH increase, and showed different temporal events to the immediate 
change induced by a stress response (Ishida et al. 2005).  The induction was also lost after 
denervation of the adrenal and after SCN lesion.  The 30 min light pulse resulted in 
increased expression of Per1 in the adrenal, when administered in the subjective night but 
not the day, also there was increased phosphorylation of ERK1/2, 60 min after the light 
pulse but not CREB phosphorylation (Ishida et al. 2005).  This is different to what is seen 
in the SCN after a light pulse in the early night, where CREB is phosphorylated in 
response to light and binds to it response element (CRE) in the promoter of Per1 (Albrecht 
et al., 1997) (section 1.5.2.1).  These data show that there is a different regulatory 
mechanism in central and peripheral tissues, with regard to light induction. 
1.10.3 The nuclear hormone receptors: glucocorticoid and mineralocorticoid  
 
The GR is part of a family of receptors which includes the mineralocorticoid receptor 
(MR), vitamin D receptors and retinoic acid receptors, which all act as ligand dependent 
transcription factors and share a similar gross structure and conservation.  The GR is 
highly conserved throughout vertebrate species and is made up of: a N-terminal region; 
DBD in which there are two zinc finger motifs to allow DNA binding; a hinge region; a 
LBD, and a C-terminal region (Stolte et al. 2006).  There are 2 GR splice variants termed 
GRβ and GRγ, in addition to the more widely known ligand binding receptor GRα, 
mentioned above.  GRβ does not bind ligand, due to differences in the C-terminal region, 
and as a result was largely ignored for many years, however, over recent years interest has 
been resurrected in this isoform due to its wide tissue specificity and the idea that it may 
act as a dominant negative mutant to the GRα isoforms (Lu and Cidlowski 2004; Yudt et 
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al. 2003).  A further splice variant GRγ has been isolated, which has an in-frame insertion 
mutation between the two zinc finger motifs in the DNA binding domain (Rivers et al. 
1999) and makes up about 4-8% of the total GR, although it has much less transcriptional 
activity than GRα and has been associated with human cancers, with a similar insertion 
found in membrane GR (mGR) and the human MR (Lu and Cidlowski 2004). 
 
In its inactive state the GR is located in the cytoplasm of the cell, bound to chaperone 
proteins, which are made up of Hsp and are essential for the opening of the cleft to allow 
the ligand to bind.  Hsp70 binds first to the GRα LBD and induces a conformational 
change in the ligand binding cleft; Hsp90 is then able to bind to this complex and fully 
open the binding cleft and allow the ligand, such as CORT, to bind (Stolte et al. 2006).  
The chaperones will then dissociate and the GR can be activated by phosphorylation and 
translocate to the nucleus, where it will bind to the palindromic response element in the 
target genes (GRE) (Fig 1.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11:  Nuclear receptor signalling:  Here the GR is shown as a homodimer yet the 
same pathway is used by the MR homodimer and the GR:MR heterodimer.  Image taken 
from http://www.panomics.com/images/94_2_GRHOW_1_V1.jpg. 
 
Despite its name, the MR shows a 10 fold higher binding affinity for Gc than the GR (De 
Kloet et al. 1998).  While GR appears to be ubiquitously expressed throughout the brain 
and periphery, at both mRNA and protein level (Arriza et al. 1988; Morimoto et al. 1996) 
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the MR seems to be far more restricted with its expression in peripheral tissues such as the 
kidney and in brain regions (like the hippocampus and pituitary) (Funder and Sheppard 
1987).   The MR cannot distinguish between its main ligand aldosterone and CORT, so 
local enzymatic conversion of active to inactive CORT is used to allow aldosterone to bind 
in target tissues such as the kidney.  Hydroxysteroid 11-β dehydrogenase (HSD11β) type 1 
and 2 mediate the conversion between active and inactive CORT.  The type 2 enzyme, 
expressed in MR target tissues removes the hydroxyl group on the 11th carbon rendering 
CORT inactive, whereas the type 1 enzyme, more widely expressed replaces it (Dickmeis 
2009).  The type 1 enzyme has been shown, in the rat, to be expressed in a circadian 
manner at the mRNA level, with increased expression in the morning relative to the 
evening, although the timing of this is out of synchronisation as peak CORT expression is 
prior to the onset of activity (in the night) and peak mRNA of the HSD11β type 1 enzyme 
is 12h earlier.  However, this has been reported in the hippocampus and has not been 
observed in the periphery (Buren et al. 2007). 
1.10.4 GR, Gcs and circadian regulation 
 
Although the circadian and ultradian regulation of glucocorticoids has been well 
documented, there have been mixed reports on the circadian regulation of GR itself, 
mainly characterised at the transcript level.  In HeLa cells, the GR transcript showed no 
circadian oscillation, either in the presence or absence of the Gc analogue DEX (Nader et 
al. 2009).  However, in the same study the highly responsive GR induced gene, the 
glucocorticoid induced leucine zipper (GILZ) did show circadian transcript regulation.  A 
further study characterising the expression of all 49 mouse nuclear receptors in 
metabolically active tissues, white and brown adipose tissue (WAT and BAT respectively), 
liver and muscle revealed that 25 were rhythmically active, including GR.  However, the 
GR was only rhythmic in WAT and BAT and peak expression was in anti- phase to each 
other, with WAT peaking at zeitgeber time 12 (ZT12) and BAT at ZT0.  Furthermore, MR 
was not found to be rhythmic in any of the tissues studied (Yang et al. 2006), although the 
tissues studied were not classical MR target tissues.  The GR protein has not been shown to 
be under direct circadian regulation, as seen in the lung (Gibbs et al. 2009), but a day/night 
difference was seen, in cytosolic expression, in the hippocampus, but not in the 
hypothalamus (Furay et al. 2006).  Furthermore, many heat shock proteins are under 
circadian control, which complex with the GR in the cytoplasm (Kornmann et al. 2007; 
Reinke et al. 2008).  The GR/heat shock complex has been shown to be under region 
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specific circadian regulation.  Furay et al. (2006) reported that there was no time of day 
difference in the cytosolic expression of Hsp70 or 90 in the hippocampus, but circadian 
variation was observed in the GR/Hsp90 complex, with a greater association in the evening 
relative to the morning. 
 
In a detailed study of the systemic regulation by glucocorticoids in SCN ablated mice 
Reddy et al. (2007) demonstrated that a single dose of DEX could re-synchronise 20% of 
the liver circadian transcriptome and almost 60% of circadian genes were either up or 
down regulated by DEX.  Interestingly, of the genes re-synchronised by DEX, two-thirds 
carried a putative GRE in their promoter or first intron, and of those, the majority were 
enriched for other regulatory transcription factors, suggesting dual regulation (Reddy et al. 
2007).  Further investigation revealed that hepatocyte nuclear factor 4 α (HNF4α) was a 
key element in co-regulation both with GRE and in the absence of the GRE.  HNF4α was 
shown to be highly rhythmic in this study, peaking in phase with Per2, and rhythmicity 
lost in the Clock -/- mouse, but interestingly no HNF4α rhythm was detected in the liver in 
the Yang et al.  (2006) study.  However, in the HNF4α gene locus there are three canonical 
E-boxes and three putative GREs and the gene is induced in response to DEX.  Together 
these data suggest that HNF4α is a true Gc signal relay, working both in partnership and 
individually with the GR to synchronise the liver clock, however, regulation of other 
peripheral tissues is undetermined. 
1.10.5 Other nuclear receptors and circadian timing 
 
This thesis has focused largely on CORT resetting of the circadian clock, mediated through 
the GR, with a contribution from the MR.  Even though CORT release is known to be 
under circadian control (section 1.10.1) and the GR almost ubiquitously expressed, the GR 
does not appear to be rhythmic in all tissues where it is expressed.  The GR has been 
shown to be rhythmically expressed, at the transcript level in WAT and BAT peaking at 
ZT0 and ZT12 respectively (Yang et al. 2006), but not other metabolically active tissue 
such as the liver and muscle.  However, at the protein level in the murine lung the GR was 
shown to be constitutively expressed (Gibbs et al. 2009).  Furthermore, in Zebrafish larvae 
the expression of GR transcript and protein is constitutive over the circadian day, even 
under a LD cycle (Dickmeis et al. 2007).  Also the MR is not thought to be under circadian 
control, as it was arrhythmic in the tissues studies in the Yang et al. (2006) study.  
However, there are 49 nuclear hormone receptors in the mouse and in the study of Yang et 
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al. (2006), which examined WAT, BAT, liver and muscle expression, 25 of these nuclear 
receptors were expressed in a circadian manner.  In all, six nuclear receptors were 
rhythmically expressed in all four tissues studied: estrogen related receptor β (ERRβ), Rev-
erbα and β, germ cell nuclear factor (GCNF) and testicular receptor 4 (TR4).  Yet 14 
others were rhythmically expressed in two or three of the tissues, such as TR2, retinoic 
acid receptor α and γ (RARα and γ), thyroid hormone α (THα) and PPAR α, γ, δ 
(peroxisome proliferator-activated receptor α) .  The vitamin D receptor, RORα and β and 
thyroid hormone receptor β only cycled in one tissue.  Interestingly, when the time of peak 
expression was characterised, ZT4 was the time when most nuclear receptor showed peak 
expression, and of the receptors that were rhythmic in more than two tissues, eight 
maintained the same phase between tissues (such as ERRα, ERRγ, Rev-erbα, Rev-erbβ, 
RORγ and TRa).  These data suggested that there is some importance surrounding ZT4, but 
the reason behind it remains unknown, although it is the early part of the subjective day 
(rest period for nocturnal animals) so perhaps it is to do with metabolising food and fat 
storage.  However, other receptors were uncoupled between tissues (such as PPARγ and δ, 
GR and GCNF).  Uncoupling is unusual and suggests that some nuclear receptors may be 
entrained by different zeitgebers in different tissues (Yang et al. 2006). 
 
In the discussion above, of the latter group of nuclear receptors, i.e. uncoupled between 
differed tissues, PPARγ is of particular interest to circadian transcriptional expression 
(Schmutz et al. 2010).  There are three members of the PPAR family (α, γ and δ), which 
have been shown to regulate lipid metabolism and energy homeostasis, in muscle, liver and 
adipose tissue (Evans et al. 2004; Lee et al. 2003).  Yang et al. (2006) showed that PPARα, 
which is involved in hepatic fatty acid oxidation (Kersten et al. 1999), cycled in WAT, 
BAT but not liver, whereas PPARγ, involved in lipid storage and lipogenesis in the liver 
(He et al. 2003), cycled selectively in WAT and liver.  PPARδ, which is ubiquitously 
expressed, is rhythmic in BAT and liver and oscillates in phase with uncoupling protein -1 
(UCP-1), which suggested a link between diurnal variations in body temperature (section 
1.5.3.5) and the circadian clock via PPARδ (Yang et al. 2006).  This link is further 
enhanced as PPARα is also expressed in phase with PCG 1α, known to be involved in cold 
and diet-induced thermogenesis (Lowell and Spiegelman 2000) and UCP-1, together 
suggesting how endogenous temperature may be linked to the circadian clock and vice-
versa. Also the PPARγ agonist, fenofibrate, has been shown to induce circadian clock gene 
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expression (mCry1, mRev-erbα and mBMAL1) in Rat-1 cells, similar to that induced by 
serum shock, although mPer2 was not mentioned in this study (Canaple et al. 2006). 
 
PER2, but not PER1, has recently been shown to coimmunoprecipitate with PPARγ via an 
LXXLL motif located at the N-terminal of the PER2 protein (Schmutz et al. 2010).  
PPARγ is known to bind to the mBMAL1 promoter and induce circadian expression in the 
liver (Canaple et al. 2006).  The interaction between PPARγ and PER2 was greatest at 
ZT20, a time when mBMAL1 expression was highest (Schmutz et al. 2010).  PER2 was 
also shown to co-precipitate with REV-ERBα, PPARα, HNF4α, and TRα, all of which 
have been shown to express in a circadian pattern (Reddy et al. 2007; Yang et al. 2006).  
Interestingly, Schmutz et al. (2010) showed that PER2 bound to the mBMAL1 promoter, 
which coincided with the repression of this gene.  PER2 binding overlapped the binding 
region of REV-ERBα, and PER2 binding was REV-ERBα dependent, as PER2 binding 
was lost in Rev-erbα -/- mice.   PER1 binding was not observed at the BMAL1 promoter.  
Furthermore, PER2 was shown to bind to the mBMAL1 promoter at a PPARγ binding site, 
at a time which correlated with mBMAL1 activation.  In conclusion, Schmutz et al. (2010) 
showed that BMAL1 regulation (in the liver) is controlled by two circadian systems:  
rhythmic REV-ERBα repression (with the addition of PER2) and rhythmic activation by 
nuclear receptors such as PPARγ, which use PER2 as a co-activator. 
 
The estrogen receptor α (ERα) is another nuclear receptor that has reported links to 
circadian timing.  PER2 suppresses ER transcriptional activation and induces its 
degradation through direct interaction.  Estrogen has also been shown to induce mPer2 
transcription (Gery et al. 2007).  Furthermore, estrogen added to tissue explants from the 
uterus of PER2::luc ovariectomised mice resulted in a period shortening effect (Nakamura 
et al. 2008).  However, there is little evidence to support any circadian oscillation of ERα, 
whereas ERβ mRNA oscillates in phase with Per2 via a conserved E-box element (Cai et 
al. 2008).  The ERRα oscillates in the liver, uterus and bone.  Interestingly, BMAL1 and 
Rev-erbα are not expressed in bone, however, Per2 is expressed and rhythmic (Horard et 
al. 2004).  This suggests an independent oscillator in this tissue, perhaps similar to the 
independent Per2 oscillator observed in the arrhythmic mouse liver in the Kornmann et al. 
(2007) study, where it was proposed that systemic signals were inducing this secular 
oscillation. 
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The androgen receptor (AR), although not directly shown to be under circadian control 
(unlike that of the ER and ERR above) has been localised to the SCN (Karatsoreos et al. 
2007).  In male and female mice the AR is localised to the ‘core’ SCN (Fig 1.3), yet with 
greater expression in male mice, which is in contrast to the GR, which is ubiquitously 
expressed apart from in the SCN (Balsalobre et al. 2000a).  Following gonadectomy, 
Karatsoreos et al. (2007) reported a lengthening of free-running period, a reduction in 
duration of activity and a decrease in the total daily activity (wheel revolutions).  The 
authors also noted a loss in activity onset precision (i.e. the difference between the 
calculated onset of activity from the previous day and the actual onset of activity).  Further 
integration between the circadian clock and the AR comes from the biphasic expression of 
testosterone release, as seen in the rat.  Testosterone peaked at 12.59h (light phase) and 
04.04h (dark phase) with the peak expression of CORT falling in between the two 
testosterone peaks.  Interestingly, the administration of the Gc analogue 
methylprednisalone in their drinking water abolished the biphasic testosterone rhythm, but 
after adrenalectomy the biphasic pattern was still observed, yet with a greater degree of 
variation (Waite et al. 2009).  Together, these data described above suggest that the GR 
and MR are not the only nuclear receptors involved in resetting the circadian clockwork 
and that many more of the 49 receptors in the mouse are either under direct circadian 
control themselves or are regulated by clock proteins (PER2 and BMAL1). 
1.10.6 Gcs and the stress response 
 
As well as synchronising to the daily light dark schedule the animal must also deal with 
environmental stressors such as a compromised immune system, restricted food 
availability, aggressive behaviour and excessive heat or cold.  The animal may also have to 
deal with internal stressors such as abnormal growths and nerve injuries (e.g. splanchnic 
nerve leading to the adrenal gland) (Nader et al. 2010).  Induced stress experiments by 
ether or a novel environment has been shown to produce an increase CORT levels over a 
24h cycle but plasma concentrations remained rhythmic, in female rats but not as 
pronounced in male rats.  Furthermore, a significant increase in adrenal CORT levels were 
observed in the stressed female rat at the start of the dark phase but not during the rest 
period (Dunn et al. 1972).  In addition to this, restraint stress has been shown to induce 
larger stress responses in the early light phase compared to the dark phase (Kant et al. 
1986) and lesioning the SCN results in the loss of the CORT rhythm but not in the ability 
to respond to stress (Sage et al. 2001). 
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The stress response is modulated by the HPA axis in a similar manner to that of the 
circadian response outlined in section 1.10.  CRH and arginine vasopressin (AVP) are 
released from the PVN and act on the corticotrophe cells of the pituitary to release ACTH, 
which acts on the adrenal cortex to release Gcs.  Gcs then feedback to inhibit their own 
production, thought to be mediated via the inhibition of glutamate release on to CRH-
containing cells in the PVN, via membrane GR (a proposed  non-genomic action) (Di et al. 
2003).  However, other brain regions and effectors are interconnected with the stress 
response.  α-melanocyte stimulating hormone and β-endorphin (both derived from pro-
opiomelanocortin i.e. POMC) and adrenaline/noradrenaline, which are produced in the 
A1/A2 centres of the brainstem’s locus ceruleus and in the central autonomic nervous 
system (Charmandari et al. 2005; Chrousos and Gold 1992).  Furthermore, the 
serotonergeic pathway located in the raphe nuclei of the mid-brain and the histaminergic 
system of the hypothalamus are also stimulated in the stress response (Chrousos 2009).  
Although the main effectors of the stress response are Gcs and adrenaline/noradrenalin, IL-
6 is released from immune cells and other peripheral cells, in a non-inflammatory stress 
response, to adrenaline via β-adrenergic receptors (Chrousos 2000).  The end result of the 
stress response is to stimulate the fear/anger and reward systems; the brain centres 
involved in sleep-wake as well as the metabolic, immune and cardio-respiratory systems 
(Chrousos 2009).  It is also very important for the animals’ survival to maintain effective 
homeostasis of the stress response as fearless individuals have increased risk of mortality 
due to underestimating danger, whereas overly fearful individuals can result in reduced 
social interaction (Chrousos 2009). 
 
Early work on the phase shifting effects of mild stressors (such as cage or litter changes, 
novel wheel confinement and social interactions) suggested that locomotor activity was 
vital for phase shifting (Mrosovsky et al. 1996).  However, other work demonstrated that 
circadian phase shifts could be induced by gentle handling combined with sleep 
deprivation, which was not a result of wheel running or increased activity (Antle and 
Mistlberger 2000).  Interestingly, in the hamster a stress response induced by forced 
restraint, during the subjective day, does not induce a circadian phase shift, nor does it 
sustain behavioural arousal.  Furthermore, restraint combined with noxious air blasts did 
induce both sustained behavioural arousal and an increased cortisol response but no phase 
shift was observed (Mistlberger et al. 2003).  Also sleep deprivation by keeping the 
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hamsters on a pedestal over water induced a small, yet significant, phase shift with 9 of the 
12 hamsters shifting less than 30 min.  In the same study by Mistlberger et al (2003) a 3h 
‘resident-intruder’ stress test induced a phase shift of over 1h (which correlated with an 
increase in activity) in the smaller (resident) animals but no difference was observed in the 
larger (intruder) ones (cortisol levels were not measured).  The results from this study 
suggest that arousal induced phase shifts do not correlate with an increase in Gc through 
the stress response, but are dependent on some degree of activity. 
 
 
Taking the behavioural and cortisol observations of Mistleberger et al. (2003) a bit further, 
it has been demonstrated that the circadian and stress response of CORT, in the mouse, can 
be uncoupled using a vasoactive intestinal peptide (VIP) KO mouse model (Loh et al. 
2008).  A large number of the SCN neurons that project to the PVN use VIP as the 
neurotransmitter and VIP injection into the PVN can induce ACTH and CORT release 
(Alexander and Sander 1994; Teclemariam-Mesbah et al. 1997), suggesting that VIP 
signalling is an integral part of the HPA axis.  However, in the VIP -/- mouse the animals’ 
locomotor activity is severely disrupted in DD, with the onset of activity occurring 8h 
earlier than predicted, from the previous LD cycle, coupled with a shorter free-running 
period and many mice becoming arrhythmic after a few weeks in constant darkness 
(Colwell et al. 2003).  In the VIP -/- mouse the circadian expression of ACTH and CORT 
was lost in both LD and DD and ACTH expression was constitutively higher in the VIP -/- 
mouse (Loh et al. 2008).  However, in response to stress by foot-shock the CORT response 
was the same in WT and VIP -/- mice, with plasma CORT showing a significant increase, 
whereas plasma CORT levels in response to light were absent in the VIP -/- animal.   
Similarly, adrenal gland mPer1 mRNA levels were significantly increased in response to 
foot shock stress in WT and VIP -/- animals, but no mPer1 mRNA induction was observed 
in the adrenal gland in the knockout mouse in response to light (Loh et al. 2008).  These 
data suggest that the loss of VIP, and a disrupted behavioural circadian rhythm, results in 
the loss of the endogenous ACTH and CORT rhythm and in the acute response to light, but 
does not affect the acute response to stress and that the circadian and stress response can be 
uncoupled. 
 
Taken together the data presented in this thesis and discussion suggest that although Gcs 
are potent signalling molecules, which can stimulate both rhythmic gene expression and 
reset the clock through direct interaction Per1 and Per2, they are just one of many re-
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setting stimuli.  These resetting stimuli include light (and dark), food, other hormones e.g. 
melatonin and serotonin, temperature and some environmental stressors.  In the research 
environment each of these stimuli are looked at individually and conclusions about their 
relevance made on that basis.  However, in practice and outside the confines of the 
research environment, it is likely that all stimuli are used in order to maintain internal 
synchrony with the external environment in order to integrate time, food availability and 
potential danger for the individuals’ ultimate survival.  
1.11 Non-genomic signalling  
1.11.1 Genomic versus non-genomic mechanisms 
 
The classical model of steroid hormone action (Fig 1.11) states that the steroid hormone, 
such as CORT, passes through the lipid bilayer binds to the receptor, which dissociates 
from its chaperones,  and can then translocate to the nucleus where it can induce gene 
transcription.  This whole process is relatively slow taking in the region of hours and is 
sensitive to transcriptional and translational inhibitors, actinomycin D and cycloheximide 
respectively (Losel and Wehling 2003).  However, there are also very rapid changes 
observed when steroids are added to both cell line and human/animal models, that occur 
within minutes or even seconds; such as oogenesis, response to stress and vasoregulation, 
which are insensitive to transcriptional and translational inhibitors (Stellato 2004).  
Furthermore, these rapid signals have been shown to have effects on enucleated cells, such 
as red blood cells (Losel and Wehling 2003) and involves the generation of intracellular 
second messengers and signal transduction cascades such as phosphatidylinositol 3-kinase 
(PI3 kinase) and MAPK (Hafezi-Moghadam et al. 2002; Solito et al. 2003).  A definition 
of non-genomic action has been given by Losel and Wehling (2003) and states that it is, 
‘Any action that does not directly or initially influence gene expression, but rather drives 
more rapid effects such as the activation of signalling cascades.’  Non-genomic effects 
have been reported with the estrogen and progesterone receptors, but more importantly in 
for this thesis, the MR (Joels et al. 2008; Karst et al. 2005) and GR (Croxtall et al. 2000; 
Croxtall JD 2002), have been shown to have non-genomic effects too.  Interestingly, 
studies have revealed that the Gc analogue DEX and the MR ligand aldosterone had rapid, 
non-genomic, effects on intracellular Ca2+ levels and localisation, that were insensitive not 
only to translational inhibition but to receptor antagonists RU486 (GR) and spironolactone 
(MR) as well (Urbach et al. 2002).  In addition, other Gc analogues (budesonide, 
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triamcilone and hydrocortisone) had a much reduced effect on Ca2+ levels, with the authors 
concluding that this was due to DEX being the least lipophilic and, therefore, would not 
readily pass through the membrane at the low concentrations used (nM), interacting more 
with membrane proteins, perhaps a membrane bound GR presumed to be located on the 
cell surface rather than transmembrane.  Indeed, membrane associated GRs were 
discovered in amphibian and human cancer cells (Gametchu et al. 1993; Orchinik et al. 
1991) and a number of years later discovered through immunofluorescence studies to be in 
human peripheral blood mononuclear cells as well and located on the cell surface  
(Bartholome et al. 2004).  Similarly a membrane associated ER was discovered, which was 
shown to associate with the protein caveolin (CAV) (section 1.11.2), found in a subset of 
specialised cholesterol rich lipid rafts called caveolae, that are involved in intracellular 
signalling (Razandi et al. 2002; Russell et al. 2000).  Leading on from this direct 
association between membrane ER and CAV coupled with down stream signalling events, 
the membrane GR was shown to associate with the protein CAV-1 and DEX induced rapid 
signalling events that were CAV-1 dependent (Matthews et al. 2008). 
1.11.2 Caveolae and caveolin  
 
Caveolae form part of a rich tapestry of membrane domains, which accumulate to create 
macromolecular structures that include lipid rafts signalling molecules, cell-cell junctions 
and membrane invaginations (clathrin coated pits and caveolae) (Lajoie et al. 2009).  
Caveolae were first described in the early 1950’s but their functions were unknown until 
the advent of knock out and transgenic mouse models, which characterised the 
involvement of caveolae in various biological events such as lipid uptake and regulation 
and tumour suppression (Parton et al. 2006).  Each caveolae is approximately 65µm at the 
bulb end and 45µm at the opening end (Fig 1.12) and results in the invagination of the 
membrane bilayer (Parton et al. 2006).  Each caveolae consists of approximately 100-200 
caveolin molecules of which there are 3 in the family, termed CAV-1, 2 and 3.  CAV-1 is 
expressed in non-muscle and smooth muscle tissue and CAV-3 is expressed in skeletal, 
cardiac and some smooth muscle.  These two isoforms appear to be the most important for 
the formation of caveolae, as separate knock out mice do not form the caveolae complex 
(Drab et al. 2001; Galbiati et al. 2001).  In contrast, CAV-2 is generally regarded as the 
dispensable member of the CAV family regarding the formation of Caveolae, yet Cav-2 -/- 
mice have been shown to have an individual phenotype concerning lung function.  CAV-2, 
often co-expressed with CAV-1 and able to form hetero-oligomers in most cell types, does 
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not disrupt the formation of caveolae when knocked-out, although there is a slight 
reduction of CAV-1 expression in some cell types (Razani et al. 2002).  The loss of Cav-2 
results in hypercellularity, exercise intolerance and an increased number of endothelial 
cells and probably accounts for this phenotype in Cav-1 -/- mice, as CAV-2 expression is 
dramatically reduced in CAV-1 -/- mice (Razani et al. 2002).  The caveolae was initially 
thought to assemble directly in the membrane bilayer, requiring a threshold of caveolin to 
be present prior to the assembly of the caveolae structure (Fra et al. 1995).  However, more 
recently this hypothesis has been disproven, as green fluorescent protein (GFP) tagged 
CAV-1 accumulates in the Golgi body and forms the caveolae structure there, before it 
trafficks to the membrane (Tagawa et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12:  A caveolin and cholesterol rich caveolae:  Adapted from 
(www.ruf.rice.edu/~rur/issue1_files/razani.html) with the dimensions from Parton (2006). 
 
Caveolae, in particular CAV-1, have been implicated in a number of inflammatory 
diseases.  The loss of CAV-1 in mice resulted in a reduced inflammatory response in an 
experimental model of inflammatory bowel disease (Chidlow et al. 2009) and CAV-1 
proteins levels were seen to increase in the WT mice on infection.  The loss of CAV-1 has 
also been shown to protect against atherosclerosis through the reduced uptake of low 
density lipoprotein (LDL) in the endothelium, an effect that is lost when CAV-1 is 
replaced (Fernandez-Hernando et al. 2009).  To further substantiate these anti-
inflammatory effects, a direct association has been made between CAV-1 and the main 
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lipopolysaccharide (LPS) receptor; toll like receptor 4 (TLR4) to significantly reduce the 
release of key inflammatory mediators IL-6, TNFα and CCL5/RANTES and this CAV-
1/TLR4 association  is enhanced with heme oxygenase, known to have anti-inflammatory 
properties (Wang et al. 2009).  This definite link between the inflammatory response and 
CAV-1 signalling will no doubt prove a great topic of interest; particularly in the circadian 
field as both IL-6 and TNFα are know to be under circadian control (section 1.12). 
1.12 Circadian clocks and the inflammatory response  
1.12.1 The innate inflammatory response 
 
The immuno-inflammatory response is a vital part of an organism’s first line of defence 
against attack by a foreign body; be it bacterial, chemical or animal based, where proteins 
are released from cells, in particular those differentiated from mononuclear phagocyte 
lineage, such as macrophages.  This is referred to as the innate immune system.  The 
proteins are known as chemokines and cytokines and induce the classic inflammatory 
response; redness, swelling, pain and heat (Pickup 2004), which protects the infected area, 
begins to attack the antigen and signals for more immune cell recruitment, such  as B cells, 
which are part of the humoral, or adaptive, response where specific antibodies are made.  
The cells which form the innate immune system, collectively known as white blood cells, 
circulate in a circadian manner.  Neutrophils, lymphocytes, monocytes, platelets and 
eosinophils all show a circadian variation in their circulating cell numbers in healthy 
humans (Haus and Smolensky 1999), with peak values during the night and trough values 
in the early morning, which is in anti-phase to circulating Gc levels (Petrovsky et al. 1998).  
When the circulating white blood cells detect a foreign body various pro-inflammatory 
cytokines and chemokines are released from virtually all cells involved in the immune 
response,  such as macrophages and eosinophils, into the local site of infection to trigger 
the immune response and fight infection (Haus and Smolensky 1999).  The release of these 
cytokines triggers various responses in other cells with cytokine receptor molecules, such 
as altering the expression of membrane proteins, the secretion of other cytokines to 
generate a cascade of events and cellular proliferation (O'Shea et al. 2002).  The release of 
cytokines is a non-linear response and very small changes in initial conditions, that is the 
release of 1 or 2 initial cytokines, can result in a large magnitude response very quickly, 
referred to as ‘chaos’ in mathematics (O'Shea et al. 2002).  The term cytokine is quite a 
loose term for a number of different protein groups; interleukins are proteins made by and 
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which act on leukocytes; lymphokines are cytokines made by lymphocytes; monokines are 
produced by monocytes and chemokines are cytokines with chemotactic properties.  
Interestingly cytokines are to some degree a redundant system, just like the clock itself, in 
that many will have the same or similar action, so as to compensate for any losses (O'Shea 
et al. 2002), or on the opposite side leading to the large magnitude ‘chaos’ response.  
However, more interestingly some cytokines have both an immunosuppressive and 
immunostimulatory effects, such as TNF α, interferon gamma (IFNγ) and IL-2, which can 
lead to autoimmune diseases such as rheumatoid arthritis (O'Shea et al. 2002).  Cytokines 
such as IL-6, TNFα and IL-1β have not only been shown to be expressed by macrophages 
and other inflammatory cell types but other resident cells like Type II alveolar 
macrophages (section 1.8.3), found in the lung (Thorley et al. 2007), showing that the fight 
against disease involves many diverse cell types.    
1.12.2 Oscillating inflammatory cells and mediators 
 
A number of cytokines have been shown to be under circadian control, in humans, even in 
the absence of any invading antigenic stimulus, such as IL-6, TNFα and IL-1 (Gudewill et 
al. 1992) as well as the non-stimulated circadian expression in rats of IL-6, TNFα and IFNγ 
at both the transcript and protein level (Arjona and Sarkar 2005; Guan et al. 2005).  Also in 
a more recent study by Beynon and Coogan 2010, where they looked at circadian 
differences between younger and older mice, they reported that the IL-1β receptor IL-1R1 
had a temporal regulation in the SCN of young mice, peaking at ZT20, but not older mice, 
yet IL-1β did not show any temporal variation (Beynon and Coogan 2010).  They also 
examined the difference between overall expression in young and old mice, and showed 
that SCN expression of IL-1β was much lower in older mice compared to the young.  The 
authors also showed an age related difference in the expression in the PVN.  In this area 
the older mice had increased expression of both IL-1β and its receptor with higher levels at 
ZT20 and ZT24 (Beynon and Coogan 2010).  However, most work has been carried out in 
the presence of a stimulant, usually LPS, a product of the gram negative bacterial cell wall, 
which works through TLR4 receptor protein and either through a MyD88 dependent or 
independent pathway, resulting with the former in cytokine production via NFκB or, with 
the latter, caspase activation (Hoshino et al. 1999).   After LPS stimulation cytokines in 
both human and animal models still show a circadian rhythm at the transcript and protein 
level, such as IL-6, TNFα, IL-12 and IFNγ (Hermann et al. 2006; Keller et al. 2009; 
Petrovsky et al. 1998).  This post stimulation oscillation was shown by Keller et al. (2009) 
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to be independent of a systemic Gc rhythm, as it still persisted in the absence of the adrenal 
gland.  Tissues involved in both the innate and humoral inflammatory response, such as the 
spleen and lymph nodes, as well as macrophage cells have functional oscillators with high 
amplitude rhythms as seen in the mouse (Hayashi et al. 2007; Keller et al. 2009) and in 
human leukocytes (Haimovich et al. 2010), although with a much reduced amplitude in the 
leukocytes.  The LPS stimulation of inflammatory cells or systemic LPS administration has 
been shown to have a potent effect on the core clock genes, resulting in their suppression, 
again in both human and rodent models (Haimovich et al. 2010; Yamamura et al. 2010).  
However, this suppression is not always seen, as shown by the lack of effect after systemic 
LPS administration in the liver of mice, in either Per1 or Per2 (Takahashi et al. 2001) and 
in opposition to the general literature, LPS induced Per1 expression after 1h in the PVN 
neurons, part of the HPA axis (section 1.10.1), in a similar manner to a forced swim test 
stress response.  Interestingly Per2 expression was not altered nor was expression of Per1 
changed in the SCN (Takahashi et al. 2001); together suggesting a very specific PVN 
based response.  Furthermore, mice carrying a loss of function mutation in the Per2 gene 
results in the loss of IFNγ rhythm, both at the transcript and protein level (Arjona and 
Sarkar 2006).  Also a Per2 -/- mouse is far more resistant to LPS induced death and that in 
the Per2 -/- mouse IFNγ and IL1β levels dramatically increase, whereas TNFα, IL6 and 
IL10 remain the same as in the WT (Liu et al. 2006b).  It has also been shown that TNFα, 
as well as IL1β, can suppress CLOCK:BMAL1 E-box mediated transcription, yet other 
cytokines such as IFNα or IL6 cannot, and therefore explains why LPS suppresses the 
clock (Cavadini et al. 2007).    The ideas discussed above all lead to the suggestion that the 
circadian clock and the immune response are very closely linked, and evolution has 
provided cross talk and feedback mechanisms in order for the organism to successfully 
defend itself from invading pathogens.  However, in the case of autoimmune diseases, such 
as rheumatoid arthritis and inflammatory bowel disease, a greater understanding of the 
clock and the inflammatory interaction, could lead to improved therapeutics and possible 
cures. 
1.12.3 Glucocorticoids, receptors and macrophages 
 
Glucocorticoids are still today the most common based therapy to treat both chronic and 
acute inflammation, ever since the discovery that cortisol could lessen the inflammatory 
response in rheumatoid arthritis patients, (Hench et al. 1949).  This suppression works in a 
number of ways using both gene activation (transactivation) and gene repression 
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(transrepression), with the latter working primarily through the dimerisation to, and 
inhibition of, NFκB and AP1 (Beck et al. 2009).  Much research has been undertaken to 
enhance the anti-inflammatory properties and reduce the unwanted side effects of Gcs 
(such as osteoporosis, growth retardation in children and skin fragility), (Barnes and 
Adcock 2003), yet little progress has been made in this regard, even though vast amounts 
are known about cell and tissue type actions. 
 
It has been shown that 28 of the 49 nuclear receptors, in the mouse, are expressed in 
macrophages including the majority of the steroid receptors, in particular the GR and MR, 
as well as the progesterone receptor and the estrogen receptor α (Barish et al. 2005).  
Furthermore, both GR and MR are known to bind Gc (as discussed section 1.10.3) and 
Barish et al. (2005) showed that both receptors had a different response to LPS 
administration in bone marrow derived macrophages.  LPS only induced GR transcript 
expression, over baseline, between 4-8h after treatment, which returned to baseline at 16h.  
However, MR transcript expression was rapidly suppressed after LPS administration 
showing no expression at 4h post treatment (Barish et al. 2005).  In addition to the 
expression of both GR and MR in macrophages, the effect of Gc, specifically in 
differentiated macrophages, is enhanced via the expression of HSD11β type I, which 
converts inactive Gc to active Gc (section 1.10.3), but the expression of the type II enzyme 
was not detected (Thieringer et al. 2001).  In the same study the authors also showed that 
HSD11β was induced by LPS in a macrophage like cell line.  This suggests that circulating 
Gcs are able to act on the macrophage gene expression via both GR and MR, which is 
enhanced in the presence of a pro-inflammatory stimulus.  The presence of MR suggests a 
dual action of Gc, depending on the local concentration and perhaps whether the 
macrophage is stimulated or not, as MR has a 10 fold higher affinity for CORT than GR 
does.  Indeed a concentration dependent response was seen in cultured peritoneal 
macrophages (Lim et al. 2007), with lower CORT concentrations (nM and sub nM) 
inducing the expression of IL-12, IFNγ and IL-6 amongst other inflammatory mediators.  
However, at higher doses of CORT (high nM and µM) this induction turned into a 
suppression of inflammatory mediators.  This dual role of CORT appears, however, to be 
mediated primarily through the GR, rather than the MR, as knock down of the GR resulted 
in the attenuation of both induction and suppression, although not fully, whereas knock 
down of the MR had no effect on either suppression or activation of gene transcription 
(Lim et al. 2007).  The MR has, however, been implicated in a number of diseases with 
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inflammatory side effects, such as hypertension and  atherosclerosis, as addition of the MR 
antagonist spironolactone acts to reduce macrophage accumulation and aldosterone 
treatment enhances inflammatory markers (Rickard and Young 2009).  Taken together 
these findings suggest that although the GR is the main mediator of the Gc effects on the 
macrophage inflammatory response, the MR may have a minor role in the unstimulated 
response to background levels of circulating Gcs, more in terms of a preparatory role prior 
to an antigenic response. 
1.13 Chronotherapy 
 
Chronotherapy is the timed administration of drugs to better combat the symptoms of 
diseases, which are known to be worse at particular times of the day.  Many diseases 
appear to have a circadian component to their symptoms such as chronic pain and 
dermatoses, which are worse in the late evening, where as congestive heart failure, seems 
to occur in the few hours after midnight with asthma and rheumatoid arthritis occurring in 
the early morning.  Interestingly epileptic seizures seem to have a biphasic onset 
surrounding sleep, with the hours prior to the onset of sleep and shortly after wake up 
being the worse times of onset (Ohdo 2010).  There are now a number of diseases for 
which timed administration of the therapeutics has been developed.  Nocturnal asthma 
appears to be better treated with an evening administration of theophylline and an evening 
dose of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase antagonist is better to help 
hyperlipidemia (Ohdo 2010).  The treatment of cancer has been shown to be improved 
with the timed administration of over 30 anticancer drugs in rodent models, with survival 
rates increased by more than 50% in some cases (Mormont and Levi 2003).  One striking 
piece of evidence for the effective use of chronotherapeutics is that in timed drug trails in 
children with acute lymphoblastic leukaemia, 80% who were treated in the evening with 6-
mercaptopurine and methotrexate were alive and disease free 5 years after the onset of the 
disease, compared to only 40% who were treated in the morning, the remainder were either 
dead or still had the disease (Mormont and Levi 2003).  Furthermore, the careful timed 
administration of cancer therapeutics has suggested that larger doses can be tolerated, 
which means greater improvements to the patients health and wellbeing (Ohdo 2010).  
IFNα stimulation of lymphocytes in mice was shown to be higher when dosed at 9am 
compared to 9pm and the number of IFNα receptors in the lymphocytes was greater at 9am 
rather than 9pm.  Also IFNα clearance, through kidney metabolism was greater at 9pm 
compared to 9am (Ohdo et al. 2000).  IFNα treatment of mice caused an IFNα induced 
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fever response (high body temperature), which correlated with the unstimulated 
temperature rhythm, but was much higher (Koyanagi et al. 1997; Ohdo et al. 1997).  There 
was also a circadian rhythm in IFNα after IFNα injection, suggesting that the animal 
responds differently to IFNα stimulus at different times of the day (Koyanagi et al. 1997).  
These data lead to the suggestion that dosing of IFNα, which is used as an antiviral drug, at 
a certain time of day could lead to better clinical results.   
 
Our expanding knowledge of the relationship between the circadian clock and health and 
disease and the ever increasing knowledge to chronotherapeutics will be a very exciting 
field over the coming years and will undoubtedly lead to greater freedom from disease 
symptoms and perhaps even recovery from cancers.   
1.14 Overall aims 
 
This thesis will address the following: 
 
• Define the mechanism of action of Gc on the pulmonary murine clock using the 
mPER2::luc mouse and in Rat-1 fibroblast cell line reporters. 
• Characterise the extent to which the inflammatory response is gated by the 
circadian clock and investigate the mechanism behind this control. 
• Investigate the transcription factor C/EBPα with regard to its circadian and Gc 
regulation.  
 
 
In this thesis, I initially expected C/EBP (in particular the α and δ isoforms) to act as the 
interface between Gc regulation and the circadian clock, which could lead to re-setting 
mechanisms on clock genes.  These ideas were formulated by knowledge from previous 
literature and tested by experiments in both cells lines and primary murine lung tissue, 
outlined in Chapter 6.  These experiments failed to replicate earlier studies (MacDougald et 
al. 1994) and showed no defined circadian rhythm, and for this reason direct actions of Gc 
on clock genes (Per1 and Per2) were investigated.  These latter experiments are therefore 
described first (Chapters 3 and 4) and data from experimental manipulations of C/EBPs are 
described in the last data chapter (Chapter 6).  Work set out in Chapter 5 describes the 
circadian effect on the innate inflammatory response and the effect an inflammatory 
Chapter 1_______________________________________________________Introduction 
 
 95 
stimulus (LPS) has on circadian gene expression.  This chapter demonstrates how the clock 
influences other fundamental biological processes and how they feedback onto the clock. 
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2.1 Mice and Primary Culture 
2.1.1 Animal maintenance 
 
All experimental procedures were within the guidelines of the Animals (Scientific 
Procedures) Act, 1986. All mice were housed at an ambient temperature of 20–22 C, and 
maintained in a 12-h light, 12-h dark (L:D, 12:12) lighting schedule, except where stated.  
Food and water was available ad libitum.  All mice used in these studies were male and 
aged between 6 and 24 weeks but due to numbering constraints both sexes were used in the 
Rev-erb -/- studies.  In general mice were killed using cervical dislocation, in order to 
maintain the trachea, unless otherwise stated, (section 2.2.1).  All killing was done in 
accordance with the schedule 1 licensing act 1981.  Carcasses were destroyed by 
incineration. 
2.1.2 Mouse lines 
 
All mice, used throughout these studies, had a C57/BL6 genetic background, regardless of 
other genetic manipulations, and these mice will be referred to as wild type (WT) mice.   
2.1.2.1 PERIOD2::luciferase mouse 
 
For the majority of studies the PERIOD2::luciferase (PER2::luc) protein reporter model 
was used, in order to report the phase and period of the circadian cycle using a photo 
multiplier tube (PMT)  (section 2.1.3).  These mice were a kind gift from Joseph Takahashi 
(University of Virginia) (Yoo et al. 2004).  The PER2::luc mice were bred through 
homologous recombination, which results in the luciferase gene, fused to the 3 prime end 
of the endogenous Period2 gene (genomic DNA not complementary, cDNA), being 
recombined into the correct genetic locus for Period2.  This homologous recombination 
means that the PER2::luc reporter is driven by the same promoter and subject to the same 
genetic environment as the WT gene, resulting in a highly representative reporter.  
However, care must be taken when interpreting the results obtained from the luciferase 
reporters as what is actually being reported is a luciferase signal and an indirect 
measurement of the protein or promoter reporter placed upstream, and is really only a 
substitute for direct protein or transcript analysis, by immuno blotting or qPCR.   
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2.1.2.2 Rev-erbα -/- mouse 
 
In the following studies a Rev-erbα  -/- mouse was used (Preitner et al. 2002).  Preitner 
(2002) used targeted disruption of the Rev-er α gene replacing part of exon 2, all of exons 
3 and 4 and part of exon 5 with a lacZ and neomycin gene.  This strategy took out the DBD 
and as a result meant that no messenger ribonucleic acid (mRNA) or protein should be 
produced, and if any protein product was produced it would be incapable of DNA binding 
and having any repressive effects.  This mouse line was a kind gift from Ueli Schibler 
(University of Geneva).  The Rev-erbα -/- mice were bred from a heterozygous X 
heterozygous mating pair (each parent had one WT copy of the Rev-erbα gene, the other 
copy was knocked-out), so only approximately 1 in 4 offspring were homozygote for the 
WT or Rev-erbα -/- genotype, this was done due to the difficulty in maintaining a 
homozygote colony.   
2.1.3 Theory behind the PMT and use of luciferase reporter models 
 
The PMTs are a way of converting a photon of light, released as a by product of an 
enzymatic reaction, into an electronic signal.  Throughout this thesis the reaction was the 
conversion of luciferin to oxyluciferin by the enzyme luciferase with a photon of light 
released as a by product of adenosine tri-phosphate (ATP) being converted to adenosine 
mono-phosphate (AMP) (Fig 2.1).  This reaction has been taken from nature and adapted 
for use in the laboratory, as the firefly (Photinus pyralis) uses the same principle when it 
glows.  As the photons of light are emitted they hit an electrode coated with a 
photosensitive material, called a photocathode, positioned at the entry window of the PMT.  
As a result electrons are released into the PMT; this is called the photoelectric effect (Fig 
2.2).  The PMT contains a number of dynodes which contain an increasing positive charge, 
giving the electrons greater energy to hit successive dynodes and cause more electrons to 
be released.  Eventually the electrons reach the terminal anode and create a large electrical 
charge which is detected by a computer software programme and results in a readable 
output.  The computer collects the signal over a 59 second period, and then stores the value 
as one value, and thus the readout is counts per minute. 
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Figure 2.1: Principle behind the PMT:  The clock protein (PER2), or promoter region of 
interest, is fused to the luciferase enzyme, (A).  When luciferin, present in the recording 
medium, binds to the luciferase it is oxidised to oxyluciferin and ATP is converted to AMP 
with the emission of a photon of light (B).  The resulting photons, converted to electrons, 
are multiplied and collected via the PMT (C) and converted to an electronic signal which 
can be viewed on a computer (D).  Diagram adapted from the internet. 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Inner workings of the PMT:  The emitted photon hits the photocathode and 
an electron is released.  The electron then causes the release of further electrons from a 
succession of dynodes, which carry an increasing positive charge, until the electrons hit the 
anode and are converted to an electrical signal and are recorded by a computer.  Diagram 
adapted from http://learn.hamamatsu.com/articles/photomultipliers.html. 
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2.1.4 PMT data collection and analysis 
 
The PMT data were collected and exported as an excel file, where all data were normalised 
to make the first full peak equal to 100 (relative units), approximately 24 h after the start.  
This was done to reduce inter assay PMT variation, in order to better calculate phase 
change, and to put the lung and cell reporter recordings on the same y-axis scale.   
 
All period and phase analysis was carried out using the rhythm analysing programme 
(RAP) analysis software, (Okamoto et al. 2005) (for all single unit PMT recordings) or 
using the Lumicycle analysis software (Actimetrics), for the Lumicycle based recordings.  
These methods use a Cosinor analysis based on a Fourier analysis.  Period and phase were 
determined starting at least 12h after the time of treatment, to remove any artefacts brought 
on by the treatment protocol. 
2.2 Preparation of primary cells and tissues 
2.2.1 Lipopolysaccharide (LPS) treated mice 
 
All mice were maintained as in 2.1.1, with access to food and water ad libitum, but were 
singly housed, for the duration of the procedure.  The mice were weighed prior to the study 
in order to calculate the correct LPS dose.  In the first experimental series, the WT mice 
used were all male.  In the second experimental series, the Rev-erbα -/- mice, and WT litter 
mates, were mixed sex but split equally.  All mice were in a 12h:12h lighting schedule 
(lights on 0800, ZT0 lights off 2000, ZT12) for 10 days prior to being released into 
constant darkness (D:D), for 24h prior to challenge.  At projected CT0/CT12, mice were 
injected, into the peritoneal cavity (i.p. injection), with LPS (usually 1-10 mg/ml), purified 
from Escherichia coli strain 0128:B12 (Sigma, UK), or 0.9% saline control.  This was 
carried out in darkness.  The mice were returned to the cages, where they remained in 
constant darkness, for 4h before sacrifice.  In order to collect blood from the animals the 
mice were first anaesthetised with 5% isofluorane in 200ml/min O2 and 500ml/min N2O 
and then decapitated.  The blood was collected into clean 1.5ml tubes and allowed to clot 
at room temperature (RT) for 2-3 min and then stored on ice.  The liver and lungs were 
then removed and snap frozen on dry ice, wrapped in heat treated tin foil (to denature 
nucleases) and stored at -80oC.  The blood was centrifuged for 10 min at 10000 x g and the 
resulting serum was removed and stored at -20oC. Sampes were assayed via the BioPlex 
(section 2.5.4.2).  
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2.2.2 Agarose perfusion of lungs 
 
Lung slices were prepared, from the PER2::luc mouse.  By sectioning the lungs in this 
manner, the structural integrity of the tissue is maintained so that they could be cultured 
and subsequently used to accurately report the phase and period of the clock.  The 
PER2::luc mouse was killed, by cervical dislocation, and the trachea and lungs exposed.  
The base of the trachea, just above where the manubrium would be, was loosely tied with 
suture.  A hole was made towards the upper end of the trachea and a thin tube (Harvard 
Apparatus) was inserted, internal diameter 0.58mm.  A 1ml syringe containing 
approximately 1ml of 2% low melting agarose, type IXA, (Sigma, UK) was fixed via a 
23G (0.25mm) needle (Benton and Dickinson, B and D) to the tube.  The agarose, 37oC, 
was slowly perfused to allow the individual lobes to inflate.  Once the agarose was fully 
administered the tube was removed and the trachea tied off with the suture.  The mouse 
was quickly placed on ice and the lungs covered to allow the agarose to set.  After 10-15 
mins the mouse was taken off the ice and the inflated lung was removed and placed in ice 
cold Hanks’ balanced buffer solution, without Ca2+ or Mg2+ (HBSS) (Gibbs et al. 2009). 
2.2.3 Slicing and Culture of the Perfused Lungs 
 
The lung, maintained in ice cold HBSS, were separated into individual lobes, 4 right and 1 
left lobe, each was sliced separately.  The individual lobe was dab dried and then fixed to a 
metal stage using superglue (Farnell electronics).  The lung and stage were placed in a 
vibratome cutting pool (Campden Instruments), filled with HBSS, and cooled to 4oC.  The 
individual lobes of the lung were then cut, using a stainless steel blade (Campden 
Instruments), to a thickness of 275µm.  Although the thickness of the slice was controlled 
the resulting area was much harder to maintain, as the lung is not a regular shape, however, 
an attempt to control this was carried out.  The resulting slices were placed in to a 24 well 
plate, containing pre-warmed 4g/litre glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM) with L-glutamine, phenol red, sodium pyruvate, sodium bicarbonate and Ca2+ 
and Mg2+ (Gibco, Invitrogen).  This medium was supplemented with streptomycin and 
penicillin (Sigma, UK) to give a final concentration of 0.1mg/ml streptomycin and 100 
Units of penicillin, but no fetal bovine serum (FBS) was added.  The lung slices were 
maintained at 37oC and supplemented with 5% CO2 (95% air) in a humidified atmosphere.  
The slices were subsequently washed 3 times over a period of 3-4h in order to wash out the 
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agarose.  Finally the slices were left for at least 16h before being used experimentally, to 
show they are free of infection. 
2.2.4 Preparation of lung slices for experimental use 
 
Prior to any experimental procedure the lung slices were synchronised to ensure the 
oscillating cells, within the lung slice and between lung slices, were re-set to the same 
phase, in a similar manner to a group of people synchronising their watches at the 
beginning of the day.  The slices were treated with 10µM forskolin (Sigma, UK) for 1h.  
This stimulates an increase in cAMP levels and activates rhythmic gene expression 
(Balsalobre et al. 2000b), in particular Per1.  The medium was removed and slices washed 
with 1x Ca2+ and Mg2+ free phosphate buffered saline (referred to as 1x PBS) (Sigma, UK) 
before being transferred to sterile 35mm dishes containing 1ml of recording medium 
(appendix A), adapted from (Yamazaki and Takahashi 2005).  The slices were placed on a 
Millicell low profile, 0.4µm membrane insert (Millipore, UK) to provide an air-liquid 
interface and to prevent slice movement.  This technique proved essential for robust and 
reproducible PMT recordings (Gibbs et al. 2009).  The dishes and slices were sealed with a 
40mm sterile glass cover slip (VWR) and high vacuum grease (Dow Corning) and placed 
in a PMT recording unit (Hamamatsu, Japan), or Lumicycle (Actimetrics) and recordings 
taken over a 5 – 7 day period.  The temperatures of the incubators was set to 37oC but 
without additional CO2 influx, as the dishes were sealed.  The addition of sodium 
bicarbonate in the recording medium (appendix A) keeps the CO2 at approximately 5%. 
2.2.5 Experimental treatment of lung slices 
2.2.5.1 The experimental protocol  
 
Preparation 
Slices were prepared as stated in 2.2.4 and put on the PMT for approximately 48h, in order 
to establish an oscillation and an accurate estimate of phase.  At the second peak 
(approximately 48h), referred to as CT12 the slice was removed from the PMT and, in a 
sterile environment, the cover slip removed and CORT (Sigma, UK) was added to the 
medium, unless otherwise stated at 100nM, and mixed by swirling.  The cover slip was 
replaced and the slice returned to the PMT and recording continued.  In the case where 
slices were pre-treated with a compound, such as an antagonist, this was carried out first 
and CORT was administered 60 min later.  All reagents were solubilised in 100% dimethyl 
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sulphoxide (DMSO) (Sigma, UK) and, as such, DMSO was used as the control at no more 
than 0.1%, except with the methyl experiments where 1% DMSO was used, due to 
solubility constraints.    
 
Antagonist treatment 
The GR and MR antagonists were used at a final concentration of 1µM RU486 (RU), (a 
kind gift from Dr. Laura Matthews, University of Manchester) and 1µM spironolactone 
(spir) (Sigma, UK).  This concentrations of RU was chosen as it is commonly used in the 
literature (Balsalobre et al. 2000b), and 1µM spir was chosen as it has GR antagonistic 
activity at higher concentrations, (Ec50 8µM) (Couette et al. 1992).   
 
Cav-1 disruption 
Caveolin signalling was disrupted using 5mM methyl cyclodextrin (methyl) (Sigma, UK), 
a non-specific compound that can disrupt lipid raft signal transduction via the removal of 
cholesterol, where caveolae are known to be located (Matthews et al. 2008).   
 
Non-steroidal agonists 
Non-steroidal GR agonists, GSK275167A and GSK275169A (referred to throughout as 
67A and 69A) (a kind gift from Dr. Stuart Farrow, GlaxoSmithKline, Stevenage) were 
used in these studies.  Although these exact compounds (67a and 69a) have not been 
published, similar acting compounds accompanied by their structure have (Biggadike et al. 
2009).  These agonists were found to have EC50 values in the very low nM range (Chapter 
3) and so were used at 10nM (10 x EC50).   
 
Transcriptional and translational inhibition 
Lung slices, treated with either 20µg/ml cycloheximide (translational inhibitor) or 10µg/ml 
actinomycin D (transcriptional inhibitor) (Sigma, UK), were either pre-treated for 30 min 
with the above inhibitors and treated with CORT or pre-treated with CORT for 30 min and 
then treated with the inhibitors, prior to half life (t1/2) analysis using a one phase 
exponential decay algorithm (GraphPad Prism).   
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LPS treatment 
LPS treated slices were prepared as in 2.2.4 but treated with a final concentration of 
100ng/ml LPS, at the second peak.  The LPS was solubilised in HBSS, so it was used as 
the control.  
2.2.5.2 Lung sections treated for quantitative polymerase chain reaction (qPCR)  
 
The intact lung was removed from the animal and washed in PBS.  The lung was cut into 
small pieces using a sterile blade, roughly 8-12 sections per lung.  The sections were 
placed in DMEM (section 2.2.3) without FBS and incubated at 37oC in 5% CO2.   The 
medium was replaced twice to remove any contaminants.  The slices were synchronised for 
1h with 10µM forskolin either 24h or 36h prior to treatment, so as to treat at the peak of 
trough of the PER2::;luc rhythm respectively.  At the indicated time the slices were treated 
with CORT or GR agonist for 4h; or pre-treated for 1h with 1µM RU486 (section 2.2.5.1) 
and then with CORT or GR agonist for 4h before RNA extraction (section 2.6.2.1).   
2.2.5.3 The phase response curve (PRC) 
 
The PRC was carried out in the Lumicycle, as it has the capacity to record a 32 sample 
experiment.  This meant a 12 point PRC for CORT and DMSO could be created at the 
same time, therefore, reducing assay variation.  Slices were set up, as in 2.2.4, and treated 
with CORT or 0.1% DMSO every 2h, over the circadian cycle, starting at CT12 (second 
peak).  The treated slices were left for 5 days and recordings were analysed, using the 
Lumicycle software. 
2.2.5.4 PRC analysis 
 
Even though there are many PRCs reported in the literature, these are in vivo and in 
response to light.  A PRC to both a DEX and forskolin was published by Izumo et al 2006, 
using mPer2::luc cellular reporters.  However, the authors used a much more 
mathematical, and therefore more objective, approach using cosine based algorithms, for 
phase and period determination (Izumo et al. 2006), which could not be re-created.  
Therefore, a simplified method was developed.  Referring to Fig 2.3, the endogenous 
period of the slice (x) was taken as the time between peaks 1 and 2, and the slice was 
treated every 2h after peak 2, (T).  However, to exclude Gc induced artefacts this region, T 
(peak 3), was avoided in the subsequent analysis and the time between peaks 2 and 4, (Y) 
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was used in the calculation.  It was assumed, in the untreated state, that the fourth peak 
would occur 2 periods after peak 2, and if it did not then this would constitute an advance, 
if the peak occurred early, or a delay, if it occurred later than predicted.  The combined 
equation 2x-y = n, where n = advance (+) or delay (-), was used as quick analysis method.  
The pre-treatment period was defined as X and the post-treatment period defined as P.   
The peaks and periods were defined using the Lumicycle analysis software and all treated 
slices (DMSO and CORT) were analysed in the same way.  This method was used in 
Gibbs et al. (2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Explanation of the PRC analysis.  Peaks 1 to 4 are labelled with the time of 
Gc treatment (CORT) shown by the red arrow.  The time between peaks 2 and 3 is not 
used in the calculations due to CORT induced artefacts. The time between peaks 1 and 2 
(X) defines the endogenous period.  The difference between X and Y (peaks 2 to 4) gives 
the advance (+) or delay (-) phase with the post-treatment period defined as P. 
2.2.6 Experimental use of Peritoneal Exudate Cells (PECs) 
2.2.6.1 Extraction of PECS 
 
The method, described below, is widely used to extract cells from the peritoneal cavity.  
Somewhere between 60-80% of these cells are macrophages, although other cells such as 
lymphocytes and plasma cells are present in small numbers.  The wash steps following the 
extraction does remove the majority of non-adherent cells leaving predominantly 
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macrophages, however, there will always be some impurity.  Some protocols suggest pre 
stimulation with thioglycollate (Bhattacharyya et al. 2007) to enrich the macrophage 
population, where others use FACS on the exudate (Keller et al. 2009) to select for 
macrophages.  However, here I have opted for a much faster protocol, where there may be 
some loss of cell purity but the cells maintain a robust inflammatory response. 
 
Mice were killed by cervical dislocation and their abdomens opened (taking care not to 
pierce the peritoneal cavity). A 21G microbalance needle (B and D) was fixed to a syringe 
and filled with 5ml of ice cold RPMI 1640 medium without Ca2+ or Mg2+, supplemented 
with 2mM L-glutamine, 5% FBS and a final concentration of 0.1mg/ml streptomycin and 
100 Units of penicillin, subsequently referred to as RPMI 1640.  The peritoneal cavity was 
slowly filled with the medium, with care taken as not to rupture any organs.  The mouse 
was agitated for 30 sec and the medium removed from the cavity and placed on ice.  This 
process was repeated.  The resulting exudate was centrifuged at 1500 x g for 5 min and the 
supernatant discarded.  The cells were washed with the RPMI 1640 and centrifuged as 
before.  After the wash step, the supernatant was removed and any red blood cells were 
lysed in 1ml deionised H2O for 30 sec before lysis being stopped with excess RPMI 1640 
(approximately 30ml).  Once more, the exudate mix was centrifuged and the supernatant 
discarded and this process was repeated a further time.  Finally the cells were re-suspended 
in 5ml RPMI 1640 and counted using a CASY cell counter (Innovarits) and cells between 
6-20µm in diameter were counted.  These parameters discard debris, dead cells and cells 
too large to be macrophages as they are generally 8-15µm in diameter (Ghosn et al. 2010).  
Cells were cultured in separate wells in a 24-well plate between 0.4 and 0.5 x106 cells/ 
well; these will be referred to as experimental cells.  The density was maintained within an 
experiment but varied between experiments due to overall cell numbers.  The PECs were 
pooled from between 3 and 5 mice, same sex for the PER2::luc cells but mixed sex for the 
Rev-erbα -/- PECs, due to number constraints.  The pooled cells were divided into 
replicates of 3 for each experimental condition.  PECs from the PER2::luc mouse were also 
cultured, into an individual 35mm dish, in order to put them under the PMT, as a 
representative trace of the phase of the circadian oscillation, roughly about 2.5 - 3 x106 
cells/well were cultured, these will be referred to as reporter cells.  All cells were placed at 
37oC in 5% CO2 for 2h and then washed in 1 x PBS and fresh RPMI 1640 was added and 
the cells were returned to incubate. 
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2.2.6.2 LPS Stimulation of PECs 
 
All cells, reporter and experimental, were synchronised 24h prior to the onset of LPS 
challenge.  The reporter cells report the phase of the oscillation and did not receive an LPS 
challenge, whereas the experimental cells were challenged at the indicated phase.  To 
synchronise, 10µM forskolin was added to the cells for 1h then the medium was removed, 
cells were washed in 1 x PBS then recording medium was added (see appendix A), 1ml for 
the experimental and 2ml for the reporter cells.  The medium for all cells was the same 
apart from the reporter cells having luciferin present in order for light to be emitted 
(section 2.1.3)  Experimental cells were placed at 37oC in 5% CO2 and the reporter cells 
were placed under the PMT (at 37oC and buffered against CO2, section 2.2.4) for the 
oscillation to be reported.  At the times indicated, usually the first peak and trough, the 
experimental cells were treated.  Firstly the medium was removed and discarded; fresh, 
warmed medium was placed on the cells containing 0.8ml of HBSS, 100ng/ml LPS or 
100ng/ml LPS mixed with 100nM CORT.  The cells were exposed for 4h before the 
medium was removed and frozen at -20oC ready to be assayed for inflammatory mediator 
release by enzyme linked immunosorbant assay (ELISA), described in section 2.5.3.  The 
remaining experimental cells were washed in PBS and frozen at -80oC until the cells were 
lysed for protein quantification, section 2.5.1. 
2.2.6.3 Cytospin of LPS treated PECs 
 
Approximately 1 – 2 x105 cells were diluted into 200µl RPMI 1640 and centrifuged at 800 
x g for 5 min onto a gelatine coated slide (VWR).  The cells were fixed in 4% 
paraformaldehyde (PFA) for 10 min on ice.  The PFA was prepared as follows: 12g PFA 
(Sigma, UK) was dissolved in 300ml PBS (5 tablets dissolved in 1 litre produce 10mM 
phosphate buffer, 2.7mM potassium chloride and 137mM sodium chloride, pH 7.4, Sigma, 
UK), heated to 50oC then 2 – 3 drops of 5M NaOH was added until the solution clarified.  
The resulting PFA was then filtered through 0.45µm filter paper (Whatman).  The fixed 
cells were washed in H2O then stained with hematoxylin and eosin (H and E) (section 
2.2.6.4). 
2.2.6.4 Hematoxylin and Eosin staining (H and E) 
 
The cells were stained with hematoxylin (Sigma, UK), a nuclear stain, for 2 min and 
washed for 4 min, in tap H2O.  The cells were then stained with eosin (Sigma, UK), a 
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cytoplasmic stain, for 4 min and then briefly washed.  The cells were dehydrated in 50%, 
70%, 90% and 100% ethanol (diluted with H2O) for 2 min each and then the ethanol was 
cleared in 100% xylene before being cover slipped.  Images were collected on an Olympus 
BX51 upright microscope using a 20x objective magnification. 
2.3 Cell Culture 
2.3.1 Maintenance of cell lines 
 
All cell lines used throughout this thesis were kept in constant conditions at 37oC in 95% 
air 5% CO2, in a humidified atmosphere, furthermore, all cells used were adherent.  All 
luciferase reporter cell lines were created from the Rat-1-R12 (Rat-1) cell line (ATCC), 
which is an immortal line derived from rat connective tissue fibroblasts.  Human 
embryonic kidney (HEK293), HeLa cells and Cav-1 WT and -/- cells (all a kind gift from 
Dr. Laura Matthews) were further cell types used in these studies.  The Cav-1 WT and -/- 
cells are an immortalised line derived through spontaneous immortalisation from the 
thymus of Cav-1 -/- mice and WT litter mates.   All cells lines were considered infection 
free and free of mycoplasma contamination.  Cells were maintained in DMEM (section 
2.2.3) supplemented with 10% FBS and 0.05mg/ml streptomycin and 50 Units of 
penicillin.  In order to maintain a healthy cell population and to utilise them, the cells were 
passaged every 7 days.  Firstly cells were detached with a 0.25% trypsin, 0.02% 
ethylenediaminetetraacetic acid (EDTA) solution (Sigma, UK), adding an appropriate 
amount to cover the base of the dish (1 ml would detach cells in a 75cm2 dish).  When the 
cells were fully detached the trypsin was inhibited by the serum in fresh DMEM and the 
cells were collected and aliquoted at an appropriate density in to plates or put back into 
new flasks to incubate. 
2.3.2 Reporter cell lines 
 
A number of circadian reporter lines have been used in this thesis, many of which were 
cloned in the Loudon laboratory by Dr. Qing-Jun Meng who kindly allowed the free use of 
all these constructs.  These include mPer2::luc 600 base pair (bp); mPer1::luc 600 bp; 
hC/ebp alpha:luc 1300, 650, 280 and 240bp and the hC/ebp delta:luc 1700bp.  The 
constructs were cloned into the pGL4.16[Luc2CP/Hygro] vector (Promega) but with added 
chicken beta globulin insulator sequences, in tandem copy, surrounding the promoter-
driven luciferase expression region (Fig 2.4).  This was previously shown to reduce 
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unwanted silencing and to maintain a robust signal (Meng et al. 2008).  The plasmid also 
carries the gene for ampicillin (Amp) resistance, which allows for selection in a bacterial 
host, and the gene for hygromycin (Hyg) resistance, which allows for selection in a 
mammalian host. Hyg (Invitrogen) was continually used to supplement the DMEM 
(section 2.3.1), at a concentration of 200ug/ml, in order to maintain the inserted plasmid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Vector map of the pGL4::luc insulated plasmid:  The plasmid contains the 
luciferase gene, shown in blue (Luc2CP), the Amp resistance gene (Ampr) and the Hyg 
resistance gene (Hygr).  The tandem repeat insulated sequences are shown in red. 
 
2.3.2.1 C/EBP alpha protein over expression 
HEK293 or HeLa cells were cultured in a sterile 6-well plate until 50%-80% confluent 
(approximately 5 – 8 x105 cells), according to the Fugene6 protocol.  A transfection mix of 
97µl serum and antibiotic free DMEM and 3µl Fugene6 (Roche) (concentration of 3µl/µg 
of plasmid) was incubated at RT for 5 min.  1µg of hC/EBP α or control plasmid, 
pcDNA4/HisMax C (Invitrogen), was added to the transfection mix (the plasmid also 
contains a 6 x histidine (His) tag, a kind gift from Dr, Qing-Jun Meng) and incubated for a 
further 20 min at RT, before being added drop wise to the cells.  The cells were incubated 
at 37oC for 48h then lysed for protein extraction, see 2.5.1. 
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2.3.2.2 Cell preparation for endogenous C/EBP alpha expression studies 
circadian C/EBP alpha expression 
 
Rat-1 cells were cultured in 35mm dishes, until 100% confluent, and synchronised with 
10µM forskolin for 1h, as in 2.2.4.  The cells were incubated as in 2.3.1 and 24h later the 
cells were lysed and protein extracted and stored at -80oC, as 2.5.1.  This was considered 
time 0 and protein was extracted from subsequent cells, every 4h over the 24h period.  
Protein was also extracted from the lungs of mice synchronised to a 12:12 L:D light cycle 
then released into constant darkness for 24h prior to schedule 1 and lung extraction.  This 
in-vivo work was carried out by Dr Julie Gibbs.  
 
DEX effect on C/EBP alpha expression 
 
Rat-1 cells were cultured in 35mm dishes, until 100% confluent, and synchronised with 
10µM forskolin, and returned to the incubator.  24h later the cells were treated with either 
100nM DEX or vehicle (0.1% DMSO) for the stated time, lysed and stored at -80oC, as 
section 2.5.1. 
 
Clock and BMAL1 over expression 
 
Rat-1 cells were cultured in 35mm dishes until 50%-80% confluent, according to the 
Fugene6 protocol.  A transfection mix of 97µl serum and antibiotic free DMEM and 3µl 
Fugene6 (concentration of 3µl/µg of plasmid) was incubated at RT for 5 min.  To separate 
tubes containing the transfection mix, either 1µg of pcDNA3 (Invitrogen) control, 0.3µg of 
pcDNA3-Clock or 0.3µg of pcDNA3-BMAL1 (each made up to a total of 1µg of DNA 
with 0.7µg of pcDNA3) was added and incubated at RT for 20 min.  Again, to a further 
tube containing the transfection mix, 0.3µg pcDNA3-Clock, 0.3µg pcDNA3-BMAL1 and 
0.4µg pcDNA3 was added and incubated for 20 min at RT, the transfection mixes were 
added drop wise to separate dishes.  The cells were incubated at 37oC for 48h then lysed 
for protein extraction, see 2.5.1.  In summary, there was a pcDNA3 control, pcDNA3-
Clock, pcDNA3-BMAL1 and a pcDNA3-Clock-BMAL1 transfection mix, all which 
contained 1µg of DNA.  All plasmids were a gift from Dr. Qing-Jun Meng. 
2.3.3 Cloning of mPer1::luc 2500bp construct 
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Mut mPer1 
1850bp
GRE
E-box
Per1 is the only clock gene with a conserved GRE present within the promoter region, 
located between -1918bp and -1933bp (table 2.3 for sequence), 5’ to the ATG 
transcriptional start site, (Yamamoto et al. 2005),  (5’ refers to the region left of the 
transcriptional start site, if transcription occurs in a left to right manner, the region to the 
right is labelled as 3’).  The construct also contains a CRE between -1800bp and -1807bp 
(Montminy et al. 1986) and three E-box elements at 226bp, 589bp and 1335bp.  A 2500bp 
region of the mPer1 promoter 5’ to the ATG was sub cloned from an existing 7500bp 
fragment in a pGL3::luc vector (Promega).   
 
 
 
 
 
 
Figure 2.5: Cloned mPer1 WT and mutant construct:  A cartoon depicting the mPer1 
promoter 3kb upstream of the transcriptional start site, showing the relative positions of the 
CRE (1807bp-red), GRE (1933bp-blue) and E-boxes (226bp, 589bp, 1335bp-black).  The 
black cross represents the mutated GRE construct (section 2.3.7) which leaves the CRE 
intact. 
 
A NheI (5’-GCTAGC-3’) restriction site was added to the 5’ end of the forward (F1) 
primer and an EcoRV (5’GATATC3’) site was added to the 5’ end of the reverse (R1) 
primer.  The sequences were taken from the genome browser website Ensembl and the 
2500bp mPer1 promoter was analysed to ensure no conflicting restriction sites.  Sequences 
were purchased from MWG biotechnology, Germany (table 2.1).  A 4 base sequence of 
CGGC was added before the restriction sites to allow the enzyme to ‘dock’.   The melting 
temperature (Tm) was calculated using Promega BioMath base stacking equation, to ensure 
both primers were within 2oC of each other.   
 
 
 
 
 
 
 
Table 2.1: mPer1 2500 primer sequences. 
5’ to 3’  Primer sequence (restriction site is show in 
bold) 
Tm ( oC)  
Forward (F1) CGG CGC TAG CGG GGA TTT ATG TGC 
ATG CT 
67 
Reverse (R1) CGG CGA TAT CAA CCC AGA AGC TCC 
GCG AG 
68 
Chapter 2_______________________________________Materials and Methods 
 
 112 
The F1 and R1 primers (MWG, Germany), mPer1::luc pGL3 (7500bp) plasmid, deoxy 
nucleotide tri-phosphates (dNTPs) (Bioline) and HotMaster Taq DNA Polymerase 
(Eppendorf) were combined and nuclease free H2O (Ambion) added to make a final 
volume of 20µl (table 2.2). The mix was placed in a thermal cycler and the 2500bp region 
of interest was amplified using the principle of the polymerase chain reaction (PCR), using 
the following sequence: initial denaturing step of 94oC for 2 mins followed by 30 
amplification cycles of 94oC for 20 sec (denaturing) and 68oC for 20 sec (annealing) and 
70oC for 3 min (elongation). 
 
Reagent Final concentration 
(per reaction) 
F1 (10µM) 0.4µM 
R1 (10µM) 0.4µM 
mPer1::luc pGL3 (7.5kb) 10-50ng  
dNTP  (2.5mM) 0.2mM 
HotMaster Buffer x 10 x 1 
HotMaster Taq DNA 
Polymerase 
0.75 Units 
 Made up to 25µl in 
nuclease free H2O 
Table 2.2: mPer1 2500kb amplification reagent. 
 
The PCR product was run on a 0.8% agarose gel, containing ethidium bromide, (both 
Sigma, UK) which intercalates into the DNA and allows its visualisation under U.V. light.  
The resulting band was cut out and purified using QIAgen gel purification kit, according to 
the manufacturer’s protocol.  The DNA was digested with 10 Units of NheI and EcoRV 
together with NEB buffer 2 (New England Biolabs, NEB) at 37oC for 3h, with a small 
aliquot run on a gel to establish purity.  The digested fragment was ligated into the 
insulated pGL4::luc vector (Fig 2.4).  Ligation was carried out at 16oC for 16h using T4 
DNA ligase (NEB), according to the manufacturers’ instructions, using a DNA to vector 
ratio of 3:1.   
2.3.4 Transformation of the plasmid  
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Transformation is the process by which a plasmid of interest is taken up by host bacteria, 
in order to take advantage of bacteria’s rapid replication machinery and amplify a gene of 
interest.  DNA is a hydrophilic molecule (water loving) and will not readily pass through 
the hydrophobic (water hating) membrane of the bacteria.  In order to allow the DNA to 
pass through the bacterial membrane cells are made competent with making small holes in 
the membrane with a high concentration of Ca2+, and DNA can then pass through the 
membrane after a brief heat shock.   
 
The DH5 alpha supercompetent bacterial cells (Invitrogen) and pGL4-mPer1 2500kb 
(pGL4-mPer1 2500bp) plasmid (10 – 50ng DNA) were mixed and incubated on ice for 30 
min; the bacteria/DNA mix was heat shocked at 42oC for 45 sec and returned to ice.  The 
heat shocked mix was added to 250µl of SOC medium (Invitrogen) and placed at 37oC for 
1h, shaking at 200 revolutions per minute (rpm).  The resulting solution was centrifuged at 
2000 x g for 1 min and 150µl of supernatant was removed and the mix was re-suspended.  
The transformation mix was spread onto a Luria-Bertani (LB) agar plate (University of 
Manchester media stores) supplemented with 100µg/ml Amp.  The plates were dried 
briefly and placed upside down, at 37oC for 16h in a humidified atmosphere, so any 
potential colonies were pure clones rather than hybrids. 
2.3.5 Amplification and purification of the plasmid 
 
Potential colonies were selected and grown for a further 16h in 2 ml of LB medium 
(University of Manchester media stores) supplemented with 100µg/ml amp, (LB Amp).  
Aliquots were taken from each colony and kept for storage at -80oC, as a glycerol stock, 
using a 50:50 mix of bacteria:40% glycerol. The resulting bacteria were lysed and plasmids 
extracted using QIAgen mini prep kit, following the manufacturers’ protocol.  Aliquots of 
extracted plasmids were digested with NheI and EcoRV and run on a gel as previous 
(section 2.3.3).   Plasmids showing a fully digested band at 2500bp were then sequenced 
(see 2.3.6),  
2.3.6 Sequencing and plasmid purification 
 
Potential plasmids containing the mPer1 insert were sequenced using the in-house 
sequencing service (University of Manchester).  First the region of choice was PCR 
amplified using BigDye terminator v3.1 cycle sequencing kit (Applied Biosystems) 
according to the manufacturers’ instructions using the F1 primer (table 2.1), this was used 
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as primers specific to the pGL4 backbone were not available.  100ng plasmid was added to 
4µl of BigDye and 1µl of 10 x reaction buffer together with 10µM of F1 primer and made 
up to 10µl with nuclease free H2O.  It was placed in a thermal cycler at 96oC for 4 min 
followed by 30 cycles of 98oC for 30 sec, 50oC for 15 sec and 60oC for 4 min.  The 
amplification reaction was purified by adding 1µl of 3M sodium acetate pH 5.2, 1µl of 
10mg/ml linear polyacrylamide (LPA) (both Sigma, UK), 0.5µl of 15mg/ml glycoblue 
(Ambion, UK) and 25µl (2.5 volumes) 100% ethanol, to the reaction. The resulting mix 
was left at RT for 20 min then centrifuged at 13000 x g for 10 min.  The supernatant was 
removed and 100µl of 70% ethanol (30% H2O) was added and mixed.  This was 
centrifuged at 13000 x g for 5 min and the supernatant was removed and the pellet air 
dried.  The pellet was sent to the sequencing facility.  Providing the sequence was correct, 
the bacteria were taken from their respective glycerol stock and grown on an LB Amp 
plate at 37oC for 16h.  Resulting colonies were cultured in 2ml LB Amp medium for 8h at 
37oC shaking at 200 rpm.  This starter culture was then transferred to a larger 50ml LB 
Amp culture using a 1 in 1000 dilution (50µl bacteria in 50ml LB Amp) and incubated for 
16h at 37oC, shaking at 200 rpm.  The resulting bacteria were lysed and plasmids extracted 
using QIAgen midi prep kit, following the manufacturers’ protocol. Nucleotide 
concentration (ng/µl) and purity (idea ratios for 260:280nm peak absorbances are 1.8 for 
DNA or 2.0 for ribonucleic acid, RNA) was determined on a NanoDrop 1000 
spectrophotometer (Thermo Scientific).  Plasmids were stored at -20oC. 
2.3.7 Mutagenesis of mPer1 GRE 
Yamamoto et al. (2005) showed that the GRE in the Per1 promoter was active through a 
mutagenesis study (Yamamoto et al. 2005).  In this study a 3 base pair mutation reduced 
the response to the Gc agonist, DEX, by 95% in a luciferase assay.  Here the mutant clone 
was re-created in order to study its effects in a real time cellular environment, in response 
to Gc stimulus.  The same mutation as Yamamoto et al. (2005) was introduced to the 
pGL4-mPer1 plasmid and PCR amplified using a mutagenesis kit (Stratagene) according to 
the manufacturers’ instructions.  The primers used are shown in table 2.3 and the Tm was 
calculated using the Stratagene Tm calculator.  Potential mutant clones were grown up, as 
in section 2.3.5, sequenced and followed by a large scale culture and purification of the 
mutant plasmid (section 2.3.6).  Plasmids of both WT and mutant clones were used to 
generate both transient and long term genome integrated (stable) reporter cell lines (section 
2.3.8.2). 
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 Sequence (5’ - 3’) Tm (oC) 
WT cca tca gcc aag aga ACA cga tgt tcc cta gtg cgc tg  
F1 
mutant 
cca tca gcc aag aga CAG cga tgt tcc cta gtg cgc tg 79.6 
R1 
mutant 
ca gcg cac tag gga aca tcg CTG tct ctt ggc tga tgg 79.6 
Table 2.3: mPer1 GRE sequence.  The WT and mutant sequences are as shown with the 
GRE highlighted in bold; the mutated bases and corresponding WT sequence are in upper 
case. 
2.3.8 Generation of transient reporters and stable cell lines  
2.3.8.1 Transient transfection of mPer1::luc luciferase reporters  
To identify experimentally functional clones for the mPer1::luc WT, and mutant reporters, 
Rat-1 cells were cultured in separate, sterile 10 cm dishes, at a density of 100 x104 cells, 
24h prior to the transfection. In separate sterile tubes (Eppendorf) 250µl of serum and 
antibiotic free Opti-MEM (Invitrogen, UK) was combined with 3µg of WT or mutant 
plasmid (Firefly luciferase) and 0.1µg of Renilla luciferase (from Renilla reniformis) as a 
control plasmid (a kind gift from Dr Midori Kayahara).  Fugene6 transfection reagent was 
finally added, at a concentration of 3µl/µg plasmid.  The transfection mix was incubated at 
RT for 30 min then added to the cells in a drop wise manner, ensuring even distribution.  
The cells were incubated for 16h at 37oC, 5% CO2 then split into a 96-well plate, using a 1 
in 200 dilution per well.  The plate was incubated for 16h, as previously described, and 
cells were treated with either: 10µM forskolin, 100nM CORT, 10nM GR agonist 67a and 
69a, or 0.1% DMSO.  After 4h incubation, cells were lysed and luciferase activity recorded 
using the Dual luciferase reporter assay system (Promega), according the manufacturers’ 
protocol, and a luminometer (Beckman).  The pGL4-Per1 (Firefly) luciferase was read first 
at 560nm, this reaction was then stopped and the Renilla luciferase was read at 480nm.  A 
ratio of Firefly to Renilla luciferase was taken and normalised relative to the WT control. 
2.3.8.2 Generation of stable reporter cell lines 
 
Both WT and mutant mPer1::luc, confirmed by a luciferase assay (section 2.3.8.1), were 
transfected into Rat-1 cells and allowed to stably integrate in the genome, through random 
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insertion.  12µg of each plasmid was linearised with SalI (NEB) for 3h at 37oC, checking 
an aliquot on a gel, as section 2.3.3.  The linearised plasmid was precipitated, as in 2.3.6, 
and the resulting plasmid was re-suspended in 50µl of nuclease free H2O and quantified.  
Rat-1 cells were cultured in 10 cm dishes and incubated until 30%-50% confluent 
(approximately 0.2 – 0.5 x 106 cells).  18µl of Fugene6 was added to 582µl of DMEM 
(supplement free) and incubated at RT for 5 min.  6µg of linearised plasmid was added to 
the transfection mix and incubated for a further 20 min at RT, then added to the cells in a 
drop wise manner.  Transfected cells were incubated at 37oC for 48h then the medium was 
removed and cells washed in 1x PBS.  DMEM supplemented with Hyg was added to the 
cell and incubated at 37oC. To drive selection of mPer1::luc positive cells the DMEM with 
Hyg medium was changed every 48h until individual colonies of 10 - 30 cells appeared.  
Successful colonies were removed by sterile, trypsin soaked 3mm cloning discs (Sigma, 
UK) and cultured in 12 well plates with DMEM and Hyg.  The medium was changed every 
48h until cells were confluent and transferred to 25 cm2 flasks (T-25) (Corning, UK) and 
eventually to a 75 cm2 flask (T-75) (Corning, UK).  Cultured cells, both WT and mutant, 
were then ready to be used experimentally within the PMTs, (section 2.3.9). 
2.3.8.3 Luciferase assays with stably transfected C/EBP alpha and delta cells 
 
Cells were cultured as 2.3.1 and prior to use were grown in sterile 6 well plates until 100% 
confluent (approximately 1 x 106 cells).  24h before experimental treatment, cells were 
synchronised with 10µM forskolin for 1h then the medium was removed and cells were 
washed with 1 x PBS and fresh medium was replaced.  24h later cells were treated with 
either 100nM DEX or 0.1% DMSO for 4 or 24h.  After the elapsed time the medium was 
removed and cells were washed in 1 x PBS then lysed and a luciferase assay was 
performed using Luciferase Assay Kit (Promega), according to the manufacturers’ protocol 
and read on a luminometer (2.3.8.1).  A Renilla control was not used as the reporter was 
integrated into the genome and the cells were grown from a single cell population.  The 
resulting luciferase values were then normalised between 0 and 100 relative luciferase 
units (RLU) with 100 units equal to the DMSO control. 
2.3.8.4 MR transactivation assay 
 
The transactivation assay is a method of exploiting the ability of a liganded nuclear 
receptor to induce transcription.  In the transactivation assay, described below, 
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transcription induced is a mouse mammary tumour virus (MMTV) luciferase reporter 
which contained 4 copies of the GRE sequence, (kind gift from Dr. Midori Kayahara, 
University of Manchester), upstream of a minimal promoter.  The transcriptional activation 
can be used to determine the median effective concentration (Ec50) value for an unknown 
compound.  This is the point that the concentration of agonist induces 50% of the total 
activation of the system.   
 
HEK293 cells were plated into sterile 10cm dishes, at a density of 100 x 104 cells per well.  
16h later, a transfection mix of 3µg of hMR expression plasmid (Govindan and Warriar 
1998)  (kind gift from Dr. M. Govindan, Laval University, Canada), 3µg MMTV-luc and 
0.1µg Renilla were added to 250µl of Opti-MEM.  To this 18µl of Fugene6 was added and 
then incubated at RT for 30 min then added, drop wise, to the cells.  The transfected cells 
were incubated at 37oC for 16h and then split in to a 96 well plate with a 1 to 222 dilution 
(45µl per well from a 10ml volume) and then incubated for a further 16h.  Cells were 
treated with the respective compound; CORT or GR agonist (67a or 69a), using a serial 
dilution ranging from 100nM to 3pM with dilutions of 1 to 3, (factoring in a 10 fold 
dilution in to the cells, therefore, making stocks 10 x greater).  Cells were incubated for a 
further 16h and then the medium was removed, cells were washed in 1 x PBS and then 
lysed and the luciferase signal read and analysed, as section 2.3.8.1.  The Ec50 value was 
defined by fitting the data points to a one phase exponential decay algorithm (GraphPad 
Prism).  The GR transactivation assay was carried out by Dr Midori Kayahara in the same 
way as described above but with an hGR expression plasmid, rather than the hMR. 
2.3.9 Experimental treatment of cell lines 
2.3.9.1 Preparation of reporter cell lines for the PMT 
 
Cells were cultured in to individual 35mm sterile dishes until they were 100% confluent, 
approximately 1 x 106 cells.  The cells were then synchronised for 1h with 10µM forskolin 
(as in section 2.2.4).  The medium was removed and the cells were washed in 1 x PBS and 
2ml of recording medium was added.  The dishes were sealed with sterile cover slips and 
grease (section 2.2.4) and were place in the PMT units, either single units or in the 
Lumicycle, and recordings taken.  Data points were collected every minute, with the single 
PMT units, or every 10 min with the Lumicycle, throughout the experiment.  All cells were 
experimentally treated, and analysed, in the same way as the lung slices (section 2.2.5.1).   
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2.3.9.2 Treatment of cells for quantitative PCR  
 
Rat-1 cells 
The cells (Rat-1 or Cav-1 WT and -/-, section 2.3.1) were cultured in 6-well plates until 
they were 100% confluent, approximately 1 x 106 cells, and synchronised for 1h with 
10µM forskolin 24h prior to treatment.  The medium was removed and the cells were 
washed in 1 x PBS and 2ml of DMEM (section 2.3.1) was added and returned to the 
incubator.  24h later Rat-1-Per2::luc cells were treated with either DMSO, CORT or GR 
agonist for 4h or pre-treated with 1µM RU486 for 1h then CORT or GR agonist was added 
before RNA extraction 4h later.  The RNA was extracted as in 2.6.2.2    
 
Cav-1 WT and -/- cells 
Cav-1 cells (WT and -/-) were synchronised as above (2.3.9.2 Rat-1 cells) with CORT or  
DMSO for 1h, 2h or 4h prior to RNA extraction.  Cav-1 WT and -/- cells were also 
synchronised as above but remained untreated and RNA extracted at the indicated times 
12h apart (Fig 4.8).  The PI3K inhibitor, LY294002 (Sigma, UK) was added at 50µM to 
Cav-1 WT cells 1h prior which to 100nM CORT administration.  The cells were then 
harvested and RNA extracted at 2h and 4h post treatment for analysis of mPer2 by qPCR.  
The RNA was extracted as in 2.6.2.2  
2.4 Flow-through culture system 
2.4.1 Background 
 
A flow-through culture system was established previously by Dr. Andrew McMaster in 
order to study the temporal effects of different stimuli on the regulation of the genome, in a 
system that could mimic the pulsatile nature of endogenous Gc (Windle et al. 1998b).  The 
advantage of this system meant that Gcs could be added and removed, on demand, without 
disturbing the cellular environment, as there was a constant flow of new medium.  The 
basic principles of this system were taken and modified, in this thesis, to establish a flow-
through reporter system linked to the PMT, so that real time recordings could be taken and 
experiments carried out at specific phases of the circadian cycle. 
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2.4.2 Linking the Flow-through to the PMT 
  
For all but one flow-through experiment, mPER2::luc lung slices were used as the reporter 
(section 2.2.3/4), as reporter cell lines would not tolerate the flow of medium. A peristaltic 
pump (Watson-Marlow, UK) was used to continually pump recording medium (appendix 
A) through sealed 35mm culture dish at a rate of 6.8ml/h.  This rate was based on Dr. 
McMaster’s previous findings where the wash out rate was able to mimic that of an 
endogenous Gc pulse.  Heat shrink (Maplin electronics, UK) was fitted to an appropriate 
length of marprene tubing (Watson-Marlow, UK) with a 0.5mm internal bore, so as to 
remain stable in the pump.  The tubing was sterilised in an autoclave and the system was 
assembled in a sterile atmosphere.   
 
Holes were placed in the filter lids of two 225cm2 (T225) flasks (one for recording medium 
and one for waste) and a T25 (recording medium with Gc).  Roughly 900ml of recording 
medium was added to the relevant T225 flask, enough for about 5.5 days and a further 
20mls, supplemented with Gc, was added to the T25.  A 35mm dish had 5 holes drilled 
into it, it was then washed and sterilised with 70% ethanol and U.V. light.  The membrane 
insert was secured, and the sterile tubing was attached, shown in Fig 2.7, and sealed with 
grease.  The free end of each tube was inserted into the respective flasks; waste, recording 
medium only and recording medium with CORT, (Fig 2.6).  The lung slice was 
synchronised, 1ml recording medium was added to the well and the dish sealed, (section 
2.2.4).   
 
The set up was transferred to a 37oC incubator, which contained the peristaltic pump and a 
mechanical on/off switch.  The switch acted to pinch close one tube (medium with CORT) 
whilst allowing the other to remain open (medium only), (John Simpson, University of 
Manchester), then at a given time this could be reversed.  A subsequent improvement to 
this linked the switch motor to a computer-driven timer, thus allowing for pre-set on/off 
events.  The tubes were fitted to the pump (using the heat shrink as a stopper) and inserted 
to the switch, as shown in Fig 2.6, in a linear manner.  The dish containing the lung slice 
was placed in the PMT unit which was sealed with tin foil.  The pump was turned on and 
the system allowed to equilibrate for 30 min before the PMT recordings began. 
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Figure 2.6: Diagram of the flow-through system.  Tubes were inserted into two 
flasks, one containing recording medium and the other recording medium with 
Gc, fed through the peristaltic pump and into a mechanical on/off switch.  The 
tubes lead into the culture dish, containing the mPER2::luc lung slice, placed in a 
PMT unit, linked to a computer.  A single output tube leads to a waste flask.  The 
flow rate was set to 6.8ml/h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Plan view of the 35mm dish modified for flow-through culture.  Holes 
were drilled at points A-E and the three tubes were fixed in position, waste (A), recording 
medium only (C) and recording medium with Gc (D).  The membrane insert was fixed in 
position with tubing (B and E) and the insert was placed on recording medium. 
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2.5 Protein quantification  
2.5.1 Protein assay 
 
The bicinchoninic acid (BCA) protein assay was used for quantification.  Cells were lysed 
in 400µl of buffer (appendix B) for 30 min at 4oC, collected and centrifuged at 13000 x g 
for 20 mins.  The supernatant was stored at -80oC and allowed to thaw, on ice, before use.  
A standard curve was made using a known concentration of bovine serum albumin (BSA) 
(Sigma, UK).  A  6 point BSA dilution series was made, 0, 100, 200, 400, 800 and 
1000µg/ml, diluted in lysis buffer and the unknown sample was diluted in lysis buffer, 1 in 
10, to make a final volume of 50µl.  An appropriate volume of the BCA reagent mix was 
prepared using 1ml BCA solution (Sigma, UK) with 40µl 4%(w/v) CuSO4 (Sigma, UK) 
per sample.  The BCA reagent was mixed and added to the sample and standards.  All 
samples were incubated at 37oC for 30 min and then read, in triplicate, at 560nm on a plate 
reader (Bio-Rad).  A colour change is detected as the protein reduces Cu2+ to Cu+ in a 
concentration dependent manner, forming a purple colour.  The BCA assay was used here 
rather than the quicker Bradford assay as the detergent, in the lysis buffer (Triton X-100, 
appendix B), interfered with the Coomassie Blue stain (active compound in the Bradford 
assay) resulting in a blue colour which was indistinguishable from a high protein 
concentration.  Therefore, the Bradford protein assay could not be used with this specific 
lysis buffer (appendix B). 
2.5.2 Immuno (Western) blotting 
 
Immuno blotting is a technique used to detect a specific protein in a mixed protein sample, 
or lysate.  The lysates which can come from cells or tissues, and are first denatured, to 
form a primary chain of amino acids, then coated with a large negative charge, using 
sodium dodecyl sulphate (SDS), they are separated by mass by passing a voltage through a 
gel matrix. 
 
The protein was quantified as in 2.5.2 and a total of 50µg was immuno-blotted against the 
respective antibodies.  The protein was denatured at 95oC for 10 min in the presence of 
20µl loading dye, (see appendix B for reagents).  The samples were separated by SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) using a 8% gel (appendix B) and passing 
120 volts (V) for 1h then 180V for 4h, through the system, using a Protean II gel ready 
system (Bio Rad).  The samples were resolved in parallel with a dual colour protein marker 
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(Bio Rad), range 15 to 250 kilodalton (kDa), in a Tris SDS running buffer (appendix B).  
The resolved proteins were transferred to a 0.2µm nitrocellulose membrane (Bio Rad) for 
16h using 35V at 4oC, in a methanol based transfer buffer (appendix B).  The transferred 
protein was stained with ponceau S (Sigma, UK), to check for even loading.  The 
membrane was washed with deionised H2O and blocked for 4 hours in 5% skimmed milk 
(Marvel) in 20mM Tris–HCl pH 7.6 buffered saline (TBS) (supplemented with 0.1% 
Tween-20, (TBST) without agitation (both Sigma, UK).  The primary antibody was added, 
diluted in 5% milk TBST, and incubated for 16h at 4oC, shaking gently.  Antibodies used 
were rabbit anti-C / EBP α, C-terminus monoclonal (Epitomics), diluted 1 in 500; alpha 
tubulin clone DM1A mouse monoclonal  (Sigma, UK), diluted 1 in 2000; anti His-tag 
mouse monoclonal (Serotec) diluted 1 in 200.  The membrane was washed with 3 x 15 min 
TBST washes, to remove unbound antibody and the secondary antibody was added diluted 
in 5% milk TBST for 1h at RT, shaking gently.  The secondary antibodies were 
horseradish peroxidase (HPR) linked anti mouse or anti rabbit (raised in sheep or donkey 
respectively) whole antibody immunoglobulin G (IgG) (GE Healthcare).  Excess antibody 
was washed off with 5 x 15 min washes in TBST and then imaged using the enhanced 
chemiluminescence (ECL) Amersham advanced detection system (GE Healthcare) and a 
manual developing/fixing protocol (Sigma, Uk) with a Biomax film (Kodak). To develop 
the exposed film, the developing and fixing reagents were made up according the 
manufacturers’ protocol, and the film was washed in the developer until a dark band 
appeared with the correct molecular weight.  The film was washed with H2O and placed in 
the fixing solution until the film was clear.  The solution was washed with H2O and the 
film left to dry.  The resulting images were quantified using densitometry software.  The 
immuno blots regarding the lung slices (section 2.2.5.5) were carried out by Dr Laura 
Matthews using GR M20 (Santa Cruz), alpha tubulin (Sigma, UK) phosphorylated (P) 
GRSer 211, pPKBser473, P-MAPK p42/44thr202 (al NEB).  The immuno blots were scanned and 
analysed by densitometry using SigmaScan software and are represented as expression 
relative to α- tubulin. 
2.5.3 Enzyme-linked immunosorbant assay (ELISA) 
 
The ELISA technique is a way of detecting and quantifying a protein of interest in an 
unknown sample.  It utilises the specificity of antibody detection, similar to an immuno 
blot, but the detection antibody, linked to the HPR enzyme, undergoes a chemical reaction, 
resulting in a colour change, which is proportional to the concentration of protein.  This 
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reaction is carried out in parallel with a known concentration of samples and so an accurate 
determination of protein can be found. 
 
ELISAS for mouse CXCL1 (KC), IL-6, TNFα, CCL5 (RANTES) and CCL2 (MCP1) were 
carried out using the ELISA DuoSet (R and D systems) according to the manufacturers’ 
protocol, as follows:  All incubations were carried out at RT.  50µl of capture antibody was 
added to a 96-well plate (Nunc, Denmark) in serum free 1 X PBS (10mM phosphate 
buffer, 2.7mM potassium chloride and 137mM sodium chloride, pH 7.4, Sigma, UK) and 
left for 16h.  The antibody was removed and the plate washed 3 times in 1 x PBS with 
0.1% tween-20 (PBST).  The plate was blocked with 150µl of 1% low endotoxin BSA 
(Sigma, UK) dissolved in 1 X PBS (referred to as reagent diluent) for 1h and washed in 
PBST.  Standards and samples were prepared and added to the plate; unknown samples 
were added neat and with a 1 in 2 and 1 in 10 dilution, to ensure they were in range with 
the standard curve.  All standards and samples were diluted in basic recording medium 
(appendix A) and 50µl was added, to the wells, and incubated for 2h.  The plate was 
washed, in PBST, and 50µl of biotinylated detection antibody was added, dissolved in 
reagent diluent, and incubated for 2h.  The plate was then washed and 50µl of streptavidin-
HRP (R and D systems), diluted 1 in 200 into reagent diluent, was added and incubated for 
20 min.  This was removed, the plate was washed and 50µl of substrate solution, a 1:1 mix 
of hydrogen peroxide and tetramethylbenzidine, was added and incubated for 20 min, in 
the dark.  25µl of 0.2M sulphuric acid was added to the substrate solution to stop the 
reaction.  This results in the solution turning yellow, in proportion to the protein 
concentration, and is read at 450nm.   
2.5.4 Bio-Plex 
2.5.4.1 Principle of the Bio-Plex 
 
The principle of the Bio-Plex (Bio Rad) is illustrated in Fig 2.8 and utilises a similar 
technique to the ELISA, with a capture and detection antibody being used to bind a protein 
of interest.  However, in addition the biotinylated detection antibody is bound to the 
steptavidin-phycoerythrin (S-PE) conjugate when added, rather than HRP.  The S-PE is a 
fluorescent reporter and is excited at 532nm and the amount of fluorescence is proportional 
to the amount of protein.  The real advantage to this technique is that the capture antibody 
is fixed to a bead, which also has a specific fluorescent tag called the ‘classification tag’ 
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which excites at 635nm.  This means that multiple proteins can be analysed at the same 
time, in the same sample, simultaneously increasing the amount of data that can be 
obtained and vastly reducing the amount of sample needed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Principle of the Bio-Plex:  A capture antibody is bound to a bead with a 
specific fluorescent ‘tag’ (A).  The assay sample is added and the antigen, specific to the 
antibody, and binds (B).  The biotinylated detection antibody is added and it binds to the 
antigen (C).  The streptavidin conjugated PE is finally added to the assay mix and this 
binds to the biotin (D).  The specificity of the bead and antibodies allows multiple beads, 
therefore, antigens, to be read in the same sample (F) and the Bio-Plex lasers can rapidly 
detect different beads using laser A and quantify the amount of antigen present using laser 
B (G).  
 
2.5.4.2 Bio-Plex assay protocol 
 
All reagents and buffers were supplied with the assay kit (Bio-Rad) and all methods were 
carried out according to the manufacturers’ protocol.  The assay standards were diluted and 
the frozen serum samples (section 2.2.1) were thawed to RT, mixed by vortexing and 
diluted 1 in 4 with mouse serum diluent (Bio Rad).  The assay plate was pre-wet with assay 
buffer and removed using a vacuum manifold filter (Bio-Rad); all subsequent solution 
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removal and wash steps used this method.  The assay beads were added to the plate 
(50µl/well) and it was washed twice with wash buffer.  The standards and samples were 
added (50µl/well) and incubated at RT for 30 min on a shaker.  The plate was washed 3 
times in wash buffer and the detection antibody (25µl/well) was added and the plated was 
incubated for 30 min as previous.  The plate was again washed 3 times in wash buffer and 
S-PE was added (50µl/well) and incubated at RT for 10 min on the shaker.  The plate was 
washed 3 times and assay buffer was added (125µl).  The plate was then analysed using the 
Bio-Plex system and the recommended Bio-Plex manager software.   
2.6 Quantitative PCR (qPCR)  
2.6.1 Principles of qPCR 
 
There are 3 main ways of quantifying the mRNA transcript of a particular gene of interest.  
These are real time (RT) PCR, semi-quantitative (or relative) qPCR and quantitative (or 
absolute) qPCR.  The RT-PCR works through the PCR amplification, of a particular 
mRNA transcript, that has been reverse transcribed to cDNA, (Fig 2.9),  but the number of 
cycles of replication is limited to between 25 and 30, to hit the linear phase of the of 
exponential growth pattern, allowing the direct comparison between transcripts.  However, 
the PCR products are resolved on an agarose gel, section 2.3.3, which makes it hard to 
quantify as the reproducibility of the gel can be difficult, and quantification is done by 
densitometry, which requires computer software and can be inaccurate.  Therefore relative 
and absolute qPCR were developed, which still utilise PCR amplification but coupled to 
fluorescent tags, (SybrGreen or taqman probes).  Throughout these studies I have used 
semi-quantitative (relative) taqman based qPCR and so will be briefly explained with the 
aid of Fig 2.9.   
 
Taqman based qPCR works on the principle of PCR but the taqman-probes have a 
fluorophore 6-carboxyfluorescein (FAM) (peak absorbance 495; emission 516) and 
quencher, tetramethylrhodamine (TAMRA) (peak absorbance 565; emission 580) attached.  
The probe binds to the target and on excitation a particular wavelength of light is emitted.  
In the normal, unbound, state, where the probe is in tact, the fluorophore will emit a 
wavelength, but this will excite the quencher whose emission spectrum cannot be detected.  
In the bound state, as the primers extend they will ‘knock’ the FAM fluorophore off the 
probe, into solution, allowing any emitted light to be detected.  The more PCR cycles, the 
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greater the amount of fluorescence recorded, until it plateaus.  The end user can then select 
the number of cycles (called cycle threshold or Ct) it took to reach a certain value of 
fluorescence, again within the linear phase of growth.  The Ct value is inversely 
proportional to the amount of transcript and this can be measured relatively or absolutely.  
If measured relatively the Ct values of the gene of interest are compared to a control gene 
that does not alter under the experimental conditions, for example beta actin or 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).  If measured absolutely then the Ct 
values are compared to the values of a standard curve, with known concentrations of 
cDNA.   
 
The region of amplification, however, is vitally important whichever method is being used.  
Genomic DNA is made up of introns and exons, sequentially arranged, and the exons are 
what produce the mature mRNA and subsequent protein.  The mRNA is reverse 
transcribed to cDNA and so in order to ensure quantification of cDNA and not genomic 
DNA the region of amplification must cross an exon boundary; a further control is to pre-
treat the RNA with DNase before reverse transcription.   
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Figure 2.9:  The principle behind Taqman qPCR: The mRNA is first reverse 
transcribed to produce cDNA (A).  The cDNA is initially single stranded but shown here as 
double stranded as it will form in subsequent cycles.  The two strands are separated by heat 
(B).  The primers and probe can then anneal to the target sequence (C) and as the 
polymerase extends from the primer it will hit the fluorophore and release it into the 
surrounding medium (D).  This will remove it from the close proximity to the quencher 
allowing it to be excited and emit a detectable wavelength of light. 
 
2.6.2 RNA extraction  
2.6.2.1 Tissue 
 
Roughly 100mg of frozen tissue was removed from the sample (liver, lung and kidney) 
using a sterile blade and quickly added to a lysing matrix D tube (MP Biomedicals) 
containing 1ml TriZol reagent (Invitrogen).  TriZol is a phenol based extraction and all 
work was carried out in the fume cupboard and caution was taken.  The tissue was 
completely homogenised in a FastPrep-24 system (MP Biomedicals) at 4oC.  The samples 
were incubated at RT for 5 min and 200µl of chloroform (Sigma, UK) was added, 
thoroughly mixed by inversion, and incubated for 2–3 min at RT, then centrifuged at 4oC 
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at 12000 x g for 15 min.  The resulting solution separated in to 3 different phases with the 
RNA in the upper aqueous phase.  500µl of the aqueous phase was removed and added to 
500µl of isopropanol and incubated for 10 min at 4oC, then centrifuged for 10 min at 
12000 x g at 4oC.  The isopropanol solution was removed as the RNA had precipitated and 
formed a pellet.  The pellet was washed in 70% ethanol (30% nuclease free H2O) and 
centrifuged for 5 min at 12000 x g at 4oC.  The ethanol was removed and the pellet air 
dried for 5-10 min and then re-suspended in 100µl nuclease free H2O.  At this stage the 
RNA from the lung tissue was stored at -80oC due to a low RNA yield of, but the RNA 
from the liver and kidney was further purified using an RNeasy extraction kit (QIAgen).  
10µl β-mercaptoethanol (Sigma, UK) was added to 1ml of RLT buffer and 350µl of this 
buffer was added to the 100µl RNA (TriZol extraction).  This was mixed thoroughly then 
250µl of 100% ethanol was added and mixed well.  The sample was applied to the 
purification column and centrifuged at 10000 x g for 15 sec.  The flow-through solution 
was discarded and the column washed twice with 500µl RPE buffer; once at 10000 x g for 
15 sec and then at 10000 x g for 2 min, the flow-through was discarded each time as 
necessary.  The RNA was eluted into a sterile RNase free tube, in 50µl of nuclease free 
H2O, and was stored at -80oC. 
2.6.2.2 Cells 
 
The RNA was extracted from the Rat-1 cells using the RNeasy extraction kit (QIAgen) 
according to the manufacturers’ instructions.  The cells were lysed in 350µl RLT (without 
β –mercaptoethanol) for 2 min on ice.  The lysate was added to a QIAshredder (QIAgen) 
column, and centrifuged at 16000 x g for 2 min, to thoroughly lyse the cells and remove 
any cell debris.  The flow-through was mixed with an equal volume of 70% ethanol, mixed 
then added to a purification column and centrifuged at 10000 x g for 15 sec.  The flow-
through was discarded and the column washed with 700µl RW1 buffer.  The flow-through 
was discarded and the column washed twice with 500µl RPE buffer; once at 10000 x g for 
15 sec and then at 10000 x g for 2 min, the flow-through was discarded as necessary.  The 
RNA was eluted into a sterile RNase free tube in 30µl of nuclease free H2O, and was 
stored at -80oC. 
2.6.3 Reverse transcription (RNA to cDNA) 
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All RNA was reverse transcribed in the same way, regardless of the original source and Fig 
2.9 (A) shows a brief description of how it occurs.  The RNA was quantified using a 
Nanodrop-100 (section 2.3.6) and 2µg of RNA was used in the reaction, it was assumed 
that all RNA was converted to cDNA.  All RNA was treated for 30 min at 37oC with 1µl 
RNase free DNase (Promega), regardless of its purity (section 2.3.6).  This reaction was 
stopped with 1µl DNase stop buffer (Promega), incubated at 65oC for 10 min.  A high 
capacity RNA to cDNA kit (Applied Biosystems) was used for the conversion.  The 2µg 
was converted in a 20µl reaction using 10µl of 2 x buffer and 1µl of 20 x enzyme mix; this 
meant that the 2µg of RNA had to be dissolved in 7µl, or less.  If this was not possible the 
reaction mix was multiplied appropriately.  The reverse transcription reaction was 
incubated at 37oC for 60 min then the reaction stopped by denaturing the enzyme with 
95oC for 5 min.  There was a no enzyme and no RNA control produced as well.  The 
cDNA was stored at -80oC.  
2.6.4 RT-PCR 
 
The cDNA (section 2.6.3) was thawed on ice and an RT-PCR master mix (table 2.4) was 
produced, in order to minimise pipetting errors.  The enzyme used was the Expand high 
fidelity PCR Taq polymerase (Roche), which has a 3’-5’ exonuclease activity to ‘proof 
read’ the new sequence.  This enhances reliability of the transcript produced.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4:  RT-PCR mastermix 
 
Reagent Final concentration (per reaction) 
F1 (10µM) 0.4µM 
R1 (10µM) 0.4µM 
cDNA (2µg) 100ng  
Deoxy nucleotide tri-
phosphates (dNTP) (2.5mM) 
0.2mM 
Expand High Fidelity buffer x 
10 
x 1 
Expand High Fidelity Taq 
DNA Polymerase 
2.6 Units 
 Made up to 25µl in nuclease free 
H2O 
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The primers MR, GR and GAPDH (MWG, Germany) (table 2.5) were designed by the 
author ensuring they were between 17 and 30bp long, had 40-80% guanidine/cytosine 
content and had a Tm between 50oC and 70oC and being no more than 2oC different.  The 
mouse GAPDH primers were a kind gift from Dr .Qing-Jun Meng and the rat MR primers 
were taken from (Zhou et al. 2000).  The primers, dNTPs (Promega), reaction buffer and 
enzyme were added to the cDNA and mixed.  The reaction mix was amplified in a thermal 
cycler using the following protocol: 94oC for 2 min; then 28 cycles of 94oC for 15 sec, 
60oC for 30 sec and 72oC for 45 sec, the final step was 72oC for 7 min.  The RT-PCR 
product was run on a 0.8% ethidium bromide agarose gel, (section 2.3.3) and imaged under 
U.V light. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A                                                                   B 
Table 2.5: Primers used for RT-PCR:  The GR, MR and GAPDH primers used to 
amplify the mouse transcripts are shown in (A) and the rat primers are shown in (B).  F1 
and R1 are the forward and reverse primer respectively and the amplified length is shown 
in the left hand column. 
 
Mouse Sequence (5’ - 3’) 
F1 AGGAATTCAGC
AAGCCACTG 
GR 
375bp 
R1 GCAAAGCATA
GCAGGTTTCC 
F1 TTCGGAGAAAG
AACTGTCCTG 
 MR 
401bp 
F1 AAGTACCTTGG
CCCACTTCA 
F1 CCTTCATTGAC
CTCAACTAC 
GAPDH 
594bp 
R1 GGAAGGCCAT
GCCAGTGAGC 
Rat Sequence (5’ - 3’) 
F1 ATCAAAGGGAT
TCAGCAAGCC 
GR  
378bp 
R1 AAAGCAGAGCA
GGTTTCCAC 
F1 CTTCAAAAGAG
CCGTGGAAGGG 
 MR 
196bp 
F1 TGCTGTGGTTGC
TCCTCGTG 
F1 GGTCATCATCTC
CGCCCCTTCC 
GAPDH 
347bp 
R1 GGAAGGCCATG
CCAGTGAGC 
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2.6.5 Taqman qPCR 
 
The principle of taqman qPCR is shown in Fig 2.9 and all primers and probes were 
sequenced by MWG, Germany, except for Rev-erb α which was used as a pre-made primer 
and probe mix (Applied Biosystems, assay number Mm00520708_m1) with an 
undisclosed sequence but which targeted a 62bp sequence crossing the exon 1 and 2 
boundary.  There primers and probes were all taken from the literature as the amplified 
transcripts were common genes in the circadian field.  The primers and probes used are 
shown in table 2.6 along with their respective concentrations.  The qPCR enzyme was the 
fast blue qPCR MasterMix Plus dTTP (Eurogentec). This contained dNTPs, buffer and 
enzyme at 2 x the concentration required, the buffer was diluted to 1 x and to this the 
primers, probes and H2O were added.  The PCR reaction was carried out in a 96-well 
MicroAmp Optical reaction plate (Applied Biosystems) in a 25µl volume with 100ng 
cDNA and so the volume of enzyme/reagent buffer mix was adjusted accordingly.  The 
amplification and data collection was carried out in an ABI 7300 (Applied Biosystems) 
using the following cycle: 50oC for 2min, 95oC for 10 min, then 40 cycles of 95oC for 15 
sec and 60oC for 1 min.  The fluorescence was recorded from cycle 2 with the linear phase 
being between cycles 12 and 34.  Each sample was run in triplicate.  The data was then 
analysed (see 2.6.6). 
 
Gene F1 (5’-3’) R1 (5’-3’) Probe (5’FAM-
3’TAMARA) 
Reference 
mBeta 
actin 
AGGTCATC
ACTATTGG
CAACGA 
(200nM) 
 
CACTTCATGA
TGGAATTGAA
TGTAGTT 
(200nM) 
TGCCACAGGAT
TCCATACCCAA
GAAGG 
(200nM) 
mPer2 GCCTTCAG
ACTCATGA
TGACAGA 
(200nM) 
TTTGTGTGCG
TCAGCTTTGG 
(200nM) 
ACTGCTCACTAC
TGCAGCCGCTC
GT 
(100nM) 
mCry1 CTGGCGTG
GAAGTCAT
CGT 
CTGTCCGCCA
TTGAGTTCTA
TG 
CGCATTTCACAT
ACACTGTATGA
CCTGGACA 
(Reddy et al. 
2007) 
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(100nM) (100nM) (200nM) 
mBMAL1 CCAAGAA
AGTATGGA
CACAGAC
AAA 
(200nM) 
GCATTCTTGA
TCCTTCCTTG
GT 
(200nM) 
 
CTGTCCGCCATT
GAGTTCTATG 
(200nM) 
mPer1 ACCTTGGC
CACACTGC
AGTA 
(200nM) 
CTCCAGACTC
CACTGCTGGT
AA 
(200nM) 
ATTCCTGGTTAG
CCTGAACCTGCT
TGACA 
(200nM) 
 
 
(Reddy et al. 
2007) 
mGILZ GTGGTGGC
CCTAGACA
ACAAG 
(200nM) 
TCACAGCGTA
CATCAGGTGG
TT 
(200nM) 
CACGAGGTCCA
TGGCCTGCTCA 
(200nM) 
(Mittelstadt and 
Ashwell 2003) 
rPer2 GCAGGCTC
ACTGCCAG
AACT 
(200nM) 
CAAGATGATT
CTATTCCAGA
AGCATT 
(200nM) 
AGCCCCAGCAA
GTGATCGAGGA
CTAAG 
(200nM) 
(Fahrenkrug et 
al. 2006) 
 
rGILZ CTTCTCTT
CTCTGCTT
GGAGGG 
(200nM) 
 
CGATCTTGTT
GTCTATGGCC
AC 
(200nM) 
CACTAGATCCA
TGGCCTGCTCA 
(200nM) 
Adapted from 
(Mittelstadt and 
Ashwell 2003) 
rC/ebp 
alpha 
AGTTGACC
AGTGACA
ATGACCG 
(300nM) 
TCAGGCAGCT
GGCGGAAGAT 
(300nM) 
AGCTGAGCCGT
GAACTGGACAC
GCT 
(200nM) 
(Sloop K W 
1998) 
rBeta actin CGTGAAA
AGATGACC
CAGATCA 
(200nM) 
CACAGCCTGG
ATGGCTACGT 
(200nM) 
TTTGAGACCTTC
AACACCCCAGC
CA 
(200nM) 
Adapted from 
(Zeng et al. 
2003) 
Table 2.6:  Primers and probes used for taqman qPCR:  All sequences are labelled 5’- 
3’ and the concentrations are shown in parenthesis. 
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2.6.6 Taqman qPCR analysis 
 
The data from the taqman qPCR experiments were analysed using the 2 –∆∆CT method 
(Livak and Schmittgen 2001).  Each experiment was self contained, which means all 
controls and comparable treatments were run on the same plate so inter experimental 
variations could be accepted.   An individual threshold value was obtained for each 
experiment and the corresponding Ct values were used to find the relative transcript 
abundance compared to a beta actin control.  To calculate a relative change the average of 
the 3 replicate Ct values for each sample was used as follows:  This example shows Per2 
as the gene of interest and beta actin as the internal control.    
 
 
1. Average Ct (Per2) – average Ct (actin) = ∆Ct 
 
2. ∆Ct – the lowest ∆Ct  = ∆∆Ct (so that 1 value = 0 and all the others a greater) 
 
3. Relative change = 2 –∆∆Ct (2 is raised to the power – ∆∆Ct, meaning that the ∆∆Ct 
value, in 2, is now inverse and the value of 0 is now 1 and all the other are 
relatively lower) 
 
4. The inverse, in 3, occurs as the Ct value is inversely proportional to transcript 
abundance and the lowest ∆∆Ct value is actually the condition with the greatest 
amount of Per2 transcript. 
 
5. The relative change is then converted to a relative fold change by making the 
smallest value equal to 1 and all other values relative to that. 
2.7 Immunohistochemistry 
2.7.1 Tissue harvest and fixing in PFA or Bouin’s solution 
 
The intact tissue was fixed in order to maintain the structural integrity of the tissue, 
through the immobilisation of proteolytic enzymes and the cross-linking of cellular 
molecules.  The tissue was removed from the animal and placed directly into 4% PFA 
(section 2.2.6.3) (all tissues) or Bouin’s solution (Sigma, UK) (brain only) and left for a 
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minimum 48h, at 4oC in order for the fixative to penetrate the tissue.  The lung and kidney 
were then embedded in paraffin/wax (section 2.7.2). 
2.7.2 Embedding in paraffin  
 
After fixation with PFA, the kidney and lung tissue was embedded in paraffin wax to 
preserve the tissue for sectioning.  Embedding was carried out using a Microm spin STP-
120 processor (UK) according to the following automated protocol:  The tissue was placed 
in an embedding cassette and put through the following solutions to dehydrate the tissue: 
70% industrial methlyated spirits (IMS) 3.5h, 90% IMS 1h, 95% IMS 1h, 100% IMS 3 x 
1h, xylene 1 x 30 min and 2 x 1h (for clearing) before going into paraffin (Lamb, UK) for 
1 x 2h and 1 x 3h. All incubations were carried out at room temperature, except for those in 
paraffin, which was at 65°C. The tissue was then removed from the processor and placed 
in the wax holding bath (EC 350-1 wax embedder, Microm, UK). The tissue was then 
transferred to a molten wax filled base mould and put onto a cold surface to solidify.  This 
was done to hold the tissue in place and protect it once it has been cut.  This tissue was cut 
in continuous 5µm sections using a microtome, which were transferred to a 40°C water 
bath, where they were mounted onto slides and left to dry.   
2.7.3 Free floating brain sections 
 
The PFA and Bouin’s fixed brains (section 2.7.1) were cut into 20µm sections on a 
freezing microtome (Leica) using a non-toxic histological mounting solution to fix the 
sections to the base.  Sections were cut to include the hippocampus.  The slices were then 
placed in 1 x PBS and washed repeatedly until the excess PFA and Bouin’s solution was 
removed and stored at 4°C until stained. 
2.7.4 Preparation of cells for immuno fluorescence 
 
Rat-1 cells were cultured on a poly L-lysine coated cover slip, approximately 13mm 
diameter and 0.17mm thick, and placed in a 6-well plate in DMEM, as section 2.3.1.  The 
poly L-lysine (Sigma, UK) was made up by filter sterilising 25mg lysine dissolved in 25ml 
deionised H2O.  The cover slip was sterilised in 100% ethanol and dried then coated in the 
poly lysine for 1h and dried.  The medium was removed from the cells, washed in 1 x PBS 
and fixed in 100% methanol at -20°C for 10 min.  The methanol was removed and the cells 
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re-hydrated in 1 x PBS.  This step permeabilises the cells to allow antibody penetration.  
The cells were stained with the respective antibody. 
2.7.5 Immunohistochemical (IHC) staining of tissue  
 
The paraffin embedded sections were de-waxed in a xylene bath for 4 x 5 min and 
rehydrated in decreasing ethanol washes (100%, 95%, 50%, and 20%) then placed in tap 
H2O.  An antigen retrieval step was added using fresh citrate buffer (11mM sodium citrate 
with HCl added to pH 6, Sigma, UK).  The sections were covered with the citrate buffer 
and placed in a microwave, approximately 900W, for 12 min and allowed to cool.  This 
step does improve the quality of staining but is unknown how it works.  At this stage the 
free floating sections were treated as follows, along with the de-waxed paraffin embedded 
tissue.   The cooled sections were washed twice, for 10 min, in a 1 x (10mM) PBS solution 
(5 x stock of 0.7M NaCl, 13mM KCl, 50mM NaHPO4 and 9mM KH2PO4) and once, for 10 
min, in PBS supplemented with 0.3% triton-X (Sigma, UK) (PBS-X), while gently 
shaking.  Endogenous peroxidase was blocked with 1% H2O2 solution (Sigma, UK) diluted 
in PBS-X for 30 min, while gently shaking.  The 2 x PBS and 1 x PBS-X wash step, as 
previous, was repeated and the slides were blocked in 5% serum in PBS-X (blocking 
solution) for 2h.  The serum used was the host species of the secondary antibody (table 
2.7).  The primary antibody was diluted accordingly in blocking solution, added to the 
sections and incubated at 4oC for 16h, shaking gently.  The primary antibody was removed 
and the section were washed 5 x in PBS-X for 5 min, then the appropriate biotinylated 
secondary antibody was added, diluted again in blocking solution, and incubated for 30 
min at RT.  The slides were washed 5 x, as before, and ABC complex was added (Vector 
labs), according to the manufacturer, and incubated for 30 min at RT.  This step adds the 
HRP enzyme linked to streptavidin in order to visualise the antibody bound protein.  The 
slides were washed 5 x as before and stained, for up to 12 min, with a 3-3’ 
diaminobenzidine (DAB) kit (Vector labs) according to the manufacturers’ protocol.  The 
nucleus was stained with hematoxylin (Sigma, UK) for 10 sec, and then excess was 
washed off (lung and kidney only).  The sections were dehydrated with increasing ethanol 
baths (20%, 50%, 95%, and 100%) then cleared with 100% xylene for 4 x 1 min.  The 
sections were cover slipped (lung and kidney) or mounted onto slides and cover slipped 
(brain) and sealed with DEPEC mounting solution, and then imaged using an Olympus 
BX51 upright microscope with a x20 objective.   
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Antibody Primary 
or 
Secondary 
Raised 
against 
Dilution  used  
 
To 
detect  
Source 
GR (M20) primary Rabbit 1:200 (IF) 
lung - 1:200 
(IHC) 
kidney - 1:400 
(IHC) 
brain - 1:2500 
(IHC) 
 Santa Cruz, 
US 
MR (c-19) primary Goat 1:200 (IF) 
lung - 1:200 
(IHC) 
kidney - 1:200 
(IHC) 
brain - 1:250 
(IHC) 
 Santa Cruz, 
US 
Biotinylated 
anti goat 
IgG  
secondary Horse 1:200 (IHC) MR Vector Labs 
Biotinylated 
anti rabbit 
IgG  
secondary Goat 1:200 (IHC) GR Vector Labs 
Texax red 
IgG anti 
rabbit 
 
secondary Goat 1:100 (IF) GR Vector Labs 
Fluorescein 
(FITC) Anti-
Goat IgG  
 
secondary Donkey 1:100 (IF) MR Jackson Labs 
Table 2.7:  Antibodies used for immunohistochemical and immunofluorescent 
staining:  Immunofluorescence (IF) and immunohistochemical (IHC).   
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2.7.6 Immunofluorescent (IF) staining of cells 
 
The methanol fixed cells (section 2.7.4) were washed 1 x PBS (section 2.7.5) and blocked 
for 30 min in 1 x PBS supplemented with 2% serum (host of the secondary antibody).  The 
cells were washed 3 x 2 min in PBS and the primary antibody, diluted in PBS, was added 
(concentration shown in table 2.7) and incubated for 30 min at RT, shaking gently.  The 
antibody was washed off with 3 x 5 min PBS-X (0.1% tween) and the secondary antibody 
was added diluted in 1 x PBS and incubated for 30 min at RT.   The cells were washed for 
3 x 5 min PBS-X to remove excess antibody and mounted onto a slide and sealed with a 
cover slip, using vector shield mounting medium (Vector labs), which contained the DNA 
stain 4',6-diamidino-2-phenylindole (DAPI).  Images were collected on an Olympus BX51 
upright microscope using a x20 objective and captured using a Coolsnap ES camera 
(Photometrics).  Specific filter sets for DAPI (excitation 365nm, emission 397nm); FITC 
(excitation 450-490, emission 515-565) and Texas red (excitation 546, emission 615) were 
used to visualise the stain. Images were then processed and analysed using ImageJ.   
2.8 Statistical analysis and representation of PMT data 
 
Statistics were carried out using GraphPad Prism software using the stated comparison 
analysis using either a One-Way or Two-way ANOVA with a  Bonferroni post-hoc 
analysis, student t-test were also used to compare two sets of data, using a paired t-test to 
compare before and after treatments or unpaired t-test for individual treatments..  Error 
bars, where shown, are standard error of the mean (SEM).  A number of data sets are 
represented by graphs showing the individual data points as well as the mean of the 
distribution.  This was done to allow the reader to see the spread of data in data sets where 
n was greater than 3.  Other data sets, where n=3 are represented by histograms ± SEM, as 
the error shown. 
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3.1 Introduction  
It is well known that Gcs affect the circadian clock (Balsalobre et al. 2000a) but little is 
known about the fundamental mechanisms involved in re-setting.  In order to investigate 
this re-setting process it is important to dissect the role of two closely related receptors 
(GR and MR) in their action on the clock as CORT binds to both (De Kloet et al. 1998).  
To investigate the re-setting mechanism I adopted two different model systems, cell lines 
and primary tissue.  The advantage to using a cell line is that one can manipulate the 
genetic pathways and insert luciferase driven reporters.  The disadvantage, as will be seen 
in this chapter is that such cell lines are not representative of normal physiology, and for 
this reason I have adopted the use of ex-vivo lung slices.  In this thesis I have used lung 
tissue from the PER2::luc mouse, which is a protein reporter but also mPer2::luc, mPer1 
2500::luc, mPer1 600::luc and mPer1 mGRE (2500)::luc with a mutated GRE, which are   
all transcriptional reporters.  Here and in subsequent chapters, I have used CORT, rather 
than DEX, as CORT is endogenous to the rodent whereas DEX has been designed to have 
a long half life (CORT 25 min, DEX 200 min (Cevc and Blume 2004; Sainio et al. 1988)) 
and therefore does not represent the true endogenous response.  In this chapter I have 
addressed three characteristics of the effect of CORT on the clock: period, phase shifting, 
amplitude response and sustained high amplitude oscillation, as described in the model 
below (Fig 3.1).  Throughout this thesis I have used the RAP software analysis (section 
2.1.4) to define the phase and period changes after treatment (Fig 3.1), where CORT 
treatment is shown by the arrow (a) and the initial amplitude response (b).  RAP calculated 
the period over 3-4 cycles from half way between the peak and trough of the CORT-
induced amplitude rise (c).  The phase shifting effects are defined as time of the subsequent 
peak following CORT treatment (g) compared to the DMSO peak (h).  The phase of 
DMSO was calculated as in Fig 3.4 and section 2.2.5.3.  The period is calculated over the 
3-4 cycles (f).  To calculate an effect on chronic amplitude, the relative change in peak to 
trough height (d versus e) was measured and compared to DMSO controls (d’ versus e’). 
 
Gc acts as a potent synchronising factor for peripheral circadian clocks and also induces 
high amplitude oscillations.  A functional GRE which is known to respond to Gc 
stimulation has been confirmed in the Per1 promoter (1800bp upstream from the 
transcriptional start site) and in this model mutation of this GRE has been shown to inhibit 
95% of the Gc activation (Yamamoto et al. 2005).  This GRE was the only confirmed GRE 
in the clock gene promoters, but bioinformatic predictions have suggested other potential 
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candidates, as yet unconfirmed (Reddy et al. 2007).  Recently, Per2 has been shown to 
contain a functional GRE but in this case not in the promoter region (within the ninth 
intron) (So et al. 2009), and other reports have suggested that Rev-erb α contains a negative 
GRE (nGRE) whereby the GR (in the presence of Gc) binds to the promoter and down 
regulates transcription (Torra et al. 2000).  
 
The GR and MR are expressed together in many central neurons, such as the hippocampus 
(Sarabdjitsingh et al. 2009) and peripheral regions, such as the lung, kidney, liver and heart 
(Gibbs et al. 2009; Yang et al. 2006).  However, little attention has been given to the 
potential influence that the MR has on circadian regulation, and its interaction with GR on 
cloned response elements (GRE).  Furthermore, hepatic mRNA cycles for the clock output 
gene mDbp appear to be similar after DEX treatment in tissue derived from WT mice and 
mice bearing a conditional mutation in the hepatic GR (Balsalobre et al. 2000a).  DEX 
treatment resulted in a 3-4h phase delay in other tissues (heart and kidney) in both WT and 
mutant mice.  Also DEX failed to induce mPer1 mRNA expression in a liver specific GR 
mutant mouse, where the GR did not functionally express.  Together these data suggests 
that the GR is required both for the induction and phase shifting effects of DEX. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1:  Schematic model of PMT analysis:  Representative oscillation of PER2::luc 
lung section and treated with CORT (red) and DMSO (black) to demonstrate where key 
measurements were taken from.  The slices were treated at point (CT12) (a).  The initial 
CORT-induced amplitude rise was measured as (b) with the sustained amplitude measured 
as the difference between peak and trough bioluminescence for DMSO (d to e) and for 
CORT (d’ to e’).  The post-treatment period was taken over the course of 3-4 oscillations 
(f) originating after any induced amplitude response (c).  The phase change is shown inset 
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as the difference between the CORT peak and the DMSO peak (g-h) taken from the first 
cycle after the CORT-induced amplitude rise. 
3.2 Aims 
 
• To characterise responses of PER2::luc primary lung tissue and Rat1 cell-line 
reporters to the endogenous Gc, CORT. 
• To define the role of the GR and MR in circadian responses. 
• To assess the role of the GRE in a clock gene promoter in the re-setting responses 
to CORT. 
• To develop an in-vitro model which mimics the endogenous ultradian pulses of 
CORT, and thereby characterise the effects of physiologic responses to active Gc 
on the pulmonary clock. 
3.3 Results 
3.3.1 Vehicle treatment of lung sections  
 
Prior to investigating the action of Gcs on the peripheral oscillator it was important to 
characterise any effect that the vehicle had on the output, as this could itself affect the 
phase and period.  Treatment of the PER2::luc fusion protein reporter (section 2.1.2.1) with 
DMSO or recording media induced a 3.5-4.5h advance in the period of the pulmonary 
oscillation compared to untreated slices (Fig 3.2).  There was no difference between either 
DMSO or recording media alone.  The outcome of these experiments is that almost any 
perturbation of the tissue model causes a phase shift.  For this reason all subsequent 
comparisons are made with reference to the DMSO control.   
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Figure 3.2:  DMSO and media effect on the PER2::luc lung oscillation:  The 
representative PER2::luc oscillations are shown in (A) with the black arrow showing the 
time of treatment (CT12); DMSO (black), recording media (red) and untreated slice 
(green).  The period lengths and time to first peak after treatment (red arrow) are shown in 
(B) and (C) respectively.  Dots represent individual repeats.  Statistical significance is 
shown using a One-Way ANOVA (in B P=0.46, in C P<0.0001) with a Bonferroni post-
hoc analysis, (a) versus (b) P< 0.001.   
 
3.3.2 Action of CORT on the pulmonary circadian clock 
 
The action of CORT on the PER2::luc pulmonary clock reporter was first addressed by 
treating lung slices with different concentrations of CORT (given at the peak of the 
PER2::luc rhythm, CT12 in Fig 3.3) and recording subsequent phase and amplitude 
changes.  There was a dose dependent delay in phase across 4 log concentrations of CORT 
(P= 0.0177, Fig 3.3b).  A representative example is shown in (Fig 3.3a), but with no 
increased effect of amplitude above 0.1µM (Fig 3.3c, P= 0).  At 0.01µM (10nM) a 4h 
phase delay was seen without any effect on amplitude (Fig 3.3a, red line).  There is a 
chronic amplitude effect at 0.1µM but not at 0.01µM (P <0.0001, Fig 3.3d). The lower 
dose (0.01µM) is equal to approximately the Ec50 of CORT on the GR and 10-fold lower 
for the MR. Concentrations of 1µM and above maybe regarded as supra-physiological 
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(Windle et al. 1998a).  A PRC to 0.1µM CORT was plotted, with a DMSO control, 
(section 2.2.5.3) over the circadian cycle resulting in large phase advances, with a maximal 
response from CT12 to CT18 showing an advance between 10h and 13h.  Likewise there 
were large delays, up to 5h, between CT6 and CT10 with the time between CT10 and 
CT12 being the transition between the advance and delay phase (Fig 3.4).  In the DMSO 
there is a significant interaction between the time of treatment (P = 0.0085, Fig 3.4c) which 
leads to approximately 3h phase advances and 1h phase delay.  Following on from this 
PRC it would have been a good idea to investigate the time between CT10 and CT12 (i.e. 
the time that switches between the delay and advance phase) more closely.  This could 
have involved treatments every 15min between these times or at the very least a treatment 
at CT11 as this was the time all subsequent treatments were made (i.e. CT12, the peak of 
PER2::luc rhythm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3:  Phase and amplitude changes of PER2::luc lung slice in response to 
CORT:  A representative lung oscillation in response to CORT (DMSO in black; 0.1µM 
CORT green; 0.01µM CORT red) (A) together with phase (B) acute amplitude (C) and 
sustained (chronic) amplitude changes (D).  The phase change is relative to DMSO and the 
amplitude calculations are as described in Fig 3.1.  Treatment time is indicated by the 
arrow (CT12).  Error bars are SEM with n = 3.  Statistical analysis is by One-Way 
ANOVA (in B: P= 0.0177, in C: P=0.0024, in D: P <0.0001) with a Bonferroni post-hoc 
analysis.  In B: (a) versus (b) P<0.05.  In C: there is no significant difference between the 
concentrations which induced an amplitude response, yet there was a difference P<0.05 
between 0.1, 1 and 10µM and 0.01µM (as 0.01µM was 0).  In D: (c) versus (d) P<0.001. 
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Figure 3.4: CORT induced lung PRC to PER2::luc lung slice:  The CORT (0.1µM) 
induced delay (A) and advance (B) shows the response to CORT (red) and DMSO (blue). 
The resulting PRC, shown with treatments every 2h, (C) shows DMSO (blue) and CORT 
(red).  A similar PRC to DEX in the pulmonary PER2::luc reporter is shown (D) (Gibbs et 
al. 2009) depicting both advances and delays of similar magnitude to that in (C).  The PRC 
time points were completed with the tissue from 1 animal.  Statistical analysis by One-Way 
ANOVA revealed an interaction between the time DMSO treatment (P=0.0085) as well as 
between CORT treatment (P<0.0001).  Error bars are SEM, n=3 animals.  Lung slices were 
prepared as in section 2.2.4.   
 
Subsequent analysis revealed that the presence of CORT in the media caused a shortening 
of period and this did not depend on the phase of the cycle at which it was added, (Fig 3.5).  
This shortening of period is in direct contrast to the vehicle control where no general 
pattern emerged following DMSO treatment.  Taken together, these data suggest that 
CORT induces both amplitude effects in the circadian oscillation, phase shifting and period 
effects, in a dose dependent manner. 
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Figure 3.5: CORT induced period change: The period of the mPER2::luc lung slice was 
compared before (grey bars) and after (black bars) treatment with either 0.1µMCORT (A) 
or DMSO (B).  Error bars are SEM, n=3 animals.  Statistical analysis was by a paired 
student’s t-test *P<0.05, **P<0.01, pre versus post treatment. 
 
3.3.3 The steroid receptors GR and MR and their influence on circadian timing 
3.3.3.1 Validating of the model systems 
 
In order to define the relative role of the GR and MR I first set out to see if they were 
expressed in primary pulmonary tissue and Rat-1 cells using RT-PCR.  Using GAPDH as 
an internal control I amplified this in parallel with the GR and MR transcripts.  As a 
comparison I have also used kidney tissue as a control since this organ is one of the main 
targets for MR action.  The data show clearly that both MR and GR are expressed in the 
lung and in Rat-1 cells (Fig 3.6).  The nature of the RT-PCR process means that absolute 
expression values using different primer sets cannot be directly compared, so the data here 
are relative.  In order to define protein expression I undertook immunohistochemical and 
immunofluorescence staining of primary tissue and Rat-1 cells (Fig 3.7 and 3.8 
respectively).  These studies show clearly that GR and MR strongly express in the cells 
surrounding the bronchial epithelia, presumed to be Clara cells (Gibbs et al. 2009).  
Furthermore, the GR and MR are expressed in other cell types in the alveolar tissue 
presumed to be Type II pneumocytes Ulich et al. (1994) (Fig 3.7).  Using these antibodies 
it is clear that both receptors are strongly expressed in the lung.  As a positive control for 
the MR antibody it can also be seen that it is strongly expressed in the renal tubules.  The 
primary negative controls are also shown in Fig 3.7.  Further antibody validation was 
carried out on the hippocampus, an area well characterised in the expression of both GR 
and MR, (appendix C) as the anti-MR antibody did not work in an immuno blot 
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Figure 3.6: mRNA transcript expression of GR and MR:  GR, MR and GAPDH 
transcripts were amplified from the mouse lung (A) and kidney (B) and the Rat-1 cells (C) 
(different primers sets were used for murine lung and Rat-1 transcript expression).  The 
data are representative expression patterns of n = 3. 
 
 
In the Rat-1 cells nuclear staining for the GR (red) and MR (green) fluorescence clearly 
overlays with nuclear DAPI staining (blue) Fig 3.8.  In conclusion, the RNA transcript and 
protein products for GR and MR are expressed in both pulmonary tissue and Rat-1 cells. 
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Figure 3.7: Immunohistochemical staining for GR and MR:  Both GR (A and B) and 
MR (C and D) are expressed in the lung (A and C) and kidney (B and D).  The black 
arrows point to areas of high expression; bronchioles in the lung, which include Clara cells, 
(Gibbs et al. 2009), and tubules in the kidney.   The red arrows mark presumptive Type II 
pneumocytes (Ulich et al. 1994).  Primary antibody negative controls are shown for GR 
and MR in the lung (E and G respectively) and for GR and MR in the kidney (F and H 
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respectively).  The positive cells for GR and MR appear brown and the nuclei appear blue.  
The scale bars represent 100µm. 
 
 
 
 
 
 
Figure 3.8: Immunofluorescent staining of Rat-1 cells for GR and MR:  Panels A-D 
show GR (red) and panels E-H show MR (green) staining.  The GR expression is shown in 
(B) and the MR expression is in (F).  Panels (D) and (H) show the GR and MR primary 
antibody, respectively, with DAPI (C) and blue overlay. The primary antibody negative 
controls are panels (A) and (E).  The scale bars represent 100µm. 
 
3.3.3.2 The relative contributions of GR and MR to CORT meditated phase re-setting 
 
In order to define the relative roles of GR and MR I next used well established antagonists 
for these two receptors.  In the case of RU486 (RU, GR antagonist) this drug is known to 
have partial agonistic effects on the GR receptor (Stevens et al. 2003) which increases p-
ser211 (Wang et al. 2002) but is not considered to act on the MR.  The MR antagonist 
spironolactone (spir) is not known to have partial agonistic effects but at 8µM (Ec50) and 
above spir engages the GR (as described in section 2.2.5.1).  For this reason I have used 
1µM spir in the experiments described below.  For RU I also used 1µM as this dose has 
previously been reported to inhibit both primary tissue and cell lines.   
 
RU significantly inhibited CORT-induced phase shifts in both the primary pulmonary 
tissue reporter and Rat-1 cells.  In both Rat-1 and pulmonary tissue RU induced phase 
shifts which may be attributed to the partial agonistic effects of this compound (Fig 3.9c).  
However, in both systems the phase shifting effects of CORT were completely blocked by 
RU (Fig 3.9).  Furthermore, RU blocked the CORT induced increase in luciferase 
expression in the pulmonary tissue and greatly attenuated the amplitude of the subsequent 
circadian oscillations in both tissue and Rat-1 cells (Fig 3.9d). 
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Figure 3.9 The relative contribution of GR to the CORT effect on the clock:  
Representative oscillations for the mPER2::luc lung (A) and mPer2::luc cellular (B) 
circadian reporters.  The oscillations for CORT (C) treatment are shown in green; DMSO 
in black; RU with CORT (RU + C) in blue and RU only in magenta.  The arrow shows the 
time of treatment (CT12).  The resulting phase change is shown in (C) and the chronic 
amplitude rise (D).  Each dot is a single experiment and the statistics are a One-way 
ANOVA (in both C and D: P< 0.0002) with a Bonferroni post-hoc analysis, (a) versus (b); 
(c) versus (d); (e) versus (f) and (g) versus (h) P<0.001.   
 
The experimental procedures used to obtain data shown in Fig 3.9 were repeated using the 
MR antagonist.  In both the pulmonary tissue and cell line reporters, antagonism of the MR 
had little effect on reducing the CORT-induced phase effects (Fig 3.10).  However, the MR 
does have an effect as MR antagonism, with spir, blocked the CORT-induced luciferase 
increase, in the lung, seen immediately after CORT treatment (Fig 3.10a).  MR antagonism 
also significantly attenuated the chronic amplitude of the subsequent circadian oscillation, 
in the lung but not the Rat-1 cell reporter (Fig 3.10d) in a similar manner to GR 
antagonism (Fig 3.9d).  Thus phase-shifting effects of CORT appear to be mediated largely 
through the GR but the amplitude is both GR and MR mediated.  In addition there is a 
significant difference between the phase effects of RU and spironolactone administration 
alone, in the PER2::luc lung section (student t-test P<0.002) but not in the mPer2::luc cell 
line reporter (student t-test P=0.47).  Therefore, the effects of CORT are three fold:  (1) 
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phase shifting; (2) strong initial rise in luciferase expression; (3) substantial high amplitude 
oscillations compared to DMSO.  Furthermore, both GR and MR antagonism blocked the 
initial rise in luciferase expression and dampened the CORT-induced high amplitude 
oscillations, in the pulmonary reporter, but only the GR antagonism inhibited the CORT-
induced phase change. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: The relative contribution of MR to the CORT effect on the clock:  
Representative oscillations for the mPER2::luc lung (A) and mPer2::luc cellular (B) 
circadian reporters.  The oscillations for CORT (C) treatment are shown in green; DMSO 
in black; spir with CORT (S+C) in blue and spir (S) only in magenta.  The arrow shows the 
time of treatment (CT12).  The resulting phase change is shown in (C) with the chronic 
amplitude rise (D).  Each dot is a single experiment and the statistics are a One-way 
ANOVA (in C and D: P<0.0002) with a Bonferroni post-hoc analysis, (a) versus (b) and 
(c) versus (d) P<0.001; (e) versus (f) P<0.01 and (e’) versus (f) P<0.001; (g) versus (h) 
P<0.01.  
 
In addition to the phase and amplitude effects of CORT on the reporter constructs, period 
effects were also seen, as in Fig 3.5.  The period shortening, as a direct result of CORT, is 
restricted to the lung as the Rat-1 cells do not show the same response (Fig 3.11).  In the 
pulmonary tissue, CORT significantly shortened the period by approximately 2h relative to 
the RU treatment alone and the period shortening effects of CORT were significantly 
reduced when RU and CORT were co-administered (Fig 3.11a).  However, there was no 
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significant interaction with DMSO control.  However, no statistical differences were 
observed for MR antagonism with spir, in either the pulmonary or Rat-1 reporters.  
Together these data suggest that CORT can shorten the period of the pulmonary reporter 
and this effect is GR rather than MR mediated, as MR antagonism had no effect. 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: CORT induced period effects and the roles of GR and MR:  The period 
analysis for the mPER2::luc lung reporter (A) treated with CORT or the respective GR or 
MR antagonist (RU or spir respectively) or the Rat-1 mPer2::luc cell reporter (B).  
Statistical analysis was by One-Way ANOVA (in A: P<0.002, in B: P = 0.82) with a 
Bonferroni post-hoc analysis, (a) versus (b) P<0.01, (b) versus (c) P<0.05 other 
comparisons are not significant.  Dots represent individual experiments. 
 
3.3.4 The effect of CORT on the mPer1 GRE  
 
The Per1 promoter is the only clock gene to contain a functional GRE (Yamamato et al., 
2005), therefore, a WT (section 2.3.3) and mutated form of the mPer1 GRE (section 2.3.7 
and Fig 3.12a), driving the luciferase reporter, was established in a Rat-1 cell line and used 
to characterise the effects of CORT on the phase and period of the oscillation.  Comparison 
of the full length (WT) and mutated GRE is shown in Fig 3.12b, which also revealed that 
the CRE (induced in response to forskolin) remained intact in the mutated GRE construct.  
Using an acute response assay measuring bioluminescence 4h after Gc treatment it was 
seen that the mutation of the GRE greatly attenuated the amplitude of the response to both 
CORT and 2 novel non-steroidal GR ligands (67a and 69a) (Fig 3.12), which are described 
in more detail later (section 3.3.5 and Fig 3.17).  In this assay, as in these described below, 
the mutation of the GRE did not impair the response to forskolin.  The acute responses to 
CORT, or the GR ligands, are profoundly affected by the loss of the GRE. 
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Figure 3.12: mPer1 WT versus mutant GRE luciferase assay:  (A ) shows a schematic 
depicting the mPer1 promoter 2500bp upstream of the transcriptional start site, showing 
the relative positions of the CRE (-1807bp-red), GRE (-1933bp-green) and E-boxes (-
226bp, -589bp, -1335bp-black).  Also represented is the Per1 mutant GRE construct (also 
2500bp upstream of the transcriptional start site) and the Per1 600 construct.  The black 
cross represents the mutated GRE construct (section 2.3.7) which leaves the CRE intact.  
WT or mutant GRE mPer1::luc 2500 constructs were treated with either CORT, GR 
agonists (67a or 69a) or forskolin relative to vehicle control (DMSO) 4h before lysis and 
analysis (B).  Units are relative luciferase units (RLU) normalised to WT vehicle.  
Statistical analysis is by Two-way ANOVA (for treatment and construct P<0.0007) with a 
Bonferroni post-hoc analysis.  (a) versus (b) P<0.001 versus relative WT counterpart or 
DMSO control. Error bars are SEM with n=6. 
 
 
The comparison of the mutated and WT forms reveals that mutation of the GRE causes a 
marked loss of circadian rhythmicity in the reporter cells (Fig 3.13 and 3.14 (a) compared 
to (b), black line).  Indeed, a large number of replicates were needed to be run for cells 
containing the mutant GRE in order to obtain a measurable circadian period, 
approximately 50% of the time it was not possible to detect an oscillation in cells 
containing the mutant GRE.  For replicates in which it was possible to detect period, phase 
and sustained amplitude rise there was no statistical significant effect of the loss of GRE 
on period, either in the mutated or truncated constructs (Fig 3.13b, 3.14b and summarised 
3.16d).  Following CORT treatment similar amplitude oscillations were observed in both 
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WT and mutant GRE reporters (Fig 3.15c).  The loss of the GRE did not impair responses 
to forskolin treatment, similar to that seen in Fig 3.12.  Truncation of the mPer1 promoter 
to 600bp (which eliminated the GRE) caused significant attenuation of the circadian 
oscillation, prior to treatment (Fig 3.14c), despite retaining 2 of the 3 E-box elements, yet 
treatment with CORT, forskolin or DMSO stimulated an oscillation.  In response to CORT 
treatment the truncated/mutated promoter element showed greatly attenuated phase shifts 
(Fig 3.15a), yet the phase was unaffected by forskolin treatment (Fig 3.15b). 
 
 
 
 
Figure 3.13: The contribution of the GRE to the period of the endogenous oscillation 
in the Rat1 cell line:  The representative endogenous (untreated) oscillations are shown in 
(A) with the resulting periods analysed (B).  Dots represent a single experiment.  Analysis 
was carried using a one-way ANOVA (P= 0.25) but showed no significance between 
groups. 
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Figure 3.14: CORT and the mPer1::luc GRE:  WT Per1 2500 (A), mutant GRE (B), 
Per1::luc 600 (C) and Per2::luc (D) representative oscillations are shown with CORT 
(green), forskolin (red) and vehicle (black).  The arrow shows the time of treatment 
(CT12). 
 
In contrast to the acute responses seen in Fig 3.12, chronic treatments with CORT sustain 
similar amplitude oscillations in both WT and GRE mutant cells (Fig 3.15c).  This effect 
may be attributable to an indirect effect of CORT or other elements of the clockwork 
which then act on the 2500kp (WT or mutant) construct.  Although earlier studies 
suggested that an additional GRE at -1226bp upstream of the transcriptional start site in the 
promoter is not important for the effect of DEX. It remains possible that this may 
contribute to the similar chronic effect that CORT has on the amplitude of the both WT 
and mutated GRE oscillation.  Although the data might imply that the GRE element alone 
in the absence of CORT (Fig 3.13a and 3.14b) contributes to the amplitude effect on the 
circadian clock, it is possible that the random insertion of this reporter in to the genome is a 
contributing factor and it may be the case that the GRE itself is not contributing to these 
effects.  There is no difference in period length with Per2::luc, Per1 2500::luc or Per1 
600::luc after vehicle, CORT or forskolin treatment (Fig 3.16), yet there is a significant 
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shortening of period after forskolin treatment with the Per1::luc mGRE construct (Fig 
3.16d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Phase effects of CORT and forskolin on the endogenous GRE:  The 
CORT induced phase change (A) and the forskolin induced change (B) on the cellular 
promoter reporters with and without an endogenous GRE.  The chronic amplitude rise is 
shown (C), DMSO (D) and CORT (C).  Dots represent a single experiment.  Analysis was 
carried using a one-way ANOVA (A: P<0.0005; B: P=0.74; C P=0.0034) with a 
Bonferroni post-hoc analysis, (a) versus (b) P<0.01, (c) versus (a) P<0.05. 
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Figure 3.16: Periods of the circadian reporters after treatment:  The periods for 
Per2::luc (A), Per1::luc 2500 (B), Per1::luc 600 (C) and the Per1::luc 2500 mutant GRE 
construct (D) were analysed after CORT or forskolin treatment relative to the vehicle 
control.  Dots represent single experiments.  Statistical analysis was by One-way ANOVA 
(in A: P = 0.6; in B: P = 0.31; in C: P=0.78; in D: P= 0.0086) with a Bonferroni post-hoc 
analysis (a) versus (b) P<0.05. 
 
3.3.5 The non-steroidal GR specific agonists 
3.3.5.1 GR and MR transactivation assays 
 
Novel non-steroidal GR specific agonists were used to further the studies (set out in Fig 3.9 
and 3.10) regarding the role of GR in mediating the phase and amplitude effects of CORT.  
They were designed to have no MR activity and high GR potency (low EC50); however, 
they were untested at the time of receipt.   The high potency and lack or MR activity was 
demonstrated using transactivation assays with both GR and MR, (Fig 3.17).  Both, 67a 
and 69a, were shown to be highly potent GR agonists with EC50 values in the sub nM 
range, 0.7nM and 0.5nM respectively, compared to the DEX control, (EC50 of 19.96nM).  
This suggested that these non-steroidal agonists were around 20-fold more potent that 
DEX.  The two GR agonists had no MR activity as the assay showed basal levels of 
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activation at all concentrations compared to the CORT control, (EC50 = 0.31nM), (Fig 
3.17b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 GR and MR transactivation assays with non-steroidal GR agonists:  GR 
transactivation assays for the non-steroidal agonists (C and E) relative to the DEX control 
(A).  MR transactivation assays for the non-steroidal agonists (D and F) relative to the 
CORT control (B).  The EC50 values are given in the upper right.   RLU are normalised 
between 0 (no activity) and 100 (full activity) and the EC50 values were determined by 
GraphPad Prism software, n=3.  The GR assays were carried out by Dr. Midori Kayahara. 
 
3.3.5.2 Non-steroidal GR agonists and their effect on the phase of the lung oscillation 
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The GR agonists were used with the pulmonary tissue and Rat-1 circadian reporters (like 
CORT, Fig 3.9), with the assurance that these compounds were GR specific.  The agonists, 
used at a GR saturating concentration (x10 EC50 concentration), were able to advance the 
phase of the PER2::luc oscillation in the pulmonary reporter.  However, the acute 
amplitude effect was different to that seen with CORT alone, as neither agonist showed an 
immediate amplitude rise (Fig 3.18).  Instead the agonist treated slices continued into a 
trough, similar to the vehicle control, but rose to the acrophase earlier than the vehicle, 
therefore, advancing the phase (Fig 3.18c).  The time to the fist peak after treatment 
occurred approximately 10h and 7h after CORT peaked for 67a and 69a respectively, and 
suggested a very different immediate mechanism of action on the PER2::luc reporter.  The 
chronic amplitude of the oscillation post treatment with either agonist or CORT was not 
significantly different to the vehicle control (Fig 3.18d) although the average amplitude 
response for CORT was similar to that seen in Fig 3.9 compared to Fig 3.19. 
 
 
 
Figure 3.18: Comparative differences between CORT and the non-steroidal GR 
agonists:  Representative mPER2::luc lung slices were treated, at the arrow (CT12), with 
DMSO (black), CORT (green) and either agonist 67a (A; red) or 69a (B; red) and the time 
to first peak after treatment was analysed (C) as well as the chronic amplitude rise (D).  
Dots represent individual experiments and analysis was by One-Way ANOVA (in C: 
P<0.0001, in D: P=0.28) with a Bonferroni post-hoc analysis, (a) versus (b) and (c) 
P<0.001 and (b) versus (c) P<0.001. 
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The two agonists responded to GR antagonist treatment, similar to CORT (Fig 3.9), even 
though there was a different temporal response in the immediate few hours following 
treatment.  The effect of the GR antagonist (RU) in conjunction with the GR specific 
agonists was similar to that seen with CORT (Fig 3.9 and 3.19). The resulting oscillation 
peaked later than the vehicle control at a time similar to that of the pulmonary tissue 
treated with RU only, approximately 4h after the control (Fig 3.9), suggesting that RU 
completely antagonises the effects of the GR agonists (Fig 3.19  a and b).  The resulting 
periods following treatment with either CORT (taken from the oscillations in Fig 3.18), 
agonist or by pre-treating with RU showed no difference between groups (Fig 3.19c).  (The 
period for lung slices treated with RU is approximately 26h, shown in Fig 3.11).  The 
chronic amplitude of the oscillation post agonist treatment was not significantly increased 
above vehicle control with either 67a or 69a nor did RU reduce the subsequent amplitude 
with respect to 67a but it was significantly reduced with 69a (Fig 3.19d).  Antagonism of 
the GR by RU in the presence of CORT results in an approximately 4.5h phase change 
(Fig 3.10) compared to a 4h and 2.9h phase change in the presence of 67a and 69a 
respectively (Fig 3.19), yet neither of these comparisons are significantly different (student 
t-test P=0.47 for 67a and P=0.08 for 69a).  
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Figure 3.19: Antagonising the effects of the non-steroidal agonists:  A representative 
mPER2::luc lung oscillation (A) shows 67a (red), RU with 67 (blue) and DMSO (black).  
The phase analysis (B) shows results for both 67a and 69a with and without RU pre-
treatment.  Overall period analysis for CORT, 67a, 69a and RU treatments is shown in (C).  
The chronic amplitude rise is shown in (D).  Dots represent individual experiments and 
analysis is a One–way ANOVA (in B: P<0.0001; in C: P=0.08; in D P=0.017) with a 
Bonferroni post-hoc analysis.  Regarding B: (a) versus (b) not significant, (a) versus (c) 
and (d) P<0.05, (b) versus (c) P<0.01 and (d) versus (e) P<0.001.  Regarding D: (f) versus 
(g) and (g) versus (h) P<0.05, (f) versus (h) is not significant.  The oscillation for 69a was 
the same as (A) but is not shown. 
3.3.5.3 Non-steroidal GR agonists and their effect on the phase of the Rat-1 oscillation 
 
To complement the effects of the agonists on the pulmonary reporter, both were 
administered to the Rat-1- Per2:luc reporter.  As in the PER2::luc pulmonary reporter, the 
agonists resulted in a phase change but this time resulted in a peak after the vehicle control, 
constituting delay (Fig 3.20a and c).  However, when the cells were pre-treated with RU 
the phase effects were significantly reduced by approximately 2h, with both agonists, 
unlike in the presence of CORT where the phase change was reduced to almost basal levels 
(Fig 3.9).  Antagonism of the GR by RU in the presence of CORT results in an 
approximately 1h phase change (Fig 3.9)  compared to a 2.6h and 3.8h phase change in the 
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presence of 67a and 69a respectively (Fig 3.20), which are significantly different (student 
t-test P=0.026 for 67a and P=0.001 for 69a).  
 
 
 
 
 
Figure 3.20 Agonist effects on the Rat-1:Per2::luc promoter reporter:  Agonists, 67a 
(A) and 69a (C), were added to the Rat-1-Per2 reporter alone or after pre-treatment with 
RU.  Treatment time is shown by the arrow (CT12).  The phase analysis is shown for 67a 
(B) and 69a (D).  DMSO (black), 67a or 69a (red) and RU with 67a or 69a (blue).  
Statistical analysis was by One-Way ANOVA (in B and D: P<0.0001) with a Bonferroni 
post-hoc analysis, (a) versus (b) and (c) P<0.001; (b) versus (c) P<0.05.  Error bars are 
SEM from n=3 repeats.  
 
In addition to the effects on phase, the agonists had large effects on the period of the post 
treatment oscillations, unlike with the agonist treated pulmonary reporter where the post 
treatment periods were not statistically different between treatment groups (Fig 3.19c).  
Both 67a and 69a significantly reduced the period length, by approximately 1h relative to 
the vehicle control, which was inhibited by pre-treatment with RU in the presence of both 
67a and 69a (Fig 3.21).  The chronic amplitude rise of the Rat-1-Per2::luc reporter did not 
significantly increase in the presence of the either agonist relative to the vehicle control but 
in the presence of RU the amplitude effects were significantly attenuated (Fig 3.21b).  
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Together suggesting that these potent agonists show subtly different effects resulting from 
type of reporter used to study them, be it a protein or promoter reporter. 
 
 
 
Figure 3.21 Agonist induced period change in the mPer2::luc promoter model:  Period 
was analysed after agonist treatment with or without the presence of RU.  Dots represent a 
single experiment.  Analysis is by One-way ANOVA (P<0.0002) with a Bonferroni post-
hoc analysis.  Regarding (A); (a) versus (b), (c) and (d) by P<0.001; (a’) versus (b) 
P<0.001; (a’) versus (d) P< 0.01; (a’) versus (c) P<0.05; (a and a’) versus (e) not 
significant; (b) versus (c) not significant and (d) versus (e) P<0.001.  Regarding (B); (g) 
versus (h) P< 0.001; (f’) versus (g’) P<0.05; (f) and (g) are not significant and (f) and (h) 
are not significant. 
 
3.3.6 Analysis of the pulsatile nature of Gc on the circadian clock 
3.3.6.1 Pulse duration with a constant Gc concentration  
 
The pulsatile nature of Gc release was explored with the development of a flow-through 
culture system linked to the PMT (section 2.4), where a pulse of Gc could be administered, 
for a set length of time, and then removed without disturbing the PMT recordings.  In order 
to develop a working model, the pulse duration was addressed while the concentration of 
the Gc remained constant.  In general, since n=1 for all the following pulse experiments, no 
conclusions can be made about the results, but they form a useful description of developing 
a technique. 
 
Pulse durations of 15, 30 and 60 min were used, on the PER2::luc pulmonary model, while 
keeping the concentration of DEX constant, at 200nM (Fig 3.22).  DEX was used as it is a 
potent Gc analogue and was thought likely to produce more robust results in the early 
stages of this model, compared to CORT.  It was evident that pulse durations of either 15 
or 30 min, even though produced an amplitude rise and a phase change, were not as robust 
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as the 60 min pulse (Fig 3.22c).  The time to the first peak after each pulse was within the 
same dynamic range as seen with the static PMT experiments (6-8h) (Fig 3.18c).  The post 
treatment periods were slightly longer than those observed previously (Fig 3.11) at 24.3h, 
24h and 25.4h for the 15 min, 30 min and 60 min pulse respectively but still well within 
the endogenous range seen with DMSO (Fig 3.2c and 3.11).  The larger amplitude of the 
60 min pulse meant that this duration was carried forward.  Furthermore, the flow rate was 
6.8ml/h with roughly a 2ml residual volume in the well, therefore, a 60 min pulse would 
see three full media changes with 200nM DEX, whereas the 30 min pulse would only see 
approximately 1.5 changes and the 15 min pulse less than1 change.  Calculations of fluid 
dynamics were not undertaken, but a 60 min pulse would allow the lung slice to see a 
concentration of 200nM DEX for a set period rather than it being diluted in the existing 
media and then removed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22: Pulse duration of the flow-through circadian mPER2::luc reporter 
model:  A timed pulse of 200nM DEX was given to the mPER2::luc lung model, under 
flow through conditions.  Pulse durations of 15 min (A), 30 min (B) 60 min (C) and a 
DMSO pulse (D) are shown by the arrow (CT12).  A flow rate of 6.8ml/h was used 
throughout.  Each oscillation is a single experiment, (n=1). 
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3.3.6.2 Gc concentration with a constant pulse 
 
Following the determination of the optimal pulse durations, different DEX concentrations 
were used while keeping the pulse duration constant.  Pulse duration of 60 min was used 
and 10, 500 or 1000nM DEX was added (60 min pulse; 200nM DEX was performed in Fig 
3.22c).  Although each concentration produced a phase effect and an amplitude response, 
the continuation of the recordings was problematic; therefore, the 500 and 1000nM 
experiments were terminated (Fig 3.23 b and c).  The 10nM DEX pulse does, however, 
produce a robust oscillation after the pulse and washout, with a period of 23.5h, together 
suggesting that the pulse duration is more influential than the concentration of Gc, at least 
using DEX. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23: Gc concentration effects on the flow-through mPER2::luc model:  
Different concentrations of DEX were administered for a 60 min pulse as shown by the 
arrow (CT12), 10nM (A), 500nM (B) and 1µM (D), a DMSO vehicle was also pulsed (D).  
A flow rate of 6.8ml/h was used throughout.  Each oscillation is a single experiment, 
(n=1). 
  
The initial work on Gc pulsatility used DEX as the model Gc (Fig 3.22 and 3.23) but the 
endogenous Gc CORT was required as to best mimic the pulsatility of Gcs on the 
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peripheral clock.  Pulse duration of 60 min was used with 50 or 200nM CORT, again using 
the PER2::luc pulmonary reporter.  Both concentrations had an effect on the phase of the 
oscillation, with the time to first peak being between 6-8h, but the 200nM pulse produced a 
far greater amplitude response (Fig 3.24a).  The resulting post treatment periods were 
23.9h and 24.5h for the 200nM and 50nM CORT pulse respectively.   This suggested a 
difference in the dynamic range of action between DEX and CORT.  Therefore, it was 
concluded that the model worked with both DEX and CORT but for subsequent 
experiments 200nM CORT; 60 min pulse was required. 
 
 
 
 
 
 
 
 
 
 
Figure 3.24: CORT induced effects under flow-through conditions using the 
mPER2::luc model:  CORT concentrations were administered through a 60 min pulse to 
the PER2::luc lung slice, 200nM (A) or 50nM (B) as shown by the red arrow (CT12).  A 
flow rate of 6.8ml/h was used throughout.  Each oscillation is a single experiment, (n=1). 
 
3.3.6.3 Multiple Gc pulses on the same sample 
 
The overall aim for this study was to address the effects of the pulsatile nature of Gcs on 
the pulmonary clock and by setting up the flow–through system this could be achieved.  
Using a 60 min pulse duration and 200nM CORT, two pulses were added to the same lung 
slice approximately 7h apart.  The aim was to pulse at the peak of the PER2::luc rhythm 
and then pulse a second time at the acrophase of the CORT-induced peak, in order to 
determine a) if the second CORT pulse would result in a further induced phase change and 
amplitude rise or b) if there was an inbuilt refractory period and the clock would not 
respond to the second pulse and continue with the oscillation and into the trough.  It was 
apparent that the second hypothesis was the biological result as the second pulse (B in Fig 
3.25), again 200nM CORT for 60 min, did not induce a second phase change or amplitude 
response and the oscillation continued into the decline and to the trough (Fig 3.25). 
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Figure 3.25:  Multiple CORT pulses on the same mPER2::luc lung sample:  Two 60 
min 200nM CORT pulses were administered to the same PER2::luc lung slice, labelled (A) 
and (B), 7h apart at the arrows (CT12 and CT19).  This oscillation is a single experiment 
where n=1. 
 
Further multiple pulse challenges were carried out with the second pulse given at different 
phases of the first Gc induced rhythm; at the trough and mid-way through the decline but 
due to complexities in the flow-through model as a reporter system the results were of poor 
quality (appendix D).  Also in an attempt to improve the quality of the flow-through 
oscillations multiple slices were used at the same time (appendix D), but again there were 
problems with reproducibility.  Likewise flow-through culture with a Rat-1 cellular 
reporter itself proved problematic, as cells readily became detached and the rhythms 
quickly became dampened (appendix D).  A more detailed analysis of the pitfalls and 
drawbacks of the flow-though systems are discussed in section 3.4.4.  
3.4 Discussion 
3.4.1 The effects of Gc on the peripheral clock 
 
Gcs, or more precisely CORT, have been shown here to be potent regulator of the 
circadian clock, having effects on the phase, period and amplitude of the oscillation, in the 
two circadian reporters used here.  Initial work, which clearly demonstrated the role of Gcs 
in synchronising the external environment and SCN with the periphery (Balsalobre et al. 
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2000a), used the potent Gc analogue DEX, initiating an increase in the transcript 
abundance of Per1, but not Per2.  Later work provided evidence that Per2 was itself 
directly regulated by DEX (So et al. 2009) but the model system used in this study was a 
primary mesenchymal stem cell, which suggested that model system used had a large 
effect on the outcome of the result.  It is also of interest to note that even though Gcs show 
both circadian and ultradian rhythms in vivo (Windle et al. 1998b), the Gc only needs to be 
present, and does not need itself to be rhythmic, to initiate a robust cell cycle rhythm 
(Dickmeis et al. 2007), which is how these studies were conducted; that is with a one time 
treatment that remained in the culture.  It has recently been hypothesised that temperature 
oscillations could be the way through which the periphery is synchronised with the SCN 
and external environment.  The authors report that there is differential sensitivity to 
temperature in the SCN i.e. some SCN neurons is sensitive to temperature change where 
others are not, which allows the SCN to drive circadian rhythms in body temperature.  This 
temperature rhythm can then act as a signal for the entrainment of other oscillators 
throughout the body, in tissues such as the liver, lung, and heart.  In the study by Buhr et 
al., 2010 the authors suggest that although there are many ways to synchronise the 
periphery e.g. Gcs, food and light they each have an effect of temperature.  For example 
Gcs inhibit the transcription of the inactive GR chaperone proteins Hsp70 and Hsp90, 
restricted feeding is associated with a decrease in body temperature and pathways 
involving cAMP and Ca2+ also activate heat shock pathways.   In this study, reported 
above, two circadian reporters were used, the Rat-1 cell line, for promoter studies and 
PER2::luc pulmonary protein reporter.  It is clear from the two reporters that CORT has an 
effect on both the transcript and protein rhythms, resulting in a dynamic response at all 
phases of the circadian cycle (Fig 3.5), with regard to the phase re-setting effects.  The 
PRC response falls into the biphasic type 0 PRC class with both an advance and delay 
seen, unlike that of the SCN which, in response to light, forms an unresponsive ‘dead zone’ 
(Takahashi et al. 1984).  The absence of the dead zone in the peripheral model means that 
it can remain responsive to Gcs at any time of the circadian cycle, and can therefore remain 
sensitive to synchronisation from the central oscillator.  The PER2::luc CORT-induced 
PRC complements earlier work that showed a similar amplitude and dynamic response of a 
Per2::luc promoter reporter in response to DEX (Gibbs et al. 2009; Izumo et al. 2006).  An 
explanation for the dynamic response to CORT that results in both an advance and delay 
phase is the local chromatin environment and the state of histone acetylation.  The key 
point of the curve is the transition between delay and advance (CT10-12), this rapid switch 
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also occurs in the Izumo (2006) curve to DEX between 32 and 36h, after serum shock.  
This time corresponds exactly with maximal histone H3 acetylation, therefore an open 
chromatin structure, on the mPer2 promoter (Naruse et al. 2004), suggesting that the 
accessibility of the local transcription environment is the cause of the advance or delay 
output.  In addition to this, the ‘dead zone’ observed in the SCN in response to light in the 
subjective light phase (CT0-12) (Takahashi et al. 1984) is likely to be caused by a lack of 
acetylation and therefore a closed structure.  Although histone H3 acetylation was not 
directly shown H3 phosphorylation, considered to significantly enhance acetylation, was 
shown to occur after a light pulse in the dark phase, in the SCN of mice kept under 
constant dark, but not when pulsed in the light phase (Crosio et al. 2000) altogether 
suggesting that the chromatin environment and histone acetylation is key to the circadian 
response to both light and hormonal cues.  However, it cannot be assumed that histone 
modification is the only way through which the PRC is formed but likely through 
numerous other interconnecting pathways such as activation of the NMDA receptor, in the 
SCN, which can closely mimic the light induced PRC when administered over the 
circadian day in the hamster (Mintz et al. 1999).  Yet glutamate administration appears to 
mimic the effects of dark pulsing suggesting that this particular pathway is not involved, 
and that the PRC is pathway specific (Meijer et al. 1988).  There could also be overlap 
with other pathways such as those activated by neuropeptide Y, which has been shown to 
induce phase shifts in the firing rate of SCN neurons and behavioural responses in the 
intact animal (Shibata and Moore 1993).  Other pathways could also be involved such as 
those leading from voltage gated calcium channels, particularly the L-type and T-type 
channels which are known to be under circadian control (Ko et al. 2009).   In particular, 
expression of the T-type channel, in the SCN, is greatest at the transition point from day to 
night suggesting involvement in phase re-setting (Nahm et al. 2005). 
 
The PER2::luc pulmonary model revealed that CORT had an immediate temporal role on 
the amplitude of the protein (as seen by the surrogate luciferase signal (Fig 3.3), which 
suggests the possibility that CORT has a non-genomic role on circadian timing.  However, 
the blockade of this response with the addition of either a GR or MR antagonist suggests 
that the response remains receptor mediated; but the immediacy of the response suggests 
the possibility of cytoplasmic, rather than nuclear, function, that could be due to rapid 
phosphorylation events.  Interestingly, the acute and chronic amplitude rises (Fig 3.3) 
occur at 0.1µM and above, in the pulmonary reporter, whereas the phase change is still 
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observed at 10nM and partly at 1nM.  Therefore this indicates that the two are exclusive 
events and that the amplitude effects are mediated via a divergent pathway to the phase re-
setting events.  Furthermore, CORT induces a similar chronic amplitude increase, seen 
over the duration of multiple cycles in the Rat-1-Per2::luc reporter, which is attenuated by 
GR rather than MR antagonism (Fig 3.9 and 3.10).  
 
CORT has been shown to affect both the phase and amplitude response of the PER2::luc 
rhythm but it has a period effect too, which appears (at least in the lung) to result in a 
significant reduction in period length at CT 0, 6, 8 and 14, (Fig 3.5) although a reduction in 
period was seen at all times. Other CT values were not significantly different to the vehicle 
control, including CT12 (the time used for further antagonist based study).  Interestingly, 
antagonism of the GR, but not the MR, resulted in a significant period lengthening when 
compared to CORT treatment at CT12, with almost a 2h difference.  Consequently GR 
antagonism can inhibit the period shortening action of CORT, (Fig 3.11) and together 
provides evidence that the GR is important in the phase effects of CORT and the 
endogenous period of the clock.  The period shortening effects of CORT, at times 
previously mentioned (CT0, 6, 8 and 14), are of similar magnitude to that seen when 
GSK3β is inhibited through siRNA (Hirota et al. 2008).  It is also know that the Gc 
analogue DEX can induce GSK3β phosphorylation and inactivation through PKB, via 
PI3K pathway and inhibition of PI3K or GR can block PKB activation (Matthews et al. 
2008).  These data provide very promising evidence that the effects of CORT on the period 
are both GR and GSK3β mediated. 
 
A functional GRE in the Per1 promoter was demonstrated through DEX induction of a 
cloned construct (Yamamoto et al. 2005), and a reduction in expression through its 
mutation, which was repeated in this study (Fig 3.12).  However, a circadian analysis and 
the importance of this element to the underlying circadian oscillation was not characterised 
and, therefore, explored in this study.  The GRE affected the magnitude of the CORT-
induced phase change, as the phase change was reduced when mutated or through 
construct truncation, but it had no effect on the period length (Fig 3.13 and 3.16) or the 
amplitude of the oscillation following CORT administration (Fig 3.15).  This is in direct 
contrast to other reports where the chronic treatment of cell lines and mice with 
prednisolone, another Gc analogue, resulted in constitutively high levels of Per1 while 
repressing the oscillations of the other clock genes, such as Per2 (Koyanagi et al. 2006a).  
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Perhaps an effect as a direct result of the half life (t1/2) of the Gc analogues used, as the t1/2 
of plasma CORT is 25 min (Sainio et al. 1988); for DEX it is 200 min and for prednisolone 
it is between 115 and 200 min (Cevc and Blume 2004), and in part explaining why CORT 
was used in this thesis rather than other, more potent, analogues.  Interestingly, the 
presence of the GRE did not induce a large amplitude rise after Gc addition, unlike that of 
the CRE after forskolin treatment (Fig 3.13), which was the same with the mutant 
construct.  This is in direct contrast to the luciferase time point assay where Gc (CORT and 
GR agonists) and forskolin induced a similar induction of mPer1::luc which was lost in the 
mutant form (Fig 3.12).  An explanation for this apparent discrepancy and maintenance of 
a robust rhythm in the mutated Per1::luc construct could be the compensatory effects of a 
further GRE, more proximal to the GRE cloned in this study and, though shown by 
Yamamoto et al. (2005) not to be functional in a luciferase assay, can still bind to the 
liganded GR in both a cellular assay and in the liver in response to stress or the presence of 
other circadian proteins on the promoter construct.  The period lengths post treatment were 
constant for all constructs; Per2, Per1 2500 and Per1 600, however, there was a shortening 
of period length with the mutant GRE after CORT and forskolin but these data did not 
reach significance. 
3.4.2 GR MR and the peripheral clock 
 
The data shown here suggests that the GR is the more dominant receptor involved in the 
CORT mediated phase re-setting of the peripheral clock, however, the MR does have a role 
in the amplitude effects of CORT on PER2::luc (Fig 3.9 and 3.10).  Interestingly RU486 
alone can alter the phase of the oscillation by approximately 3.7h, in the PER2::luc lung 
slice which is significantly different to DMSO, suggesting that it is indeed acting as a 
partial agonist previously described by Stevens et al., 2003 and Wang et al., 2002 (Fig 
3.9c).  Although a 1h phase change is observed in the Per2::luc cell line reporter this is not 
significantly different to DMSO.  The MR has an approximately x10-fold higher kd for 
CORT than for the GR, (0.5-1nM for MR and 2.5-5nM for GR (De Kloet et al. 1998) 
which suggests that the MR will be saturated by CORT at physiological concentrations and 
only effective when CORT is at very low amounts.  The GR itself seems not to be under 
circadian control, as seen at the protein level in the mouse lung (Gibbs et al. 2009) and at 
both transcript and protein level in the Zebrafish (Dickmeis et al. 2007), however, similar 
studies for the MR have not been undertaken.  Interestingly, both the GR and MR 
transcript have been shown to oscillate in an ultradian fashion, with an 8h and 12h rhythm 
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respectively in muscle (Yang et al. 2006).  This is similar to the reported circadian 
harmonic oscillations of a variety of transcripts which cycled with 8h and 12h periods, 
however, neither MR nor GR were reported here, although some heat shock proteins did 
show a 12h oscillation (Hughes et al. 2009).  
 
It has been shown that the GR and MR can heterodimerise to form CORT mediated 
transrepression via a negative GRE (nGRE) (Ou et al. 2001) and with work by Torra et al. 
(2000) the Rev-erbα promoter is thought to contain a nGRE showing a direct association 
with a known circadian regulated gene. However, further work on their transactivation 
properties has not yet been revealed.  In a more recent study it was found that aldosterone 
could induced Per1 mRNA expression in a mouse cell line and in the kidney, which could, 
at least in part, be blocked by siRNA knock down of MR but fully inhibited by knock 
down of the GR (Gumz et al. 2009).  A further study also demonstrated aldosterone 
induced transcription of Per2, as well as Per1 in a cardiomyoblast cell line, which was 
inhibited by the MR antagonist spironolactone (Tanaka et al. 2007).  Although the work in 
Fig 3.10 suggested that the MR does not have a functional role in the CORT mediated 
phase re-setting of the clock, this may just be a result of the reporters used, as the lung 
especially is not an aldosterone (MR) target tissue and may, therefore, have a different 
cellular biology to other MR target organs, such as the kidney.  It would be of particular 
interest to repeat the experiments used in Fig 3.9 and 3.10 in kidney, ovary or heart 
sections and to make use of gene knock down techniques to complement antagonist 
treatment, perhaps in this case a more prominent role for the MR would be discovered.  
Furthermore, recent evidence has suggested that the MR is indispensable for CORT 
mediated non-genomic signalling in the hippocampal neurons, where it is responsible for 
glutamate release (Karst et al. 2005). In this work it was shown that GR had surprisingly 
little effect on the rapid signalling events.  This idea links with work in this thesis as the 
immediate amplitude effects seen on PER2::luc after CORT administration, although can 
be inhibited by a GR antagonist, can be inhibited by a MR antagonist.  This immediate 
effect is considered to be too rapid for genomic signalling and the potential non-genomic 
signalling effects of CORT are further explored in Chapter 4. 
3.4.3 Non-steroidal GR agonists 
 
The selectivity of these two agonists is an invaluable tool in order to try and differentiate 
between the activity of the GR and MR.  The two agonists used in this thesis are both very 
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potent (sub nM kd) and GR specific, that is they have no MR activation potential (Fig 
3.17), and so, whereas with CORT, the observed effects were always a mix of GR and MR 
activity with the agonists the effects are GR mediated only.  The observed differences are 
substantial, particularly in the immediate few hours after treatment.  The two agonists 
respond as expected to pre-treatment with RU (Fig 3.19) but when added to the lung slice 
neither agonist resulted in the immediate amplitude effects seen with CORT and it took 10-
15h before the PER2::luc protein first peaked after agonist treatment (Fig 3.18), yet the 
peak still occurred before the vehicle control, resulting in a phase advance.  These agonists 
provide further evidence that there is a non-genomic element to the effects of CORT on the 
clock, or at least PER2, and that there is potential for receptor selectivity.  However, the 
agonists are non-steroidal (Biggadike et al. 2009), that is they do not have the cholesterol 
backbone of CORT and, as a result, cause the GR binding pocket to take on a different 
confirmation on agonist binding, potentially leading to downstream binding difficulties 
with other proteins and resulting in the different characteristics seen in the immediate few 
hour post treatment.  However, this does link well with the MR, rather than GR, mediated 
non-genomic effects on glutamate release from the hippocampus (section 3.4.2).  
Furthermore, in the lung there was no period shortening in the presence of the agonist 
relative to the period of agonist and the GR antagonist (RU) (Fig 3.19) unlike that seen 
with CORT (Fig 3.11).  However, in the Rat-1-Per2::luc cellular reporter both agonists, 
67a and 69a, significantly shortened the period relative to DMSO, which was attenuated by 
RU (Fig 3.21).  There was no effect of 67a on the sustained (chronic) amplitude after 
treatment in the lung and nor was the resulting amplitude attenuated by RU administration; 
however 69a did show a sustained response which was attenuated by RU (Fig 3.18d and 
3.19d).  This suggests that the two agonists have subtly different effects on the amplitude 
of the PER2::luc rhythm.  However, administration of RU did attenuate the chronic 
amplitude effects of both agonists in the Rat-1 cellular reporter (Fig 3.21b). 
3.4.4 Flow-through culture 
 
The flow-through culture system was a novel set-up designed to mimic the endogenous 
pulsatile nature of Gc release in the rodent.  A constant flow of media through the system 
meant that CORT could be added and removed from the system without disturbing the 
tissue slice, as removing and replacing media manually would itself act to re-set the 
oscillator and CORT mediated effects would be lost.  The work in this thesis was carried 
out on a single lung slice, as cell lines were not robust enough to cope with the flow-rates 
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used.  As this system was essentially developed by the author, although building on 
previous work by Dr. Andrew McMaster, there were many technical difficulties to deal 
with; the main issue being an inefficient out-flow.  The issue here was ensuring that the 
out-flow was at the same rate as the in-flow, the two rates were theoretically the same as 
they were controlled by the same pump, but any slight discrepancy meant that the media 
would build up and flood the system.  This reason meant that the results shown here 
(section 3.3.6) were just an n=1 experiment and the system itself proved very unreliable.  
Furthermore, electronic spiking was an issue, seen to some extent in Fig 3.22, perhaps as a 
result of tissue movement due to different flow-rates; this also resulted in the loss of data 
and remained unresolved.  Improvements to the system were made and issues were in part 
resolved, but the whole process was very much work in progress.  The 35mm dish (Fig 
2.6) was replaced with a Perspex block with fixed bore holes for the tubing, yet an 
anomaly regarding the flow rates still existed, even though a large improvement on the 
35mm dish. Perhaps a greater investment of time into the pump and flow-rates would yield 
a more reliable model.  A similar technique was established by Stavreva et al. (2009) where 
they used pulsatile induction by CORT to stimulate gene transcriptional events and GR 
signalling, rather than investigating clock gene regulation (Stavreva et al. 2009), 
suggesting that the technique can work.  However, the results from section 3.3.6, do 
suggest that the pulsatile nature of CORT can induce a phase and amplitude response in 
PER2, like with the static culture (where CORT was added and left throughout the 
experiment), using a 60 min pulse of 200nM CORT.  The effect of DEX, although a more 
robust model with an effective concentration as low as 10nM, being better than CORT, 
was not taken forward as DEX is a potent Gc analogue with a very long t1/2 compared to 
CORT.   
 
The ultimate aim with this work was to expose the same tissue slice to multiple pulses of 
CORT, and to address the issue of how the clock responds to the pulsatility of endogenous 
CORT release.  The ultradian pulse of CORT occurs once every 50 min (Windle et al. 
1998b), yet to establish methods the multiple pulse experiments were first attempted at the 
peak of PER2::luc and at the subsequent induced peak.  The result from this provided 
evidence for either further induction of phase and amplitude or an inbuilt refractory period, 
with the latter being the case (Fig 3.25).  The peripheral clock is able to ‘ignore’ the 
secondary signals from circulating CORT once it has been re-set and the phase of the 
oscillation changed.  This model makes sense because if the clock responded to each pulse, 
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one every 50 min, there would be no circadian rhythm and peripheral clocks (liver, lung) 
would by arrhythmic.  However, due to the technical difficulties associated with this model 
system further investigations into the dynamic range of this refractory period were not 
revealed.  Appendix D does, however, show secondary pulses given at the trough and mid-
way through the decline, but clear analysis was difficult.  It would be nice to hypothesise 
that there is a window of 12h where there is no response to secondary signals, whatever the 
phase of the initiating one.  
3.5 Conclusions 
 
Work here has shown the potent effects of Gcs on the peripheral clock which can induce a 
significant response at all times of circadian day  and can alter both phase and period of the 
circadian oscillation.  These effects have been shown here to be GR rather than MR 
mediated.  CORT also has an immediate effect on the PER2::luc protein; seen as a rapid 
amplitude rise as well as a chronic (sustained) amplitude effect, which can be blocked 
through the inhibition of both the GR and MR, therefore implicating the MR, in the 
amplitude effects of the Gc on PER2.   
 
For the first time a mPer1::luc reporter construct containing a functional GRE has been 
cloned into a circadian cell line, as well as a mutant GRE construct, to address the affect 
that the GRE had on the underlying oscillation.  The GRE had no effect on the period or 
amplitude of the oscillation but has a significant affect on the phase change in the presence 
of CORT. 
 
The use of highly potent novel, non-steroidal GR specific agonists has revealed, for the 
first time, large temporal differences in the amplitude response of PER2::luc with respect 
to CORT, in that there was no acute amplitude effect with the agonists, yet a chronic 
amplitude increase was observed with regard to 69a rather than 67a.  No chronic amplitude 
effect was observed in the Rat-1 cellular model relative to DMSO but RU did significantly 
attenuate the effect.  The GR agonists still induced a phase change, which was GR 
mediated, but with no period shortening in the lung, unlike that seen with CORT.  There 
was an agonist induced period shortening effect in the cell lines but not in the presence of 
CORT. 
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A novel flow-through system was developed which linked an existing flow-through culture 
system with a transgenic luciferase tissue reporter to a bioluminescent recording system, in 
order to study the real-time pulsatile effects of Gc on the peripheral clock.  This model was 
achieved and a single lung slice was subjected to two 1h pulses CORT pulses, timed at 
subsequent peaks of the PER2::luc rhythm.  Most importantly, though, the micro 
environment of the slice was not disturbed by the operator during the process, that is the 
exchange from media - to media with CORT and back to media was constant.  This is a 
potential breakthrough in the development of a real time mimic of an endogenous process.  
3.6 Future directions 
 
• A more thorough investigation into the role of the MR in phase, period and 
amplitude effects on the clock, with particular regard to PER2, but in a MR target 
tissue such as the kidney or liver (or isolated cell cultures), as the limited MR 
effects seen here could be due to the chosen tissue, the lung, rather than the MR 
itself.  Furthermore, use of siRNA or shRNA to both GR and MR would be 
advantageous as pharmacological inhibition, although a very useful tool may not be 
portraying the full picture.    
 
•  The circadian field, in general, has very few commercial antibodies and even less 
that have been proven to work repeatedly well for both western (immuno) blotting 
and immunohistochemistry studies, which is why there has been a reliance on 
luciferase based reporters and transcript expression in this thesis.  Therefore, the 
production of an array of antibodies would be very beneficial, to study sub-cellular 
localisation, protein stability (Chapter 3 and 4) and protein binding studies; 
answering the question, ‘does protein ‘A’ bind to PER2? and at what time of the 
circadian cycle does this occur?  A lot of work on post-translational modification 
events and binding partners could be achieved with antibody developments, 
including work within this thesis. 
 
• The work in this thesis, and circadian work in general, would benefit from having 
other clock protein luciferase reporter, or other fluorescent reporters, to 
complement the PER2:: luc mouse, so as to determine if the results obtained with 
the PER2 reporter are maintained or different to that of CRY1 or BMAL1 and to 
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determine clock component specificities and similarities in the ever, rapidly 
evolving circadian field.   
 
• The work on the flow-through system and the refractory state of the clock, in 
response to CORT, would benefit greatly from more time spent developing a robust 
mechanical system.  Unfortunately, a quick fix will not work here and serious time 
must be spent to achieve a greater than 80% experimental success rate, identifying 
and resolving the problems created through trial and error.  If this is done properly 
great advances could be made, not only in observing rapid pulsing of CORT on the 
clock, or any other compound, but the need for experimenter manipulation would 
be removed and a much more in-vivo like model would be created.   
 
• Further work with regard the potential non-genomic effects of CORT were 
explored in Chapter 4 so future directions will be discussed in that summary. 
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4.1 Introduction 
 
Gcs act, in the mammalian system, through the ubiquitously expressed GR, but are also 
known to bind to the MR (Funder 1992; Krozowski and Funder 1983).  Work in this thesis 
has shown that the MR has little influence on the phase and period response to Gc but is 
involved in the amplitude response (both acute and chronic) (Chapter 3).  Gcs bind to the 
unliganded GR within the cytosol, the GR will rapidly translocate to the nucleus (Nishi et 
al. 2001), where a GR monomer will bind to the GRE containing genes, such as Per1 and 
Per2 with regard to circadian timing (So et al. 2009; Yamamoto et al. 2005).  A second 
monomer will then bind to form a homodimer and this will induce transcription.  Although 
a classical pathway involving the genomic action of GR is now well defined it is also 
known that responses can occur within minutes and these later responses are insensitive to 
transcriptional inhibition and cannot therefore be a consequence of de-novo transcription.  
This action is referred to as non-genomic (Croxtall et al. 2000; Croxtall JD 2002).  The 
non-genomic action of Gcs is mediated via signalling molecules such as PI3K (Hafezi-
Moghadam et al. 2002) and MAPKs (Solito et al. 2003).  Studies have shown that the non-
genomic actions of Gcs are, at least in part, associated with membrane bound GR 
(Gametchu et al. 1993) and this class of receptors has been shown to associate with CAV-
1, a protein found in cholesterol rich regions of the lipid bilayer called lipid rafts, or more 
precisely a subset of these termed caveolae, which are involved in signalling pathways 
(Matthews et al. 2008).  Matthews et al. (2008) showed that the Gc analogue DEX could 
induce rapid kinase phosphorylation events in minutes and that these were mediated 
through CAV-1.  DEX induced the phosphorylation of CAV-1, Akt and GSK3β within 10 
min of treatment, which was lost in Cav-1 knock-out cells (i.e. no CAV-1 expression and 
constitutive phosphorylation of both Akt and GSK3β).  More importantly, this had no 
affect on the transactivation potential of GR, so a definite non-genomic signalling effect.  
GSK3β has also been shown to phosphorylate the central circadian proteins, such as PER2 
(Iitaka et al. 2005) and BMAL1 (Sahar et al. 2010), suggesting direct links between the 
non-genomic actions of Gc, with membrane bound GR, and circadian function.  
Experiments described in Chapter 3 revealed a very rapid response to CORT for the 
PER2::luc construct in a time course incompatible with classical genomic signalling.  
Experiments described in this chapter explore this rapid response system in more detail. 
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4.2 Aims 
• To explore potential non-genomic action of CORT on the clock (outlined in 
Chapter 3), in particular the mPER2::luc protein reporter. 
 
• To characterise the role of the membrane protein CAV-1 in the action of CORT on 
the Per2 transcript and its protein product through the mPER2::luc pulmonary 
model. 
 
• To build on previous literature and examine links between CAV-1, Akt and GSK3β 
signalling following CORT administration,  
4.3 Results 
4.3.1 Cort mediated PER2 protein stability 
4.3.1.1 Translational inhibition 
 
To further explore the immediate and potential non-genomic, amplitude effects of CORT 
on PER2::luc, cycloheximide (CHX) was used to inhibit de novo protein synthesis, in the 
presence or absence of CORT.  This technique has been previously used, with PER2::luc to 
study degradation rates in conjunction with immuno blots (Meng et al. 2008a).  Because 
antibodies to PER2 were not available for immuno blotting the luciferase signal was used.  
The goal was to test the hypothesis that immediate changes in PER2::luc following CORT 
treatment were a consequence of altered degradation rates of PER2.  Since studies with the 
non-steroidal agonists induce strong phase shifts but without the concordant rise in 
PER2::luc expression (Fig 3.18 and 3.19) a further prediction would be that CORT and the 
non-steroidal agonist may have different impacts on PER2::luc degradation rates following 
CHX treatment. The results from these experiments clearly reveal that there is no 
significant difference between the decay rates of the PER2::luc signal in lung slices treated 
with CORT or the non-steroidal agonist (67a) (Fig 4.1 and 4.2 respectively).  In all cases 
the t1/2 was approximately 1.75h.  Furthermore, following CORT treatment there was no 
immediate sustained rise in PER2::luc signal in the CHX treated slices. 
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Figure 4.1: Effect of translational inhibition on CORT induced mPER2::luc stability:  
A representative oscillation of mPER2::luc lung slices after 20µg/ml cycloheximide 
(CHX) induced translational inhibition with CORT treated either 30 min before or 30 min 
after CHX (A), with CORT only (dark green) and DMSO (black).  Treatment indicated by 
the arrow (CT12).  The degradation rates are shown in (B) with CHX (red), CHX with 
CORT pre-treatment (blue) and CORT with CHX pre-treatment (light green).  The 
resulting degradation rates
 
are shown in (C) and were calculated using a one phase 
exponential decay algorithm (GraphPad Prism).  Statistical analysis was by One-way 
ANOVA P= 0.8. 
 
 
 
 
 
Figure 4.2: Effect of translational inhibition on agonist induced mPER2::luc stability:  
The degradation rates are shown in (A) with 20µg/ml CHX (red), CHX with agonist (67a) 
pre-treatment (blue) and 67a with CHX pre-treatment (light green).  The slices were treated 
as previous at CT12 (oscillation not shown).  The resulting degradation rates
 
are shown in 
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(B) and were calculated using a one phase exponential decay algorithm (GraphPad Prism).  
Statistical analysis was by One-way ANOVA P= 0.5 
4.3.1.2 Transcriptional inhibition 
 
The above studies suggested that PER2::luc protein stability rates are not altered by Gc 
signalling.  In order to test the role of the transcription mechanism underpinning the 
responses, similar studies to those described above were undertaken.  In these experiments 
CORT was added to PER2::luc expressing lung slices 30 min before or after actinomycin 
D (Act D) treatment.  It can be seen (Fig 4.3a) that transcriptional inhibition blocked the 
immediate amplitude rise in PER2::luc expression following CORT administration.  
Comparing normalised PER2::luc degradation rates it can be seen that there are no 
significant differences consequent on the order Act D was administered (Fig 4.3b).  
Blockade of translation by CHX, without any effect by CORT (Fig 4.1) suggests that the 
immediate amplitude rise is not due to post-translational modification.  Furthermore, 
blockade of transcription by ActD, without any effect of CORT, suggests that the acute 
amplitude rise is transcriptionallly mediated and requires de novo transcription of mPer2.  
Translational inhibition of mPER2::luc by CHX has previously been used to show more 
rapid degradation of the mPER2::luc tau protein compared to the WT protein (Meng et al., 
2008a), which suggests that both PER2 and the LUCIFERASE proteins are being degraded 
at the same rate, rather than PER2 being degraded much faster than the LUCIFERASE 
protein and leading to a false negative result.  
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Figure 4.3:  Effect of transcriptional inhibition on CORT induced mPER2::luc 
stability:  A representative oscillation of lung slices after 10µg/ml act D induced 
transcriptional inhibition with CORT treated before or after act D (A), with CORT only 
(dark green) and DMSO (black).  Treatment time is indicated by the arrow (CT12).  The 
degradation rates are shown in (B) with act D (red), act D with CORT pre-treatment for 30 
min (blue) and CORT with act D pre-treatment for 30 min (light green).  The resulting 
degradation rates are shown in (C) and were calculated using a one phase exponential 
algorithm (GraphPad Prism).  Statistical analysis was by One-way ANOVA (P= 0.27). 
4.3.2 CORT mediated Per2 transcript induction 
 
The previous section (4.3.1) showed no significant effects of CORT on the degradation 
rate of the PER2::luc signal (a surrogate measure for PER2 protein turnover) and so here 
studies were extended to measure the CORT effect on Per2 mRNA, as the results (Fig 4.3) 
suggested de novo mRNA synthesis.  Lung sections were treated at either the projected 
peak or trough (24 or 36h after synchronisation, section 2.2.5.2) of the PER2::luc protein 
rhythm (a representative oscillation was not used), to assess the response of CORT in the 
induction of Per2.  Lung sections were collected 4h later and the RNA extracted; mPer2 
and mGILZ transcripts were quantified by qPCR.  The lung slices showed a significant 4-5 
fold increase in transcriptional expression to Gc as measured by the induction of the 
glucocorticoid responsive gene, mGILZ (Fig 4.4a).   mGILZ is used here as a positive 
marker of GR mediated genomic activation (D'Adamio et al. 1997).  The induced response 
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was equivalent at both the peak and trough of the PER2::luc rhythm, and with no 
difference between CORT and the agonist (67a).  In contrast, the induction of mGILZ to 
both CORT and the non-steroidal agonist (67a) was completely blocked by the GR 
antagonist RU, clearly indicating that the responses were largely mediated through the 
classical genomic signalling pathway (Fig 4.4a).  In contrast, the relative induction of 
mPer2 mRNA was of lower magnitude to that of mGILZ with an approximate 2-fold 
response to 100nM CORT (comparison of treatment administered at the trough of the 
cycle, Fig 4.4b).  RU had relatively less effect than that observed for mGILZ and 
consequently did not significantly reduce the mPer2 response to CORT (Fig 4.4b).   
 
Figure 4.4: CORT and agonist induction of mPer2 transcript in the lung:  CORT or 
GR agonist (67a, 10nM) was used to treat lung sections, at either the peak (CT12, red) or 
trough (CT0, green) of the mPER2::luc protein rhythm alone or with 1h pre-treatment with 
1µM RU486 (RU), for 4h prior to the RNA extraction. Transcript expression for the 
positive control mGILZ (A) and mPer2 (B) are shown as fold change relative to the DMSO 
control.  Both mGILZ and mPer2 were assayed from the same RNA sample.  Analysis was 
by Two-Way ANOVA (there is no interaction with regard to time in A: P=0.58 or B: 
P=0.074) with a Bonferroni post-hoc analysis for treatment.  Error bars are SEM of n=3 for 
each treatment.  (a) versus (b), (c) and (d) P<0.001; (b) versus (e) and (d) versus (f) 
P<0.001; (g) versus (h) P< 0.05.  
 
These experiments were next repeated using Rat-1 cells carrying the Per2::luc mRNA 
reporter (section 2.3.9.2).  In these experiments CORT and 67a were administered at the 
peak of the Per2::luc rhythm (24h after synchronisation).   CORT  was administered here 
at the peak, as the previous work treating at both the peak and trough of the mPER2::luc 
rhythm (Fig 4.4) had shown there to be no interaction with regard time (One-Way 
ANOVA P=0.58 and P=0.074 for mGILZ and mPer2 respectively).  Also, all previous 
experiments were carried out at the peak of the mPer2 rhythm (either protein or transcript) 
and robust and reproducible results were observed, and if there was an effect of CORT at 
the transcript level then it would occur readily at the peak.  Although CORT, administered 
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at the trough, induced a greater mPer2 response at 100nM CORT this was not replicated at 
1000nM nor with regard RU486 treatment or in the mGILZ response.  Together these data 
suggest that CORT administration at the trough of the Per2::luc rhythm was no different to 
peak administration. 
 
Similar to the experiments above, using lung tissue, rGILZ exhibited a robust response to 
CORT and 67a and these were totally blocked by pre-treatment with RU (Fig 4.5a).  In 
contrast rPer2 mRNA induction was of lower amplitude but a significant difference was 
observed between DMSO and 100nM CORT which was blocked by RU (Fig 4.5b).  (A 
similar magnitude of response was seen with 67a the induction or blockade by RU did not 
reach significance.  Together the results from Fig 4.3, 4.4 and 4.5 suggest that the 
immediate amplitude rise seen with CORT (and not with the agonist) (Fig 3.18) is as a 
result of induced de novo Per2 transcription, yet there is no significant difference between 
CORT and agonist induction at the transcript level (Fig 4.4 and 4.5), and therefore this 
difference must be a result of some other, uncharacterised mechanism capable of an 
immediate response. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: CORT and agonist induction of rPer2 transcript in the Rat-1-Per2::luc 
cell line:  CORT or GR agonist (67a, 10nM) was used to treat the Rat-1 cells, at the peak 
(CT12) of the mPer2 transcript rhythm alone or with pre-treatment with 1µM RU486 
(RU), for 4h prior the RNA extraction.  Transcript expression for the positive control 
rGILZ (A) and rPer2 (B) are shown as fold change relative to the DMSO control.  Both 
rGILZ and rPer2 were assayed from the same RNA sample.  Analysis was by One-Way 
ANOVA (in A: p<0001, in B: P=0.0056) with a Bonferroni post-hoc analysis. Error bars 
are SEM of n=3 for each treatment. (a) versus (b), (c) and (d) P<0.001; (g) versus (h) 
P<0.05. 
4.3.3 The disruption of lipid raft signalling on the circadian oscillation 
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The studies above suggest that CORT acts on the clock largely through a transcription 
mediated process.  Yet since changes in the PER2::luc protein signal are acute and rapid 
(Fig 3.3, 3.4, 3.9, 3.10, 3.18 and 4.1) this still suggests a non-genomic mechanism.  In all 
the figures above, it can be seen that increases in bioluminescence are detected within 30 
min of treatment (PMT resolution is per min).  In order to test whether a rapid non-
genomic mediated signalling pathway may be involved the potential involvement of 
membrane-bound lipid rafts (Caveolae) was investigated.  Using the lung slice model the 
cholesterol rich lipid raft region of the membrane was disrupted with methyl cyclodextrin 
(section 2.2.5.1).  Pre-treatment of lung slices with methyl cyclodextrin followed by CORT 
completely blocked the expected acute rise in the PER2::luc signal (Fig 4.6a).  Following 
methyl treatment the expected CORT induced phase shift was also blocked (Fig 4.6a and 
b).  There was no significant difference between DMSO and methyl alone.  There was no 
overall period effect of methyl cyclodextrin (with or without CORT, Fig 4.6c), but methyl 
cyclodextrin did reduce the chronic CORT-induced amplitude effect, similar to the effect 
with RU (Fig 3.9).  In these experiments it was necessary to use a relatively high DMSO 
concentration to dissolve the methyl cyclodextrin (1% versus the normal 0.1%, a 10-fold 
increase).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Disruption of lipid raft signalling on circadian oscillation of the 
mPER2::luc protein reporter:  A representative oscillation (A) with CORT (green), pre-
Chapter 4____________Non-genomic glucocorticoid regulation of circadian timing 
 
 186 
Time (h)
DMSO       Methyl        Methyl Cort
+ Cort
Pe
rio
d 
(h
)
e
f
N
o
rm
a
lis
ed
 
bi
o
lu
m
in
e
sc
en
ce
DMSO
Methyl + CORT
CORT
methyl
mPer2:luc (cells)
DMSO       Methyl        Methyl Cort
+ Cort
Ch
ro
n
ic
 
a
m
pl
itu
de
 
ris
ed
g
hh
g
A
C D
DMSO       Methyl    Methyl Cort
+ Cort
Ph
as
e 
ch
a
n
ge
 
(h
)
a
c
c’
B
b
 
treated with 5mM methyl for 30 min then with CORT (red), methyl only (blue) and DMSO 
(black).  Treatments were administered at the arrow (CT12).  The phase change relative to 
the vehicle control is shown (B) and the post treatment periods are shown in (C) with the 
chronic amplitude rise shown in (D).  Dots represent single experiments and statistical 
analysis is by one-way ANOVA (in B: P<0.0001, in C: P=0.26, in D: P<0.0001) with a 
Bonferroni post-hoc analysis; (a) versus (b) P<0.001. 
 
The above experiments were next repeated using the Rat-1-Per2::luc cells (Fig 4.7).  Here 
methyl did not significantly attenuate the CORT-induced phase shift (P>0.05), although it 
did reduce the phase change by approximately 2h.  In these data there was a significant 
interaction between methyl and CORT - the phase shifts such that methyl and methyl with 
CORT treatment differed significantly (Fig 4.7b), yet there is no significant difference 
between DMSO and methyl alone.  Methyl also significantly reduced the amplitude of the 
chronic circadian oscillation in these cells (Fig 4.7d).  In contrast to the lung slices CORT 
(with and without methyl) significantly shortened the period of the Rat-1-Per2::luc 
oscillation by approximately 1h (Fig 4.7c).  These experiments described above implicate 
lipid rafts in the rapid responses of PER2::luc to CORT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Disruption of lipid raft signalling on the circadian oscillation of the Rat-1-
mPer2::luc promoter reporter:  A representative oscillation (A) with CORT (green), pre-
treated with 5mM methyl for 30 min then CORT (blue), methyl only (red) and DMSO 
(black).  Treatment time is indicated by the arrow (CT12).  The phase change was relative 
to the vehicle control (B) and the post treatment periods are shown in (C) with the chronic 
amplitude rise shown in (D).  Dots represent single experiments and statistical analysis is 
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by One-way ANOVA (in B, C and D: P<0.0001) with a Bonferroni post-hoc analysis.  In 
B: (a) versus (b) and (c) not significant; (a) versus (c’) P<0.001; (b) versus (c) P<0.05, (b) 
versus (c’) P<0.001 and (c) versus (c’) not significant. In C: (d) versus (e) P<0.05 and (f) 
P< 0.01.  In D: (g) versus (h) P<0.001. 
4.3.4 Cav-1 WT and -/- cells and circadian gene expression 
4.3.4.1 Differential expression of circadian genes in the Cav-1 WT and -/- cells 
 
The fibroblast cell line was derived from the thymus gland of Cav-1 WT and -/- mice 
(section 2.3.1).  Since these cells lack any circadian reporter it was necessary to determine 
whether loss of Cav-1 impacted directly on the core circadian clock work.  Primary cells 
are difficult to transfect and the Cav-1 -/- cells show no contact inhibition in cell culture 
growth, and for this reason the insertion of a conventional luciferase reporter was not 
attempted.  Accordingly, Cav-1 WT and -/- cells were synchronised for 1h by forskolin 
treatment, cells were washed and left in culture for 24h prior to sampling at the 
presumptive CT0 and CT12.  qPCR determination of mBMAL1 showed high amplitude 
differences between CT0 and CT12 in WT cells and a reduced but significant difference in 
Cav-1 -/- cells (Fig 4.8a).  mPer2 expression revealed an anti-phase pattern (with respect to 
BMAL1) with high amplitude changes in both WT and -/- cells (Fig 4.8b).  Collectively, 
these data reveal that the positive (BMAL1) and negative feedback (Per2) arms of the clock 
show predicted changes at 2 circadian time points in both Cav-1 WT and -/- cells. 
 
 
Figure 4.8:  Temporal mBMAL1 and mPer2 expression in WT and Cav-1 -/- cells:  
Relative transcript expression is shown at CT0 (red) and CT12 (green) for BMAL1 (A), 
Per2 (B).  Expression is represented as fold change relative to the lowest expression.  Error 
bars are SEM of n=3, Per2 and BMAL1 expression was quantified from the same samples.  
Statistical analysis was by Two-way ANOVA (in both A and B: P<0.0001 for time 
interaction and in A: P=0.17 and in B: P=0.21 for genotype interaction) with a Bonferroni 
post-hoc analysis, (a) versus (b) and (c) P<0.001, (c) versus (d), (b) versus (d) P<0.05, (e) 
versus (f) P<0.01. 
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4.3.4.2 CAV-1 effects on the CORT mediated expression of mPer2 
 
In order to compare a time course of response to CORT and 67a, Cav-1 WT and -/- cells 
were treated for 1h, 2h and 4h and 2h and 4h with CORT and 67a.  Treatment with CORT 
induced a small but significant increase in mPer2 expression at 1h in WT cells and the 
response was further augmented at 2h and 4h (Fig 4.9).  The treatment with 67a also 
strongly induced mPer2 expression at 2h and 4h (Fig 4.9).  (The data shown in both Fig 4.9 
and 4.10 are CORT or 67a treated samples as a fold induction over their respective DMSO 
control in order to show a time effect.  These data are re-plotted in appendix J along with 
their respective DMSO control to show time point induction over control values). 
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Figure 4.9:  CORT and non-steroidal GR agonist-induced mPer2 expression over 1h, 
2h and 4h in Cav-1 WT and -/- cells:  Cav-1 WT or -/- cells were treated with either 
CORT or the non-steroidal agonist (67a) for 1h (CORT only, black), 2h (red) or 4h (blue) 
prior to RNA extraction and qPCR analysis for mPer2.  Data are shown relative to their 
respective DMSO control (fold change of 1) in order to show time effects of CORT; a 
further representation is shown in appendix J.  Statistical analysis was by two-way 
ANOVA (P<0.05 for time and genotype with CORT and 67a) with a Bonferroni post-hoc 
analysis and error bars are SEM of n=3. ** P< 0.01, (a) versus (b) P< 0.05; (c) versus (d) 
P< 0.001. 
 
 
In contrast, Cav-1 -/- cells showed no significant responses at 1h and 2h for CORT but 
similar increase in amplitude responses at 4h to those seen in WT cells (Fig 4.9 and 
appendix J).  The 2h response to CORT was significantly reduced in the Cav-1 -/- cells 
with respect to the WT (Fig 4.9, red bars) but no difference was observed a either 1h or 4h.  
Similarly the 2h expression of mPer2 was significantly reduced in the presence of 67a (Fig 
4.9, red bars) but no difference was observed at 4h.  In contrast, mGILZ showed significant 
responses to CORT at 1h, 2h and 4h in WT cells and to 67a at 2h and 4h (Fig 4.10).  
Responses of Cav-1 -/- cells to CORT and 67a were significantly augmented at 2h and 4h 
but overall the amplitude of response was significantly lower than the WT cells at 4h 
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(blue) for CORT and 2h (red) and 4h (blue) for 67a.  (Again the data in Fig 4.10 are re-
plotted in appendix J for a direct comparison to DMSO). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10:  CORT and non-steroidal GR agonist-induced mGILZ expression over 
1h, 2h and 4h in Cav-1 WT and -/- cells:  Cav-1 WT or -/- cells were treated with either 
CORT or the non-steroidal agonist (67a) for 1h (CORT only, black), 2h (red) or 4h (blue) 
prior to RNA extraction and qPCR analysis for mGILZ.   Data are shown relative to their 
respective DMSO control (fold change of 1) in order to show time effects of CORT; a 
further representation is shown in appendix J.  Statistical analysis was by two-way 
ANOVA (P<0.0001 for time and genotype with CORT and 67a) with a Bonferroni post-
hoc analysis and error bars are SEM of n=3.  * P< 0.05, ** P< 0.01, ***P< 0.001; (a) 
versus (b) P< 0.001; (c) versus (d) P< 0.001 and (e) versus (f) P< 0.001. 
4.3.5 Inhibition of phosphatidylinositol 3 (PI3) kinase pathway 
 
To attempt to further investigate the signalling pathway behind the Cav-1 mediated 
attenuation of CORT induction of mPer2 transcription (Fig 4.9), the signalling molecule 
PI3 kinase was inhibited and the action of CORT on mPer2 transcription was assayed.  
This pathway was chosen specifically due to previous work characterising the relationship 
between rapid Gc signalling and PI3 kinase (Matthews et al. 2008).  PI3 kinase plays an 
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important role in mediating Cav-1 signalling and lies up-stream of the kinase PKB, which 
is involved in Cav-1 signalling.  A prediction would be that inhibition of PI3 kinase should 
block or attenuate the induction of mPer2 following CORT administration.  Cells were pre-
treated with LY294002 (section 2.3.9.2) for 1h prior to administration of 100nM CORT, in 
the Cav-1 WT cells.  Cells were sampled at 2h and 4h.  There was a significant induction 
in mPer2 expression after CORT administration after 2h and 4h (1.9-fold and 3-fold 
respectively).  PI3 kinase inhibition had a weak inhibitory effect, in the presence of CORT, 
at 2h, but a weak inductive effect at 4h.  However, PI3 kinase inhibition did not 
significantly alter the responses to CORT at either 2h or 4h (Fig 4.11a and b).     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: PI3 kinase inhibition of mPer2 transcript induction after CORT:  CORT 
or 50µM PI3 kinase inhibitor were added to Cav-1 WT cells for 2h (A) or 4h (B) prior to 
RNA extraction and the mPer2 transcript was measured.  Transcript expression is fold 
change relative to the DMSO control.  Error bars are SEM of n=3.  Statistical analysis is by 
One-way ANOVA (P<0.0026 for both A and B) with a Bonferroni post-hoc analysis, (a) 
versus (b) P<0.001; (c) versus (e) P<0.001, (c) versus (d) P< 0.01 and (d) versus (e) 
P<0.001. 
4.3.6 Mechanistic overview of known genomic and non-genomic CORT inducted 
interactions 
 
The classical genomic pathway shows CORT passing through the bilayer and into the 
cytoplasm where it binds to the GR and the chaperone proteins are released, the GR 
becomes active, by phosphorylation, and translocates to the nucleus where it will induce 
transcription of GRE containing genes, Per1 and 2 are the circadian genes.  This generally 
takes between 2 and 4h to produce a maximal response.  Coupled to this CORT can induce 
rapid amplitude effect on the PER2 protein, seen as a surrogate luciferase signal (Fig 3.18), 
which are too rapid to be genomic based.  This effect has been proposed here to act 
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through membrane bound CAV-1 and associated GR (Matthews et al., 2008) and a kinase 
signalling cascade which involves the phosphorylation and subsequent activation of PKB; 
the phosphorylation and inactivation of GSK3β (Beaulieu et al. 2004) and the activation of 
MAPK p42/44 (Goold and Gordon-Weeks 2005).  The inactivation of GSK3β results in 
the stabilisation and subsequent retention of PER2 in the cytoplasm, which is then 
phosphorylated by other kinases such as CK1ε, δ and CK2 for subsequent but delayed 
protein turnover (Gallego and Virshup 2007; Iitaka et al. 2005; Lowrey et al. 2000).  CAV-
1 has a direct transcriptional effect on Per2 too, which is different to that seen with GILZ 
induction (Fig 4.9 and 4.10), hence it is a Per2 specific effect.  In this Chapter, I have 
shown that disruption of Caveolae signalling using methyl cyclodextrin inhibits the rapid 
rise in the PER2::luc signal and inhibits the phase change induced by CORT, and that 
knocking out Cav-1 has a direct effect on mPer2 mRNA expression, as shown by the red 
dashed arrows in Fig 4.12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12:  Diagram of rapid (non-genomic) and slow (genomic) actions of CORT:  
The black-dashed curly arrows depict known phosphorylation events.  The solid black 
arrow shows translocation events and the red-dashed arrow shows the events described in 
this thesis.  All proteins are labelled, glucocorticoid receptor (GR), CORT (co), 
transactivation (TA) and transrepression (TR).  The oscillation next to BMAL1, PER2, p-
MAPKp42/44 and p-GSK3β show that they are rhythmic. 
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4.4 Discussion 
4.4.1 PER2::luc protein amplitude response 
 
It is becoming more evident that Gcs have a rapid, non-genomic, action on the cell 
(Croxtall 2002) as well as the more established ‘classical’ genomic action (Nishi et al. 
2001).  In this thesis I have shown a clear, rapid amplitude effect of CORT on the clock 
protein PER2 (Fig 3.3) and that this rapid effect is not seen in the presence of novel non-
steroidal GR specific agonists (Fig 3.18).  Furthermore, this rapid amplitude rise can be 
inhibited by GR and MR antagonism (Fig 3.9 and 3.10 respectively) suggesting that the 
effect is mediated through these two receptors.  There is less published evidence to support 
a role for MR-mediated induction of the clock by CORT.  There is some evidence that the 
MR is involved in non-genomic signalling, at lease in the brain (Karst et al. 2005).  
However, further work on the non-genomic re-setting effects of either receptor was not 
investigated in this thesis. 
 
The rapid amplitude rise of PER2 after CORT treatment was not a product of immediate 
post-translational modification events, since CORT treatment after protein synthesis 
inhibition did not result in altered degradation rates (Fig 4.1).  However, it is known that 
active GSK3β can phosphorylate PER2 and induce nuclear translocation (Iitaka et al. 
2005), resulting in the inhibition of CLOCK/BMAL1 mediated transcription (Sato et al. 
2006a).  If GSK3β function is increased, this can induce a phase advance, whereas a 
decrease in function results in a phase delay (Iitaka et al. 2005).  So the lack of an apparent 
increase in protein stability, after protein synthesis inhibition, in the presence of CORT 
may be due to the complexity of post-translational interactions; as with GSK3β mediated 
phosphorylation of PER2, this essentially results in nuclear localisation and subsequent 
degradation, rather than stabilisation.  It must be considered here that the degradation 
assays are just a direct measure of luciferase degradation and not PER2 itself.  The 
degradation of PER2 is inferred as the luciferase protein is fused to the C-terminal of the 
PER2 protein (Yoo et al. 2004).  Furthermore, as predicted from the PER2::luc protein 
oscillations (Fig 3.18) the presence of the GR agonist had no stabilisation effects on PER2, 
after protein synthesis inhibition.  Despite similar degradation rates following CORT or 
agonist treatment there was a clear difference in the pattern of PER2::luc induction.  Since 
effects of CORT after transcriptional inhibition (Fig 4.3) caused no difference in PER2::luc 
degradation suggesting that the CORT effects on PER2::luc are likely to be a 
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transcriptional-dependent process.  At a transcript level, there was no difference between 
the Per2 induction by CORT or the agonist 67a, treated at either the peak or trough of the 
PER2::luc rhythm, in the lung, or treated at the peak of the rPer2 transcript rhythm in the 
Rat-1 cells.  There was perhaps a small attenuation of induction by 67a, at the peak in the 
lung, but this was not replicated at the trough or in the Rat-1 model nor did it reach 
significance.  In summary, the different immediate temporal events observed after CORT 
or GR agonist treatment could not be readily explained by either post-translational 
modification events or transcriptional differences in mPer2.  There must yet be a further 
explanation. 
4.4.2 Non-genomic Caveolae signalling on the clock 
 
Evidence had suggested that the GR could associate with the membrane bilayer with a 
larger molecular mass to the more common cytoplasmic form (145kDa and 95kDa 
respectively), and with a separate function to the cytoplasmic/nuclear GR (Gametchu et al. 
1993).  The GR has been shown to co-precipitate with CAV-1 (Matthews et al. 2008), a 
major protein component of a sub-set of lipid rafts which are involved in rapid kinase 
signalling events (Matthews et al. 2008; Okamoto et al. 1998).  The compound methyl 
cyclodextrin is part of a family of compounds which are used to regulate cholesterol 
insertion into the membrane bilayer.  This compound is very non-specific but will indicate 
lipid raft-mediated membrane signalling and was used to indicate the potential 
involvement in the immediate amplitude effects of CORT on PER2.  Methyl cyclodextrin 
had three effects on the PER2::luc rhythm; it inhibited the CORT-induced acute amplitude 
rise, similar to that seen with the GR and MR antagonists (Fig 3.9 and 3.10); it inhibited 
the phase shifting effects of CORT, reducing it to a level relative to the vehicle control (Fig 
4.6) and it inhibited the CORT-induced chronic amplitude rise (Fig 4.6).  Period effects 
were not seen in the PER2::luc pulmonary reporter.  The phase and chronic amplitude 
inhibition were also seen with the Rat-1-Per2 promoter reporter (Fig 4.7), again similar to 
that seen with the GR and MR antagonists (Fig 3.9 and 3.10).  Interestingly in the Rat-1-
Per2::luc reporter CORT significantly shortened the period of the resulting oscillation (Fig 
4.7c), yet this was not inhibited by methyl.  This was in direct contrast to the inhibition of 
the period shortening effects by GR blockade with RU (Fig 3.11), suggesting independent 
actions on period clock function between membrane based and classical genomic action of 
CORT.  However, the rapid kinase signalling events induced by DEX were inhibited by 
RU mediated GR blockade (Matthews et al. 2008).  It is also known that inhibition, or 
Chapter 4____________Non-genomic glucocorticoid regulation of circadian timing 
 
 195 
knock down of GSK3β, results in a period shortening of approximately 2h, using a 
BMAL1::luc reporter (Hirota et al. 2008), which complements the effects seen with CORT 
and subsequent RU blockade.  This cannot yet explain the lack of attenuation of period 
shortening by methyl cyclodextrin, as this disrupts PKB inactivation of GSK3β, by 
phosphorylation; therefore GSK3β theoretically remains active in the presence of methyl. 
 
The Cav-1 -/- cells were used to enhance the studies using methyl cyclodextrin.  A 
significant draw back to using this model was that the cells did not have a circadian 
reporter, transcript or protein, to study and analyse.  Instead, the endogenous mPer2 
transcript was used to report the effect of CORT on the Cav-1 WT and -/- cells.  The 
CORT induction of mPer2 transcript was not observed in the Cav-1 -/- cells at 1h and 2h 
compared to the WT construct but induction was equivalent at 4h.  This suggested that 
CAV-1 is involved in the immediate induction of mPer2 transcription.  Responses seen at 
4h suggest that CORT was functioning through a classical genomic mechanism.  Blockade 
of GR signalling, by RU, would block predicted rapid non-genomic and slower genomic 
mediated pathways.  Recent studies have shown this is the case (Matthew (2008) and Fig 
3.9).  In contrast to the mPer2, mGILZ induction was relatively unaffected by the loss of 
CAV-1 although the Cav-1 -/- cells did exhibit a reduced amplitude of response to CORT 
(Fig 4.10).  A further prediction from these studies is that the non-steroidal agonist (67a) 
may be expected to act exclusively through genomic mediated pathways.  However, data 
shown here suggest that loss of CAV-1 also significantly alters the response to the agonist 
with greatly attenuated amplitudes of response at 2h (Fig 4.9 and appendix J).  However, 
conclusions over the origin of the protein expression (Fig 3.18) differences cannot be fully 
made form these results. 
 
The loss of CAV-1 did not alter rhythmic expression of mPer2 but there was a significant 
dampening of mBMAL1 expression over the two time points studied, yet to fully 
characterise the response CT6 and CT18 time points should be analysed (Fig 4.8).  This 
may be a consequence of GSK3β mediated phosphorylation.  GSK3β can phosphorylate 
BMAL1, which targets it for proteasomal degradation (Sahar et al. 2010).  One model  is 
that in the Cav-1 -/- cells, GSK3β is not inactivated by PKB (Akt) phosphorylation, and 
could therefore phosphorylate BMAL1 at all times resulting in degradation; hence 
reducing the amplitude of the protein rhythm and feeding back to result in an almost 
constitutive transcript rhythm (Fig 4.8).  Further to this, GSK3β is known to phosphorylate 
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and stabilise REV-ERBα protein (Yin et al. 2006), which acts to repress BMAL1, resulting 
in much lower transcript expression.  However, it is known that BMAL1 does not need to 
oscillate to induce a functional Per2 rhythm (Liu et al. 2008).  This may explain why 
despite dampened mBMAL1 expression in the Cav-1 -/- cells mPer2 expression is as robust 
as in the WT cells (Fig 4.8b).  Other clock genes such as mCry1 were not analysed, so the 
expression pattern of mPer2 does not necessarily mean that the entire circadian complex 
was rhythmic, as Per2 is known to oscillate independent, of a functional clock (Kornmann 
et al. 2007).   
4.4.3 PI3 kinase inhibition 
 
In an attempt to try and identify an individual signalling pathway, downstream of the 
membrane based CAV-1 signalling, the effect of CORT on mPer2 induction after PI3 
kinase inhibition was addressed.  This pathway had been shown to mediate the Gc induced 
rapid signalling events resulting in PKB and GSK3β phosphorylation (Hafezi-Moghadam 
et al. 2002; Matthews et al. 2008), which has reported downstream effects on clock protein 
(Iitaka et al. 2005; Sahar et al. 2010).  The inhibition of PI3 kinase directly inhibits the 
phosphorylation of PKB (Wu et al. 2008) which therefore remains inactive, and results in 
an unphosphorylated, active GSK3β, which can phosphorylate PER2.  PI3 kinase 
inhibition had direct opposite effects depending on the length of its exposure and the 
presence of CORT did not affect this.  After 2h PI3 kinase inhibitor alone had no effect on 
mPer2 induction yet together with CORT resulted in a reduced mPer2 expression, 
although this was not shown to be significant (Fig 4.11).  This result complies with the 
hypothesis that CORT is working through CAV-1 and via the PI3 kinase pathway as the 
same net result is reached with Cav-1 -/- cells and PI3 kinase inhibition after 2h, that is 
mPer2 expression is reduced, however, firm conclusions cannot be drawn.  A greater 
response may be gained with other, more potent PI3 kinase inhibitors, such as wortmannin, 
which has an IC50 value of 7nM compared to 10µM of LY294002, used in this study (Wu 
et al. 2008).  However, after 4h incubation with CORT and the PI3 kinase inhibitor, the 
opposite effect was seen.  The PI3 kinase inhibitor alone significantly induced mPer2 over 
basal levels (Fig 4.11), which was augmented by the presence of CORT, yet did not 
significantly induce mPer2 over CORT alone.  This result is not coincident with the earlier 
model proposed for 2h induction, suggesting that either other pathways are causing the 
effect, or that the inhibitor is no longer working as the half life of LY294002 is 3.5h 
(Balciunaite and Kazlauskas 2001), which means at the 4h time point the inhibitor has 
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been exposed to the cell for 5h (added 1h before CORT) and well over a half life has 
passed. 
4.4.4 The proposed genomic and non-genomic model   
 
CORT has been shown to induce rapid non-genomic signalling events mediated through 
Cav-1 and PI3 kinase cascade (Matthews et al. 2008), which includes PKB 
phosphorylation and inactivation of GSK3β (Cross et al. 1995) (drawn up on diagram, Fig 
4.12).  In accordance with previous work, disruption of lipid raft (CAV-1 signalling) via 
methyl cyclodextrin or Cav-1 -/- resulted in the disruption to this described cascade, which 
affected down stream targets.  In the case of the work reported here, the target measured 
was the mPer2 transcript and the luciferase surrogate of the mPER2 protein.  Active 
GSK3β is known to have a significant role in the post-translational modification of clock 
proteins with its phosphorylation of PER2 (Iitaka et al. 2005), BMAL1 (Sahar et al. 2010), 
CRY1 (Harada et al. 2005) and REV-ERB α (Yin et al. 2006).  GSK3β exhibits a circadian 
phosphorylation rhythm, peaking in phase with PER2 expression (Iitaka et al. 2005), and 
as such this may implicate PKB as a rhythmic component directly upstream of GSK3β.  
Direct involvement of kinsase PKB, GSK3β, MAPKp42/44 was not shown in this thesis 
but it would be an interesting to hypothesise that they are involved in mediating the 
immediate response of PER2::luc to CORT administration similar to that shown by 
Matthews et al. (2008), and that the agonists 67a and 69a do not activate such pathways.  
Cav-1 -/- cells were also shown to have a direct, although transient, effect on mPer2 
transcription, which has not been shown, or even implicated, previously in the literature.  
As a result it is unknown how this is mediated, whether it is via constitutive inactivation of 
GSK3β, as shown by Matthews et al. (2008) or some other pathway.  
4.5 Conclusions 
 
It has been shown here, and in Chapter 3, that there is a rapid change in PER2::luc signal 
by CORT, but not with the GR agonist, which could point to a non-genomic mechanism 
via post-translational modifications such as phosphorylation.  However, this appears not to 
be the case as CORT had no effect on PER2::luc decay rates after protein synthesis 
inhibition.  The transcript responses to CORT and the novel agonist were identical.  These 
are novel findings and are currently under further investigation. 
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For the first time here, a direct link between the circadian clock, Per2 transcript and 
respective protein product, has been made with membrane bound caveolae (lipid raft) and 
CAV-1 based signalling.  Disruption of the lipid raft with methyl cyclodextrin can inhibit 
both phase and amplitude effects of CORT in the lung and Rat-1 cell models.  
Furthermore, knocking out Cav-1 in the cell has a transient effect on CORT induction of 
mPer2 transcription, as seen at 2h but not at 4h.  Also the GR agonist failed to induce a 
significant mPer2 induction at either time, leading to potential mechanistic differences.  
For the first time Cav-1 knock out cells were shown to have robust mPer2 rhythm but a 
dampened mBMAL1 rhythm, potentially leading to clock based perturbations. 
 
The CAV-1 mediated CORT induction on mPer2 was not shown to be mediated via the 
PI3 kinase signalling pathway, as small molecule inhibition of PI3 kinase did not replicate 
the effects seen with the Cav-1 knock out cells.  At 2h there was a small, yet insignificant, 
reduction but this turned into a small induction after 4h.  This suggests either that PI3 
kinase signalling is not involved or that the inhibitor is ineffective.   
4.6 Future directions 
 
• What is the extent of the CAV-1 influence on the circadian clock?  Will the clock 
continue to oscillate in Cav-1 -/- cells, and if so is it dampened or induced? 
 
• In Cav-1 -/- cells how is the cytoplasmic/nuclear distribution of PER2 affected, is 
turnover increased or is it stabilised, perhaps a parallel with the tau mouse/hamster? 
 
• To further investigate the signalling pathway through which CORT is signalling.  It 
is not through the PI3 kinase pathway, so it may well be acting through the MAPK 
pathway and therefore such inhibitors should be used.  Also this pathway should be 
tested in relation to the difference between CORT and the GR agonist as there is a 
clear difference in action, between the two compounds, at the protein level.  
 
• The activation of kinases such as GSK3β, Akt and MAPK p42/44 also needs to be 
investigated after CORT and agonist treatment of lung slices/primary cells to 
identify differences between CORT and agonist activation within the first few 
hours following treatment. 
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• Recent work by Wang et al. (2009) has provided an association between TLR4 and 
CAV-1, where the presence of CAV-1 reduces the LPS induction of IL-6 and 
TNFa, in macrophages.  Does this association contribute to the CORT induced 
inflammatory suppression?  What would happen in Cav-1 -/- cells, would the 
gating be lost?  Does this CAV-1 association have any part to play in the increased 
expression in Rev-erbα knock out cells? 
 
• What effect does the loss of Cav-1 have on the whole animal circadian phenotype 
and what would the response to LPS i.p. challenge be?  Increased mortality? 
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5.1 Introduction 
The innate (or non-specific) immune system is the organism’s initial defence against 
invading pathogens, chemical or physical attack where a rapid response is needed to 
prevent further widespread damage to the body and to initiate the repair process.  
Inflammation, a by-product of innate immunity, is characterised by swelling, heat, redness 
and pain around the compromised area followed by a gradual loss of function within the 
affected organ (Pickup 2004).  Innate immunity involves several cell types but most 
important are those derived from the mononuclear phagocyte lineage, such as macrophages 
(Hansson et al. 2002).  Macrophages have membrane receptors, such as TLRs, that 
recognise invading pathogens and respond by triggering signalling cascades that activate, 
amongst others, NF-κB and MAPK pathways (Guha and Mackman 2001), leading to the 
production of many cytokines (IL-6 and TNF α), chemokines (IL-8 and CCL2/MCP1) and 
transcription factors (i.e. p50 and c-Rel) (Guha and Mackman 2001). 
 
Several elements of the innate immune response are thought to be under endogenous 
circadian control, even in the absence of pathogen attack, including serum levels of 
cytokines and chemokines (Cutolo et al. 2003; Guan et al. 2005) but also lymphocyte 
proliferation (T and B cells), part of the adaptive immune response (Hiemke et al. 1995).  
Isolated macrophages, in mice and man, have been shown to express all the core clock 
genes and oscillate with a robust rhythm (Guan et al. 2005; Hayashi et al. 2007; Keller et 
al. 2009) as well as other major tissues of the immune system, such as the spleen and 
lymph nodes (Keller et al. 2009). 
 
The majority of studies in this field have looked in-vivo and in-vitro at responses to LPS 
challenge.  LPS is a component of the gram negative bacterial cell wall which activates 
TLR4, which then induces a potent immune, and therefore, inflammatory response.  LPS 
can induce rhythmic secretion of both IL-6 and TNF-α which is independent of systemic 
cues, like glucocorticoids, suggesting that secretion is under endogenous circadian control 
(Keller et al. 2009).  Furthermore, direct links have been made between individual clock 
genes and cytokine production.  Knock down of BMAL1 inhibited CCL2/MCP1 and NFκB 
production at the transcript level, whereas CLOCK/BMAL1 expression vectors induced its 
expression, albeit weakly (Hayashi et al. 2007).  PER2 has also been shown to regulate 
IFN-γ and IL-1β after LPS administration.  Both are down regulated in Per2 deficient mice 
(Liu et al. 2006b), which has the effect of increasing LPS induced mortality, suggesting 
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that PER2 has immune stimulatory properties. REV-ERBα has also been shown to be 
involved in the secretion of MCP-1 and TNF-α, in an LXRα dependent manner (a 
transcription factor involved in Rev-erbα transcript induction) (Fontaine et al. 2008).  
Interestingly LPS can also induce a circadian phase delay, by approximately 43 min, if 
administered in the early part of the subjective night (CT15) (Marpegan et al. 2005), which 
is not augmented by a simultaneous light pulse.  Individual clock gene, such as Per1 
transcription can be transiently induced after LPS challenge, in specific brain regions, like 
the PVN (Takahashi et al. 2001), which is a region that releases CRF in response to stress 
(section 1.6).  This acute induction, however, does not occur in the SCN or periphery, as 
seen in the liver, although other reports show that transient suppression in the SCN does 
occur after LPS challenge (Okada et al. 2008).  This shows a direct regulation of the 
circadian clock by LPS and that the clock has an important role in cytokine synthesis and 
secretion. 
 
A number of inflammatory diseases, such as asthma, (Martin et al. 1991) and rheumatoid 
arthritis (Cutolo et al. 2008), are known to have a circadian component to their pathology 
symptoms with the hypothalamic-pituitary-adrenal axis and cortisol being implicated in the 
circadian phenotypes of their respective symptoms.  Rheumatoid arthritis is generally 
worse in the morning (Cutolo et al. 2008) and nocturnal asthma exacerbations are 
associated with the early morning nadir of cortisol (Fujitaka et al. 2000).  These 
observations connect the core circadian clock with the inflammatory response in serious, 
often debilitating, disease states.  
 
Glucocorticoids are potent anti-inflammatory drugs and are often used in the treatment of 
inflammatory diseases (Barnes 1998).  These steroids inhibit the production of pro-
inflammatory cytokines (such as TNFα, and IL-6) (Wang et al. 2008), to reduce the side 
effects of inflammation and to ultimately prevent shock and even death.  Glucocorticoids 
are also potent regulators of the circadian clock (Chapter 3 and Balsalobre et al, (2000)), 
suggesting potential circadian effects on the suppression of the inflammatory response. 
 
5.2 Aims 
• To investigate the circadian variation of cytokine and chemokine secretion after 
LPS challenge (the gated response) in both the whole animal and isolated peritoneal 
exudate cells (PECs). 
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• To characterise the effects of timed administration of Gc on the suppression of the 
inflammatory response. 
 
• To identify a mechanism by which the gated response occurred, using a Rev-erbα -
/- mice mouse line. 
 
• To address the effect of LPS on clock gene transcription, using both PER2::luc lung 
slices and individual tissues from WT and Rev-erbα -/- mice. 
5.3 Results 
5.3.1 LPS dosing effects on serum cytokine levels  
 
Prior to any large scale in vivo experiments, using LPS, a suitable dose had to established 
in order to produce cytokine secretion that was well below reported doses at which 
mortality occurs, within the detectable range and at a non-saturating dose.  Mice were 
injected i.p. with saline control, 1mg/kg or 10mg/kg LPS for 4h before sacrifice and serum 
cytokine quantification.  IL-6, TNF-α, CXCL1/KC and CCL2/MCP1 were all assayed (Fig 
5.1) and all, except CXCL1/KC (due to high variation), showed a significant release in 
response to 1mg/kg LPS with a much higher release to 10mg/kg, which were almost above 
detectable levels.  A 1mg/kg dose of LPS produced IL-6, CCL2/MCP1 and TNF-α 
expression that was within a previously reported range (Bhattacharyya et al. 2007; 
Renckens et al. 2006), with CXCL1/KC expression being higher.  The mice showed no 
obvious behavioural response to the 1mg/kg dose, whereas with the 10mg/kg does, animals 
were immobile, possibly due to a high body temperature although temperature analysis 
was not undertaken, and a fever like response.  On this basis 1mg/kg was chosen as an 
effective does to use for future studies as the cytokine expression at 1mg/kg lies well 
within the dose response curve (Fig 5.1). 
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Figure 5.1:  Dose dependent release of inflammatory mediators after LPS challenge:  
Saline, 1mg/kg or 10mg/kg LPS was injected i.p. 4h before sacrifice and quantification of 
serum expression of IL-6 (A), CXCL1/KC (B), TNFα (C) and CCL2/MCP1 (D).  The 
serum concentration is measured in pg/ml.  Statistical analysis is by One-Way ANOVA (in 
all graphs P<0.0118) with a Bonferroni post-hoc analysis.  Error bars are SEM.  With 
regard (A) and (B):  (a) versus (b) P< 0.05, (a) versus (c) and (b) versus (c) P< 0.01.  With 
regard (C):  (d) versus (e) P< 0.05 and (d) versus (f) and (e) versus (f) P<0.001.  With 
regard (D):  (g) versus (h), (g) versus (i) and (h) versus (i) P<0.05.  
5.3.2 Gated inflammatory response  
5.3.2.1 Testing the gated response in WT mice 
 
Animal treatments: 6-8 week old male mice were entrained to a 12h light: 12h dark cycle 
(lights on 0800: lights off 2000) for 10 days and then released into constant darkness for 
24h prior to challenge.  Saline or 1mg/kg LPS was administered, at either subjective CT0 
or CT12 (section 2.2.1).  Animals were killed by decapitation 4h post challenge, when 
blood and liver samples were taken.   A panel of 23 inflammatory mediators (cytokines and 
chemokines) were assayed for each condition using the BioPlex assay system (section 
2.5.4).  Of the 23 inflammatory mediators screened, 8 did not respond to the LPS 
challenge; and 12 mediators increased after LPS challenge but with an equivalent response 
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at both times, such as TNFα and G-CSF (Fig 5.2a and b).  Interestingly, only 3 of the 23 
mediators were induced by LPS with a time of day, gated, response, (Fig 5.2c, d and e).  In 
contrast, none of the mediators showed a temporal difference in response to the saline only 
control, such that there was no endogenous, unstimulated expressed gated response, (see 
table 5.1 for a full breakdown of the results). 
Chemokine/Cytokine 
CT 0  
(Saline - LPS 
difference) 
CT 12 
(Saline-LPS 
difference) 
CT 0 LPS- 
CT12 LPS 
difference 
CT0 Saline-CT 
12 saline 
IL-1 a *** **   NO 
IL-1 b *** ***   NO 
IL- 2  **     NO 
IL- 3       NO 
IL- 4       NO 
IL- 5       NO 
IL- 6 * *** ** NO 
IL- 9       NO 
IL- 10 *** **   NO 
IL- 12 p40 *** *** * NO 
IL- 12 p70       NO 
IL- 13       NO 
IL- 17       NO 
Eotaxin ** ***   NO 
G-CSF * **   NO 
GM-CSF       NO 
IFN-g *     NO 
CXCL1/KC *** ***   NO 
CCL2/MCP1 *** ***   NO 
MIP1 alpha ** *   NO 
MIP1 beta *** ***   NO 
CCL5/RANTES *** *** * NO 
TNFα *** ***   NO 
Table 5.1:  Serum release of 23 inflammatory mediators 4h after LPS challenge:  A 
panel of 23 inflammatory mediators were screened in mouse serum 4h after i.p. 1mg/kg 
LPS challenge.  The table shows if there was an LPS induced increase in release after 
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challenge at either projected ZT0 or ZT12, relative to the saline control.  The table also 
shows which mediators showed a time of day, gated, response to LPS (bold).  Statistical 
analysis was by Two-way ANOVA with a Bonferroni post-hoc analysis, * P<0.05, ** 
P<0.01, *** P<0.001, n>7 for each condition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2:  Timed LPS challenge on inflammatory mediator release in WT mouse 
serum:  WT mice were injected with 1mg/kg LPS i.p. for 4h prior to serum quantification 
of inflammatory mediators.  TNFα (A) and G-CSF (B) are shown here with no difference 
between the LPS challenge (non-responders).  IL-6 (C), CCL5/RANTES (D) and IL-12 
p40 (E) all showed a time of day response (responders) to 1mg/kg LPS challenge given at 
CT0 and CT12.  Dots represent individual mice, n=7-9.  Statistical analysis is by Two-way 
ANOVA (in all cases P<0.0001 for treatment interaction and in A: P=0.119 in B: P=0.41, 
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in C: P=0.020, in D: P=0.046 and in E: P=0.065 for time interaction) with a Bonferroni 
post-hoc analysis; * P<0.05, ** P<0.01. 
 
IL-6, CCL5/RANTES and IL-12 p40 showed gated responses to LPS challenge, with 
greater expression at ZT12, (Fig 5.2).  This differential expression conforms nicely with 
the peak expression of the Per2 rhythm (Fig 5.3).  The difference in mean cytokine 
secretion 4h after treatment between ZT0 and ZT12 treatment times is approximately 2-
fold with respect to IL-6 and 1.5-fold difference for CCL5/RANTES and IL-12 p40 (Fig 
5.2).   
5.3.2.2 LPS effect on clock gene transcript expression in WT liver 
 
In order confirm that the mice were entrained to the L:D cycle (lights on ZT0: lights off 
ZT12) qPCR validation of tissue was performed (mPer2, mBMAL1, mCry1 and mRev-erb 
α).  Furthermore, as LPS has been reported to alter clock gene expression, comparisons 
were made between the LPS and saline treated groups, (Okada et al. 2008), (Fig 5.3).  As 
expected each gene exhibited a significant time of day difference in saline controls with 
mPer2 having a 40- fold difference between CT0 and CT12 expression (mBMAL1 with a 
3.5-fold; mRev-erbα with a 3-fold and mCry1 with a 1.5-fold change).  There was 
differential expression between mPer2 and mBMAL1, which showed that they were in anti-
phase.  Furthermore, mCry1 was expressed in phase with mPer2 and mBMAL1 and mRev-
erbα were also in phase with each other and in anti-phase to mPer2/Cry1 (Fig 5.3). 
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Figure 5.3:  Clock gene transcript expression in the murine liver post LPS challenge:  
mPer2 (A), mBMAL1 (B), mCry1 (C) and mRev-erbα (D) transcript expression was 
quantified after saline or LPS challenge at ZT0 and ZT12 with the samples collected 4h 
later (ZT4 and ZT16).  Statistical analysis was by Two-way ANOVA (in A and B: 
P<0.0001 for time and treatment interaction, in C: P<0.0001 for time and P=0.79 for 
treatment interaction, in D: P<0.0047 for time and treatment interaction) with a Bonferroni 
post-hoc analysis.  With regard to (A): (a) versus (b) and (b) versus (c) P< 0.001.  With 
regard to (B): (d) versus (e), (d) versus (f) and (e) versus (g) P< 0.001, (f) versus (g) P< 
0.05.  With regard to (C): (h) versus (i ) P<0.05, (h) versus (j) P< 0.001, (i) versus (j) not 
significant (n.s).  Error bars are SEM with n=6-8 mice per challenge.  
 
At CT0 LPS had no effect on mPer2 relative to the saline control, but at CT12 LPS 
significantly reduced mPer2 transcript expression by approximately 4-fold (Fig 5.3a), 
whereas mCry1 exhibited no significant suppression at either CT0 or CT12.  Rev-erbα 
expression was significantly suppressed at CT0 but not at CT12.  In summary, LPS 
significantly reduced the expression of known transcriptional repressors Per2 and Rev-
erbα at CT0 (Rev-erb α) and ZT12 (Per2) (Fig 5.3a and d).  Contrary to this, mBMAL1 was 
significantly induced after LPS at CT0 and CT12, (Fig 5.3b). 
5.3.2.3 The loss of gating with Rev-erb α -/- mice 
 
Previous studies have implicated REV-ERBα, an output from the clock, in regulating 
downstream physiology (Duez and Staels 2008).  The loss of Rev-erbα in mice does not 
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Chemokine/Cytokine WT ZT0 vs ZT12 KO ZT0 vs ZT12
IL 6 * ns
G-CSF * ns
KC ns ns
MIP1 alpha ns ns
MIP1 beta ns ns
RANTES ns ns
TNF alpha ** ns
prevent expression of normal circadian rhythmic behaviour (Preitner et al. 2002) and these 
observations led to the proposition that Rev-erbα was part of the stabilisation loop rather 
than an essential clock component.  Earlier studies, in the Chapter (Fig 5.2), showed 
significant circadian gating for a subset of cytokines (IL-6, CCL5/RANTES and IL-
12p40).  In order to test whether Rev-erbα was part of that gating mechanism the LPS 
response in WT and Rev-erbα -/- mice was compared at different time points. 
 
Using the same protocols as described above (section 5.3.2.1) mice were treated with LPS 
at two circadian time points and cytokines responses were measured.  The data is 
summarised in Fig 5.4 and table 5.2.  It can be seen that a time of day dependence of LPS 
response for IL-6, G-CSF and TNFα were lost in the Rev-erbα -/- mice.  For 
CCL5/RANTES the earlier comparison revealed a significant circadian component to its 
LPS response (Fig 5.2), augmented at ZT12.  But in this second study no significant 
responses were observed for WT or Rev-erbα-/- mice (Fig 5.4b). 
 
 
 
 
 
 
 
 
Table 5.2: Summary of inflammatory mediator release 4hr after LPS challenge in 
WT and Rev-erbα -/- mice:  A panel of 7 inflammatory mediators were screened in mouse 
serum 4hr after i.p. 1mg/kg LPS challenge in either Wild type (WT) or Rev-erbα -/- (KO) 
mice.  The table shows if there was gated response to LPS administration in either WT or 
KO mice.  Mediators in bold showed a gated response in the WT that was lost in the KO 
mice.  Representative data are shown in Fig 5.4.  Statistical analysis was by Two-way 
ANOVA with a Bonferroni post-hoc analysis, * P<0.05, ** P<0.01, non significant (n.s), 
n=6-8 for each genotype. 
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Figure 5.4: Loss of gating in Rev-erbα -/- mice:  WT or Rev-erb α -/- mice (KO) were 
treated with 1mg/kg LPS at CT0 or CT12 for 4hr prior to analysis.  IL-6 (A), 
CCL5/RANTES (B), G-CSF (C) and TNF-α (D) were all analysed.  Dots represent 
individual animals and statistical analysis was by Two-way ANOVA (A: P<0.078 for time 
and genotype interaction, in B: P=0.1 for genotype and P=0.42 for time interaction, in C: 
P=0.55 for genotype and P=0.036 for time interaction and in D: P=0.79 for genotype and 
P=0.099 for time interaction) with a Bonferroni post-hoc analysis; * P<0.05, ** P<0.01, 
not significant (n.s).  There was not significant difference between genotype, n=6-8. 
5.3.2.4 LPS affect on clock gene transcript expression in Rev-erbα -/- peripheral 
tissues. 
 
As in section 5.3.2.2, samples of peripheral tissues were taken, along with the serum, for 
clock gene analysis.  Previously only liver samples were taken but this time both liver and 
lung samples were removed.  The lung was to act as a control tissue to ensure that the 
results obtained with the liver were a reflection of the periphery and not individual to the 
liver.  The two clock genes mPer2 and mCry1 were analysed in both WT and Rev-erbα -/- 
liver and lung (Fig 5.5).  In general both mPer2 and mCry1 were expressed in a similar 
pattern to the previous study (Fig 5.3) in both liver and lung.  The amplitude of response 
was less in Rev-erbα -/- lung compared to the WT for mPer2 (5-fold versus 3-fold) and 
mCry1 (5-fold versus 2-fold), and in the liver, mCry1 (5-fold versus 2-fold) and mPer2 (7-
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fold versus 4-fold) (Fig 5.5).  The LPS also suppressed mPer2 and mCry1 mRNA 
expression, in both tissues, at CT12.  Together these data (Fig 5.5) showed that the 
previous effects seen with the WT mice (Fig 5.3) were reproducible, in both the WT litter 
mates and the Rev-erbα -/- mice and that data obtained with the KO mice would be an 
accurate biological representation.   
 
Clock gene expression in the Rev-erbα -/- mice showed a very similar response to LPS in 
both liver and lung, to their WT counterparts i.e. suppression (Fig 5.5).  Both mCry1 and 
mPer2 expression was maintained in the Rev-erbα -/- tissue with a significant induction at 
ZT12, with regard to the saline control, yet overall expression was reduced.  LPS 
significantly suppressed mPer2 expression at ZT12 in both liver and lung of the Rev-erbα -
/- genotype.  However, LPS only significantly suppressed mCry1 expression in the Rev-
erbα -/- liver, but not the lung, (Fig 5.5).   
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Figure 5.5:  Clock gene transcript expression in WT litter mates and Rev-erb α -/- 
mice after LPS challenge:  Transcript induction is shown mPer2 and mCry1 for liver (A-
D) and lung (E-H) with WT responses (red) and mRev-erbα -/- responses (blue).  Induction 
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is fold change over the lowest value (CT0 saline (sal) or LPS).  Statistical analysis is by 
two-way ANOVA (with regard to Per2 P<0.004 for time and treatment interaction and for 
Cry1 P<0.0036 for time and for treatment P=0.0059 (C), P=0.0023 (D), P=0.15 (G), 
P=0.82 (H)) with a Bonferroni post-hoc analysis.  With regard to (A):  (1) versus (2) P< 
0.001.  With regard to (B): (3) versus (4) P< 0.01, (4) versus (5) P< 0.001, (3) versus (5) 
n.s.  With regard to (C): (6) versus (7) P< 0.001, (6) versus (8) P<0.001, (7) versus (8) P< 
0.01.  With regard to (D): (9) versus (10) P<0.05, (10) versus (11) P< 0.05, (9) versus (11) 
not significant.  With regard to (E):  (a) versus (b) P< 0.05, (a) versus (c) P< 0.001, (b) 
versus (d) P< 0.001, (c) versus (d) P< 0.001.  With regard to (F):  (f) versus (g) P< 0.001, 
(e) versus (f) P< 0.001, (e) versus (g) not significant.  With regard to (G):  (h) versus (i) P< 
0.001, (h) versus (j) P< 0.01, (i) versus (j) not significant.  With regard to (H): (k) versus 
(l) P< 0.01.  
5.3.3 LPS effects on the phase and period of the pulmonary oscillator 
 
The action of LPS on both the phase and period of the lung circadian clock was 
investigated, using the PER2::luc pulmonary model. Following LPS administration at the 
peak of the PER2::luc rhythm the phase of the subsequent PER2 rhythm was delayed, 
relative to vehicle controls, by 3.12 ± 0.75h (n=3, student t-test P< 0.037).  This treatment 
had no effect on the subsequent period of the oscillation (Fig 5.6).  These data showed that 
LPS has and acute re-setting effect on the pulmonary oscillator but not on the subsequent 
period.  Furthermore, LPS does not induce an amplitude response (acute or chronic), unlike 
CORT (Chapter 3), just a phase re-setting response.  
 
 
Figure 5.6: Phase and period effects of LPS on the lung:  A representative oscillation 
(A) shows LPS (red) and HBSS (black) with the time of treatment (full arrow).  The 
subsequent phase delay is shown relative to the HBSS control (dashed arrow).  The 
respective periods after treatment are shown (B).  Error bars are SEM of n=3. 
 
5.3.4 The response of peritoneal exudate cells (PECs) to LPS challenge 
5.3.4.1 WT PECs and LPS 
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PECs were extracted from the peritoneal cavity of WT mice (section 2.2.6) and cultured 
for experimental use (an example of the cells extracted from the exudate mix is shown in 
appendix I).  As stated in section 2.2.6, some extracted cells were used as a temporal 
reference for the phase of the oscillation, as they contained the PER2::luc transgene.  These 
reporter cells meant that an average period of the PECs oscillation could be derived (Fig 
5.7), which was 23.24 ± 0.7h (n=5).  This period is slightly shorter than that stated in Fig 
5.6, but the cells used here were isolated PECs not lung slices.  The representative 
oscillation (Fig 5.7) also depicts the time at which the experimental cells were treated with 
LPS at either the peak or trough of the PER2::luc oscillation, assuming that both the 
reporter and experimental cells maintained constant phase with one another.  Cells were 
treated with LPS and 4h later the serum was collected for cytokine analysis.  Total protein 
was also extracted from the adherent cells and the concentration quantified.  Although the 
protein concentrations showed a large degree of variation, there was no statistical variation 
between treatment groups (Fig 5.7b), perhaps due to the sensitivity of the assay. 
 
 
Figure 5.7:  Representative PEC oscillation and protein concentration from WT 
PER2::luc mouse:  PECs were cultured from the WT PER2::luc mouse and a 
representative oscillation is shown (A), with the post treatment protein concentrations 
shown in (B).  The times of challenge were either (A); peak 1 (P1), trough 1 (T1), peak 2 
(P2) or trough 2 (T2).  The average period was based on n=3 biological repeats using a 
pool of 5 male mice and the protein was based on n=3 of 1 experiment using a pool of 5 
male mice.  Statistical analysis was by One-Way ANOVA (P=0.48) but no significance 
was found.  Error bars are SEM. 
 
Initially PECs were treated with either LPS or vehicle at the first two peaks and troughs, 
and the resulting media collected 4h later.  This was in order characterise any prolonged 
temporal effects on the release of inflammatory mediators, as potentially release may alter 
after 48h (compared to 24h) as the amplitude of the oscillation changed.  The results 
showed (Fig 5.8) that challenging the cells at the first peak and trough after 
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synchronisation; that is 24h and 36h after the onset of the experiment (P1 Fig 5.7), was the 
more appropriate treatment time, as IL-6 showed a greater amplitude response between 
first peak and trough treatment, as against the second peak and trough treatment.  Also 
CCL2/MCP1 showed much less variation in expression when treated at the first peak and 
trough, (Fig 5.8).  LPS treatment induced IL-6, CCL2/MCP1 and CXCL1/KC when 
administered at the peak of the PER2::luc rhythm, but less induction was observed when 
administered at the trough, (Fig 5.8).  Similarly, both IL-6 and CCL2/MCP1 showed a 
significant gated response to LPS when challenged at either the first peak or trough, but 
significance was lost with CCL2/MCP1 when challenged at the second peak or trough.  IL-
6 expression was also dampened when challenged at the second peak and trough (Fig 
5.8a).  CXCL1/KC and TNFα showed no gated response when treated at the first peak and 
trough but TNFα was gated when treated at the second peak and trough.  Therefore, further 
challenges were carried out at either the first peak or trough of the PER2::luc rhythm.  
Saline controls exhibited very low to non-detectable cytokine release but these values have 
been subtracted to provide normalisation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8:  Expression of inflammatory mediators after LPS challenge at the peak 
and trough of the PER2::luc rhythm:  PECs were treated at subsequent peak (P) and 
trough (T) of the PER2::luc rhythm with LPS and expression of IL-6 (A), CCL2/MCP1 (B) 
and CXCL1/KC (C) were measured.  Results were normalised to peak expression.  
Statistical analysis was by One-way ANOVA (in A and D: P<0.0014, in B: P=0.012 and in 
C: P=0.059) with a Bonferroni post-hoc analysis, (a) versus (b) P<0.05, (a) versus (c) P< 
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0.01, (c) versus (d) P< 0.05, (a) versus (d) n.s.  Error bars are SEM and are taken from 3 
internal replicates from pooled cells from 5 male mice. 
 
5.3.4.2 WT PECs: LPS and CORT 
 
In order to test Gc mediated suppression of cytokine response, PECs were treated with LPS 
or LPS plus CORT (co-administered), at both the peak and trough of the PER2::luc 
rhythm.  A representative PER2::luc oscillation is shown with a representative protein 
concentration from LPS and LPS plus CORT treated PECs (Fig 5.9), with no statistical 
difference between treatment groups.  4h after treatment the medium was analysed for 
cytokine release.  In confirmation of earlier studies (Fig 5.8) LPS administration at the 
trough of the PER2::luc rhythm resulted in significantly reduced expression of all 4 
cytokines (CXCL1/KC, IL-6, TNFα and CCL2/MCP1) compared to the peak 
administration.  Co-administration of CORT with LPS reduced cytokine responses, when 
administered at both peak and trough of the PER2::luc cycle, for all 4 cytokines measured 
(Fig 5.10).  The strongest suppression, by CORT, was seen for CXCL1/KC, TNFα and IL-
6 with greater than 50% suppression.  However, there was no difference in the magnitude 
of suppression when CORT was co-administered at either the peak or trough.  CORT 
significantly suppressed CCL2/MCP1 when co-administered at the peak but not when 
administered at the trough (Fig 5.10 b). 
 
 
Figure 5.9:  Representative PEC oscillation and protein expression from the WT 
PER2::luc mouse:  PECs were cultured from the WT PER2::luc mouse and a 
representative oscillation is shown (A), with the post treatment protein concentrations 
shown in (B).  The time of challenge is shown in (A); peak (P, CT12), trough (T, CT0).  
The oscillation was based on a pool of 5 male mice and the protein was based on n=3 from 
within that pool.  Statistical analysis was by One-Way ANOVA (P=0.17) but no 
significance was observed.  Error bars are SEM. 
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Figure 5.10:  CORT suppression of LPS induced inflammatory mediators after PEC 
challenge at the peak and trough of the PER2::luc rhythm:  PECs were treated at the 
first peak and trough (Fig 5.9) with LPS only, or combined with cort, and expression of IL-
6 (A), CCL2/MCP1 (B) CXCL1/KC (C) and TNFα (D) were measured.  Results were 
normalised to the LPS peak expression.  Statistical analysis was by One-way ANOVA 
(P<0.0001 for each cytokine) with a Bonferroni post-hoc analysis.  Error bars are SEM of 
n=3 (taken from 3 separate experiments using cells from a pool of 5 male mice).  With 
regard to (A): (a) versus (b), (a) versus (c) and (c) versus (d) P< 0.001, (b) versus (d) not 
significant.  With regard to (B):  (e) versus (g) P< 0.01, (e) versus (f) P< 0.05, (f) versus 
(g) not significant.  With regard to (C):  (h) versus (i) and (j) versus (i) P< 0.001, (h) versus 
(j) P< 0.01.  With regard to (D):  (k) versus (l), (k) versus (m) and (m) (l) P< 0.001.   
5.3.5 Responses to LPS in Rev-erb α -/- PECs  
 
PECs from the PER2::luc mouse were also cultured in parallel to the Rev-erbα WT and -/- 
mice to act as a reporter for the phase of the PER2 oscillation, as neither the Rev-erbα WT 
or -/- mice carried the luciferase reporter.  Rev-erbα -/- mice have a reported free-running 
circadian period of 23.28h ± 0.45 (Preitner et al. 2002)  and mPER2::luc mice have a 
period of 23.69h ± 0.07 (Yoo et al. 2004) so using the PER2::luc reporter as a circadian 
reference is justified.  WT or Rev-erbα -/- PECs were treated with vehicle or LPS at the 
peak or trough of the PER2::luc rhythm and 4h later the medium was removed and 
analysed for cytokine release.  As previously described, IL-6, CCL2/MCP1, CXCL1/KC 
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and TNFα were each quantified after LPS treatment in WT or -/- PECs.  IL-6, 
CCL2/MCP1 and TNFα each showed a significant gated response, with reduced 
expression at the trough, relative to the peak, in WT cells (Fig 5.11).  The amplitude of 
response seen in the WT peak to trough comparison was greatly diminished in the Rev-erb 
α -/- mice with CCL2/MCP1, IL-6 and TNFα, but with respect to IL-6 and TNFα 
significant differences were still observed (Fig 5.11).  CXCL1/KC showed no significant 
difference in peak to trough expression in either genotype but a significant increase in 
expression was observed between WT and Rev-erbα -/- cells (Fig 5.11c).  Similarly, IL-6 
expression in the Rev-erbα -/- cells was significantly increased yet TNFα expression was 
significantly diminished (Fig 5.11a and d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11:  Expression of inflammatory mediators after LPS challenge in WT and 
Rev-erb α -/- PECs at the peak and trough of the PER2::luc rhythm:  IL-6 (A), 
CCL2/MCP1 (B), CXCL1/KC (C) and TNFα (D) were treated with LPS at the peak and 
trough of the PER2::luc rhythm in either Rev-erb α -/- or WT litter mates PECs.  
Expression was normalised to the WT peak values.  Statistical analysis was by Two-way 
ANOVA (in A: P<0.0001 for time and genotype, in B: P=0.66 for genotype and 0.013 for 
time, in C: P=0.012 for genotype and 0.067 for time and in D: P<0.0001) with a 
Bonferroni correction.   Error bars are standard deviation of an n=2 (TNFα was n=1) 
experiment each consisting of pooled cells from 3 mice of each genotype.   With regard to 
(A):  (a) versus (b), (a) versus (c), (c) versus (d) and (b) versus (d) P< 0.01.  With regard to 
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(B):  (e) versus (f) P< 0.01, (e) versus (g) and (f) versus (g) are not significant.  With 
regard to (C):  (h) versus (i) P< 0.05.  With regard to (D):  (j) versus (k) and (j) versus (l) 
P< 0.001, (l) versus (m) P< 0.05, (k) versus (m) not significant. 
5.4 Discussion 
5.4.1 The LPS induced gated response in WT (C57/BL6) mice and PECs 
 
Although the innate immune system has an immediate response to an external challenge, 
this work demonstrates that only a small number of inflammatory mediators are gated by 
the circadian clock, the response to LPS (table 5.1).  
 
In each experimental protocol in this chapter, be it in-vivo or in-vitro, IL-6 showed a gated 
response to LPS challenge, confirming the observations previously reported, (Keller et al. 
2009).  However, the circadian element to IL-6 protein secretion has been well 
documented, with expression highest during times of sleep compared to times of 
wakefulness, in humans (Redwine et al. 2000; Vgontzas et al. 2002) but IL-6 has also been 
shown to oscillate in various rat tissues, such as the pituitary (Seres et al. 2004) 
hypothalamus and periphery (Guan et al. 2005).  The IL-6 transcript itself has also been 
shown to be under circadian control with 3 conserved canonical E-boxes in its promoter, 
which have been shown to oscillate, albeit weakly, in luciferase reporter studies (PhD 
thesis of Andrew McMaster, 2007, University of Manchester) and at the endogenous 
transcript level (Hayashi et al. 2007).  Therefore, IL-6 was used more as an internal control 
in theses studies, as its circadian regulation has been well characterised.   
 
Like IL-6, TNFα has been shown to freely oscillate at both the transcript (Hayashi et al. 
2007) and protein level (Arjona and Sarkar 2005), even in the absence of any immune 
challenge and has two conserved E-boxes within its promoter (PhD thesis of Andrew 
McMaster, 2007).  Upon immune challenge with LPS, TNFα still showed a robust 
oscillation at the protein level, like that of IL-6 (Keller et al. 2009).  However, in the 
studies shown here the results were different.  In the WT mouse in-vivo LPS challenge 
TNF-α did not show a gated response (Fig 5.2), yet in the WT litter mates to the Rev-erbα -
/- mice a robust gated response was seen (Fig 5.4), likewise in the in-vitro PEC studies 
there was a peak/trough gated response to LPS (Fig 5.10 and 5.11).  Interestingly, in the 
studies presented here (Fig 5.2 and 5.4) that there is no unstimulated rhythm (saline 
controls) in any of the cytokines in the WT mice used (table 5.1); this is of note 
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considering that IL-6 is known to by rhythmic in plasma in the naive animal (Guan et al., 
2005).  In this series of experiments (table 5.1), saline controls were at undetectable levels 
i.e. below 5pg/ml (IL-6, RANTES and G-CSF) via BioPlex analysis.  This is perhaps due 
to the 1 in 4 dilution factor used in order to ensure that the LPS stimulated samples were 
within the detectable range of the assay.  Guan et al., 2005 reported serum samples of IL-6 
in the upper range of 40pg/ml so if my samples were diluted 1 in 4 this would take the 
working concentration to 2.5pg/ml and below detectable levels.  If there was sufficient 
time and funding available assaying the neat saline controls would no doubt show 
differential expression.  Together these data suggest that TNFα, like IL-6, is under 
circadian regulation yet the experimental model used to characterise these effects needs to 
be considered carefully, as the underlying circadian regulation is not as robust as IL-6. 
 
Interestingly two other inflammatory mediators, CCL5/RANTES and IL-12p40 (Fig 5.2) 
showed a time of day, gated, response to LPS challenge, yet as with IL-6 and TNFα a 
gated response was not seen under baseline conditions.  CCL5/RANTES has not been 
shown previously to be under circadian control, although it is documented that both its 
mRNA and protein expression are increased in response to TNFα (itself circadian, Keller 
(2010)) and melatonin (Luo et al. 2004).  However, TNFα did not show a gated response in 
the study with WT mice (Fig 5.2) nor do the mice used in the study (C57/BL6) express 
melatonin, so there must be yet another source of the gated response, perhaps direct E-box 
regulation.  A search of 3kbp 5’ to the transcriptional start site of the CCL5/RANTES 
promoter revealed no canonical, or non-canonical, E-box elements at described by Ueda 
(2005), yet 10 CACATG motifs were present, which fits the generic CANNTG (where N is 
any base) E-box motif (appendix G), and therefore, may contribute to the gated response to 
LPS.  CCL5/RANTES showed a mixed gated response dependent on the model and 
conditions that were investigated.  CCL5/RANTES was gated in the WT mouse LPS study 
(Fig 5.2) but not in the WT litter mates to the Rev-erbα -/- mice (Fig 5.4), and there was an 
equal discordance of results with the isolated PECs (Appendix H). A gated response was 
shown in the WT and Rev-erbα -/- cells, with an approximate 50% reduced expression with 
treatment at the trough, but in the WT LPS with and without CORT a gated response was 
not shown between peak and trough LPS and the CORT showed no significant suppression 
of release.  This variability in the gated response between the two WT strains (C57/BL6 
and WT litter mates to the Rev-erbα -/- mice) could be due to sex differences in the 
experimental set up used.  For the WT experiments (Figs 5.2, 5.8 and table 5.1) male mice 
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were exclusively used, whereas in the WT versus Rev-erbα -/- experiments (Fig 5.4, 5.11 
and table 5.2) mixed sex mice were used due to breeding and number constraints of the 
Rev-erbα -/- mice, and it was thought better to maintain matched sex experiments for the 
WT versus Rev-erbα -/- studies rather than unequal matching. 
 
The response to LPS in the WT PECs was very similar to the whole animal response where 
the greater expression coincided with the peak of the PER2::luc oscillation (Fig 5.7 and 
5.9).  The mediators involved were a little different though.  IL-6, as expected, showed a 
robust gated response but so did JE/MCP1 and TNFα, previously not seen in the whole 
animal study (table 5.1), yet Keller et al. (2009) has shown TNFα to oscillate in the 
response to LPS in ex-vivo macrophages.  Furthermore, CCL5/RANTES was shown to be 
gated (Fig 5.2) at the whole animal level but conflicting results were seen at the cellular 
level, (appendix H), as previously described.  Also mediators such as CXCL1/KC, even 
though they were expressed in response to LPS in both whole animal and at the cellular 
level, did not produce a gated response in either model.  Together these data suggested that 
the response seen may well be a product of the model system used and that there is not just 
a global systemic inflammatory response, more individual to a particular area or organ. 
5.4.2 Loss of gated response in the Rev-erbα -/- mice and PECs 
 
LPS has been previously shown to modulate a bi-phasic response of Rev-erbβ expression 
in bone marrow derived macrophages, with an immediate decrease in expression at 4-8h 
followed by an increase at 12-16h (Barish et al. 2005).  Furthermore, the over expression 
of Rev-erbα in vascular smooth muscle cells induced NF-κB transactivation and an 
increase in the pro-inflammatory response, with factors such as IL-6 (Migita et al. 2004).  
Furthermore, the reverse occurs with the over expression of RORα in human cells, in this 
instance IL-6 and IL-8 (human homologue of CXCL1/KC) expression were suppressed 
(Delerive et al. 2001).  Together these data suggested an important role of REV-ERB and 
ROR in mediating the magnitude of the inflammatory response.  The data shown in Fig 5.4 
revealed, for the first time, that the loss of Rev-erbα can result in the loss of the gated 
response to LPS and that basal expression is increased relative to the WT counterparts.  
These data are in contrast to the work of Migita et al. (2004) as the authors saw an increase 
in mediator expression after Rev-erbα over expression, whereas in Fig 5.4, a loss of Rev-
erb α resulted in an increased expression, yet the reduced TNFα expression in the Rev-erbα 
-/- cells does correlate with the Migita et al. (2004) study (Fig 5.11).  Furthermore, the 
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work here takes the analysis much further and includes the loss of a gated response with G-
CSF and TNFα in the Rev-erbα -/- genotype, relative to the WT mice.  However, other 
mediators such as CCL5/RANTES, previously shown to be gated, in WT mice, in response 
to LPS challenge (Fig 5.2) did not show a similar gated response in the WT counterparts to 
the Rev-erbα -/- mice, although a similar trend was still apparent and expression was 
increased in the Rev-erbα -/- genotype.  Little work has been carried out into the role of the 
REV-ERBs, and RORs, in the inflammatory response particularly with respect to the 
gating effects, but Rev-erbα -/- mice do show a shorter activity cycle that their WT 
counterparts in both DD and LD conditions, approximately by 30 min (Preitner et al. 
2002).  However, inflammatory mediators are not reported to have RORE sites in their 
promoters, although this does not rule out a direct effect at other locations of the genetic 
locus.  If this were the case, then this could account for the increased expression in the 
Rev-erbα -/- model, as the repressive effects of REV-ERB would have been lifted, in 
particular subjective day repression when Rev-erbα (Fig 5.3) expression peaks, followed 
by its protein product.   If there is no direct REV/ROR effect then this suggests that an 
intermediate protein may be involved, potentially plasminogen activator inhibitor 1 (PAI-
1), which has a circadian component to its transcript cycle, it is suppressed by REV-ERBα 
and has been shown to play a role in the inflammatory response (Wang et al. 2006).  
Inflammation has been associated with a strong rise in circulating PAI-1 levels, and PAI-1 
-/- mice show an increased expression of IFN-γ, IL-6, IL-12 p70, (incidentally, IL-12p70 
was not gated in this study nor did was it induced by LPS and IFN-γ only showed a weak 
induction at CT0, table 5.1) (Renckens et al. 2006).  Indeed, further work needs to be 
carried out before the contribution of PAI1 can be fully concluded. 
 
The in-vitro cellular (PECs) study presented similar findings to the in-vivo whole animal 
study, where the gated response was lost in the Rev-erbα -/- cells.  However, the mediators 
involved were slightly different.  In the whole animal study (Fig 5.4) both IL-6 and TNFα 
lost the gated response in the Rev-erbα -/- genotype, (G-CSF also but this was not 
replicated in the PECs study), yet in the PECs study (Fig 5.11) gating was lost with 
CCL2/MCP1 but not lost with either TNFα or IL-6, the amplitude of response was just 
diminished.  Furthermore, in whole animal study (Fig 5.4), the trend with IL-6 and TNFα 
expression in the Rev-erbα -/- mice was increased but with the cells, although IL-6 
expression did increase, TNFα expression significantly decreased.  Again this suggests 
differential regulation in the different model systems used.  The overall loss of the gated 
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response is perhaps largely due to the effects of Rev-erbα on core clock gene expression, at 
both transcript and protein level.  In the Rev-erbα -/- genotype both CLOCK and BMAL1 
are expressed at higher, constitutive levels than in the WT, no longer showing a circadian 
rhythm (Preitner et al. 2002).  This explains why the gated response is lost and why basal 
levels are higher, particularly in IL-6, however, fails to explain the loss of expression in the 
TNFα response in the PECs. 
5.4.3 CORT and its immunosuppressive activity 
 
Although Gcs have been known for many decades to suppress the inflammatory response 
(Berry and Smythe 1964; Spink and Anderson 1954), little characterisation on the 
circadian component to their action has been carried out.  It has been shown here (Fig 5.10) 
that, as predicted, CORT inhibited the pro-inflammatory effects of LPS but this action was 
not itself circadian gated.  Previous work by Yamamura et al. (2010) has shown that mouse 
TNF α serum protein levels were suppressed 2h after LPS/DEX co-administration i.p., but 
TNFα transcript was not.  However, a circadian component to its expression at either 
transcript or protein level was not investigated in their study nor were other inflammatory 
mediators characterised.  Furthermore, contrary to previous reports neither Per1 nor Per2 
transcription was induced by DEX, in the heart, over control levels nor could DEX 
counteract LPS suppression of either Per1 or Per2 (Yamamura et al. 2010), suggesting that 
LPS is much more potent in its effects on clock gene transcription than DEX is.  
Furthermore, the GR (which induces Per1 and Per2 transcription) is negatively regulated, 
by clock transcription factor, CLOCK, through the acetylation of lysine residues on its 
hinge region.  When the HAT containing CLOCK acetylates GR, it is no longer able to 
induce transcription (Nader et al. 2009).  This could explain a gated response to CORT 
treatment, however, this was not seen (Fig 5.10), suggesting that CORT acts equally 
irrespective of the time of day. 
5.4.4 LPS and clock gene transcription 
 
It has been shown here that 1mg/kg LPS can both suppress Per2, Cry1 and Rev-erbα and 
enhance BMAL1 clock gene transcription (Fig 5.4) in the WT mouse liver.  The 
suppression of Per2 compares well with previous studies with suppression in both mouse 
heart and liver 4-6h after 1mg/kg LPS challenge (Yamamura et al. 2010).  The data 
presented here (Fig 5.4) also aligns with previous reports that LPS suppresses Per2 in the 
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rat SCN (Okada et al. 2008), and the suppression of Per2, Cry1 and Rev-erbα in human 
blood leukocytes to 2ng/kg of LPS (Haimovich et al. 2010). However, the data regarding 
BMAL1 expression contradicts that shown by Haimovich B et al., (2010) in leukocytes, yet 
is in agreement with data from male horses in which a 0.045µg/kg of LPS was injected 
(Murphy et al. 2007); where BMAL1 transcript expression was increased 4h after LPS, 
although so was Per2 in this model system.  It is perhaps for the fist time here that 
differential expression has been documented with regard to LPS and it action on the core 
clock in the liver.  Although the direct effect of LPS on the clock gene transcription cannot 
be ruled out, mediated through transcription factors such as NF-κB, it seems unlikely as it 
would have to cause simultaneous up and down regulation.  Recent evidence suggested 
that the regulation is likely to be mediated through TNFα and the suppression of E-box 
mediated transcription (Cavadini et al. 2007).  In their work Cavadini et al. (2007) showed 
that TNFα, and IL-1β (both induced by LPS, table 5.1) could suppress transcription of 
Per1, 2 and Rev-erbα, in both liver and cell line studies (but this suppression could not be 
replicated by IL-6 or IFN α).  In this study Cry1 was not investigated.  The reason for Per2 
suppression appears to be protective, as Per2 KO mice are far more resistant to LPS-
induced death than WT counterparts (Liu et al. 2006b), suggested to be due to reduced 
IFN-γ and IL-10 and as such may provide evidence for PER2 regulation.  Cavadini et al. 
(2007) also showed that BMAL1 expression was not affected, in either cell line or whole 
mouse study, as it is not under direct E-box regulation.  However, this does not explain 
why BMAL1 was up regulated in this study, which leads back to a direct mechanism, 
perhaps through NF-κB but the specific promoter based elements have not yet been shown.  
Overall, this relationship between LPS, TNFα/IL-1β and clock gene suppression could 
have important implications in the development of effective chronotherapeutics. 
 
It was also shown here, for the first time, (Fig 5.5) that Per2 transcription was largely 
unaffected by the loss of Rev-erb α in both the liver and lung and expression in both tissues 
showed significant suppression after LPS challenge.  This, however, could be expected 
given that TNFα is the likely mechanism though LPS mediated suppression, and TNFα 
was still expressed in the Rev-erbα -/- mice (Fig 5.4) and that mPer2 itself is known to 
oscillate even in the absence of a functional clock (Kornmann et al. 2007), perhaps taking 
it cues from systemic signals, such as glucocorticoids.  Cry1 expression was very much the 
same as Per2, (Fig 5.5) with time dependent expression in both liver and lung but with a 
much dampened expression in the Rev-erbα -/- tissue and no LPS induced suppression in 
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the lung.  The dampened expression can, in part, be explained by the loss of the repressive 
effects of REV-ERBα resulting in constitutive BMAL1 expression at both transcript and 
protein level (Preitner et al. 2002).  This has been shown to maintain high level of Cry1 
transcript throughout the circadian day, in the liver, and thereby raising basal expression 
and reducing the magnitude of the amplitude change.  mPer2 expression does not change 
in the event of the loss of Rev-erbα (Preitner et al. 2002) and so explains why the 
amplitude of the response was largely unaffected in both WT and Rev-erbα -/- liver.  Data 
for the lung has not been determined but a similar mechanism of action is assumed as the 
results between the liver and lung were largely consistent for Per2 and Cry1.  Greater 
attenuation of the amplitude response was not seen, most likely due to the compensatory 
effects of Rev-erbβ, which has been shown to play a redundant role in the absence of Rev-
erbα (Liu et al. 2008). 
5.5 Conclusions 
 
LPS has been shown here to induce a gated inflammatory response in both inflammatory 
cells and in a whole animal model, (through i.p. administration and serum analysis).  IL-6 
was shown to be gated in both model systems yet other mediators such as TNFα and 
CCL5/RANTES showed differential regulation.  Likewise CXCL1/KC and CCL2/MCP1 
showed a gated response to LPS, alongside IL-6 and TNFα, in the PECs but were not gated 
in the whole mouse study.  The different observations with the two different models most 
likely come from the different cell types involved.  The PECs, although not 100% pure, are 
largely resident peritoneal macrophages and are therefore just one cell type, whereas in the 
in-vivo challenge all the organs of the mouse are being stimulated by LPS.  In this case 
resident macrophages from all cell types containing the TLR-4 receptor are being 
stimulated and are contributing to the observation, and as such contribute to the differential 
effects.  Furthermore, the gated response appears to be REV-ERBα mediated as the loss in 
REV-ERBα resulted in the loss (or attenuation IL-6 and TNFα PEC study) of the gated 
response where it was present in the WT. 
 
CORT significantly reduced the expression of the inflammatory mediators, although 
interestingly the reduction was equivalent at both phases of the circadian day (peak and 
trough), and although CORT is itself under circadian regulation, this is not transferred to 
the suppressive effects on the innate immune response. 
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LPS attenuated transcription of the core clock genes Per2 and Rev-erbα at their relative 
peak expression, which has been shown by Cavadini et al. (2007) to be TNFα mediated, 
but with an increase in BMAL1 transcription at both phases of treatment, which has 
currently no mechanistic answer to the observations.  The effects of LPS on Per2 and Cry1 
transcription were generally maintained in the absence of Rev-erbα although small 
differences were seen, Per2 still maintained a response to LPS, as in the WT, and Cry1 
expression was maintained in the WT and Rev-erbα -/- liver but some minor differences in 
the lung.  Ultimately these data lead to the conclusion that there is not a global response to 
immune challenge via LPS, and that the mediators and underlying genetic response vary 
slightly depending on the tissues and models that are used in the experimental design. 
5.6 Future directions 
 
• To further investigate the role of REV-ERBα on circadian gating, by using cell line 
studies with siRNA knock down of Rev-er β on its own and in conjunction with a 
Rev-erbα -/- genotype, to address and redundancy issues described by Liu et al. 
(2008). 
 
• To look at whether the phenotype seen in the Rev-erbα -/- genotype is a direct 
result of the loss of REV-ERBα or as a result of constitutive BMAL1 expression, 
due to the loss of REV-ERBα repression (Preitner 2002).  To address this siRNA 
knock down of BMAL1, and possibly over expression of REV-ERBα (as in 
Kornmann er al. (2007)), would be used in LPS stimulated macrophages. 
 
• A further validation of the mechanism behind Per2 suppression and BMAL1 
induction after LPS challenge.  Cavadini et al. (2007) showed that both TNFα and 
IL-1β could suppress E-box mediated transcription but not IL-6 or IFNγ, explaining 
both Per2 and Rev-erb, findings, but what is the mechanism behind BMAL1 
induction and how rapid is this regulation.  Could the BMAL1 induction be NFκB 
mediated?  Also can Per2 expression be induced, if so by what mediator? 
 
• What is the basis behind the protective role of Per2 suppression after LPS 
challenge, seemingly TNFα and IL-1 β mediated?  What does the PER2 protein do, 
what does it induce?  On a similar thought will BMAL1 over expression reduce 
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LPS mortality and will it reduce the inflammatory response and will BMAL1 knock 
out induce a greater response and increase mortality?  
 
• CORT is known to suppress the inflammatory response but also induce Per1 and 
Per2 transcripts.  Why then does LPS suppress Per2, via TNFα, and that this 
suppression is protective against LPS induced mortality, but CORT also being 
immuno suppressive has the effect of inducing Per2.  Yamamura et al. (2010) 
showed that DEX cannot override LPS induced Per2 suppression.  How does this 
occur?  Why is it better to suppress Per2 in the anti-inflammatory response than 
inducing it?  Perhaps Per2 is the basis behind the undesirable effects of CORT 
treatment. 
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6.1 Introduction 
 
The C/EBP proteins are a family comprising six transcription factors, all of which contain 
a highly conserved bZIP domain, for DNA binding and dimerisation, located at the C-
terminal.  As a result all members of the family, except C/EBP ζ, can heterodimerise and 
bind to DNA (Ramji and Foka 2002).  Two members of this family have been shown to be 
potently regulated by Gcs; C/EBPα which is down regulated and C/EBPδ which is up 
regulated.  However, a consensus GRE has not been located within either promoter 
(MacDougald et al. 1994).  C/EBPα and δ are both highly expressed in adipose tissue, 
intestine and in the lung, with C/EBPα also being expressed in the liver (Ramji and Foka 
2002).  However, knockout of the α isoform in mice causes death soon after birth (Wang et 
al. 1995), indicating the vital importance of this protein, whereas if δ is knocked out this 
just impairs the ability of BAT to take up lipids and express the protein uncoupling 
protein-1 (UCP-1) (Tanaka et al. 1997).  Furthermore, C/EBPα is thought to be regulated 
by itself and the β and δ isoforms (Cao et al. 1991), which are induced early in cellular 
differentiation.   
 
C/EBPα has been shown to have a direct link to the clock through activation of Per2 and 
an inhibitory effect on Rev-erbα (Gery et al. 2005).  The Per2 promoter contains a C/EBP 
binding site between -900 and -1500 bp, 5’ to the transcriptional start site, to which 
C/EBPα and ε can bind to induce Per2 transcription by 7 fold and 5 fold respectively (Gery 
et al. 2005).  However, the inhibitory mechanism behind Rev-erbα regulation is unknown.  
Furthermore, the C/EBP homologue in the California sea slug, Aplysia californica, 
(ApC/EBP) has a circadian variation in expression (Lyons et al. 2006), suggesting that the 
mammalian homologues too could be under circadian regulation, in particular C/EBPα.  In 
addition to this, C/EBPα is known to be activated by GSK3β phosphorylation (Datta et al. 
2007; Ross et al. 1999).  The activity of which is under circadian control (Iitaka et al. 
2005).   
 
C/EBPα and δ are known to induce transcription of the Clara cell secretory protein (CCSP) 
gene (Cassel et al. 2000), which is specific to the Clara cells that surround the bronchioles 
in the lung. Clara cells are known to show a robust oscillation when isolated in culture 
(Gibbs et al. 2009).  There are further links between the C/EBP family and circadian output 
pathways such as the inflammatory response (discussed previously in Chapter 5).  The 
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anti-inflammatory effects of TNFα, shown to be under circadian regulation, Chapter 5 and 
(Keller et al. 2009), have been shown to be in part mediated through the induction of 11β 
hydroxysteroid dehydrogenase type 1, an enzyme that converts inactive cortisol or 
corticosterone into its active form.  This Gc conversion enzyme is induced by C/EBPβ with 
basal regulation mediated by C/EBPα (Ignatova et al. 2009).  Furthermore, C/EBPα -/- 
mice cannot undergo full myeloid differentiation and as a result fail to produce mature 
neutrophils, leading to a lack of receptors for G-CSF and IL-6, (Zhang et al. 1997).  IL-6 is 
a known inflammatory cytokine under circadian control (Guan et al. 2005) and G-CSF was 
further discussed in Chapter 5.  C/EBPα has also been shown to directly up regulate both 
IL-6 and G-CSF transcription, (Zhang et al. 1998), as well as TNFα receptor production 
(Bristol et al. 2009), therefore, having a direct effect on the inflammatory response. 
6.2 Aims 
 
• To define whether C/EBPα has a circadian component to its expression at either 
transcript or protein level. 
 
• To show that C/EBPα was directly regulated by the clock. 
 
• To characterise its response to glucocorticoids at both transcript (luciferase 
reporters) and protein level. 
 
• To characterise the effects of glucocorticoids on C/EBP δ transcript expression 
(using a luciferase reporter). 
 
6.3 Results 
6.3.1 Validation of the C/EBP α antibody 
 
Previous commercial antibodies (Santa Cruz: code Sc-61 (Wolins et al. 2006)) proved to 
be somewhat misleading in the model systems used within this thesis.  In both the Rat-1 
cell line and murine lung tissue, a band which was larger than the predicted (43kDa) was 
observed.  Because of this, I employed a different antibody (Epitomics: code 1074-1 
(Bristol et al. 2009)) to characterise C/EBPα.  This was first validated with the use of an 
over expression plasmid (Fig 6.1).  Putative C/EBPα expression was confirmed in HEK293 
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and HeLa cells, and as a result of this HEK293 cells were used for future over expression 
studies, as expression was shown to be much greater in this cell line (Fig 6.1a).  
Furthermore, the over expression plasmid contained a His6 tag which was used to validate 
the over expressed band shown with the C/EBPα antibody (Fig 6.1b).  This antibody, 
however, would only recognise one of the two C/EBPα isoforms, the p42 and not the p30.  
This did not pose a great problem as the latter is just a truncation of the former.  The over 
expressed (upper band) is approximately 4kDa larger than the putative endogenous lower 
band, due to the His6 tag at the C-terminal end. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Validation of the C/EBPα antibody:  C/EBPα was immuno blotted in either 
HeLa or HEK293 cells using an anti-C/EBPα antibody (A), which showed putative (lower 
band) or C/EBPα over expression (upper band).  C/EBPα expression was confirmed by 
immuno blotting against the His6 tag, over expressed with C/EBPα (B), in both HeLa and 
HEK293 cells.  Control (con) and over expressed (OX). 
 
6.3.2 Circadian expression of C/EBP α mRNA and protein.  
 
To detect whether C/EBPα was circadian in expression, protein was collected, again from 
the Rat-1 cells over the circadian day with a 4h temporal resolution and immuno blotted 
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for C/EBPα.  There was no overall effect of time on protein expression (using One-Way 
ANOVA), nor did a pair-wise comparison between peak (CT4 or CT20) and trough 
(CT12) values reveal any significant difference (P= 0.07) (Fig 6.2b).   
 
The expression of C/EBPα was also characterised at the transcriptional, mRNA, level 
using the Rat-1 cell line, with a 2h resolution throughout the circadian day using Taqman 
qPCR.  The clock gene Per2 was assayed in parallel as a marker of circadian phase, using 
cells samples 24h post-synchronisation (CT0).  Per2 expression showed clear circadian 
expression, as expected, with minimal expression between 8h and 12h and maximal 
expression between 20h and 22h, approximately a 4.5-fold increase between the two time 
points (Fig 6.2c).  However, C/EBPα expression was minimal at 0h and steadily increased 
as time progressed, which resulted in a 6-fold increase between 0h and 22h (Fig 6.2c) with 
no apparent circadian variation.  These data suggested that C/EBPα gene expression was 
not under circadian control in the Rat-1 cell line.  The C/EBPα protein expression does, to 
some extent, conform to Per2 transcript expression, with a 2-4h phase lag (Fig 6.2c versus 
b), as minimal rPer2 mRNA expression is reached at 8 to 12h, and 12h showed minimal 
protein expression.  The Per2 transcript then increased at 16h and the C/EBPα protein 
showed maximal expression between 20h and 22h.  However, the small amplitude 
oscillation in C/EBPα protein expression did not correlate with the respective transcript 
expression, and therefore, must be a result of post-translational modification. 
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Figure 6.2: Putative C/EBPα protein and endogenous transcript expression in the 
Rat-1 cells over 24h:  Putative protein expression was characterised for C/EBP α (A; 
representative blot, upper panel) and α-tubulin (A; representative blot, lower panel) in the 
Rat-1 cells every 4h over the circadian day by immuno blot. Quantified expression is 
relative to α-tubulin (B).  C/EBPα transcript expression was characterised for rC/EBPα 
(red) and rPer2 (black) in the Rat-1 cells every 2h, over the circadian day, by Taqman 
qPCR.  Expression is fold change over basal expression.  Error bars are SEM of n=3. 
 
 
To complement the expression in the Rat-1 cells, lung protein was extracted from mice 
collected over the circadian cycle, (section 2.3.2.2).  The results from the immuno blot (Fig 
6.3) showed that there was no defined C/EBPα protein rhythm in the lung.  The results 
from Fig 6.3 are based on only 2 replicates per time point due to limited sample 
availability.  The representative blot (Fig 6.3a, upper panel) showed constitutive expression 
over the time course.  Together with rhythm in the Rat-1 cells (Fig 6.2) this suggested that 
the C/EBPα protein was only weakly rhythmic and if so, perhaps only in certain cell/tissue 
types. 
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Figure 6.3:  C/EBP α protein expression in mouse lung over 24h:  Protein expression 
was characterised for C/EBP α (A; representative blot, upper panel) and α-tubulin (A; 
representative blot, lower panel) in the WT mouse lungs every 4h over the circadian day, 
by immuno blot. Expression is relative to α-tubulin (B).  There are no error bars due to 
n=2. 
6.3.3 CLOCK/BMAL1 mediated E-box regulation of C/EBP α 
 
Previous sequence searches of the C/EBPα promoter, carried out by Dr. Qing-Jun Meng, 
had revealed there to be two classic E-boxes (CACGTG) and three non-canonical ones 
(CACATG) within 5kb of the transcriptional start site (refer to schematic Fig 6.7a).  Thus, 
CLOCK/BMAL1 regulation of the C/EBPα protein was characterised.  The resulting 
immuno blots showed that a co-transfection of CLOCK/BMAL1 had no effect on C/EBPα 
protein expression, above CLOCK or BMAL1 single transfection or the empty vector 
control, pcDNA3.1 (One-Way ANOVA P=0.66, Fig 6.4), although in work appendix E 
suggests that CLOCK/BMAL1 can induce a C/EBPα::luc promoter.  These data suggest 
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that the E-boxes were either non-functional, although endogenous transcript was not 
analysed, or that C/EBPα protein expression is constitutive and regulation, circadian or 
otherwise, is controlled at a post-translational level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4:  C/EBPα protein expression after CLOCK/BMAL1 over expression:  
Protein expression was characterised for C/EBPα (A; immuno blot, upper panel) and α-
tubulin (A; immuno blot, lower panel) 24h after CLOCK, BMAL1 or CLOCK/BMAL1 
was over expressed. Expression is relative to α-tubulin (B).  Error bars are SEM of n=3 
with all replicas shown (1-3). 
6.3.4 Glucocorticoid regulation of C/EBPα 
6.3.4.1 DEX regulation of C/EBPα protein 
 
Previous published work had shown that DEX can repress C/EBPα protein expression after 
4h, yet at the same time increase C/EBPδ expression.  To confirm this report, synchronised 
Rat-1 cells were treated with 100nM DEX and protein was extracted over the following 8h 
(Fig 6.5).  It was clear that DEX did not repress C/EBPα protein at any of the time points 
studied, relative to the vehicle control (One-Way ANOVA P=0.097).  However, protein 
expression was reduced after 8h but this also occurred in the presence of the vehicle, which 
suggested that this was a result of the endogenous decline in expression towards the trough 
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of the relatively weak circadian rhythm, previously shown in the Rat-1 cells (Fig 6.2) and 
not a result of DEX regulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5:  C/EBPα protein expression after DEX:  Protein expression was 
characterised for C/EBPα (A; representative blot, upper panel) and α-tubulin (A; 
representative blot, lower panel) over 8h following 100nM DEX. Expression is relative to 
α-tubulin (B).  Error bars are SEM of n=3. 
6.3.4.2 DEX regulation of C/EBPα and δ promoter reporters 
 
As DEX did not appear to regulate C/EBPα at the protein level, at least in the Rat-1 cells, 
the effect of DEX on the various promoters constructs of both α and δ was characterised.  
There were 4 α constructs (1300bp, 650bp, 280bp and 240bp) and 1 δ construct (1700bp) 
each 5’ to the transcriptional start site (section 2.3.2) supplied by Dr Qing-Jun Meng.  DEX 
was added to the C/EBPα 1300bp and δ construct for either 4h or 24h, using a range of 
concentrations (Fig 6.6), and its affects analysed by luciferase assay.  DEX had significant 
repressive effects on both constructs, after 4h, with all the concentrations of DEX used.  
DEX had a greater repressive effect on C/EBPδ resulting in an approximate 40% 
reduction, relative to the DMSO control, compared to a 27% reduction with C/EBPα 
shown with 100nM DEX (Fig 6.6a and b) but both constructs showed significant 
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reduction.  Importantly DMSO alone had no significant effects on the constructs as there 
was no difference between DMSO treated cells and untreated cells (labelled as cells, Fig 
6.6).  
 
 
 
 
 
 
 
 
 
Figure 6.6: DEX effects on C/EBPα 1300bp and C/EBPδ 1700bp promoter 
constructs:  DEX was added to Rat-1 cells expressing either C/EBPα or δ reporter 
constructs for 4h (A and B respectively) or 24h (C and D respectively), then analysed using 
a luciferase assay.  DEX concentrations are shown with DMSO as the vehicle control, cell 
refers to untreated cells.  Units are RLU, normalised to DMSO.  Error bars are SEM of n=3 
repeated 3 times.  Statistical analysis was by Two-Way ANOVA (P<0.0014 for DEX 
interaction with both constructs and P=0.9 for time interaction with the delta construct, and 
P=0.0008 for a time interaction with the alpha construct) with a Bonferroni post-hoc 
analysis.  With regard (A): (a) versus (b) P< 0.001, (a) versus (c) P< 0.01, (b) versus (c) 
not significant.  With regard to (B) and (D): (d) versus (e) and (d) versus (f) P< 0.001, (e) 
versus (f) P<0.05.  There is no significant specific interaction with regard time for either 
the alpha or delta construct after post-hoc analysis.       
     
 
However, the repressive effects of DEX on the α construct were only transient, relative to 
the δ construct, as the DEX suppression was still observed after 24h with the δ construct 
but was not detectable using the α construct (Fig 6.6c and d).  Taking the 100nM DEX 
treatment as an example, after 24h there was a significant 50% reduction, relative to the 
DMSO control, with the δ construct, but only a 20% reduction with the α construct, which 
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was not shown to be significant.  This suggested that although DEX was able to repress 
both constructs, up to 4h, the effects of DEX were much more sustained with regard to the 
δ construct, with repression up to at least 24h after DEX treatment. 
 
As different truncated constructs of C/EBPα were available, the repressive effects of DEX 
were further investigated, to try and isolate a particular region of the promoter responsible 
for the observed effects and to relate it to a known mechanism.  DEX was added to the 4 
C/EBPα constructs (1300bp, 650bp, 280bp and 240bp) and the effects were analysed, by 
luciferase assay after 4h, based on the earlier work (Fig 6.6).  As a control the 1300bp 
construct showed significant inhibition in the presence of DEX, relative to DMSO, with an 
approximate 22% reduction (Fig 6.7b), as seen in Fig 6.6.  Further to this the 650bp 
construct also showed significant repression in the presence of DEX, with a significant 
20% reduction in luciferase signal.  However, with the 280bp construct no significant DEX 
induced suppression was shown (Fig 6.7b).  Basal expression, as seen by DMSO, was 
increased relative to the 650bp construct, by approximately 10%, but this did not reach 
significance with DEX expression being significantly increased by approximately 20% 
(relative to 650bp construct), but still much less than the 1300bp construct.  The 240bp 
construct showed only background expression in the presence of either DMSO or DEX.  
Together these data suggest that in the 370bp between the 280 and 650bp constructs there 
is an element that can mediate the effects of DEX via the GR, yet within this region there 
is also a repressive element, or simply the loss of further inducing elements, that results in 
the overall reduction of basal expression.   
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Figure 6.7:  DEX mediated repression of various C/EBP α constructs:  A cartoon 
diagram of the 4 C/EBP α constructs (1300, 650, 280 and 240bp) with canonical E-boxes 
(402bp and 1290, black); non-canonical E-boxes (2589bp, 3012bp and 3856bp, dark 
green); putative AP-1 sites (331bp and 441bp, red) and the putative C/EBP α binding site 
(316bp, light green).  Each construct was treated with either 100nM DEX (blue), DMSO 
(green) or untreated (cells, red) for 4h before lysis and quantification by luciferase assay 
(B).  Expression is relative to the 1300bp construct treated with DMSO.  Error bars are 
SEM of n=3 repeated 3 times.   Statistical analysis was by Two-Way ANOVA (P<0.0001 
for treatment and construct length) with a Bonferroni correction, (a) versus (b) and (c) 
versus (d) P<0.001, (d) versus (e) P<0.05, (a) versus (c) and (b) versus (d) P<0.001. 
 
6.4 Discussion 
6.4.1 Rational for the C/EBP studies 
 
At an early phase in this study I started out to test whether C/EBP (α and δ) proteins were a 
key link between Gc and the circadian clock.  This hypothesis was supported by early 
literature which reported strong circadian control of C/EBP at both the RNA and protein 
level in Aplysia (Hattar et al. 2002; Lyons et al. 2006).  C/EBPα had also been shown to 
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induce Per2 transcription (Gery et al. 2005).  Earlier studies had reported significant action 
of DEX on both C/EBPα and δ isoforms (MacDougald et al. 1994), thereby providing a 
mechanism where Gc could re-set the clock through the intermediary action of C/EBP.  
Unexpectedly, this hypothesis proved not to be the case as the reported effect of DEX 
could not be repeated nor was the transcript or protein overtly rhythmic.   
6.4.2 Circadian expression of C/EBPα transcript and respective protein 
 
The antibody used to detect C/EBPα protein was a rabbit monoclonal antibody, which even 
though very specific, shown by the data here (Fig 6.1) and Bristol et al. 2009, only 
recognised the larger, p42, isoform and not the p30.  Furthermore, the qPCR data (Fig 6.2) 
was non specific, and as such, did not distinguish between either isoform.  However, both 
isoforms are a product of the same genetic locus and are therefore subject to the same 
promoter and enhancer effects (Ramji and Foka 2002), which suggest that what is seen 
with one will be the same as the other, at least at the transcript level, but has also been 
shown at the protein level, with respect to DEX repression (MacDougald et al. 1994).  The 
C/EBPα transcript does not oscillate in phase with Per2 expression, even though there is a 
time of day difference, where 0h showed minimal expression and 22h showed maximal 
expression, however, these data do not suggest purely E-box mediated circadian regulation.  
It is perhaps possible that C/EBPα is under circadian regulation via multiple mechanisms 
as there are three elements that are known to regulate circadian transcription; E/E’ boxes 
(so called canonical and non-canonical respectively), D-boxes and RORE (Ueda et al. 
2005).  As described by Ueda et al. (2005) a combination of these three transcriptional 
regulatory elements determines the phase of expression within the circadian day.  There are 
two canonical E-boxes within the hC/EBPα promoter region (used in the luciferase assay 
studies), at -402bp and -1290bp and a potential RORE at -706bp.  The human and mouse 
promoters also have 2 canonical E-boxes within 2kb of the transcriptional start site and 
potential RORE.  There may also be further regulatory elements upstream or, as in the case 
of the GRE in the Per2 gene (So et al. 2009), downstream within the intronic region.  If 
this hypothesis is correct and there is both E-box and RORE regulation of C/EBPα then 
this will put transcription in phase with Cry1 and phase delayed relative to Per2 
(Etchegaray et al. 2003; Ueda et al. 2005).  Although more recent studies have suggested 
this delay can be achieved through the E-box alone (Fustin et al. 2009).  rCry1 expression 
was not analysed in this model system,  
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The protein product was shown to be weakly rhythmic with the peak at 0h and a trough at 
12h (Fig 6.2) but only in the Rat-1 cell model, and expression in the lung was constitutive 
across the circadian day.  Absence of circadian changes in the lung may be a reflection of 
the complications of using the tissue explant with multiple cell types, only some of which 
appear to be under circadian control (Gibbs et al. 2009).  The only other previously 
reported circadian oscillation of C/EBP has been in the A. californica (Hattar et al. 2002; 
Lyons et al. 2006).  Taken together, C/EBPα is at best only weakly circadian and only in 
specific cell types.  However, there could be a post-translational oscillation, like that of 
GSK3β (Iitaka et al. 2005), as C/EBPα is a target protein of GSK3β (Ross et al. 1999). 
6.4.3 Gc regulation of the C/EBPα transcript and respective protein 
 
In the Rat-1 model DEX failed to repress C/EBPα protein expression, as shown previously 
by MacDougald et al. (1994) but a DEX mediated repression in promoter expression was 
shown (Fig 6.6a) similar to that of MacDougald et al. (1994), that reached a minimum at 
2h post DEX (4h shown in this study) and returned to baseline expression after 6h (24h in 
this study).  However, opposing results were seen with respect of C/EBPδ, since 
MacDougald et al. (1994) showed an immediate increase in δ mRNA expression after 
DEX, that reached a maximum at 4h, and then returned to basal expression after 24h.  In 
the study presented above, sustained δ repression was seen up to 24h in the presence of 
DEX (Fig 6.6b and d) but this was not reported by MacDougald et al. (1994).  Taken 
together the repressive effects of DEX on C/EBPα are not observed at the protein level and 
as such do not conform to the previous literature; likewise opposing effects on the δ 
isoform were seen.  These conflicting results can only be explained by differences in cell 
models and DEX concentration.  Endogenous RNA from 3T3-Ll adipocytes were used by 
MacDougald et al. (1994) with 1µM DEX, whereas Rat-1 cells were used with 100nM 
DEX, in this study presented above.  This also means that the use of limited size promoter 
constructs will no doubt exclude other regulatory sites and as a result could produce 
conflicting outcomes compared to an endogenous readout. 
 
The inhibitory effect of DEX on the C/EBPα promoter fragments was of some interest as 
there was significant inhibition regarding the two larger fragments, 1300bp and 650bp, but 
no inhibition with the smaller fragments, 280bp and 240bp (Fig 6.7).  These results suggest 
that there is an inhibitory element in the promoter between the 650bp and the 280bp region 
upstream of the transcriptional start site.  A simple promoter search for transcription factor 
Chapter 6:_________________ The circadian regulation of C/EBP alpha and delta 
 
 242 
binding sites, using the bioinformatics software, Genomatix, revealed an AP1 binding 
element was located within 370bp region.  AP1 is transcription factor made up of cJun 
homodimers or c-Jun/c-Fos heterodimers and the subsequent interactions determines 
whether glucocorticoids have positive, negative or no effect on transcription.  No effect 
means that there is a high cJun:cFos ratio and repression is a result of a  high cFos:cJun 
ratio (Imai et al. 1993).  However, following on from these findings no further work was 
carried out on the C/EBP promoter fragments, as these results conflicted with published 
work and the endogenous protein no rhythmic.  
6.4.4 E-box mediated regulation of C/EBPα protein 
 
The CLOCK/BMAL1 mediated induced expression was first shown with the C/EBPα 1300 
and 650bp, at the construct level by Dr. Qing-Jun Meng (appendix E), but not with 
C/EBPδ 1700bp, perhaps due to there being only one non-canonical E-box (CACATG) 
within the promoter region at -1184bp.  There was significant induction over the empty 
vector control by CLOCK/BMAL1 co-transfection with the alpha constructs but no 
induction with the delta construct.  This E-box induced expression was similar to work 
with a Per1::luc construct where CLOCK/BMAL1 transfection significantly induced 
expression (Motzkus et al. 2007).  However, the expression shown at the promoter level, 
with regard to alpha, was not replicated at the protein level, where CLOCK/BMAL1 over 
expression failed to induce significant expression over the empty vector control.  This 
suggested that although C/EBPα transcription was under E-box, CLOCK/BMAL1, 
mediated circadian regulation, the protein product was not (Fig 6.4), and coupled with the 
weak endogenous protein rhythm (Fig 6.2) suggested that there was no post-translational 
modification coupled to degradation that defined a circadian oscillation.   
6.4.5 Post-translational modification of C/EBPα 
 
However, there could be a phosphorylated C/EBPα rhythm as GSK3β, known to be under 
circadian regulation (Iitaka et al. 2005), has been shown to phosphorylate C/EBPα on 
amino acids T222 and T226 and is involved in adipocyte differentiation (Ross et al. 1999).  
Although others have reported that C/EBPα is a very poor substrate for GSK3β in in-vitro 
cells line studies of hepatic gene expression (Liu et al. 2006a).  This perhaps points to 
tissue specific regulation of C/EBPα and why more promising results were not seen in this 
study, as cell lines and lung tissue were used.  Furthermore, phosphorylation of C/EBPα, 
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by MAPKP42/44 at S21, has also been shown induce conformational changes causing the 
amino termini of the C/EBPα homodimer to move apart and consequently lose 
transcriptional activity (Ross et al. 2004).  Sumolyation, a small ubiquitin-related modifier 
like protein, is another reported post-translational modification of C/EBPα.  Sumolyation 
itself adds approximately 20kDa to the protein, producing a 64kDa product which inhibits 
the transcriptional potential of C/EBPα, as seen in the differentiation of hepatocytes (Sato 
et al. 2006b).  However, there is little evidence to support extensive post-translational 
modification and regulation of C/EBPδ 
6.6 Conclusions 
 
C/EBP α has been shown here to be weakly rhythmic at the protein level, in the Rat-1 cell 
line, but with constitutive expression in the lung.  There is also no obvious transcript 
rhythm in the Rat-1 cells, although differential expression was shown it is not in phase 
with Per2.  At the promoter level CLOCK and BMAL1 were shown to induce expression 
of C/EBPα but not δ, likely to have been through the multiple E-boxes, however, this did 
not carry through to a direct protein regulation of C/EBP α.   Furthermore, direct regulation 
of C/EBPα by the glucocorticoid analogue, DEX, was not shown although this has been 
established in the literature.  However, at the promoter level DEX did repress both C/EBPα 
and δ expression, which confirms that seen in the literature with regard to C/EBPα at the 
protein level but was opposite to the induction seen at the protein level with respect to 
C/EBPδ.  The Gc regulation of C/EBPα was further narrowed down to a 370bp region 
between -280bp and -650bp, which is potentially an AP-1 binding site.  However, a more 
thorough investigation of C/EBPδ was not undertaken, nor was this initial work with 
C/EBPα progressed due to it lack of circadian and Gc regulation in the model systems used 
here. 
6.7 Future directions 
 
• C/EBPα did not appear to oscillate at the transcript level and only with a weak 
rhythm at the protein level but a phospho-protein rhythm was not investigated and 
therefore would be useful, if only to rule it out.   
 
• A transcript rhythm of C/EBP delta was not investigated here and neither was the 
protein rhythm, so these too should be investigated, if nothing else than for 
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completeness.  However, there was no CLOCK/BMAL1 induction of the delta 
construct (appendix E) so perhaps there is no rhythm to be found. 
 
• There is literature linking C/EBPβ and the induction of HSD11β type 1 (the 
enzyme converting inactive CORT to active CORT) in association with TNFα, also 
C/EBPα and beta directly bind to and induce the TNFα receptor.  Therefore, it 
would be interesting to further characterise these inflammatory associations, 
particularly with respect to the circadian component of TNFα both under basal and 
stimulated conditions.  Is the TNFα gene regulated by C/EBP α and β, how does 
this link in with the circadian characteristics of TNFα, is IL-6 regulation similar? 
 
• To take a C/EBPα expression vector and added it to both clock promoter reporters 
and primary protein reporters, such as the lung, to characterise direct C/EBPα input 
effects on the clock.  Does C/EBPα change the phase of the clock?  Does it induce, 
as suggested by Gery et al. (2005), or suppress the oscillation?    
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7.1 Thesis overview 
 
There have been two major themes throughout this thesis, one being circadian timing and 
the other being its regulation by the steroid hormones, glucocorticoids.  The study began 
by investigating the effects of the endogenous glucocorticoid, CORT, on the core clock 
genes Per1 and 2 and the PER2 protein itself; with the aid of transgenic luciferase 
reporters using both cell lines, a reductionist approach, and using tissue reporters, primarily 
the lung.  Use of the lung as a peripheral model is novel, as most work to date had focussed 
on the liver (Kornmann et al. 2007; Reddy et al. 2007).  However, the lung has been shown 
to have a functional oscillator using ex-vivo slice preparations, and isolated pulmonary cell 
types such as the Clara cells, which are robustly rhythmic (Gibbs et al. 2009; Yoo et al. 
2004).  Further to this, respiratory diseases such as asthma and COPD have been shown to 
have a circadian component to their symptoms, while Gcs are one of the main treatments 
of choice in the suppression of inflammatory responses, used specifically to alleviate 
airway tightness in asthma (Barnes and Adcock 2003).   Glucocorticoid resistance is a 
problem in COPD and these hormonal agents are often ineffective (Barnes et al. 2004). 
The mechanisms underpinning this are poorly understood.  Lung tissue has provided a 
robust and reproducible model to study circadian timing, using luciferase transgenes and 
the PMT system.  Lung slices have also been a much better peripheral reporter than other 
tissues such as the liver or kidney, most likely due to the nature of the lung being a very 
light, open structure compared to the dense nature of the liver or kidney making it difficult 
for photons of light to be emitted and detected. 
 
CORT has been shown to be a potent regulator of circadian timing, especially in the 
periphery of the mammalian system.  It has been proposed that this may act as one of the 
key systemic signalling molecules that confer the phase of the central clock, located in the 
SCN, to the rest of the brain and peripheral oscillators (Balsalobre et al. 2000a), allowing 
individual oscillators throughout the organism to maintain and co-ordinate time.  The 
nature of glucocorticoid regulation on the peripheral clock, using the lung as a model, was 
investigated in Chapter 3, with particular attention paid to the roles of the closely related 
nuclear hormone receptors the GR and MR. It is clear from these studies that GR and MR 
act differently on the CORT-mediating re-setting of the circadian clockwork.  These 
repeatable observations formed the basis of studies reported in Chapter 4 and the concept 
of non-genomic glucocorticoid regulation of the pulmonary clock, mediated through CAV-
1 signalling. This is novel and has not previously been reported in the literature.  
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In addition to studies regarding the central clock and glucocorticoid regulation, the 
influence of the circadian clock on the innate inflammatory response was characterised.  
Many inflammatory cell types and mediators, such as IL-6 and TNFα have been shown to 
exhibit a circadian rhythm and, perhaps more interestingly, in anti-phase to that of the 
circulating glucocorticoids (Haus and Smolensky 1999; Petrovsky et al. 1998).  This 
background led to the work in Chapter 5 where the in–vivo gated inflammatory response 
was investigated in relation to LPS challenge, revealing that a small number of mediators 
had a circadian-gated response to LPS.  This work was repeated in a primary cell culture 
model using PECs, which revealed a slightly different response in terms of mediators 
involved. However, effects on IL-6 remained consistent throughout the different 
experimental protocols.  It was also shown, in Chapter 5, that REV-ERBα has a significant 
role on the gated inflammatory response, particularly with regard to IL-6, where gating 
was lost in a Rev-erbα -/- genetic background. This is currently uncharacterised in the 
literature, and the mechanism previously only hypothesised (Chapter 5 discussion).  A 
recent study has provided a link between the inflammatory response and CAV-1 (Wang et 
al, 2009), and CAV-1 was discussed with regard to the non-genomic action of CORT on 
the clock in Chapter 4.  These authors provided evidence that CAV-1 signalling is 
associated with TLR4, and that this association reduced inflammatory mediator expression 
after LPS challenge, mediators such as IL-6, CCL5/RANTES, TNFα and IL-12p40, 
amongst others, all of which were shown to be gated in response to LPS challenge.  
Together theses data provide a link between the clock and a clock output process (the 
inflammatory response), in terms of Cav-1 signalling. 
 
C/EBPα was hypothesised to be under circadian regulation at both the transcript and 
protein level, as such acting as a clock output gene, but also C/EBPα was shown by Gery et 
al. (2005) to induce Per2 transcription and, as such, acting as a clock input.  Therefore, 
C/EBPα potentially has a dual role in relation to the clock.  Lyons et al. (2006) had shown 
the C/EBP homologue in the sea slug Aplasia to have a circadian expression pattern, and 
MacDougald et al. (2004) had provided evidence that DEX suppressed C/EBPα and 
induced C/EBPδ protein expression.  However, these observations on C/EBPα could not be 
confirmed in this study (Chapter 6), nor a robust transcript or endogenous protein rhythm 
detected in either cell lines or lung tissue. Therefore, although C/EBPα had began with 
potential as clock regulator and itself regulated by the clock, this did not materialise and 
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further experiments were not undertaken.  However, more recent evidence has now 
provided a link between C/EBPα and the pro-inflammatory response and the anti-
inflammatory effects of CORT.  C/EBPα acts as a transcription factor that forms part of the 
pathway involved in TNFα receptor transcription (Bristol et al. 2009), and in this way 
C/EBPα regulates pro-inflammatory responses.  Also C/EBPα is involved, along with 
C/EBPβ, in the basal regulation of 11-β HSD type1, which is the enzyme that converts 
inactive CORT to active CORT (Ignatova et al. 2009), and has been shown to have 
circadian rhythm in expression at the mRNA level in the hippocampus (Buren et al. 2007).  
Therefore, C/EBPα has both pro-inflammatory and anti-inflammatory properties, with 
significant circadian links. It is possible that the reason for not detecting a role in the 
studies reported in this thesis is that the wrong cell types were used, and in this regard an 
inflammatory cell mediator (i.e. macrophage) may prove more reliable. 
 
7.2 The complexity of Gc signalling: integrating circadian and ultradian pulses  
 
Plasma CORT levels are known to oscillate in a circadian manner, in both rodents and 
humans, peaking prior to the onset of activity and in phase with Per1 and Per2 mRNA 
expression (Oster et al. 2006; Takimoto et al. 2005; Yang et al. 2009b).  However, CORT 
also oscillates in an ultradian manner, as shown in the rat, peaking approximately every 50 
min (Windle et al. 1998a; Windle et al. 1998b), which has been proposed to be in response 
to pulsatile ACTH and CRF release, yet the origin of the pulsatile release is still unknown 
(Carnes et al. 1988; Mershon et al. 1992).   
 
It has been shown from the work in Chapters 3 and 4 of this thesis, and from other 
published work, that Gcs can reset the circadian clock and stimulate rhythmic gene 
expression, yet have no direct effect on the SCN, as the GR is not expressed (Balsalobre et 
al. 2000a).  The effect of the ultradian oscillation has been shown to be biologically 
relevant at both the behavioural and transcriptional level.  At the behavioural level the 
ultradian pulses have been shown to be vital in the animals’ response to stress (Lightman et 
al. 2008; Windle et al. 1998b).  If the animal (female rat in this study) was exposed to 
noise stress, which coincided with a rise in the endogenous ultradian rhythm, then plasma 
CORT increased rapidly.  However, if the stress coincided with the decline in the ultradian 
rhythm then no CORT induction was observed, and therefore the animal failed to respond 
to the stress situation (Windle et al. 1998b).  At the transcriptional level the cell and GR 
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has been shown to respond effectively to rapid pulsing of CORT, but not other long lasting 
steroid agonists such as DEX or prednisolone (Stavreva et al. 2009).  Through pulsing 
experiments the authors showed that 10 min after removal of CORT (wash out) the GR 
will dissociate from the GRE within a target gene, yet endogenous GR levels remained 
constant, showing that the GR-CORT interaction is highly dynamic.  Furthermore, the un-
liganded GR must re-associate with chaperone proteins (HSP90) prior to new ligand 
binding, which provides an inbuilt delay mechanism (Stavreva et al. 2009).  Of particular 
interest in this study was the clock gene Per1.  Per1, as well as other genes, responded 
differently when exposed to pulsatile and continuous CORT treatment.  The nascent Per1 
transcript (unspliced or pre-mRNA) was rapidly induced by the CORT pulse and 
expression quickly fell after washout, whereas continuous CORT treatment gave 
constitutively high levels.  Further to this, when the mature Per1 transcript (spliced and 
prepared for translation) was quantified, CORT pulsing resulted in significantly lower 
levels of expression relative to continuous treatment but showed no pulsing effects, which 
was mirrored by two other genes and at the protein level (Stavreva et al. 2009).  Together 
these data provide evidence that CORT pulsing is biologically relevant and is interpreted 
by the animal at a behavioural and gene transcript level, and has a direct effect on the 
circadian clock (Per1).   
 
So how then does the body integrate an ultradian and circadian signal, which can entrain 
the peripheral clock (including brain regions except the SCN) but whose signal can also be 
ignored at times other than when required, so that the peripheral body is not reset every 50 
min?  The answer to this question remains undetermined, but it is likely to be mediated 
through a gating mechanism in the adrenal clock and the effects of light directly on the 
adrenal gland (Ishida et al. 2005; Oster et al. 2006).   
 
The canonical clock genes (Per1, Per3, Cry1, BMAL1 and Rev-erbα) are all preferentially 
expressed in the cortical layers, rather than the medulla, of the adrenal gland (ZF and ZG), 
which are the areas from where CORT is synthesised and released (Simpson and 
Waterman 1988).  Interestingly, Per2, Cry2 and Clock mRNA were not preferentially 
expressed in the cortex, but PER2 protein expression did show a defined temporal 
difference in the ZF and ZG compared to the medulla (CRY2 and CLOCK protein was not 
tested) (Oster et al. 2006).  Using WT and Per2/Cry1 knock out, arrhythmic mice Oster et 
al. (2006) showed that in WT mouse the ACTH rhythm peaks 2h prior to the peak of the 
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CORT rhythm.  They also showed that both rhythms are lost in the arrhythmic mouse, in 
both LD and DD conditions, with consistent low levels of expression.  Together these data 
suggest that in the absence of a functional clock, the adrenal gland cannot properly respond 
to ACTH and fails to integrate a rhythmic output (CORT).  Furthermore, Oster et al 
(2006), using a series of transplant experiments involving Per2/Cry1 knock out mice being 
transplanted with WT adrenals and vice versa, concluded that the adrenal clock can be 
light entrained, even in the absence of a rhythmic SCN clock.  Also, that there is no 
apparent feedback from the adrenal clock to the SCN (most likely due to the absence of the 
GR), but the adrenal gland does affect CORT rhythms by gating sensitivity to ACTH, as 
CORT rhythms were observed in arrhythmic mice (constitutive ACTH levels) implanted 
with WT adrenals in LD, but not DD.  Incidentally, a WT adrenal transplanted into an 
arrhythmic mouse did not restore differential expression in Per1 and Rev-erbα transcript in 
the kidney in LD or DD; rather expression reflected the genotype of the host animal.  
Taken together these data suggest that rhythmic CORT release requires a functional 
adrenal clock yet only requires constitutive ACTH release under LD conditions.   
 
In addition to ACTH stimulation of CORT release from the adrenal glands, the adrenals 
are innervated through multiple synapses, resulting in the innervation of the adrenal with a 
branch of the splanchnic nerve (Buijs et al. 1999; Ishida et al. 2005).  Ishida et al (2005) 
showed that a 30 min light pulse can induce Per1::luc expression in the adrenal gland, with 
specific Per1 mRNA expression observed in the ZF, ZG and zona reticularlis (ZR).  The 
30 min light pulse induced a rapid, yet transient rise in plasma CORT levels which were 
maximal 30 min after the light exposure and had declined to basal levels by 180 min.  
Importantly, this light induced release of CORT was independent of ACTH changes.  
Denervation of the adrenal gland resulted in the loss of light-induced Per1 expression, in a 
similar manner to lesion of the SCN itself.  Interestingly, Ishida et al (2005) showed that 
light intensity had a dose dependent effect on serum CORT release, leading to maximal 
release in response to an intensity of 40 lux roughly equal to sunset and sunrise (beginning 
and end of activity phase).  Also serum CORT levels and Per1 mRNA expression only 
responded to light in the subjective night under constant darkness, similar to how the SCN 
responds to a light pulse (section 1.9.2.1).   
 
Therefore, in the rodent, the adrenal release of CORT is gated by the clock, which follows 
ACTH release, and peaks prior to the onset of activity.  Light is also able to induce Per1 
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expression and CORT release, with a maximal response at intensity similar to that 
observed at dawn and dusk, but does not induce expression during the subjective day; 
therefore light at dusk is likely to be the first light the animal can respond to at a molecular 
level.  The pulsing of CORT occurs every 50 min and is involved in the stress response, 
but does not result in an ultradian Per1 transcript rhythm.  So the animals response to 
CORT is two fold.  First the circadian response and induction of Per1 and rhythmic clock 
gene expression, perhaps being an integration of multiple zeitgebers such as CORT, light 
(indirectly via the SCN) and other entraining factors such as melatonin and ghrelin 
(sections 1.9.3.1 and 1.9.3.4 respectively), which are induced in response to darkness 
(melatonin) and as an appetite stimulant (ghrelin).  Second to the circadian expression is 
the ultradian CORT pulses, which will induce Per1 transcription but perhaps due to the 
lack of integration with other zeitgebers these pulses do not constantly reset the peripheral 
clock and only become relevant under a stress response and then only when the stress 
coincides with a rise in the pulse. 
7.3 Why is there a rapid re-setting of the clock and amplitude response of PER2? 
 
Work in this thesis (Chapter 3) has shown that CORT can not only alter the phase, period 
and sustained (chronic) amplitude of the PER2::luc rhythm, but can induce an immediate 
(acute) amplitude rise (as seen through the luciferase signal).  It is understandable that a 
stimulus, like CORT, should induce a transcriptional response (i.e. Per1 and Per2) which 
in turn produces more protein, and results in a phase advance or delay.  This entrainment 
process (one of many) is in place in order to synchronise peripheral clocks with the SCN, 
and therefore the external environment.  It is also advantageous to be a slower, 
transcriptional based response so that the peripheral clocks are not constantly re-set every 
time a stimulus passes by via the circulation (melatonin, serotonin, CORT and food 
signals), as this would easily lead to internal de-synchrony.  However, why would it be 
necessary to produce a CORT-induce rapid protein response?   
 
In Chapter 3, I showed only a CORT-induced acute amplitude response of PER2::luc (Fig 
3.3 and 3.9), a response to other stimuli was not shown nor was the response of other clock 
proteins tested (CRY1, PER1 or BMAL1).  It is therefore currently unknown whether this 
effect is specific to PER2 and CORT, or a general response to re-setting stimuli.  However, 
work with the non-steroidal agonists (Fig 3.18) did not induce an acute amplitude rise, 
even though it induced a phase shift.  Also in Chapter 5 (Fig 5.6), LPS induced a phase 
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shift but, like the non-steroidal agonists, did not result in an acute amplitude rise.  This 
suggests that the amplitude effects seen with CORT are specific and not just a general re-
setting effect.  
 
Presumably CORT does not re-set all peripheral clocks every time it is released, or in this 
case high amplitude ultradian pulsatility would certainly cause de-synchrony (Windle et al. 
1998b).  However, CORT no doubt has a synchronising effect due to its circadian 
oscillation, with peak levels of Per1, 2 and 3 mRNA in the human aligning with the 
morning peak of the cortisol rhythm (Bjarnason et al. 2001; Takimoto et al. 2005) with the 
same occurring in the mouse but in the evening (Lee et al. 2001; Yang et al. 2009b).  The 
clock has also been shown to gate CORT production in response to ACTH in the adrenal 
gland (Oster et al. 2006), and therefore there is a reciprocal interaction between CORT and 
the clock.  So then, what is the advantage of a rapid PER2 protein induction? In an attempt 
to answer this question it is worth thinking about why CORT is released, one major reason 
is in response to stress (Windle et al. 1998b), which could result in the ‘fight or flight’ 
response.  Work with the Per2 -/- mouse has shown that the loss of this clock gene results 
in reduced wheel running activity compared to the WT mice but with no other 
physiological i.e. muscle mass, body mass or muscle contractile differences (Bae et al. 
2006; Yang et al. 2009).  This observation links nicely with a stress-induced escape 
response, in that if the ability to run is reduced with the loss of Per2, then the protein must 
have an effect when present.  In the study by Bae et al (2006) they looked at the effect of 
the loss of Per2 on proteins involved in muscle contraction, metabolic pathways, stress 
proteins and regulatory proteins.  The reduced running ability of the Per2 -/- mice was 
hypothesised to be due to an increased dependence on glycolysis, as key enzymes in the 
process were increased in the Per2 -/- mouse.  Triose-phosphase isomerase and 
phosphopyruvate dehydratase were both increased in the absence of PER2.  However, the 
link between PER2 protein and these enzymes remains undetermined.  Furthermore, the 
enzyme carbonic anhydrase III was reduced in the Per2 -/- genotype.  This enzyme buffers 
the cells and blood against acidic conditions, as it converts CO2 + H2O to HCO3 + H+ and 
vice-versa, and at a reduced level this will result in serious discomfort to the individual, 
particularly as an increase reliance on glycolysis will result in increased H+, which will 
acidify the local environment.  These data indicate that PER2 is involved in metabolic 
processes in the cell, which are enhanced in a stress response, and without PER2 the 
animal is severely hindered, particularly in terms of behavioural activity.  There is a 
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limited amount of published literature on the range of genes induced by effects of clock 
protein transcription, but above gives a small insight into the wide range of effects clock 
genes can have on the organism, in response to various stimuli. 
7.4 The circadian inflammatory response 
 
Evidence presented in this thesis (Chapter 5) and in the published literature has shown that 
the innate immune response is under circadian control, but is it direct (i.e. by 
CLOCK:BMAL1) or indirect (i.e. influenced by systemic factors)?  If it is under direct 
control it is perhaps important to ask the question, ‘what is the advantage of this control?’  
 
Isolated immune cells have been shown to oscillate in terms of their raw numbers in the 
circulation (Arjona and Sarkar 2005; Haus and Smolensky 1999).  Also tissues from the 
immune system have been shown to oscillate both as tissue explants (using the PER2::luc 
mouse, Chapter 3) and as mRNA (mPer2 and mRev-erbα) extracted from mice in constant 
darkness over the 48h (Keller et al. 2009).  Furthermore, mediators of the inflammatory 
response have been shown to oscillate independently and in response to LPS challenge in 
both humans and mice (Chapter 5 and (Guan et al. 2005; Keller et al. 2009; Petrovsky et al. 
1998).  It could be, at least in-vivo that the circadian oscillations of the various cells, genes 
and proteins of the inflammatory system are due to synchronising factors such as Gc or 
melatonin.  Gcs are released in a circadian manner and have been shown to negatively 
correlate with cytokine production (IFNγ, TNFα and IL-12) i.e. peak Gc expression 
correlates with minimal cytokine expression (Petrovsky et al. 1998).  Other studies, using 
human volunteers have shown that IL-6 and IL-1β expression do not correlate with Gc 
release but IFN-γ, IL-8 and TNFα do, so it seems that circulating Gc expression does, 
affect circulating cytokine expression.  An association between Gc and TNFα production 
has been shown in serum (Parant et al. 1991), where pre-treatment of adrenalectomised 
mice with Gc stopped TNFα release, in response to LPS.  Yet, there is no difference in 
TNFα or IL-6 circadian expression between the spleens of WT and adrenalectomised mice, 
removed and then treated with LPS over the circadian day (Keller et al. 2009), and so are 
therefore devoid of Gc  signals.  This suggests that although in-vivo cytokine production 
can be influenced by circulating Gcs other factors have an effect or, more likely, that they 
are direct outputs of the circadian clock, as some cytokines (TNFα and IL-6) remain 
rhythmic even their absence.  Furthermore, Keller et al. (2009) showed through an array 
study that 8% of the macrophage transcriptome is under circadian control with multiple 
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levels of the inflammatory response.  Genes involved in wound healing, the stress response 
and phagocytosis all exhibit circadian expression.  Also genes, whose protein products act 
in complexes like cFOS and cJUN (AP-1) and CD-180 and MD-1 (TLR4 inhibitory 
molecules) were in-phase with each other, suggesting firm circadian control.  Taken 
together, although circulating factors such as Gcs can, and do affect cytokine production 
and inflammatory cells, cytokines like TNFα and IL-6, as well as other genes involved in 
the inflammatory response could be under direct circadian control, rather than influenced 
by systemic factors. 
 
To address the question set out at the beginning, ‘what is the advantage of this control?’  
One hypothesis may be that at different times of the day an inflammatory response may be 
more harmful (i.e. lethal) than at other times.  Doses of TNFα that are high enough to kill 
mice, are less likely to kill them when administered at the mid to late activity phase 
(subjective night) (Hrushesky et al. 1994), a time when endogenous levels are low.  In the 
Keller et al. (2009) study, the peak TNFα and IL-6 expression occurred during the mid to 
late subjective day (prior to the onset of activity), alongside macrophages and monocytes, 
reaching their maximum number at time that corresponds with a high degree of TNFα 
induced mortality in mice (Hrushesky et al. 1994).  This suggests that if TNFα is induced 
at a time of peak expression this will readily kill the animal.  Evolutionary speaking it will 
be an advantage to the individuals’ survival to be better prepared against bacterial infection 
at certain times of day than others.  For example, it could be a waste of energy to maintain 
a high level of circulating cytokines/chemokines at times of rest and in relative safety, 
whereas when hunting or foraging for food (onset of night for the nocturnal rodent) it is 
very likely that an immune response will be required.  Therefore, to better defend this more 
likely attack, a higher level of circulating cytokines/chemokines would be beneficial to the 
organism, and hence a circadian oscillation is born.  Linking back to the previous point 
(TNFα and IL-6 being highest prior to the onset of activity) this may be in preparation for 
moving out of the relative safety of the nest, a time when the animal could be disorientated 
and susceptible to attack.  Later on during the late night, the animals’ senses should be 
more heightened and is overall more alert to the environment, therefore requiring less 
circulating cytokines.  However, very tight regulation would be required so as to not 
produce too much of a response, resulting in un-necessary death, and so the circadian clock 
has a controlling role.  Furthermore, circadian control of the inflammatory response would 
be beneficial to allow it to keep in phase with the rest of the organ system.  An example 
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here would be to better prepare the body for any ingested pathogens taken in when eating, 
and putting the immune response in phase with the metabolic response would allow this to 
occur, and increase the organisms’ survival rate.   
 
The immune system can directly influence the core clock as well as the clock causing the 
oscillation of cytokine expression, and the relationship is therefore bi-directional.  LPS can 
suppress E-box mediated transcription (Per2, Cry1 and Rev-erbα) via TNFα (Cavadini et 
al. 2007) which is most likely another ‘pro-survival’ mechanism as the loss of Per2 has 
been shown to increase survival after LPS administration (Liu et al. 2006b). However, this 
is opposite to the effects previously described above where TNFα is less likely to kill when 
administered during the late subjective night, when PER2 protein is at it highest.  
Therefore, a lot more work needs to be carried out to further clarify this bi-directional 
relationship between the inflammatory response, the clock and ultimate survival. 
7.5 Caveats and improvements 
 
If I had my time again, and with the benefit of hindsight, I would have approached a 
number of things differently.  Perhaps the first thing to mention is that I would not pursue 
the C/EBPα story, as this turned out to rather a bust line of research, although there is clear 
evidence in the literature that C/EBPα affects the clock, in particular Per2 (Gery et al., 
2005) and the work by MacDougald et al. 1994 quite clearly showed that C/EBPα (both 
transcript and protein) was inhibited after DEX treatment.  So although not pursued 
without good evidence, it was sadly not as fruitful as it could have been.  Most probably I 
would not have worked on the gated inflammatory response either.  Although this work 
produced good results i.e. showing that the gated response of certain cytokines was lost in 
the absence of Rev-erbα, the work contained in Chapter 5 was very time consuming and 
fairly labour intensive (qPCR and repeating the in vivo finding in the PECs).  This meant 
that the time I could commit to my other projects (Chapters 3 and 4) had to be shared, yet 
on reflection it would have been better to concentrate more of my time on the findings and 
progression of Chapter 4, rather than pursuing the work in Chapter 5.  However, most of 
the work in Chapter 4 happened towards the end of my research time, so it is with 
hindsight that I make this statement. 
 
In Chapter 3, with regard to PRC in Fig 3.4, it would have been wise to carry out further 
treatments between the change from delay to advance (CT10-12), perhaps treating the 
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slices every 10 to 20min to better define the cross-over point.  This is not only important in 
its own right, but CT12 (the peak of the PER2::luc rhythm) was the treatment time I chose 
for the rest of the work in that Chapters 3 and 4.  Therefore, without knowing more 
accurately when the delay to advance switch occurred, I could have treated subsequent 
experiments in the delay phase and then next time in the advance phase, thereby altering 
the findings.  Even though this could have been the case I think that the results in Chapters 
3 and 4 were reproducible enough to say that time of the treatments were given in the same 
phase of the PRC, or that perhaps it does not matter what phase the treatment is 
administered.  In Fig 3.7 although Gibbs et al., 2009 showed co-localisation of PER2 and 
CLOCK with CCSP, in order to show that the clock proteins were expressed in the Clara 
cells, there was no co-localisation of GR.  Therefore, it would have been wise for me to 
show GR and MR in the Clara cells, which they appear to be.  In the end of Chapter 3 (Fig 
3.22-3.25) I showed the development of the flow-through system.  Although I do not regret 
pursuing this line of work, it was very time consuming and did not yield the results I had 
hoped for, and because of this I think my time would have been more wisely spent on other 
research i.e. what is contained in the early part Chapter 3 and Chapter 4.  The flow-through 
work needs a PhD all to itself, or someone who can dedicate far more time than I. 
 
One of the major problems (or even hardships) with study in circadian biology is the fact 
that to categorically show that something is circadian it requires experimental setups which 
include multiple time points, and possibly over more than 24h.  This experimental design 
then requires someone to collect samples (mice, cells or tissues) over the 24 to 48h and 
then to analyse the results.  This is often too difficult or impractical i.e. the numbers of 
mice would be too great, and is why two time points are usually used 12h apart (CT0 and 
CT12).  This in itself creates a slight problem with the interpretation of borderline or 
apparent non-circadian results, such as those seen in Fig 4.8a.  In this Figure the 
differential expression of mBMAL1 in the Cav-1 -/- cells was greatly dampened with 
respect to the WT control.  As a result I concluded that the loss of Cav-1 dampened the 
BMAL1 mRNA rhythm.  Indeed this could be the case, and that it is mediated through 
REV-ERB stabilisation (section 4.4.2), yet it could also be true that the two time points I 
chose are 6h out of phase with the peak and trough, and therefore I measured the rising and 
falling portions of the BMAL1 oscillation and measured almost equal quantities.  To 
resolve this issue 4 time points, over 24h, taken every 6h would need to be carried out, then 
it would be obvious to see if the rhythm is dampened or just out of phase. 
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 This same problem occurred with the in vivo LPS challenge in Chapter 5.  In Fig 5.2 and 
5.4 and table 5.1 and 5.2, mice were only injected at two time points (CT0 and CT12) 
although these mice were under a previous LD cycle (12h:12h), it again could have been 
the case where we missed the peak and trough of the rhythm and hit the rising and falling 
arms.  If this happened I could have reported false negative results i.e. cytokines that did 
not appear gated but would have been found to be gated if further time points were carried 
out.  To that end if the work was done again, and the mice were in plentiful supply, then 
CT6 and CT18 should be included too.  This was not and issue with the PEC studies as a 
reference oscillation was used to define the treatments at the peak (CT12 and trough CT0 
of the PER2::luc rhythm).  Furthermore, the mice used for the WT versus Rev-erb -/- 
studies were mixed sex, although for each experiment and equal distribution was used e.g. 
3 males and 4 females for each genotype.  This mix of sexes could have resulted in the 
difference between gating seen in the WT animals i.e. TNFa was not gated in the WT 
males used in Fig 5.2 but was gated in the WT males/females mix in Fig 5.4.  Therefore, if 
carried out again, and with sufficient mice, the work should be carried out with males only 
and then females.  In this case sex differences can be analysed thoroughly.  Also a LPS 
PRC should have been carried out to define the relationship between time and LPS, which 
expands on Fig 5.6.  If this was carried out, parallels and differences could be characterised 
between LPS and CORT in terms of amplitude and cross-over from delay to advance.  
However, this would require a lot of time to complete and therefore was not done in this 
thesis. 
7.6 Future directions 
 
The main work in this thesis has been concerned with Gc and the clock, and in the work in 
Chapter 4 with the immediate re-setting effects.  This work is very promising and should 
be further explored, and to my knowledge no other groups are working on this theme so is, 
as it stands, novel work:   
 
• Even though Cav-1 -/- cells had an effect on the induction of mPer2 and 
disruption of the lipid raft with methyl cyclodextrin inhibited both the acute 
amplitude response and phase change, no defined pathway has been described.  
Therefore, the first experiment would be to grow up some WT-non PER2::luc 
primary lung fibroblasts and treat with either CORT or the GR agonist 67a over a 
4h time course (in line with the rise in luciferase signal Fig 3.18) and Western blot 
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for the phosphorylated forms of GSK3β, MAPKp42/44, PKB and GR, as in 
Matthews et al., 2008, and compare the differences.  The hypothesis would be that 
specific phosphorylation events will be apparent in the CORT treated samples but 
no in the 67a treated samples.  This would then provide a mechanism for the 
differences seen in Fig 3.18.   
 
• The next step is to treat PER2::luc lung slices or PER2::luc primary fibroblasts 
with specific inhibitors (based on the results of the Western blot) in the presence 
or absence of either CORT or 67a.  The hypothesis would be that specific 
inhibitors would disrupt the rapid amplitude rise in the PER2::luc signal after 
CORT, but would not affect the 67a response and give additional weight to the 
Western blot data. 
 
• It may be of interest to characterise if CAV-1 and PER2 co-localise in the 
cytoplasm, like that seen with CAV-1 and GR (Matthews et al., 2008).  This could 
easily be done with co-immuno precipitation, and if CAV-1 and PER2 did co-
localise this could add to a new hypothesis of how PER2 is regulated i.e. in the 
presence of CORT PER2 is sequestered to the Caveolae and subsequently 
stabilised, yet in the presence of the agonist 67a PER2 is not sequestered to the 
membrane Caveolae. 
 
•  Co-immunofluorescence imaging of GR, CAV-1 and PER2 would be useful in 
specific cell types of the lung e.g. Clara cells with CCSP as well as CAV-1 and 
PER2 together in the lung. This would give a good indication as to how this 
interaction formed in vivo and what specific cell types it occurred in. 
 
• Perhaps not of immediate interest but a PRC to the GR agonist 67a would shed 
light on differences in their relative responses.  Is the amplitude of advance and 
delay the same in both cases and does the delay to advance cross-over occur at the 
same time as CORT i.e. CT10-12.     
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Appendix A 
Recording Medium 
 
The base medium: 
 
• 1 pot of DMEM powder with 1000 mg/L glucose and L-glutamine, without sodium 
bicarbonate and phenol red (Sigma, UK). 
• 4g glucose, cell culture grade (Sigma, UK). 
• 4.7ml of 7.5% sodium bicarbonate solution (Sigma, UK) to give a 0.035% final 
concentration. 
• 10ml of 1M HEPES buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
(Sigma, UK), to give a 10mM final concentration. 
• 2.5ml of 10mg/ml streptomycin and 10,000 Units of penicillin to give a final 
concentration of 25µg/ml streptomycin and 25 Units of penicillin. 
 
The above were dissolved and made up to a final volume of 1 litre, in deionised H2O, and 
filter sterilised through a 0.22µm membrane (Fisher, UK).  The medium was stored at 4oC 
and only opened in a sterile environment.  Prior to experimental use working aliquots of 
the medium were made. 
 
The working medium: 
 
• 47.5ml of the base medium was aliquoted in to a sterile tube, wrapped in tin foil to 
avoid light exposure. 
• To that 2.5ml of FBS (Sigma, UK) was added to give a final concentration of 5%.  
(B27 supplement can be used as an alternative (Gibco, Invitrogen, UK)). 
• 50µl of 0.1M Beetle Luciferin K salt (Promega, UK) was added to give a final 
concentration of 0.1mM.   
• The luciferin is light sensitive so prolonged exposure was avoided. 
• The working recording medium was be stored at 4oC for no longer than 4 weeks. 
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Appendix B 
Cell Lysis Buffer 
 
In to a final volume of 500µl of deionised H2O the following was added: 
 
 
Volume (ml 
unless stated) 
or mass (g)  
Reagent Final 
concentratio
n 
Function 
5 Triton X -100 1% Non-ionic detergent to 
stabilise membrane proteins 
15 5M NaCl (sodium 
chloride) 
150mM To lyse the membrane 
5 1M Tris-HCl pH 
7.4 
1M Buffer to maintain pH 
1 0.5M EDTA pH 8 1mM Chelates divalent ions (Ca2+ 
and Mg2+) 
0.19 g EGTA (ethylene 
glycol tetraacetic 
acid 
1mM Chelates specifically Ca2+ 
2.5 NP-40 0.5% Isolates membrane 
complexes 
 
 
When all reagents were in solution the buffer was stored at RT.  Prior to cell lysis a general 
protease inhibitor cocktail (Roche) was added and 0.1M phenylmethanesulfonylfluoride 
(PMSF) (Sigma,UK) was added at a 1 in 500 dilution, as a serine protease inhibitor. 
 
 
Immuno blot buffers.  All reagents are from Sigma, UK unless otherwise stated. 
 
 
Resolving gel - 0.8% bis-acrylamide 
 
11.5ml of deionised H2O; 6ml of 1.5M Tris pH 8.8; 6.4ml of 30% acrylamide ProtoGel 
(National diagnostics); 100µl of 10% amino persulphate (APS) and 10µl of TEMED were 
mixed. 
 
Stacking gel 
 
4ml of deionised H2O; 1.5ml of 0.5M Tris pH 6.8; 1ml of 30% acrylamide ProtoGel, 100µl 
APS and 10µl TEMED were mixed. 
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Tris buffered saline (TBS) and TBS-Tween 20 (TBST) 
 
10 X TBS was made by dissolving the 0.2M Tris and 1.37M) sodium chloride (NaCl) into 
1 litre of H2O.  The buffer was reduced to pH 7.6 with hydrogen chloride (HCl) and stored 
at RT, (all regents Sigma, UK). 
 
To use, the 10 x TBS was diluted to 1 x in deionised H2O and 0.1% Tween20 (Sigma, UK) 
was added and mixed and stored at RT. 
Running buffer 
 
10 X running buffer was made by dissolving 1.92M glycine and 0.25M Tris into 5 litres of 
deionised H2O and to this SDS was added to a final concentration of 0.1% and stored at 
RT. 
 
Transfer buffer 
 
200ml 100% methanol was added to 1 X running buffer and made to 1 litre with deionised 
H2O and stored at 4oC.   
 
Loading Dye 
 
6 x loading dye was prepared using 6% (w/v) SDS, 45mM Tris-HCl pH 6.8, 15% (v/v) β-
mercaptoethanol and 60% (v/v) glycerol.  This was mixed and stored at -20oC until used. 
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GR: HippocampusA B
100µm
MR: HippocampusC D
Appendix C  
Hippocampal expression of GR/MR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C:  The mouse hippocampus was stained with an anti-GR (A and B) and an anti-MR (C 
and D) antibody at 1 in 2500 and 1 in 250 dilution for GR and MR respectively.  The brains were 
fixed in Bouin’s solution and imaged using a x 10 magnification (A and C) and x 40 magnification (B 
and D) of the same sample.  Primary negative samples are not shown due to the image being too 
light to define relevant nuclei.  Scale bar is equivalent to 100µm. 
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Appendix D 
Flow-through culture:  Multiple pulses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D1:  Multiple pulses on the same sample:  Two 60 min pulses with 200nM 
CORT given at the peak (CT12) and mid decline (CT18, A) or trough (CT0, B) shown by 
the arrows, using the PER2::luc lung slice, under a 6.8ml/h constant flow rate.  
Experiments are single slices and n=1. 
 
 
Flow-through culture:  Multiple slices and cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D2:  Multiple lung slices and BMAL1 reporter cells:  Multiple PER2::luc 
lung slices were assayed at the same time (A) or mBMAL1::luc reporter cell line (B), under 
flow-through conditions, using a 6.8ml/h flow rate.  The multiple slices were assayed with 
(black) and without (red) serum. 
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Appendix E 
CLOCK/BMAL E-box induction of C/EBP alpha and delta constructs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix E:  Clock and Bmal1 induced expression of C/EBP alpha and delta 
constructs:   C/EBP alpha 650bp, 1300bp and C/EBP delta 1700bp luciferase constructs 
were induced with empty vector (red), mclock (green), mBmal1 (dark blue) or mClock and 
mBmal1 (light blue) for 24h before analysis.  Error bars are SEM of n=3.  Statistical 
analysis was by One-way ANOVA (P<0.0001) with a Bonferroni post-hoc analysis, * P< 
0.05, **P< 0.01, ***P<0.001 versus empty vector; $ P<0.05 versus Clock + Bmal1; % 
P<0.01 versus Clock + Bmal1.  Work carried out by Dr. Qing-Jun Meng. 
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Appendix G 
CCL5/RANTES - 3000bp 5’ to the ATG 
 
Read as 5’ to 3’ 
 
cacacaaatgaaaataagtaaataaatttgtaaaagatactatgctcacagagttaagagacaatgctgtaatgtcaacaccacagaga
atgaggaagtaaatttaaggtcaactgggtttcagtatgagcaacagaaaagacaaaagacaaggccagtaaaaggtggttcacaatta
aggagtatatatttacttgtgtgtagtctgtctgccttctgctactccatcccagagccttcacaagagttgctggatttctgtagaaacaatgaag
ggtggtggaaagtggtcactcattcagtgaggtctaccactgcaagtcacggccataagctatgtacttcacctctctaagcttgacccaacc
tcctcaaaggctcagactcagaatcctcctgccttagcctcccaagtgggtgtgctagtatacatttgtaaatggacaaggtggatgtggtagt
acacaattgtaaatcccagtatttaggagcaccggcaagaggattgctgtgagtatcgagtccagcctggtccatataacaagttcagtcta
gccatggctacatagaaagaacctgtctgtctcaaaaagaaatctggaaaacaaaaccaaacattgctctttccaatgtctagttttgtctag
attcttatctcttactcacaaaccaatttcagaccctaccccctgactaaattatcactaattctcaattggagatgcatccaatcctttggcgtga
gtgagcccccacccccaccccgtctctaaggagtccctatcctttactatccagttatactaaatagacagtgaaccaaaatgagacacact
acagttggcttccggtcccagtgttttcattcatctgcaatgtgttctgagccagttactcctctctgagcctcactttctccctctgcagcagagaa
agagcactccactgttatgcctgggtagagaaaaaaattagtgaaaaaaaaaataggaaaacttccccgatgccccctaaactttctgtctt
ccatagcctttgtgcacaagactgtagagatgagttggtggatacatttatccactaacgtcatggtgatgtcatggtcatgatgaaaacaag
aagtactccttagaagaatcatcccagctcttattttctgaaggaaaagcctccagtgtccagctgagatgcactgtcctagtcatgggggga
ggggggactcccaccccttcagaacttatcccccctcaggaaatcctctcatacgtaacacttgagatcagactgtgcccaattctatcttggt
gttgtgtaaaacaacagttttacaagttgtgcctttccctgggagactccattgcacaagtagttttaactacattctgaatgcaaacacagag
atggggtgactctgtaccttggtgggcactctgtctggcaccaaccataggcacagatggttaataacttttgtctaaatgtataaaaggatga
catcccaaaaatgtatttaaaaaaaatgaaaaacaaacaggacagacttgggaccatatgagcacatcagtatgtttaaatcatctaaaa
acaaataggtccaagaacttactgaatgcatcagcactctcacctggaccccataaagagaagagctaacatcatgatggtaacagcct
ccaccagcctgtcatctggccacatggtgtgtgtgtcacaggactgacagccagagaattgcagactgtcccaggagttggagcttagatc
cattcccactgtggcacgccttctggaactaccacccgctggcccatccacttggacctgccatccgtttgctttcccattgtctatcttgaccca
gcctcccattcccctccactgcatccatgttctttacattttgctcctatgctgggactagactgtgacgttcagctctgacctgtggccctgaagc
ttgactctggactaggcacctcaacaaagaataaggcggagactgattgaatgctaagcatcctcctgtgcccaccattcacacactgattg
aatgttaggcatcctcctgtgcccaccattcacacacatgcgcacatacacatgcacacacatgcacacacacatgtacacacatgcaca
cacatgcacacacatatgtacacacacatgtacacacacacatgcacacacacatgcacacacacacacacacacacacacacaca
cacacacactttttttaaatctttatttccacagagattctttgtagccctatcagatcccttgactcctagacaaacagacagacagacagaca
ataaatagatattacagatagataatagatggacatagaggacacaactcttttgttcccatcttagttactaatgttaactctcagatcacatgt
cacacactaagtgtaagtatgcctatatctacctagttatctgggaatcaggattacctggcaaattccttacaacaaatctcctataccttgtta
acttattgttatcaatgacacaagtgtggtctgtttctgatatggtatgctcatgacaaatactcttccatggagaaaacagaaagaccaaaat
caagtctgggctacaacttgggaatttgccaagtgaagaccaatggcttgaccttaactgacccctacttgccttaagacaacagctccctg
ctacctggagaggccctgagtgggacggcagatctgagggggagggggagggggaggaagaaattttcccctactgtatttggccaga
gagggagtcatcctggactggagggcagttagaggcagagtcatacttccaagggtgatttcagttttcttttccattttgtgttttcattttatgac
agcaacaagtgtttggtgtcttttgtggaaactccccaagtcctggggctgggggggggcacttcctctgctaccctggctccctataaaagg
tctgcctgagctgcagagcaccc………………………start of transcription 
 
 
• 10 non-canonical E-box motifs (CACATG) that fit the generic description of the E-box 
CANNTG. 
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Appendix H  
CCL5/RANTES expression in murine PECs 
 
Effect of a timed LPS challenge on inflammatory mediator release in isolated mouse PECs 
 
 
 
 
 
Appendix F:  Timed LPS challenge on inflammatory mediator release in isolated 
mouse PECs:  PECs from WT or Rev-erb alpha knock out mice were treated with 
100ng/ml LPS for 4h prior to the quantification of CCL5/RANTES release (A) or WT 
PECs were treated with 100ng/ml LPS with or without 100nM cort prior to 
CCL5/RANTES quantification (B).  Error bars are standard deviation from 3 internal 
replicates of pooled PECS from 3 mixed sex mice (A) or 5 male mice (B), (overall n=1).  
Statistical analysis was by Two-way ANOVA (in A: P<0.0001 for time of treatment and 
P=0.24 for genotype interaction; in B: P=0.026 for time and treatment interaction) with a 
Bonferroni post-hoc analysis, *** P<0.001. 
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Appendix I 
Composition of the peritoneal exudate used for the cellular LPS studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I:  WT and Rev-erb alpha knock out PECs:  Peritoneal cells were isolated 
(section 2.2.6) and cultured from WT (A and B) and Rev-erb alpha knock out (C and D) 
mice and prepared for staining (section 2.2.6.3), representative cells are shown above.  The 
arrows refer to the resident macrophages, evident due to their large cytoplasm surrounding 
the nucleus.  The red arrow points to the other obvious cell type the T-lymphocyte or 
natural killer cell, noted for its large nucleus.  Scale bars is equal to 100µm. 
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Appendix J 
 
mPer2 and mGILZ expression after CORT or GR agonist administration in WT and 
Cav-1 -/- cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix J1:  Per2 and GILZ transcript expression in WT and Cav-1 knock out cells 
after 1h and 2h CORT exposure:  WT or Cav-1 -/- cells were exposed to CORT for 1h 
(A and B) or 2h (C and D) prior to RNA extraction.  Per2 (A and C) or GILZ (B and D) 
transcripts were assayed from the same RNA sample.  Expression is given as fold change 
relative to the lowest value.  Error bars are SEM of n=3.  Statistical analysis was by Two-
way ANOVA (in A: P=0.1 for treatment and P=0.027 for genotype interaction; in B: 
P=0.0006 for treatment and P=0.0004 for genotype interaction; in C: P<0.0027 for both 
treatment and genotype interaction; in D: P<0.0008 for both treatment and genotype 
interaction) with a Bonferroni post-hoc analysis.  With regard to A:  (a) versus (b) P<0.05; 
(a) versus (c) and (b) versus (d) P<0.01; (c) versus (d) n.s.  With regard to B: (f) versus (g) 
P< 0.01; (f) versus (h) P< 0.05; (g) versus (I) P< 0.001; (h) versus (I) n.s.  With regard to 
C: (j) versus (k) and   (k) versus (m) P<0.001; (k) versus (m) and (j) versus (l) n.s.  With 
regard to D:  (n) versus (o) P<0.001; (p) versus (q) P<0.01; (o) versus (q) P< 0.001; (n) 
versus (p) n.s. 
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Appendix J2:  Per2 and GILZ transcript expression in WT and Cav-1 -/- cells after 4h 
cort exposure:  WT or Cav-1 -/- cells were exposed to cort for 4h prior to RNA extraction.  
Per2 (A) or GILZ (B) transcripts were assayed from the same RNA sample.  Expression is 
given as fold change relative to the lowest value.  Error bars are SEM of n=3.  Statistical 
analysis was by Two-way ANOVA (in A and B P<0.005 for both treatment and genotype 
interaction) with a Bonferroni post-hoc analysis   With regard to A: (a) versus (b) and (c) 
versus (d) P< 0.05; (b) versus (d) P< 0.01, (a) versus (c) n.s.  With regard to B: (e) versus 
(f) and (f) versus (h) P<0.001, (g) versus (h) and (e) versus (g) P< 0.01;  
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Appendix J3: Per2 and GILZ transcript expression in WT and Cav-1 -/- cells after GR 
agonist (67a) exposure:  WT or Cav-1 -/- cells were exposed to 67a for 2h or 4h prior to 
RNA extraction.  Per2 2h (A), Per2 4h (B), GILZ 2h (C) or GILZ 4h (D) transcripts were 
assayed from the same RNA sample (with respect to time).  Expression is given as fold 
change relative to the lowest value.  Error bars are SEM of n=3.  Statistical analysis was by 
Two-way ANOVA (in A to D P<0.001 for treatment and genotype interaction) with a 
Bonferroni post-hoc analysis.  With regard to A: (a) versus (b) and (b) versus (d) P<0.001, 
(a) versus (c) and (c) versus (d) n.s.  With regard to B: (j) versus (k) and (k) versus (m) P< 
0.001, (l) versus (m) P< 0.05, (j) versus (l) n.s.  With regard to C: (f) versus (g) P< 0.01, 
(g) versus (i) P< 0.05, (h) versus (i) and (f) versus (h) n.s.  With regard to D: (n) versus (o) 
and (o) versus (q) P< 0.001, (p) versus (q) and (n) versus (p) n.s. 
 
 
 
 
 
 
 
 
 
 
